http://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CliffwaterLlcMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CliffwaterLlcMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NxgenBuyerInc.Memberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NxgenBuyerInc.Memberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NxgenBuyerInc.Memberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NxgenBuyerInc.Memberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProjectKBuyercoIncMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProjectKBuyercoIncMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WharfStreetRatingsAcquisitionLlcMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AcmAsofViiiLclubLlcMemberhttp://stonepoint.com/20241231#ConsumerFinanceMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ExeterShortTermFundingLlcMemberhttp://stonepoint.com/20241231#ConsumerFinanceMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HarborPurchaserIncMemberhttp://stonepoint.com/20241231#DiversifiedConsumerServicesMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HoughtonMifflinHarcourtCoMemberhttp://stonepoint.com/20241231#DiversifiedConsumerServicesMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AdvisorGroupHoldingsIncMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AlpCfo2024L.p.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ChoreoBuyerLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ChoreoBuyerLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EdelmanFinancialCenterMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HbwmIntermediateIiLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HbwmIntermediateIiLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HbwmIntermediateIiLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IvyHillAssetManagementL.p.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#LendingtreeInc.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#LendingtreeInc.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MaiCapitalManagementIntermediateLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MaiCapitalManagementIntermediateLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MaiCapitalManagementIntermediateLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinotaurAcquisitionInc.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinotaurAcquisitionInc.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinotaurAcquisitionInc.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinotaurAcquisitionInc.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NewMountainGuardianIvIncomeRatedFeederIiLtdMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NewMountainGuardianIvRatedFeederIiiLtdMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NewMountainGuardianIvRatedFeederIiiLtdMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NewMountainGuardianIvRatedFeederIiiLtdMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NexusBuyerLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WegSubIntermediateHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AlkemeIntermediaryHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AlkemeIntermediaryHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ApHighlandsHoldingsL.p.Memberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ApHighlandsCoInvestL.p.Memberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArdenInsuranceServicesLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArdenInsuranceServicesLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArdonaghFincoB.v.Memberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArmstrongReceivableManagementMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArmstrongReceivableManagementMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArmstrongReceivableManagementMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BabylonBuyerIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BabylonBuyerIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CaptiveResourcesMidcoLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CaptiveResourcesMidcoLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EuclidTransactionalLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OnedigitalBorrowerLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ThgAcquisitionLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ThgAcquisitionLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ThgAcquisitionLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WorldwideInsuranceNetworkLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WorldwideInsuranceNetworkLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AuctaneHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AuctaneHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BottomlineTechnologiesIncMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BottomlineTechnologiesIncMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DcertBuyerIncMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DsAdmiralBidcoLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EvergreenServicesGroupPikHoldcoLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EvergreenServicesGroupPikHoldcoLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HelpsystemsHoldingsIncMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#LytxIncMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinistryBrandsHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinistryBrandsHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinistryBrandsHoldingsLlcMemberhttp://fasb.org/us-gaap/2024#TransportationSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AlkuIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AlkuIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AprioAdvisoryGroupLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AprioAdvisoryGroupLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AprioAdvisoryGroupLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BakerTillyAdvisoryGroupL.p.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BakerTillyAdvisoryGroupL.p.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BakerTillyAdvisoryGroupL.p.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BdoUsaP.c.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CherryBekaertAdvisoryLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CherryBekaertAdvisoryLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ExplorerInvestorIncMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IgInvestmentsHoldingsLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IgInvestmentsHoldingsLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#KrivAcquisitionInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#KrivAcquisitionInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#KrivAcquisitionInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MboPartnersInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MboPartnersInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OmniaPartnersLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PasParentInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PasParentInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PasParentInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PasParentInc.Memberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#People2.0IncMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PetraBorrowerLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PetraBorrowerLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PetraBorrowerLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MoreCowbellIiLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MoreCowbellIiLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MoreCowbellIiLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WilliamsMartsonLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WilliamsMartsonLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WilliamsMartsonLlcMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccuserveSolutionsIncMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccuserveSolutionsIncMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccuserveSolutionsIncMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FreedomMortgageCorpMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GuardianRestorationPartnersBuyersLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GuardianRestorationPartnersBuyersLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GuardianRestorationPartnersBuyersLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SouthpawApBuyerLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SouthpawApBuyerLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SouthpawApBuyerLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TitanHomeImprovementLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TitanHomeImprovementLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TitanHomeImprovementLlcMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AnaplanIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AnaplanIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EclipseBuyerInc.Membertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EclipseBuyerInc.Membertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EclipseBuyerInc.Membertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GovdeliveryHoldingsLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GovdeliveryHoldingsLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GovdeliveryHoldingsLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GsAcquisitioncoIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GsAcquisitioncoIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GsAcquisitioncoIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HylandSoftwareInc.Membertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HylandSoftwareInc.Membertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MandolinTechnologyIntermediateHoldingsIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Maverick1LlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OnezeroFinancialSystemsLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OnezeroFinancialSystemsLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OnezeroFinancialSystemsLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OrionAdvisorSolutionsIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OrionAdvisorSolutionsIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SimplifiHoldingsIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SimplifiHoldingsIncMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SyntaxSystemsLimitedMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SyntaxSystemsLimitedMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TamarackIntermediateLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TamarackIntermediateLlcMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://stonepoint.com/20241231#HealthCareProvidersServicesMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProjectKBuyercoIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProjectKBuyercoIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ProjectKBuyercoIncMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ResoluteInvestmentManagersIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HarborPurchaserIncMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#ConsumerSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AdvisorGroupHoldingsIncMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#USfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BeaconPointeHarmonyLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CliffwaterLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CliffwaterLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EdelmanFinancialCenterMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GcTwoIntermediateHoldingsIncMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#USfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IvyHillAssetManagementL.p.Memberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#USfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MillenniumTrustCo.LlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MoreCowbellILlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MoreCowbellILlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MoreCowbellILlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PetraBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PetraBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PetraBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TaWegIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://stonepoint.com/20241231#FinthriveSoftwareIntermediateHoldingsIncMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#GraphpadSofwareLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#GraphpadSofwareLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#GraphpadSofwareLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#GraphpadSofwareLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#GraphpadSofwareLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#ImagineAcquisitioncoLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://stonepoint.com/20241231#ImagineAcquisitioncoLlcMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccuserveMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccuserveMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeGroupLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeGroupLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AmerilifeGroupLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArmstrongReceivableManagementMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArmstrongReceivableManagementMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ArmstrongReceivableManagementMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CaptiveResourcesMidcoLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CaptiveResourcesMidcoLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EuclidTransactionalLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FoundationRiskPartnersCorpMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HarringtonReinsureanceHoldingsLimitedMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NeptuneFloodIncorporatedMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NeptuneFloodIncorporatedMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NfpCorpMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OnedigitalBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OnedigitalBorrowerLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscAcquisitionIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AuctaneHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AuctaneHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BottomlineTechnologiesIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BottomlineTechnologiesIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DcertBuyerIncMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EnsonoIncMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HelpsystemsHoldingsIncMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinistryBrandsPurchaserLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinistryBrandsPurchaserLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MinistryBrandsPurchaserLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NeptuneBidcoUsIncMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#VisionSolutionsIncMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WwexUniTopcoHoldingsLlcMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#TechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AccordionPartnersLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AlkuIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CherryBekaertAdvisoryLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CherryBekaertAdvisoryLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ExplorerInvestorIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GeosyntecConsultantsIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GeosyntecConsultantsIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GeosyntecConsultantsIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IgInvestmentsHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IgInvestmentsHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#IgInvestmentsHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MboPartnersInc.Memberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MboPartnersInc.Memberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#PasParentInc.Memberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MboPartnersIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#People2.0IncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WilliamsMartsonLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WilliamsMartsonLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#WilliamsMartsonLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#ProfessionalServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HoldcoIncTwoTenMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HoldcoIncTwoTenMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#RealEstateSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AnaplanIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#AnaplanIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#DiligentCorporationMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GovdeliveryHoldingsLlcMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GovdeliveryHoldingsLlcMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GovdeliveryHoldingsLlcMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GsAcquisitioncoIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HylandSoftwareInc.Memberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#HylandSoftwareInc.Memberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MandolinTechnologyIntermediateHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Maverick1LlcMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#OrionAdvisorSolutionsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SimplifiHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SimplifiHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SyntaxSystemsLimitedMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SyntaxSystemsLimitedMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TamarackIntermediateLlcMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TamarackIntermediateLlcMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ImagineAcquisitioncoLlcMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GtPolarisHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GalwayBorrowerLlcMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#RscTopcoIncMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GtPolarisHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EquitySecuritiesOtherThanWarrantsMemberhttp://stonepoint.com/20241231#SpiritRrHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ResoluteInvestmentManagersIncMemberhttp://stonepoint.com/20241231#CapitalMarketSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#WarrantMemberhttp://stonepoint.com/20241231#GivingHomeHealthCareMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMembertruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#ThlFundIxInvestorsPlymouthL.p.Memberhttp://fasb.org/us-gaap/2024#FinancialServicesSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SpiritRrHoldingsIncMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GivingHomeHealthCareMemberhttp://stonepoint.com/20241231#HealthCareProvidersServicesMemberhttp://xbrl.sec.gov/country/2024#UStrue0001825384--12-312024FYfalsehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CnsiHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CnsiHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CoraHealthHoldingsCorpMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#CoraHealthHoldingsCorpMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GivingHomeHealthCareMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GivingHomeHealthCareMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#GivingHomeHealthCareMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#KwolAcquisitionInc.Memberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#KwolAcquisitionInc.Memberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MirraPrimeaccessHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#MirraPrimeaccessHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NextgenHelathcareMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NextgenHelathcareMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#NextgenHelathcareMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SpecialtycareIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SpecialtycareIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SpecialtycareIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TrinityPartnersHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TrinityPartnersHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TstIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#TstIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#HealthcareSectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EllkayLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#EllkayLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://stonepoint.com/20241231#HealthCareTechnologySectorMemberhttp://xbrl.sec.gov/country/2024#UStruehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://fasb.org/us-gaap/2024#InvestmentUnaffiliatedIssuerMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#AcentraHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#AcentraHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#AcentraHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#AcentraHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ActionBehaviorCentersTherapyLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ActionBehaviorCentersTherapyLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ActionBehaviorCentersTherapyLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#BelmontBuyerIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ChartisGroupLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ChartisGroupLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ChartisGroupLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ContinentalBuyerInc.Memberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ContinentalBuyerInc.Memberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ContinentalBuyerInc.Memberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#CoraHealthHoldingsCorpMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#CoraHealthHoldingsCorpMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#CovetrusInc.Memberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#KwolAcquisitionInc.Memberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#KwolAcquisitionInc.Memberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#GivingHomeHealthCareMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#Mb2DentalSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#MirraPrimeaccessHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#MirraPrimeaccessHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#NextgenHelathcareMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#NextgenHelathcareMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#NextgenHelathcareMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#OneCallCorp.Memberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ProjectRubyUltimateParentCorpMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SpecialtycareIncMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SpecialtycareIncMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SpecialtycareIncMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SteppingStonesHealthcareServicesLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#TrinityPartnersHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#TrinityPartnersHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#TstIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#TstIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#TstIntermediateHoldingsLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#VitalCareBuyerLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#VitalCareBuyerLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#EllkayLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#EllkayLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#HomecareSoftwareSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#HomecareSoftwareSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#HomecareSoftwareSolutionsLlcMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ImagineAcquisitioncoLlcMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#ImagineAcquisitioncoLlcMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://xbrl.sec.gov/country/2024#UShttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#UnsecuredNoteMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://fasb.org/us-gaap/2024#InsuranceSectorMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://fasb.org/us-gaap/2024#EquitySecuritiesMemberhttp://fasb.org/us-gaap/2024#EquitySecuritiesMemberhttp://fasb.org/us-gaap/2024#EquitySecuritiesMemberhttp://fasb.org/us-gaap/2024#EquitySecuritiesMemberhttp://fasb.org/us-gaap/2024#EquitySecuritiesMember1500000http://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienDelayedDrawTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#SecondLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienTermLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#FirstLienRevolvingLoanMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://stonepoint.com/20241231#SoftwareSectorMemberhttp://xbrl.sec.gov/country/2024#UShttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#PreferredEquityMemberhttp://stonepoint.com/20241231#CommonEquityAndWarrantsMemberhttp://stonepoint.com/20241231#CommonEquityAndWarrantsMemberhttp://stonepoint.com/20241231#CommonEquityAndWarrantsMemberhttp://fasb.org/us-gaap/2024#WarrantMemberhttp://fasb.org/us-gaap/2024#BaseRateMemberhttp://fasb.org/us-gaap/2024#EurodollarMemberhttp://fasb.org/us-gaap/2024#EurodollarMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberP10Dhttp://fasb.org/us-gaap/2024#DebtAndEquitySecuritiesRealizedGainLosshttp://fasb.org/us-gaap/2024#UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionPriceChangeOperatingBeforeTax0001825384us-gaap:CommonStockMember2024-07-022024-07-020001825384us-gaap:CommonStockMember2024-04-022024-04-020001825384us-gaap:CommonStockMember2024-03-282024-03-280001825384us-gaap:CommonStockMember2023-12-282023-12-280001825384us-gaap:CommonStockMember2023-09-292023-09-290001825384us-gaap:CommonStockMember2023-06-282023-06-280001825384us-gaap:CommonStockMember2023-04-032023-04-030001825384us-gaap:CommonStockMember2023-03-292023-03-290001825384us-gaap:CommonStockMember2022-12-302022-12-300001825384us-gaap:CommonStockMember2022-09-282022-09-280001825384us-gaap:CommonStockMember2022-06-292022-06-290001825384us-gaap:CommonStockMember2022-03-292022-03-290001825384us-gaap:CommonStockMember2022-03-252022-03-250001825384us-gaap:CommonStockMember2024-12-312024-12-310001825384us-gaap:CommonStockMember2024-12-302024-12-300001825384us-gaap:CommonStockMember2024-09-272024-09-270001825384us-gaap:CommonStockMember2024-06-282024-06-280001825384us-gaap:CommonStockMember2024-03-262024-03-260001825384us-gaap:CommonStockMember2023-12-262023-12-260001825384us-gaap:CommonStockMember2023-09-272023-09-270001825384us-gaap:CommonStockMember2023-06-262023-06-260001825384us-gaap:CommonStockMember2023-03-272023-03-270001825384us-gaap:CommonStockMember2022-12-272022-12-270001825384us-gaap:CommonStockMember2022-09-262022-09-260001825384us-gaap:CommonStockMember2022-06-272022-06-270001825384us-gaap:CommonStockMember2022-03-242022-03-240001825384none:TwoThousandTwentyFiveNotesMember2022-08-182022-08-180001825384none:TwoThousandTwentyFiveNotesMember2022-05-192022-05-190001825384none:SubAdministrationAgreementMember2024-01-012024-12-310001825384none:SubAdministrationAgreementMember2023-01-012023-12-310001825384none:SubAdministrationAgreementMember2022-01-012022-12-3100018253842020-09-070001825384none:InvestmentAdvisoryAgreementMember2024-12-310001825384none:InvestmentAdvisoryAgreementMember2023-12-310001825384none:InvestmentAdvisoryAgreementMember2023-01-012023-12-310001825384none:InvestmentAdvisoryAgreementMember2022-01-012022-12-310001825384none:ScenarioTwoMemberus-gaap:RevolvingCreditFacilityMember2021-06-282021-06-280001825384none:ScenarioThreeMemberus-gaap:RevolvingCreditFacilityMember2021-06-282021-06-280001825384none:ScenarioOneMemberus-gaap:RevolvingCreditFacilityMember2021-06-282021-06-280001825384none:CapitalCallFacilityMembernone:LetterAgreementForFourthAmendmentMember2024-12-270001825384none:CapitalCallFacilityMembernone:LetterAgreementForThirdAmendmentMember2023-12-220001825384none:AssetBasedRevolvingLoanFacilityTwoMember2023-08-140001825384none:AssetBasedRevolvingLoanFacilityOneMember2023-08-140001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForThirdAmendmentMember2023-06-300001825384none:CapitalCallFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-12-270001825384none:CapitalCallFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-12-260001825384none:CertainCircumstancesToIncreaseSizeOfCreditFacilityMemberus-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-01-280001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-01-280001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-01-280001825384none:CertainCircumstancesToIncreaseSizeOfCreditFacilityMemberus-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForAmendmentMember2021-10-150001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForAmendmentMember2021-10-150001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForAmendmentMember2021-06-280001825384us-gaap:SecuredDebtMember2023-08-140001825384us-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:EquitySecuritiesMember2024-12-310001825384none:PreferredEquitySecuritiesMember2024-12-310001825384none:DebtInvestmentsMember2024-12-310001825384us-gaap:WarrantMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputEbitdaMultipleMembernone:ValuationTechniqueEnterpriseValueAnalysisMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputRecoveryRateMembernone:ValuationRecoveryAnalysisMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityMemberus-gaap:MeasurementInputEbitdaMultipleMembernone:ValuationTechniqueEnterpriseValueAnalysisMember2024-12-310001825384us-gaap:HealthcareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:EquitySecuritiesOtherThanWarrantsMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsExcludingInvestmentsMeasuredAtNVMember2024-12-310001825384us-gaap:FairValueInputsLevel2Membernone:UnsecuredNoteMember2024-12-310001825384us-gaap:FairValueInputsLevel2Membernone:SecondLienLoansMember2024-12-310001825384us-gaap:FairValueInputsLevel2Membernone:FirstLienLoansMember2024-12-310001825384us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2024-12-310001825384us-gaap:FairValueInputsLevel2Member2024-12-310001825384us-gaap:FairValueInputsLevel12And3Member2024-12-310001825384none:CommonEquityAndWarrantsExcludingInvestmentsMeasuredAtNVMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputEbitdaMultipleMembernone:ValuationTechniqueEnterpriseValueAnalysisMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384us-gaap:HealthcareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMemberus-gaap:WarrantMember2023-12-310001825384us-gaap:FairValueInputsLevel2Membernone:UnsecuredNoteMember2023-12-310001825384us-gaap:FairValueInputsLevel2Membernone:SecondLienLoansMember2023-12-310001825384us-gaap:FairValueInputsLevel2Membernone:FirstLienLoansMember2023-12-310001825384us-gaap:FairValueInputsLevel2Member2023-12-310001825384us-gaap:TechnologySectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384us-gaap:RealEstateSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:EquitySecuritiesOtherThanWarrantsMember2024-12-310001825384us-gaap:RealEstateSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384us-gaap:InsuranceSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2024-12-310001825384us-gaap:InsuranceSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384us-gaap:HealthcareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384us-gaap:FinancialServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384none:SoftwareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:EquitySecuritiesOtherThanWarrantsMember2024-12-310001825384none:SoftwareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384none:ProfessionalServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:EquitySecuritiesOtherThanWarrantsMember2024-12-310001825384none:ProfessionalServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384none:HealthCareTechnologySectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384none:CapitalMarketSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:EquitySecuritiesOtherThanWarrantsMember2024-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2024-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:CommonEquityAndWarrantsMember2024-12-310001825384none:UnsecuredNoteMember2024-12-310001825384none:SecondLienLoansMember2024-12-310001825384none:PreferredEquityMember2024-12-310001825384none:FirstLienLoansMember2024-12-310001825384none:CommonEquityAndWarrantsMember2024-12-310001825384none_cnst_string_TaWegIntermediateHoldingsLlcUnsecuredNoteDue52620332024-12-310001825384us-gaap:InsuranceSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2023-12-310001825384us-gaap:HealthcareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:FinancialServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:FinancialServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:CommonEquityAndWarrantsMember2023-12-310001825384us-gaap:ConsumerSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384none:SoftwareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2023-12-310001825384none:SoftwareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384none:SoftwareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:CommonEquityAndWarrantsMember2023-12-310001825384none:HealthCareTechnologySectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2023-12-310001825384none:HealthCareTechnologySectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384none:CapitalMarketSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:CommonEquityAndWarrantsMember2023-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMember2023-12-310001825384none:UnsecuredNoteMember2023-12-310001825384none:SecondLienLoansMember2023-12-310001825384none:PreferredEquityMember2023-12-310001825384none:FirstLienLoansMember2023-12-310001825384none:CommonEquityAndWarrantsMember2023-12-310001825384Worldwide Insurance Network, LLC, First Lien Term Loan, Due 5/28/20302024-01-012024-12-310001825384Worldwide Insurance Network, LLC, First Lien Delayed Draw Term Loan, Due 5/28/20302024-01-012024-12-310001825384Williams Martson, LLC, First Lien Term Loan, Due 8/25/20282024-01-012024-12-310001825384Williams Martson, LLC, First Lien Revolving Loan, Due 8/25/20282024-01-012024-12-310001825384Williams Marston, LLC, First Lien Delayed Draw Term Loan, Due 8/25/20252024-01-012024-12-310001825384Wharf Street Ratings Acquisition LLC, Unsecured Note, Due 12/8/20282024-01-012024-12-310001825384Vital Care Buyer LLC, First Lien Term Loan Due 7/30/20312024-01-012024-12-310001825384Vital Care Buyer LLC, First Lien Revolving Loan Due 7/30/20312024-01-012024-12-310001825384TST Intermediate Holdings, LLC, First Lien Term Loan, 12/31/20282024-01-012024-12-310001825384TST Intermediate Holdings, LLC, First Lien Revolving Loan, 12/31/20282024-01-012024-12-310001825384TST Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, 12/31/20282024-01-012024-12-310001825384Trinity Partners Holdings LLC, First Lien Term Loan, Due 12/21/20282024-01-012024-12-310001825384Trinity Partners Holdings Llc First Lien Delayed Draw Term Loan Due 06/21/20252024-01-012024-12-310001825384Titan Home Improvement, LLC, First Lien Term Loan, Due 5/31/20302024-01-012024-12-310001825384Titan Home Improvement, LLC, First Lien Revolving Loan, Due 5/31/20302024-01-012024-12-310001825384Titan Home Improvement, LLC, First Lien Delayed Draw Term Loan, Due 6/2/20262024-01-012024-12-310001825384THG Acquisition, LLC, First Lien Term Loan, Due 10/31/20312024-01-012024-12-310001825384THG Acquisition, LLC, First Lien Revolving Loan, Due 10/31/20312024-01-012024-12-310001825384THG Acquisition, LLC, First Lien Delayed Draw Term Loan, Due 10/31/20262024-01-012024-12-310001825384Tamarack Intermediate, L.L.C., First Lien Term Loan, Due 3/13/20282024-01-012024-12-310001825384Tamarack Intermediate, L.L.C., First Lien Revolving Loan, Due 3/13/20282024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, Unsecured Note, Due 5/26/20332024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, Two, Due 10/4/20272024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, One, Due 10/4/20272024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Two, Due 10/4/20272024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Three, Due 10/4/20272024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, One, Due 10/4/20272024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Four, Due 10/4/20272024-01-012024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Five, Due 10/4/20272024-01-012024-12-310001825384Syntax Systems Limited, First Lien Term Loan, One, Due 10/30/20282024-01-012024-12-310001825384Syntax Systems Limited, First Lien Term Loan, Due 10/30/20282024-01-012024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Term Loan, Due 1/2/20292024-01-012024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Revolving Loan, Due 12/29/20262024-01-012024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Delayed Draw Term Loan, Two, Due 1/2/20292024-01-012024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Delayed Draw Term Loan, One, Due 1/2/20292024-01-012024-12-310001825384SpecialtyCare, Inc, First Lien Term Loan, Due 6/19/20282024-01-012024-12-310001825384SpecialtyCare, Inc, First Lien Revolving Loan, Due 6/18/20262024-01-012024-12-310001825384SpecialtyCare, Inc, First Lien Delayed Draw Term Loan, Due 6/19/20282024-01-012024-12-310001825384Southpaw AP Buyer, LLC, First Lien Term Loan, Due 3/2/20282024-01-012024-12-310001825384Southpaw AP Buyer, LLC, First Lien Revolving Loan, Due 3/2/20282024-01-012024-12-310001825384Southpaw AP Buyer, LLC, First Lien Delayed Draw Term Loan, Due 3/2/20282024-01-012024-12-310001825384Simplifi Holdings, Inc., First Lien Term Loan, Due 10/1/20272024-01-012024-12-310001825384Simplifi Holdings, Inc., First Lien Revolving Loan, Due 10/1/20272024-01-012024-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Two Due 10/30/20292024-01-012024-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Three Due 10/30/20292024-01-012024-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, One Due 10/30/20292024-01-012024-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Two Due 10/30/20292024-01-012024-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, One Due 10/30/20292024-01-012024-12-310001825384Project Ruby Ultimate Parent Corp Second Lien Term Loan Due 3/12/20292024-01-012024-12-310001825384Project K BuyerCo, Inc, First Lien Term Loan, Due 12/10/20272024-01-012024-12-310001825384Project K BuyerCo, Inc, First Lien Revolving Loan, Due 12/10/20272024-01-012024-12-310001825384Petra Borrower, LLC, First Lien Term Loan, Due 11/15/20302024-01-012024-12-310001825384Petra Borrower, LLC, First Lien Revolving Loan, Due 11/15/20292024-01-012024-12-310001825384Petra Borrower, LLC, First Lien Delayed Draw Term Loan, Due 11/15/20302024-01-012024-12-310001825384People 2.0, Inc, First Lien Term Loan, Due 7/12/20282024-01-012024-12-310001825384PAS Parent Inc., First Lien Term Loan, Due 12/29/20282024-01-012024-12-310001825384PAS Parent Inc., First Lien Revolving Loan, Due 12/30/20272024-01-012024-12-310001825384PAS Parent Inc., First Lien Delayed Draw Term Loan, Due 6/26/20262024-01-012024-12-310001825384PAS Parent Inc., First Lien Delayed Draw Term Loan, Due 12/29/20282024-01-012024-12-310001825384Orion Advisor Solutions Inc., Second Lien Term Loan, Due 9/24/20282024-01-012024-12-310001825384Orion Advisor Solutions Inc., Second Lien Delayed Draw Term Loan, Due 9/24/20282024-01-012024-12-310001825384oneZero Financial Systems, LLC, First Lien Term Loan, Due 10/7/20312024-01-012024-12-310001825384oneZero Financial Systems, LLC, First Lien Revolving Loan, Due 10/7/20312024-01-012024-12-310001825384oneZero Financial Systems, LLC, First Lien Delayed Draw Term Loan, Due 10/7/20262024-01-012024-12-310001825384OneDigital Borrower LLC, Second Lien Term Loan, Due 7/2/20322024-01-012024-12-310001825384One Call Corp First Lien Term Loan Due 4/22/20272024-01-012024-12-310001825384OMNIA Partners LLC, Second Lien Term Loan, Due 5/31/20322024-01-012024-12-310001825384NXGen Buyer, Inc. Second Lien Term Loan, 4/28/20282024-01-012024-12-310001825384NXGen Buyer, Inc. Second Lien Term Loan Two, 4/28/20282024-01-012024-12-310001825384NXGen Buyer, Inc. First Lien Term Loan, 10/29/20272024-01-012024-12-310001825384NXGen Buyer, Inc. First Lien Revolving Loan, 10/29/20272024-01-012024-12-310001825384Nexus Buyer LLC, Second Lien Term Loan, 11/5/20292024-01-012024-12-310001825384NextGen Healthcare, First Lien Term Loan, Due 11/11/20302024-01-012024-12-310001825384NextGen Healthcare, First Lien Revolving Loan, Due 11/9/20292024-01-012024-12-310001825384NextGen Healthcare, First Lien Delayed Draw Term Loan, Due 11/10/20252024-01-012024-12-310001825384New Mountain Guardian IV Rated Feeder III, Ltd., Unsecured Note, Six, Due 8/28/20372024-01-012024-12-310001825384New Mountain Guardian IV Rated Feeder III, Ltd., Unsecured Note, Four, Due 8/28/20372024-01-012024-12-310001825384New Mountain Guardian IV Rated Feeder III, Ltd., Unsecured Note, Five, Due 8/28/20372024-01-012024-12-310001825384New Mountain Guardian IV Income Rated Feeder II, Ltd. Unsecured Note, Due 4/3/20372024-01-012024-12-310001825384More Cowbell II LLC, First Lien Term Loan, Due 9/2/20302024-01-012024-12-310001825384More Cowbell II LLC, First Lien Revolving Loan, Due 9/3/20292024-01-012024-12-310001825384More Cowbell II LLC, First Lien Delayed Draw Term Loan, Due 9/1/20252024-01-012024-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Term Loan, Due 7/29/20262024-01-012024-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Revolving Loan, Due 7/29/20262024-01-012024-12-310001825384Minotaur Acquisition, Inc., First Lien Delayed Draw Term Loan, Due 5/10/20302024-01-012024-12-310001825384Minotaur Acquisition, Inc. Minotaur Acquisition, Inc, Due 5/10/20302024-01-012024-12-310001825384Minotaur Acquisition, Inc. First Lien Term Loan, Due 5/10/20302024-01-012024-12-310001825384Minotaur Acquisition, Inc. First Lien Delayed Draw Term Loan, One, Due 5/11/20262024-01-012024-12-310001825384Ministry Brands Holdings, LLC, First Lien Term Loan, Due 12/28/20282024-01-012024-12-310001825384Ministry Brands Holdings, LLC, First Lien Revolving Loan, Due 12/30/20272024-01-012024-12-310001825384Ministry Brands Holdings, LLC, First Lien Delayed Draw Term Loan, Due 12/28/20282024-01-012024-12-310001825384MBO Partners, Inc, First Lien Term Loan, Due 5/23/20282024-01-012024-12-310001825384MBO Partners, Inc, First Lien Delayed Draw Term Loan, Due 5/23/20282024-01-012024-12-310001825384MB2 Dental Solutions, LLC, First Lien Term Loan, One, Due 1/29/20272024-01-012024-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Two, Due 2/13/20312024-01-012024-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Three, Due 1/29/20272024-01-012024-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, One, Due 2/13/20312024-01-012024-12-310001825384Maverick 1 LLC, Second Lien Term Loan, Due 5/18/20292024-01-012024-12-310001825384Mandolin Technology Intermediate Holdings, Inc., Second Lien Term Loan, Due 7/30/20292024-01-012024-12-310001825384MAI Capital Management Intermediate LLC, First Lien Term Loan, 8/29/20312024-01-012024-12-310001825384MAI Capital Management Intermediate LLC, First Lien Revolving Loan, 8/29/20312024-01-012024-12-310001825384MAI Capital Management Intermediate LLC, First Lien Delayed Draw Term Loan, 8/29/20312024-01-012024-12-310001825384Lytx, Inc., First Lien Term Loan, Due 2/28/20282024-01-012024-12-310001825384LendingTree, Inc.., First Lien Term Loan, Due 3/27/20312024-01-012024-12-310001825384LendingTree, Inc., First Lien Delayed Draw Term Loan, Due 3/27/20252024-01-012024-12-310001825384KRIV Acquisition Inc., First Lien Term Loan, Due 7/6/20292024-01-012024-12-310001825384KRIV Acquisition Inc., First Lien Delayed Draw Term Loan, Due 9/25/20262024-01-012024-12-310001825384KRIV Acquisition Inc., First Lien Delayed Draw Term Loan, Due 7/6/20292024-01-012024-12-310001825384Ivy Hill Asset Management, L.P., Unsecured Note, Due 6/29/20282024-01-012024-12-310001825384Imagine Acquisitionco, LLC, First Lien Term Loan, Due 11/16/20272024-01-012024-12-310001825384Imagine Acquisitionco, LLC, First Lien Delayed Draw Term Loan, Due 11/16/20272024-01-012024-12-310001825384IG Investments Holdings, LLC, First Lien Term Loan, Two, Due 9/22/20282024-01-012024-12-310001825384IG Investments Holdings, LLC, First Lien Revolving Loan, Two, 9/22/20282024-01-012024-12-310001825384Hyland Software, Inc, First Lien Term Loan, Due 9/19/20302024-01-012024-12-310001825384Hyland Software, Inc, First Lien Revolving Loan, Due 9/19/20292024-01-012024-12-310001825384Houghton Mifflin Harcourt Co, First Lien Term Loan, 4/9/20292024-01-012024-12-310001825384Homecare Software Solutions LLC, First Lien Delayed Draw Term Loan, Due 6/16/20312024-01-012024-12-310001825384Helpsystems Holdings, Inc., Second Lien Term Loan, Due 11/19/20272024-01-012024-12-310001825384HBWM Intermediate II, LLC, First Lien Term Loan, 11/17/20312024-01-012024-12-310001825384HBWM Intermediate II, LLC, First Lien Revolving Loan, 8/18/20312024-01-012024-12-310001825384HBWM Intermediate II, LLC, First Lien Delayed Draw Term Loan, 11/16/20262024-01-012024-12-310001825384Harbor Purchaser Inc, Second Lien Term Loan, Due 4/8/20302024-01-012024-12-310001825384Guardian Restoration Partners Buyers, LLC, First Lien Term Loan, Due 11/3/20312024-01-012024-12-310001825384Guardian Restoration Partners Buyers, LLC, First Lien Revolving Loan, Due 11/3/20312024-01-012024-12-310001825384Guardian Restoration Partners Buyers, LLC, First Lien Delayed Draw Term Loan, Due 11/3/20312024-01-012024-12-310001825384GS Acquisitionco, Inc., First Lien Term Loan, 5/25/20282024-01-012024-12-310001825384GS Acquisitionco, Inc., First Lien Revolving Loan, 5/25/20282024-01-012024-12-310001825384GS Acquisitionco, Inc., First Lien Delayed Draw Term Loan, 5/25/20282024-01-012024-12-310001825384GraphPAD Software, LLC, First Lien Term Loan, One, Due 4/27/20272024-01-012024-12-310001825384GovDelivery Holdings LLC, First Lien Term Loan, Due 1/17/20312024-01-012024-12-310001825384GovDelivery Holdings LLC, First Lien Revolving Loan, Due 1/17/20312024-01-012024-12-310001825384GovDelivery Holdings LLC, First Lien Delayed Draw Term Loan, Due 1/17/20312024-01-012024-12-310001825384Giving Home Health Care, Second Lien Term Loan, Due 2/18/20282024-01-012024-12-310001825384Giving Home Health Care, First Lien Term Loan, Due 8/19/2072024-01-012024-12-310001825384Giving Home Health Care, First Lien Revolving Loan, Due 8/19/20272024-01-012024-12-310001825384Galway Borrower LLC, First Lien Term Loan, Due 9/29/20282024-01-012024-12-310001825384Galway Borrower LLC, First Lien Revolving Loan, Due 10/2/20282024-01-012024-12-310001825384Galway Borrower LLC, First Lien Delayed Draw Term Loan, Two Due 9/29/20282024-01-012024-12-310001825384Galway Borrower LLC, First Lien Delayed Draw Term Loan, Due 9/29/20282024-01-012024-12-310001825384Freedom Mortgage Corp, Unsecured Note, Due 10/1/20302024-01-012024-12-310001825384Foundation Risk Partners, Corp., First Lien Term Loan, Two Due 10/29/20302024-01-012024-12-310001825384Foundation Risk Partners, Corp., First Lien Term Loan, One Due 10/29/20302024-01-012024-12-310001825384Foundation Risk Partners, Corp., First Lien Revolving Loan, Due 10/29/20292024-01-012024-12-310001825384Foundation Risk Partners, Corp., First Lien Delayed Draw Term Loan, Two Due 10/29/20302024-01-012024-12-310001825384Foundation Risk Partners, Corp., First Lien Delayed Draw Term Loan, Three Due 10/29/20302024-01-012024-12-310001825384Foundation Risk Partners, Corp., First Lien Delayed Draw Term Loan, One Due 10/29/20302024-01-012024-12-310001825384FINThrive Software Intermediate Holdings, Inc, Second Lien Term Loan, Due, 12/17/20292024-01-012024-12-310001825384Explorer Investor, Inc, First Lien Term Loan, Due 6/28/20292024-01-012024-12-310001825384Exeter Short Term Funding LLC, First Lien Revolving Loan, 2/9/20262024-01-012024-12-310001825384Evergreen Services Group PIK Holdco, LLC, Unsecured Note, Due 4/7/20312024-01-012024-12-310001825384Evergreen Services Group PIK Holdco, LLC, Unsecured Note, Due 4/7/20252024-01-012024-12-310001825384Euclid Transactional, LLC, First Lien Term Loan, Due 10/2/20282024-01-012024-12-310001825384Ellkay, LLC, First Lien Term Loan, Due 9/14/20272024-01-012024-12-310001825384Ellkay, LLC, First Lien Revolving Loan, Due 9/14/20272024-01-012024-12-310001825384Edelman Financial Engines Center LLC/The Second Lien Term Loan, Due 10/6/20282024-01-012024-12-310001825384Eclipse Buyer, Inc., First Lien Term Loan, Due 9/8/20312024-01-012024-12-310001825384Eclipse Buyer, Inc., First Lien Revolving Loan, Due 9/8/20312024-01-012024-12-310001825384Eclipse Buyer, Inc., First Lien Delayed Draw Term Loan, Due 9/7/20262024-01-012024-12-310001825384DS Admiral Bidco LLC, First Lien Term Loan, 6/26/20312024-01-012024-12-310001825384Diligent Corporation, First Lien Term Loan, Two Due 8/6/20302024-01-012024-12-310001825384Diligent Corporation, First Lien Term Loan, One Due 8/6/20302024-01-012024-12-310001825384Diligent Corporation, First Lien Revolving Loan, Due 8/6/20302024-01-012024-12-310001825384Diligent Corporation, First Lien Delayed Draw Term Loan, Due 4/30/20262024-01-012024-12-310001825384DCert Buyer, Inc., Second Lien Term Loan, Due 2/19/20292024-01-012024-12-310001825384Covetrus, Inc. First Lien Term Loan Due 10/12/20292024-01-012024-12-310001825384CORA Health Holdings Corp, First Lien Term Loan, Due 6/15/20272024-01-012024-12-310001825384CORA Health Holdings Corp, First Lien Delayed Draw Term Loan, Due 6/15/20272024-01-012024-12-310001825384Continental Buyer Inc. First Lien Term Loan, Due 4/2/20312024-01-012024-12-310001825384Continental Buyer Inc. First Lien Revolving Loan, Due 4/2/20312024-01-012024-12-310001825384Continental Buyer Inc. First Lien Delayed Draw Term Loan, Due 4/2/20262024-01-012024-12-310001825384Cliffwater, LLC, First Lien Term Loan, Due 10/7/20302024-01-012024-12-310001825384Cliffwater, LLC, First Lien Revolving Loan, Due 10/7/20302024-01-012024-12-310001825384Choreo Buyer, LLC, First Lien Term Loan, Due 2/18/20282024-01-012024-12-310001825384Choreo Buyer, LLC, First Lien Delayed Draw Term Loan, Due 3/20/20262024-01-012024-12-310001825384Cherry Bekaert Advisory LLC, First Lien Term Loan, Due 6/30/20282024-01-012024-12-310001825384Cherry Bekaert Advisory LLC, First Lien Delayed Draw Term Loan, Due 6/30/20242024-01-012024-12-310001825384Chartis Group, LLC, First Lien Term Loan, Due, 9/17/20312024-01-012024-12-310001825384Chartis Group, LLC, First Lien Revolving Loan, Due, 9/17/20312024-01-012024-12-310001825384Chartis Group, LLC, First Lien Delayed Draw Term Loan, Due, 9/17/20262024-01-012024-12-310001825384Captive Resources Midco, LLC, First Lien Term Loan, Due 7/2/20292024-01-012024-12-310001825384Captive Resources Midco, LLC, First Lien Revolving Loan, Due 7/1/20282024-01-012024-12-310001825384Bottomline Technologies, Inc., First Lien Term Loan, Due 5/14/20292024-01-012024-12-310001825384Bottomline Technologies, Inc., First Lien Revolving Loan, Due 5/15/20282024-01-012024-12-310001825384Belmont Buyer, Inc., First Lien Term Loan Two, Due, 6/21/20292024-01-012024-12-310001825384Belmont Buyer, Inc., First Lien Term Loan One, Due, 6/21/20292024-01-012024-12-310001825384Belmont Buyer, Inc., First Lien Revolving Loan, Due 6/21/20292024-01-012024-12-310001825384Belmont Buyer, Inc., First Lien Delayed Draw Term Loan Two, Due, 1/26/20262024-01-012024-12-310001825384Belmont Buyer, Inc., First Lien Delayed Draw Term Loan One, Due, 6/21/20292024-01-012024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Term Loan, Due 12/29/20282024-01-012024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Revolving Loan, Due 12/29/20272024-01-012024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Two, Due 12/29/20282024-01-012024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Three, Due 12/29/20282024-01-012024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, One, Due 12/29/20282024-01-012024-12-310001825384BDO USA, P.C., First Lien Term Loan, Due 8/31/20282024-01-012024-12-310001825384Baker Tilly Advisory Group, L.P., First Lien Term Loan, Due 6/3/20312024-01-012024-12-310001825384Baker Tilly Advisory Group, L.P., First Lien Revolving Loan, Due 6/3/20302024-01-012024-12-310001825384Baker Tilly Advisory Group, L.P., First Lien Delayed Draw Term Loan, Due 6/3/20262024-01-012024-12-310001825384Babylon Buyer, Inc., First Lien Term Loan, Due 3/8/20302024-01-012024-12-310001825384Babylon Buyer, Inc., First Lien Revolving Loan, Due 3/8/20302024-01-012024-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, Two Due 10/5/20282024-01-012024-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, One Due 10/5/20282024-01-012024-12-310001825384ARMStrong Receivable Management, First Lien Term Loan, Due 10/5/20292024-01-012024-12-310001825384ARMStrong Receivable Management, First Lien Revolving Loan, Due 10/5/20292024-01-012024-12-310001825384ARMStrong Receivable Management, First Lien Delayed Draw Term Loan, Due 10/5/20292024-01-012024-12-310001825384Ardonagh Finco B.V., First Lien Term Loan, Due 2/18/20312024-01-012024-12-310001825384Arden Insurance Services LLC, First Lien Term Loan, Due 11/27/20302024-01-012024-12-310001825384Arden Insurance Services LLC, First Lien Revolving Loan, Due 11/27/20302024-01-012024-12-310001825384Aprio Advisory Group, LLC, First Lien Term Loan, Due 8/1/20312024-01-012024-12-310001825384Aprio Advisory Group, LLC, First Lien Revolving Loan, Due 8/1/20312024-01-012024-12-310001825384Aprio Advisory Group, LLC, First Lien Delayed Draw Term Loan, Due 8/1/20312024-01-012024-12-310001825384AP Highlands Holdings, L.P., Unsecured Note, Due 10/16/20282024-01-012024-12-310001825384AP Highlands Co-Invest, L.P., Unsecured Note, Due 10/16/20282024-01-012024-12-310001825384Anaplan, Inc, First Lien Term Loan, Due 6/21/20292024-01-012024-12-310001825384Anaplan, Inc, First Lien Revolving Loan, Due 6/21/20282024-01-012024-12-310001825384Amerilife Holdings LLC, First Lien Term Loan, Due 8/31/20292024-01-012024-12-310001825384AmeriLife Holdings LLC, First Lien Revolving Loan, Due 8/31/20282024-01-012024-12-310001825384Amerilife Holdings LLC, First Lien Delayed Draw Term Loan, Two, Due 8/31/20292024-01-012024-12-310001825384Amerilife Holdings LLC, First Lien Delayed Draw Term Loan, One, Due 8/31/20292024-01-012024-12-310001825384ALP CFO LP, Unsecured Note, 10/15/20362024-01-012024-12-310001825384ALKU Intermediate Holdings, LLC, First Lien Term Loan, Two Due 5/23/20292024-01-012024-12-310001825384ALKU Intermediate Holdings, LLC, First Lien Term Loan, One Due 5/23/20292024-01-012024-12-310001825384Alkeme Intermediary Holdings, LLC, First Lien Term Loan, Due 10/28/20262024-01-012024-12-310001825384Alkeme Intermediary Holdings, LLC, First Lien Delayed Draw Term Loan, Due 10/28/20262024-01-012024-12-310001825384Advisor Group Holdings, Inc, Unsecured Note, Due 8/1/20272024-01-012024-12-310001825384Action Behavior Centers Therapy LLC, First Lien Term Loan, Due, 7/2/20312024-01-012024-12-310001825384Action Behavior Centers Therapy LLC, First Lien Revolving Loan, Due, 7/2/20312024-01-012024-12-310001825384Action Behavior Centers Therapy LLC, First Lien Delayed Draw Term Loan, Due, 7/2/20312024-01-012024-12-310001825384ACM ASOF VIII LCLUB LLC, First Lien Term Loan, 6/30/20232024-01-012024-12-310001825384Acentra Holdings, LLC, First Lien Term Loan, Two, Due 12/17/20292024-01-012024-12-310001825384Acentra Holdings, LLC, First Lien Term Loan, Due 12/17/20292024-01-012024-12-310001825384Acentra Holdings, LLC, First Lien Revolving Loan, Due, 12/17/20292024-01-012024-12-310001825384Acentra Holdings, LLC, First Lien Delayed Draw Term Loan, Due 3/19/20262024-01-012024-12-310001825384Accuserve Solutions, Inc., First Lien Term Loan, Due 3/15/20302024-01-012024-12-310001825384Accuserve Solutions, Inc., First Lien Revolving Loan, Due 3/15/20302024-01-012024-12-310001825384Accuserve Solutions, Inc., First Lien Delayed Draw Term Loan, Due 3/16/20262024-01-012024-12-310001825384Accordion Partners LLC, First Lien Revolving Loan, Due 11/17/20312024-01-012024-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan, Due 11/16/20262024-01-012024-12-310001825384none:CapitalMarketSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:CommonEquityAndWarrantsMember2023-01-012023-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2023-01-012023-12-310001825384WWEX Uni Topco Holdings, LLC, Second Lien Term Loan, Due 7/26/20292023-01-012023-12-310001825384Williams Martson, LLC, First Lien Term Loan, Due 8/25/20282023-01-012023-12-310001825384Williams Martson, LLC, First Lien Revolving Loan, Due 8/25/20282023-01-012023-12-310001825384Williams Martson, LLC, First Lien Delayed Draw Term Loan Due 8/26/20242023-01-012023-12-310001825384Vision Solutions, Inc, Second Lien Term Loan, Due 4/23/20292023-01-012023-12-310001825384Two Ten Holdco, Inc, First Lien Term Loan, Due 3/26/20262023-01-012023-12-310001825384TST Intermediate Holdings, LLC, First Lien Term Loan, Due 11/27/20262023-01-012023-12-310001825384TST Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Due 11/27/20262023-01-012023-12-310001825384Trinity Partners Holdings LLC, First Lien Term Loan, Due 12/21/20282023-01-012023-12-310001825384Trinity Partners Holdings Llc First Lien Delayed Draw Term Loan Due 06/21/20252023-01-012023-12-310001825384Tamarack Intermediate LLC, First Lien Revolving Loan, Due 3/13/20282023-01-012023-12-310001825384Tamarack Intermediate Llc First Lien Delayed Draw Term Loans Due 3/13/20282023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, Unsecured Note, Due 5/26/20332023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, Two, Due 10/4/20272023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, One, Due 10/4/20272023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Two, Due 10/4/20272023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Three, Due 10/4/20272023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, One, Due 10/4/20272023-01-012023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Four, Due 10/4/20272023-01-012023-12-310001825384Syntax Systems Limited, First Lien Term Loan, Due 10/29/20282023-01-012023-12-310001825384Syntax Systems Limited, First Lien Delayed Draw Term Loan, Due 10/15/20282023-01-012023-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Term Loan, Due 1/2/20292023-01-012023-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Revolving Loan, Due 12/29/20262023-01-012023-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Delayed Draw Term Loan, Due 1/2/20292023-01-012023-12-310001825384SpecialtyCare, Inc, First Lien Term Loan, Due 6/19/20282023-01-012023-12-310001825384SpecialtyCare, Inc, First Lien Revolving Loan, Due 6/18/20262023-01-012023-12-310001825384SpecialtyCare, Inc, First Lien Delayed Draw Term Loan, Due 6/19/20282023-01-012023-12-310001825384Simplifi Holdings, Inc, First Lien Term Loan, Due 10/1/20272023-01-012023-12-310001825384Simplifi Holdings, Inc, First Lien Revolving Loan, Due 10/1/20262023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Two, Due 11/1/20292023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Three, Due 11/1/20292023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Due 11/1/20292023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Two, Due 11/1/20292023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Three, Due 11/1/20292023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, One, Due 11/1/20292023-01-012023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Four, Due 11/1/20292023-01-012023-12-310001825384Resolute Investment Managers, Inc, First Lien Revolving Loan, Due 4/30/20242023-01-012023-12-310001825384Project K BuyerCo, Inc, Unsecured Note, Due 12/10/20282023-01-012023-12-310001825384Project K BuyerCo, Inc, First Lien Term Loan, Due 12/10/20272023-01-012023-12-310001825384Project K BuyerCo, Inc, First Lien Revolving Loan, Due 12/10/20272023-01-012023-12-310001825384Petra Borrower, LLC, First Lien Term Loan, Due 11/15/20302023-01-012023-12-310001825384Petra Borrower, LLC, First Lien Revolving Loan, Due 11/15/20292023-01-012023-12-310001825384Petra Borrower, LLC, First Lien Delayed Draw Term Loan, Due 5/15/20252023-01-012023-12-310001825384People 2.0, Inc, First Lien Term Loan, Due 7/12/20282023-01-012023-12-310001825384PAS Parent, Inc., First Lien Revolving Loan, Due 12/30/20272023-01-012023-12-310001825384PAS Parent, Inc., First Lien Delayed Draw Term Loan, Due 12/15/20252023-01-012023-12-310001825384Orion Advisor Solutions, Inc, Second Lien Term Loan, Due 9/24/20282023-01-012023-12-310001825384OneDigital Borrower LLC, First Lien Term Loan, Due 11/16/20272023-01-012023-12-310001825384One Digital Borrower Llc First Lien Delayed Draw Term Loan Due 9/16/20242023-01-012023-12-310001825384none_cnst_string_AmerilifeGroupLlcFirstLienDelayedDrawTermLoanDue83020242023-01-012023-12-310001825384NFP Corp, Unsecured Note, Due 8/15/20282023-01-012023-12-310001825384NextGen Healthcare, First Lien Term Loan, Due 11/11/20302023-01-012023-12-310001825384Next Holdco, LLC First Lien Revolving Loan, Due 11/9/20292023-01-012023-12-310001825384Next Holdco, Llc First Lien Delayed Draw Term Loan Due 11/10/20252023-01-012023-12-310001825384Neptune Flood Incorporated, First Lien Term Loan, Due 5/8/20292023-01-012023-12-310001825384Neptune Flood Incorporated, First Lien Revolving Loan, Due 5/8/20292023-01-012023-12-310001825384Neptune BidCo US Inc, Second Lien Term Loan, Due 10/11/20292023-01-012023-12-310001825384More Cowbell II LLC, First Lien Term Loan, Due 9/2/20302023-01-012023-12-310001825384More Cowbell II LLC, First Lien Revolving Loan, Due 9/3/20292023-01-012023-12-310001825384More Cowbell II LLC, First Lien Delayed Draw Term Loan, Due 9/1/20252023-01-012023-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Term Loan, Due 7/29/20262023-01-012023-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Revolving Loan, Due 7/29/20262023-01-012023-12-310001825384Ministry Brands Purchaser, LLC, First Lien Term Loan, Due 12/28/20282023-01-012023-12-310001825384Ministry Brands Purchaser, LLC, First Lien Revolving Loan, Due 12/24/20272023-01-012023-12-310001825384Ministry Brands Purchaser, LLC, First Lien Delayed Draw Term Loan, Due 12/28/20282023-01-012023-12-310001825384Millennium Trust Co., LLC, First Lien Term Loan, Due 3/27/20262023-01-012023-12-310001825384MBO Partners, Inc, First Lien Term Loan, Due 5/23/20282023-01-012023-12-310001825384MBO Partners, Inc, First Lien Delayed Draw Term Loan, Due 5/23/20282023-01-012023-12-310001825384MB2 Dental Solutions, LLC, First Lien Term Loan, One, Due 1/29/20272023-01-012023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Two, Due 1/29/20272023-01-012023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Three, Due 1/29/20272023-01-012023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, One, Due 1/29/20272023-01-012023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Four, Due 1/29/20272023-01-012023-12-310001825384Maverick 1 LLC, Second Lien Term Loan, Due 5/18/20292023-01-012023-12-310001825384Mandolin Technology Intermediate Holdings, Inc, Second Lien Term Loan, Due 7/30/20292023-01-012023-12-310001825384Kwol Acquisition Inc, First Lien Term Loan, Due 12/12/20292023-01-012023-12-310001825384Kwol Acquisition Inc, First Lien Revolving Loan, Due 12/12/20292023-01-012023-12-310001825384Ivy Hill Asset Management, L.P., Unsecured Note, Due 6/29/20282023-01-012023-12-310001825384Imagine Acquisitionco, LLC, First Lien Term Loan, Due 11/16/20272023-01-012023-12-310001825384Imagine Acquisitionco, LLC, First Lien Delayed Draw Term Loan, Due 11/16/20232023-01-012023-12-310001825384IG Investments Holdings, LLC, First Lien Term Loan, Two, Due 9/22/20282023-01-012023-12-310001825384IG Investments Holdings, LLC, First Lien Term Loan, One, Due 9/22/20282023-01-012023-12-310001825384IG Investments Holdings, LLC, First Lien Revolving Loan, Due 9/22/20272023-01-012023-12-310001825384Hyland Software, Inc, First Lien Term Loan, Due 9/19/20302023-01-012023-12-310001825384Hyland Software, Inc, First Lien Revolving Loan, Due 9/19/20292023-01-012023-12-310001825384Helpsystems Holdings, Inc, Second Lien Term Loan, Due 11/19/20272023-01-012023-12-310001825384Harrington Reinsureance Holdings Limited, Unsecured Note, Due 6/29/20312023-01-012023-12-310001825384Harbor Purchaser Inc, Second Lien Term Loan, Due 4/8/20302023-01-012023-12-310001825384GS Acquisitionco, Inc, First Lien Term Loan, Due 5/22/20262023-01-012023-12-310001825384GraphPAD Sofware, LLC, First Lien Term Loan, Three, Due 4/27/20272023-01-012023-12-310001825384GraphPAD Sofware, LLC, First Lien Term Loan, One, Due 4/27/20272023-01-012023-12-310001825384GraphPAD Software, LLC, First Lien Term Loan, Two, Due 4/27/20272023-01-012023-12-310001825384GraphPAD Software, LLC, First Lien Term Loan, Four, Due 4/27/20272023-01-012023-12-310001825384GraphPAD Software, LLC, First Lien Delayed Draw Term Loan, Due 4/27/20272023-01-012023-12-310001825384GovDelivery Holdings, LLC, First Lien Term Loan, Due 1/29/20272023-01-012023-12-310001825384GovDelivery Holdings, LLC, First Lien Revolving Loan, Due 1/29/20272023-01-012023-12-310001825384GovDelivery Holdings, LLC, First Lien Delayed Draw Term Loan, Due 1/29/20272023-01-012023-12-310001825384Giving Home Health Care, Second Lien Term Loan, Due 2/18/20282023-01-012023-12-310001825384Giving Home Health Care, First Lien Term Loan, Due 8/19/20272023-01-012023-12-310001825384Giving Home Health Care, First Lien Revolving Loan, Due 8/19/20272023-01-012023-12-310001825384Geosyntec Consultants, Inc, First Lien Term Loan, Due 5/18/20292023-01-012023-12-310001825384Geosyntec Consultants, Inc, First Lien Revolving Loan, Due 5/18/20272023-01-012023-12-310001825384Geosyntec Consultants Inc First Lien Delayed Draw Term Loan Due 5/18/20292023-01-012023-12-310001825384GC Two Intermediate Holdings, Inc, Unsecured Note, Due 4/1/20292023-01-012023-12-310001825384Galway Borrower, LLC, First Lien Term Loan, Two, Due 9/29/20282023-01-012023-12-310001825384Galway Borrower, LLC, First Lien Term Loan, Due 9/29/20282023-01-012023-12-310001825384Galway Borrower, LLC, First Lien Revolving Loan, One, Due 9/30/20272023-01-012023-12-310001825384Galway Borrower, LLC, First Lien Delayed Draw Term Loan, Due 10/28/20242023-01-012023-12-310001825384Freedom Mortgage Corp, Unsecured Note, Due 10/1/20302023-01-012023-12-310001825384Foundation Risk Partners, Corp, First Lien Term Loan, Due 10/27/20282023-01-012023-12-310001825384Foundation Risk Partners, Corp, First Lien Delayed Draw Term Loan, Due 10/27/20282023-01-012023-12-310001825384FINThrive Software Intermediate Holdings, Inc, Second Lien Term Loan, Due, 12/17/20292023-01-012023-12-310001825384Explorer Investor, Inc, First Lien Term Loan, Due 6/28/20292023-01-012023-12-310001825384Euclid Transactional, LLC, First Lien Term Loan, Due 10/2/20282023-01-012023-12-310001825384Ensono, Inc, Second Lien Term Loan, Due 5/28/20292023-01-012023-12-310001825384Ellkay, LLC, First Lien Term Loan, Due 9/14/20272023-01-012023-12-310001825384Ellkay, LLC, First Lien Revolving Loan, Due 9/14/20272023-01-012023-12-310001825384Edelman Financial Center, Second Lien Term Loan, Due 7/20/20262023-01-012023-12-310001825384Diligent Corporation, First Lien Term Loan, Two, Due 8/4/20252023-01-012023-12-310001825384Diligent Corporation, First Lien Term Loan, One, Due 8/4/20252023-01-012023-12-310001825384Diligent Corporation, First Lien Revolving Loan, Due 8/4/20252023-01-012023-12-310001825384Dcert Buyer, Inc, Second Lien Term Loan, Due 2/19/20292023-01-012023-12-310001825384CORA Health Holdings Corp, First Lien Term Loan, Due 6/15/20272023-01-012023-12-310001825384CORA Health Holdings Corp, First Lien Delayed Draw Term Loan, Due 6/15/20272023-01-012023-12-310001825384CNSI Holdings, LLC, First Lien Term Loan, Due 12/15/20282023-01-012023-12-310001825384CNSI Holdings, LLC, First Lien Revolving Loan, Due 12/17/20272023-01-012023-12-310001825384Cliffwater, LLC, First Lien Term Loan, Due 10/7/20302023-01-012023-12-310001825384Cliffwater, LLC, First Lien Revolving Loan, Due 10/7/20302023-01-012023-12-310001825384Cherry Bekaert Advisory LLC, First Lien Term Loan, Due 6/30/20282023-01-012023-12-310001825384Cherry Bekaert Advisory LLC, First Lien Delayed Draw Term Loan, Due 6/30/20242023-01-012023-12-310001825384Captive Resources Midco, LLC, First Lien Term Loan, Due 6/29/20292023-01-012023-12-310001825384Captive Resources Midco, LLC, First Lien Revolving Loan, Due 7/1/20282023-01-012023-12-310001825384Bottomline Technologies, Inc, First Lien Term Loan, Due 5/14/20292023-01-012023-12-310001825384Bottomline Technologies, Inc, First Lien Revolving Loan, Due 5/15/20282023-01-012023-12-310001825384Belmont Buyer, Inc., First Lien Term Loan, Due 6/21/20292023-01-012023-12-310001825384Belmont Buyer, Inc., First Lien Revolving Loan, Due 6/21/20292023-01-012023-12-310001825384Belmont Buyer, Inc., First Lien Delayed Draw Term Loan, Due 6/21/20292023-01-012023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Term Loan, Due 12/29/20282023-01-012023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Revolving Loan, Due 12/29/20272023-01-012023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Two, Due 12/29/20282023-01-012023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Due 12/29/20282023-01-012023-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, Two, Due 10/5/20282023-01-012023-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, One, Due 10/5/20282023-01-012023-12-310001825384ARMStrong Receivable Management, First Lien Term Loan, Due 10/5/20292023-01-012023-12-310001825384ARMStrong Receivable Management, First Lien Revolving Loan, Due 10/5/20292023-01-012023-12-310001825384ARMStrong Receivable Management, First Lien Delayed Draw Term Loan, Due 10/6/20252023-01-012023-12-310001825384Anaplan, Inc, First Lien Term Loan, Due 6/21/20292023-01-012023-12-310001825384Anaplan, Inc, First Lien Revolving Loan, Due 6/21/20282023-01-012023-12-310001825384AmeriLife Group LLC, First Lien Term Loan, Due 8/31/20292023-01-012023-12-310001825384AmeriLife Group LLC, First Lien Revolving Loan, Due 8/31/20282023-01-012023-12-310001825384ALKU Intermediate Holdings, LLC, First Lien term Loan, Due 5/23/20292023-01-012023-12-310001825384Advisor Group Holdings, Inc, Unsecured Note, Due 8/1/20272023-01-012023-12-310001825384Accuserve, First Lien Term Loan, Due 8/13/20292023-01-012023-12-310001825384Accuserve, First Lien Delayed Draw Term Loan, Due 8/13/20242023-01-012023-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan, Two, Due 8/29/20292023-01-012023-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan, One Due, 8/29/20292023-01-012023-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan Three, Due, 8/29/20292023-01-012023-12-310001825384Accordion Partners LLC First Lien Term Loan Due 8/29/20292023-01-012023-12-310001825384Accordion Partners LLC First Lien Revolving Loan Due 8/31/20282023-01-012023-12-310001825384Accordion Partners LLC First Lien Delayed Draw Term Loan Due 8/29/20292023-01-012023-12-310001825384none:SoftwareSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2024-12-310001825384none:HealthCareTechnologySectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2024-12-310001825384us-gaap:ConsumerSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384none:ConsumerFinanceMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384none:CapitalMarketSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2024-12-310001825384us-gaap:TechnologySectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:RealEstateSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:InsuranceSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384none:ProfessionalServicesSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:DebtInvestmentsMember2023-12-310001825384us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-12-310001825384us-gaap:BaseRateMember2023-12-310001825384Wharf Street Ratings Acquisition LLC, Unsecured Note, Due 12/8/20282024-12-310001825384THL Fund IX Investors (Plymouth), L.P, Equity Investment2024-12-310001825384TA/WEG Intermediate Holdings, LLC, Unsecured Note, Due 5/26/20332024-12-310001825384Spirit RR Holdings, Inc., Equity Investment2024-12-310001825384RSC Topco, Inc.2024-12-310001825384Resolute Investment Managers, Inc. Equity Investment2024-12-310001825384New Giving Acquisition, Inc., Equity Investment2024-12-310001825384Ivy Hill Asset Management, L.P., Unsecured Note, Due 6/29/20282024-12-310001825384Imagine Acquisitionco, LLC, Equity Investment2024-12-310001825384GT Polaris Holdings, Inc, Preferred Equity Investment2024-12-310001825384Galway Borrower, LLC, Equity Investment One2024-12-310001825384Freedom Mortgage Corp, Unsecured Note, Due 10/1/20302024-12-310001825384Evergreen Services Group PIK Holdco, LLC, Unsecured Note, Due 4/7/20312024-12-310001825384Evergreen Services Group PIK Holdco, LLC, Unsecured Note, Due 4/7/20252024-12-310001825384Eclipse Buyer, Inc. Preferred Equity 9/6/20242024-12-310001825384AP Highlands Holdings, L.P., Unsecured Note, Due 10/16/20282024-12-310001825384AP Highlands Co-Invest, L.P., Unsecured Note, Due 10/16/20282024-12-310001825384ALP CFO LP, Unsecured Note, 10/15/20362024-12-310001825384Advisor Group Holdings, Inc, Unsecured Note, Due 8/1/20272024-12-310001825384ACM ASOF VIII LCLUB LLC, First Lien Term Loan, 6/30/20232024-12-310001825384Accordion Partners Holdings LLC Unsecured Note Due 11/15/20342024-12-310001825384ACC Ultimate Holdings, L.P., Equity Investment2024-12-310001825384none:CapitalMarketSectorMemberus-gaap:InvestmentUnaffiliatedIssuerMembernone:CommonEquityAndWarrantsMember2023-12-310001825384us-gaap:InvestmentUnaffiliatedIssuerMembernone:PreferredEquitySecuritiesMember2023-12-310001825384THL Fund IX Investors (Plymouth), L.P, Equity Investment2023-12-310001825384TA/WEG Intermediate Holdings, LLC, Unsecured Note, Due 5/26/20332023-12-310001825384Spirit RR Holdings, Inc., Equity Investment2023-12-310001825384RSC Topco, Inc, Equity Investment2023-12-310001825384Resolute Investment Managers, Inc. Equity Investment2023-12-310001825384Project K BuyerCo, Inc, Unsecured Note, Due 12/10/20282023-12-310001825384NFP Corp, Unsecured Note, Due 8/15/20282023-12-310001825384Ivy Hill Asset Management, L.P., Unsecured Note, Due 6/29/20282023-12-310001825384Imagine Acquisitionco, LLC, Equity2023-12-310001825384Harrington Reinsureance Holdings Limited, Unsecured Note, Due 6/29/20312023-12-310001825384GT Polaris Holdings, Inc., Equity Investment2023-12-310001825384Giving Home Health Care, Warrants2023-12-310001825384Giving Home Health Care, Second Lien Term Loan, Due 2/18/20282023-12-310001825384GC Two Intermediate Holdings, Inc, Unsecured Note, Due 4/1/20292023-12-310001825384Galway Borrower, LLC, Equity Investment2023-12-310001825384Freedom Mortgage Corp, Unsecured Note, Due 10/1/20302023-12-310001825384Advisor Group Holdings, Inc, Unsecured Note, Due 8/1/20272023-12-3100018253842020-09-082020-12-3100018253842024-12-272024-12-2700018253842024-09-262024-09-2600018253842024-06-262024-06-2600018253842024-03-252024-03-2500018253842023-12-222023-12-2200018253842023-09-252023-09-2500018253842023-06-232023-06-2300018253842023-03-242023-03-2400018253842022-12-232022-12-2300018253842022-09-232022-09-2300018253842022-06-242022-06-2400018253842022-03-232022-03-230001825384Worldwide Insurance Network, LLC, First Lien Term Loan, Due 5/28/20302024-12-310001825384Worldwide Insurance Network, LLC, First Lien Delayed Draw Term Loan, Due 5/28/20302024-12-310001825384Williams Martson, LLC, First Lien Term Loan, Due 8/25/20282024-12-310001825384Williams Martson, LLC, First Lien Revolving Loan, Due 8/25/20282024-12-310001825384Williams Marston, LLC, First Lien Delayed Draw Term Loan, Due 8/25/20252024-12-310001825384Vital Care Buyer LLC, First Lien Term Loan Due 7/30/20312024-12-310001825384Vital Care Buyer LLC, First Lien Revolving Loan Due 7/30/20312024-12-310001825384TST Intermediate Holdings, LLC, First Lien Term Loan, 12/31/20282024-12-310001825384TST Intermediate Holdings, LLC, First Lien Revolving Loan, 12/31/20282024-12-310001825384TST Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, 12/31/20282024-12-310001825384Trinity Partners Holdings LLC, First Lien Term Loan, Due 12/21/20282024-12-310001825384Trinity Partners Holdings Llc First Lien Delayed Draw Term Loan Due 06/21/20252024-12-310001825384Titan Home Improvement, LLC, First Lien Term Loan, Due 5/31/20302024-12-310001825384Titan Home Improvement, LLC, First Lien Revolving Loan, Due 5/31/20302024-12-310001825384Titan Home Improvement, LLC, First Lien Delayed Draw Term Loan, Due 6/2/20262024-12-310001825384THG Acquisition, LLC, First Lien Term Loan, Due 10/31/20312024-12-310001825384THG Acquisition, LLC, First Lien Revolving Loan, Due 10/31/20312024-12-310001825384THG Acquisition, LLC, First Lien Delayed Draw Term Loan, Due 10/31/20262024-12-310001825384Tamarack Intermediate, L.L.C., First Lien Term Loan, Due 3/13/20282024-12-310001825384Tamarack Intermediate, L.L.C., First Lien Revolving Loan, Due 3/13/20282024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, Two, Due 10/4/20272024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, One, Due 10/4/20272024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Two, Due 10/4/20272024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Three, Due 10/4/20272024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, One, Due 10/4/20272024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Four, Due 10/4/20272024-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Five, Due 10/4/20272024-12-310001825384Syntax Systems Limited, First Lien Term Loan, One, Due 10/30/20282024-12-310001825384Syntax Systems Limited, First Lien Term Loan, Due 10/30/20282024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Term Loan, Due 1/2/20292024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Revolving Loan, Due 12/29/20262024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Delayed Draw Term Loan, Two, Due 1/2/20292024-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Delayed Draw Term Loan, One, Due 1/2/20292024-12-310001825384SpecialtyCare, Inc, First Lien Term Loan, Due 6/19/20282024-12-310001825384SpecialtyCare, Inc, First Lien Revolving Loan, Due 6/18/20262024-12-310001825384SpecialtyCare, Inc, First Lien Delayed Draw Term Loan, Due 6/19/20282024-12-310001825384Southpaw AP Buyer, LLC, First Lien Term Loan, Due 3/2/20282024-12-310001825384Southpaw AP Buyer, LLC, First Lien Revolving Loan, Due 3/2/20282024-12-310001825384Southpaw AP Buyer, LLC, First Lien Delayed Draw Term Loan, Due 3/2/20282024-12-310001825384Simplifi Holdings, Inc., First Lien Term Loan, Due 10/1/20272024-12-310001825384Simplifi Holdings, Inc., First Lien Revolving Loan, Due 10/1/20272024-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Two Due 10/30/20292024-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Three Due 10/30/20292024-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, One Due 10/30/20292024-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Two Due 10/30/20292024-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, One Due 10/30/20292024-12-310001825384Project Ruby Ultimate Parent Corp Second Lien Term Loan Due 3/12/20292024-12-310001825384Project K BuyerCo, Inc, First Lien Term Loan, Due 12/10/20272024-12-310001825384Project K BuyerCo, Inc, First Lien Revolving Loan, Due 12/10/20272024-12-310001825384Petra Borrower, LLC, First Lien Term Loan, Due 11/15/20302024-12-310001825384Petra Borrower, LLC, First Lien Revolving Loan, Due 11/15/20292024-12-310001825384Petra Borrower, LLC, First Lien Delayed Draw Term Loan, Due 11/15/20302024-12-310001825384People 2.0, Inc, First Lien Term Loan, Due 7/12/20282024-12-310001825384PAS Parent Inc., First Lien Term Loan, Due 12/29/20282024-12-310001825384PAS Parent Inc., First Lien Revolving Loan, Due 12/30/20272024-12-310001825384PAS Parent Inc., First Lien Delayed Draw Term Loan, Due 6/26/20262024-12-310001825384PAS Parent Inc., First Lien Delayed Draw Term Loan, Due 12/29/20282024-12-310001825384Orion Advisor Solutions Inc., Second Lien Term Loan, Due 9/24/20282024-12-310001825384Orion Advisor Solutions Inc., Second Lien Delayed Draw Term Loan, Due 9/24/20282024-12-310001825384oneZero Financial Systems, LLC, First Lien Term Loan, Due 10/7/20312024-12-310001825384oneZero Financial Systems, LLC, First Lien Revolving Loan, Due 10/7/20312024-12-310001825384oneZero Financial Systems, LLC, First Lien Delayed Draw Term Loan, Due 10/7/20262024-12-310001825384OneDigital Borrower LLC, Second Lien Term Loan, Due 7/2/20322024-12-310001825384One Call Corp First Lien Term Loan Due 4/22/20272024-12-310001825384OMNIA Partners LLC, Second Lien Term Loan, Due 5/31/20322024-12-310001825384NXGen Buyer, Inc. Second Lien Term Loan, 4/28/20282024-12-310001825384NXGen Buyer, Inc. Second Lien Term Loan Two, 4/28/20282024-12-310001825384NXGen Buyer, Inc. First Lien Term Loan, 10/29/20272024-12-310001825384NXGen Buyer, Inc. First Lien Revolving Loan, 10/29/20272024-12-310001825384Nexus Buyer LLC, Second Lien Term Loan, 11/5/20292024-12-310001825384NextGen Healthcare, First Lien Term Loan, Due 11/11/20302024-12-310001825384NextGen Healthcare, First Lien Revolving Loan, Due 11/9/20292024-12-310001825384NextGen Healthcare, First Lien Delayed Draw Term Loan, Due 11/10/20252024-12-310001825384New Mountain Guardian IV Rated Feeder III, Ltd., Unsecured Note, Six, Due 8/28/20372024-12-310001825384New Mountain Guardian IV Rated Feeder III, Ltd., Unsecured Note, Four, Due 8/28/20372024-12-310001825384New Mountain Guardian IV Rated Feeder III, Ltd., Unsecured Note, Five, Due 8/28/20372024-12-310001825384New Mountain Guardian IV Income Rated Feeder II, Ltd. Unsecured Note, Due 4/3/20372024-12-310001825384More Cowbell II LLC, First Lien Term Loan, Due 9/2/20302024-12-310001825384More Cowbell II LLC, First Lien Revolving Loan, Due 9/3/20292024-12-310001825384More Cowbell II LLC, First Lien Delayed Draw Term Loan, Due 9/1/20252024-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Term Loan, Due 7/29/20262024-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Revolving Loan, Due 7/29/20262024-12-310001825384Minotaur Acquisition, Inc., First Lien Delayed Draw Term Loan, Due 5/10/20302024-12-310001825384Minotaur Acquisition, Inc. Minotaur Acquisition, Inc, Due 5/10/20302024-12-310001825384Minotaur Acquisition, Inc. First Lien Term Loan, Due 5/10/20302024-12-310001825384Minotaur Acquisition, Inc. First Lien Delayed Draw Term Loan, One, Due 5/11/20262024-12-310001825384Ministry Brands Holdings, LLC, First Lien Term Loan, Due 12/28/20282024-12-310001825384Ministry Brands Holdings, LLC, First Lien Revolving Loan, Due 12/30/20272024-12-310001825384Ministry Brands Holdings, LLC, First Lien Delayed Draw Term Loan, Due 12/28/20282024-12-310001825384MBO Partners, Inc, First Lien Term Loan, Due 5/23/20282024-12-310001825384MBO Partners, Inc, First Lien Delayed Draw Term Loan, Due 5/23/20282024-12-310001825384MB2 Dental Solutions, LLC, First Lien Term Loan, One, Due 1/29/20272024-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Two, Due 2/13/20312024-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Three, Due 1/29/20272024-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, One, Due 2/13/20312024-12-310001825384Maverick 1 LLC, Second Lien Term Loan, Due 5/18/20292024-12-310001825384Mandolin Technology Intermediate Holdings, Inc., Second Lien Term Loan, Due 7/30/20292024-12-310001825384MAI Capital Management Intermediate LLC, First Lien Term Loan, 8/29/20312024-12-310001825384MAI Capital Management Intermediate LLC, First Lien Revolving Loan, 8/29/20312024-12-310001825384MAI Capital Management Intermediate LLC, First Lien Delayed Draw Term Loan, 8/29/20312024-12-310001825384Lytx, Inc., First Lien Term Loan, Due 2/28/20282024-12-310001825384LendingTree, Inc.., First Lien Term Loan, Due 3/27/20312024-12-310001825384LendingTree, Inc., First Lien Delayed Draw Term Loan, Due 3/27/20252024-12-310001825384KRIV Acquisition Inc., First Lien Term Loan, Due 7/6/20292024-12-310001825384KRIV Acquisition Inc., First Lien Delayed Draw Term Loan, Due 9/25/20262024-12-310001825384KRIV Acquisition Inc., First Lien Delayed Draw Term Loan, Due 7/6/20292024-12-310001825384Imagine Acquisitionco, LLC, First Lien Term Loan, Due 11/16/20272024-12-310001825384Imagine Acquisitionco, LLC, First Lien Delayed Draw Term Loan, Due 11/16/20272024-12-310001825384IG Investments Holdings, LLC, First Lien Term Loan, Two, Due 9/22/20282024-12-310001825384IG Investments Holdings, LLC, First Lien Revolving Loan, Two, 9/22/20282024-12-310001825384Hyland Software, Inc, First Lien Term Loan, Due 9/19/20302024-12-310001825384Hyland Software, Inc, First Lien Revolving Loan, Due 9/19/20292024-12-310001825384Houghton Mifflin Harcourt Co, First Lien Term Loan, 4/9/20292024-12-310001825384Homecare Software Solutions LLC, First Lien Delayed Draw Term Loan, Due 6/16/20312024-12-310001825384Helpsystems Holdings, Inc., Second Lien Term Loan, Due 11/19/20272024-12-310001825384HBWM Intermediate II, LLC, First Lien Term Loan, 11/17/20312024-12-310001825384HBWM Intermediate II, LLC, First Lien Revolving Loan, 8/18/20312024-12-310001825384HBWM Intermediate II, LLC, First Lien Delayed Draw Term Loan, 11/16/20262024-12-310001825384Harbor Purchaser Inc, Second Lien Term Loan, Due 4/8/20302024-12-310001825384Guardian Restoration Partners Buyers, LLC, First Lien Term Loan, Due 11/3/20312024-12-310001825384Guardian Restoration Partners Buyers, LLC, First Lien Revolving Loan, Due 11/3/20312024-12-310001825384Guardian Restoration Partners Buyers, LLC, First Lien Delayed Draw Term Loan, Due 11/3/20312024-12-310001825384GS Acquisitionco, Inc., First Lien Term Loan, 5/25/20282024-12-310001825384GS Acquisitionco, Inc., First Lien Revolving Loan, 5/25/20282024-12-310001825384GS Acquisitionco, Inc., First Lien Delayed Draw Term Loan, 5/25/20282024-12-310001825384GraphPAD Software, LLC, First Lien Term Loan, One, Due 4/27/20272024-12-310001825384GovDelivery Holdings LLC, First Lien Term Loan, Due 1/17/20312024-12-310001825384GovDelivery Holdings LLC, First Lien Revolving Loan, Due 1/17/20312024-12-310001825384GovDelivery Holdings LLC, First Lien Delayed Draw Term Loan, Due 1/17/20312024-12-310001825384Giving Home Health Care, Second Lien Term Loan, Due 2/18/20282024-12-310001825384Giving Home Health Care, First Lien Term Loan, Due 8/19/2072024-12-310001825384Giving Home Health Care, First Lien Revolving Loan, Due 8/19/20272024-12-310001825384Galway Borrower LLC, First Lien Term Loan, Due 9/29/20282024-12-310001825384Galway Borrower LLC, First Lien Revolving Loan, Due 10/2/20282024-12-310001825384Galway Borrower LLC, First Lien Delayed Draw Term Loan, Two Due 9/29/20282024-12-310001825384Galway Borrower LLC, First Lien Delayed Draw Term Loan, Due 9/29/20282024-12-310001825384Foundation Risk Partners, Corp., First Lien Term Loan, Two Due 10/29/20302024-12-310001825384Foundation Risk Partners, Corp., First Lien Term Loan, One Due 10/29/20302024-12-310001825384Foundation Risk Partners, Corp., First Lien Revolving Loan, Due 10/29/20292024-12-310001825384Foundation Risk Partners, Corp., First Lien Delayed Draw Term Loan, Two Due 10/29/20302024-12-310001825384Foundation Risk Partners, Corp., First Lien Delayed Draw Term Loan, Three Due 10/29/20302024-12-310001825384Foundation Risk Partners, Corp., First Lien Delayed Draw Term Loan, One Due 10/29/20302024-12-310001825384FINThrive Software Intermediate Holdings, Inc, Second Lien Term Loan, Due, 12/17/20292024-12-310001825384Explorer Investor, Inc, First Lien Term Loan, Due 6/28/20292024-12-310001825384Exeter Short Term Funding LLC, First Lien Revolving Loan, 2/9/20262024-12-310001825384Euclid Transactional, LLC, First Lien Term Loan, Due 10/2/20282024-12-310001825384Ellkay, LLC, First Lien Term Loan, Due 9/14/20272024-12-310001825384Ellkay, LLC, First Lien Revolving Loan, Due 9/14/20272024-12-310001825384Edelman Financial Engines Center LLC/The Second Lien Term Loan, Due 10/6/20282024-12-310001825384Eclipse Buyer, Inc., First Lien Term Loan, Due 9/8/20312024-12-310001825384Eclipse Buyer, Inc., First Lien Revolving Loan, Due 9/8/20312024-12-310001825384Eclipse Buyer, Inc., First Lien Delayed Draw Term Loan, Due 9/7/20262024-12-310001825384DS Admiral Bidco LLC, First Lien Term Loan, 6/26/20312024-12-310001825384Diligent Corporation, First Lien Term Loan, Two Due 8/6/20302024-12-310001825384Diligent Corporation, First Lien Term Loan, One Due 8/6/20302024-12-310001825384Diligent Corporation, First Lien Revolving Loan, Due 8/6/20302024-12-310001825384Diligent Corporation, First Lien Delayed Draw Term Loan, Due 4/30/20262024-12-310001825384DCert Buyer, Inc., Second Lien Term Loan, Due 2/19/20292024-12-310001825384Covetrus, Inc. First Lien Term Loan Due 10/12/20292024-12-310001825384CORA Health Holdings Corp, First Lien Term Loan, Due 6/15/20272024-12-310001825384CORA Health Holdings Corp, First Lien Delayed Draw Term Loan, Due 6/15/20272024-12-310001825384Continental Buyer Inc. First Lien Term Loan, Due 4/2/20312024-12-310001825384Continental Buyer Inc. First Lien Revolving Loan, Due 4/2/20312024-12-310001825384Continental Buyer Inc. First Lien Delayed Draw Term Loan, Due 4/2/20262024-12-310001825384Cliffwater, LLC, First Lien Term Loan, Due 10/7/20302024-12-310001825384Cliffwater, LLC, First Lien Revolving Loan, Due 10/7/20302024-12-310001825384Choreo Buyer, LLC, First Lien Term Loan, Due 2/18/20282024-12-310001825384Choreo Buyer, LLC, First Lien Delayed Draw Term Loan, Due 3/20/20262024-12-310001825384Cherry Bekaert Advisory LLC, First Lien Term Loan, Due 6/30/20282024-12-310001825384Cherry Bekaert Advisory LLC, First Lien Delayed Draw Term Loan, Due 6/30/20242024-12-310001825384Chartis Group, LLC, First Lien Term Loan, Due, 9/17/20312024-12-310001825384Chartis Group, LLC, First Lien Revolving Loan, Due, 9/17/20312024-12-310001825384Chartis Group, LLC, First Lien Delayed Draw Term Loan, Due, 9/17/20262024-12-310001825384Captive Resources Midco, LLC, First Lien Term Loan, Due 7/2/20292024-12-310001825384Captive Resources Midco, LLC, First Lien Revolving Loan, Due 7/1/20282024-12-310001825384Bottomline Technologies, Inc., First Lien Term Loan, Due 5/14/20292024-12-310001825384Bottomline Technologies, Inc., First Lien Revolving Loan, Due 5/15/20282024-12-310001825384Belmont Buyer, Inc., First Lien Term Loan Two, Due, 6/21/20292024-12-310001825384Belmont Buyer, Inc., First Lien Term Loan One, Due, 6/21/20292024-12-310001825384Belmont Buyer, Inc., First Lien Revolving Loan, Due 6/21/20292024-12-310001825384Belmont Buyer, Inc., First Lien Delayed Draw Term Loan Two, Due, 1/26/20262024-12-310001825384Belmont Buyer, Inc., First Lien Delayed Draw Term Loan One, Due, 6/21/20292024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Term Loan, Due 12/29/20282024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Revolving Loan, Due 12/29/20272024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Two, Due 12/29/20282024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Three, Due 12/29/20282024-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, One, Due 12/29/20282024-12-310001825384BDO USA, P.C., First Lien Term Loan, Due 8/31/20282024-12-310001825384Baker Tilly Advisory Group, L.P., First Lien Term Loan, Due 6/3/20312024-12-310001825384Baker Tilly Advisory Group, L.P., First Lien Revolving Loan, Due 6/3/20302024-12-310001825384Baker Tilly Advisory Group, L.P., First Lien Delayed Draw Term Loan, Due 6/3/20262024-12-310001825384Babylon Buyer, Inc., First Lien Term Loan, Due 3/8/20302024-12-310001825384Babylon Buyer, Inc., First Lien Revolving Loan, Due 3/8/20302024-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, Two Due 10/5/20282024-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, One Due 10/5/20282024-12-310001825384ARMStrong Receivable Management, First Lien Term Loan, Due 10/5/20292024-12-310001825384ARMStrong Receivable Management, First Lien Revolving Loan, Due 10/5/20292024-12-310001825384ARMStrong Receivable Management, First Lien Delayed Draw Term Loan, Due 10/5/20292024-12-310001825384Ardonagh Finco B.V., First Lien Term Loan, Due 2/18/20312024-12-310001825384Arden Insurance Services LLC, First Lien Term Loan, Due 11/27/20302024-12-310001825384Arden Insurance Services LLC, First Lien Revolving Loan, Due 11/27/20302024-12-310001825384Aprio Advisory Group, LLC, First Lien Term Loan, Due 8/1/20312024-12-310001825384Aprio Advisory Group, LLC, First Lien Revolving Loan, Due 8/1/20312024-12-310001825384Aprio Advisory Group, LLC, First Lien Delayed Draw Term Loan, Due 8/1/20312024-12-310001825384Anaplan, Inc, First Lien Term Loan, Due 6/21/20292024-12-310001825384Anaplan, Inc, First Lien Revolving Loan, Due 6/21/20282024-12-310001825384Amerilife Holdings LLC, First Lien Term Loan, Due 8/31/20292024-12-310001825384AmeriLife Holdings LLC, First Lien Revolving Loan, Due 8/31/20282024-12-310001825384Amerilife Holdings LLC, First Lien Delayed Draw Term Loan, Two, Due 8/31/20292024-12-310001825384Amerilife Holdings LLC, First Lien Delayed Draw Term Loan, One, Due 8/31/20292024-12-310001825384ALKU Intermediate Holdings, LLC, First Lien Term Loan, Two Due 5/23/20292024-12-310001825384ALKU Intermediate Holdings, LLC, First Lien Term Loan, One Due 5/23/20292024-12-310001825384Alkeme Intermediary Holdings, LLC, First Lien Term Loan, Due 10/28/20262024-12-310001825384Alkeme Intermediary Holdings, LLC, First Lien Delayed Draw Term Loan, Due 10/28/20262024-12-310001825384Action Behavior Centers Therapy LLC, First Lien Term Loan, Due, 7/2/20312024-12-310001825384Action Behavior Centers Therapy LLC, First Lien Revolving Loan, Due, 7/2/20312024-12-310001825384Action Behavior Centers Therapy LLC, First Lien Delayed Draw Term Loan, Due, 7/2/20312024-12-310001825384Acentra Holdings, LLC, First Lien Term Loan, Two, Due 12/17/20292024-12-310001825384Acentra Holdings, LLC, First Lien Term Loan, Due 12/17/20292024-12-310001825384Acentra Holdings, LLC, First Lien Revolving Loan, Due, 12/17/20292024-12-310001825384Acentra Holdings, LLC, First Lien Delayed Draw Term Loan, Due 3/19/20262024-12-310001825384Accuserve Solutions, Inc., First Lien Term Loan, Due 3/15/20302024-12-310001825384Accuserve Solutions, Inc., First Lien Revolving Loan, Due 3/15/20302024-12-310001825384Accuserve Solutions, Inc., First Lien Delayed Draw Term Loan, Due 3/16/20262024-12-310001825384Accordion Partners LLC, First Lien Revolving Loan, Due 11/17/20312024-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan, Due 11/16/20262024-12-310001825384Accordion Partners LLC First Lien Term Loan Due 11/17/20312024-12-310001825384WWEX Uni Topco Holdings, LLC, Second Lien Term Loan, Due 7/26/20292023-12-310001825384Williams Martson, LLC, First Lien Term Loan, Due 8/25/20282023-12-310001825384Williams Martson, LLC, First Lien Revolving Loan, Due 8/25/20282023-12-310001825384Williams Martson, LLC, First Lien Delayed Draw Term Loan Due 8/26/20242023-12-310001825384Vision Solutions, Inc, Second Lien Term Loan, Due 4/23/20292023-12-310001825384Two Ten Holdco, Inc, First Lien Term Loan, Due 3/26/20262023-12-310001825384Two Ten Holdco, Inc, First Lien Revolving Loan, Due 3/26/20262023-12-310001825384TST Intermediate Holdings, LLC, First Lien Term Loan, Due 11/27/20262023-12-310001825384TST Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Due 11/27/20262023-12-310001825384Trinity Partners Holdings LLC, First Lien Term Loan, Due 12/21/20282023-12-310001825384Trinity Partners Holdings Llc First Lien Delayed Draw Term Loan Due 06/21/20252023-12-310001825384Tamarack Intermediate LLC, First Lien Revolving Loan, Due 3/13/20282023-12-310001825384Tamarack Intermediate Llc First Lien Delayed Draw Term Loans Due 3/13/20282023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, Two, Due 10/4/20272023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Revolving Loan, One, Due 10/4/20272023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Two, Due 10/4/20272023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Three, Due 10/4/20272023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, One, Due 10/4/20272023-12-310001825384TA/WEG Intermediate Holdings, LLC, First Lien Delayed Draw Term Loan, Four, Due 10/4/20272023-12-310001825384Syntax Systems Limited, First Lien Term Loan, Due 10/29/20282023-12-310001825384Syntax Systems Limited, First Lien Delayed Draw Term Loan, Due 10/15/20282023-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Term Loan, Due 1/2/20292023-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Revolving Loan, Due 12/29/20262023-12-310001825384Stepping Stones Healthcare Services, LLC, First Lien Delayed Draw Term Loan, Due 1/2/20292023-12-310001825384SpecialtyCare, Inc, First Lien Term Loan, Due 6/19/20282023-12-310001825384SpecialtyCare, Inc, First Lien Revolving Loan, Due 6/18/20262023-12-310001825384SpecialtyCare, Inc, First Lien Delayed Draw Term Loan, Due 6/19/20282023-12-310001825384Simplifi Holdings, Inc, First Lien Term Loan, Due 10/1/20272023-12-310001825384Simplifi Holdings, Inc, First Lien Revolving Loan, Due 10/1/20262023-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Two, Due 11/1/20292023-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Three, Due 11/1/20292023-12-310001825384RSC Acquisition, Inc, First Lien Term Loan, Due 11/1/20292023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Two, Due 11/1/20292023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Three, Due 11/1/20292023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, One, Due 11/1/20292023-12-310001825384RSC Acquisition, Inc, First Lien Delayed Draw Term Loan, Four, Due 11/1/20292023-12-310001825384Resolute Investment Managers, Inc, First Lien Revolving Loan, Due 4/30/20242023-12-310001825384Project K BuyerCo, Inc, First Lien Term Loan, Due 12/10/20272023-12-310001825384Project K BuyerCo, Inc, First Lien Revolving Loan, Due 12/10/20272023-12-310001825384Petra Borrower, LLC, First Lien Term Loan, Due 11/15/20302023-12-310001825384Petra Borrower, LLC, First Lien Revolving Loan, Due 11/15/20292023-12-310001825384Petra Borrower, LLC, First Lien Delayed Draw Term Loan, Due 5/15/20252023-12-310001825384People 2.0, Inc, First Lien Term Loan, Due 7/12/20282023-12-310001825384PAS Parent, Inc., First Lien Revolving Loan, Due 12/30/20272023-12-310001825384PAS Parent, Inc., First Lien Delayed Draw Term Loan, Due 12/15/20252023-12-310001825384Orion Advisor Solutions, Inc, Second Lien Term Loan, Due 9/24/20282023-12-310001825384OneDigital Borrower LLC, First Lien Term Loan, Due 11/16/20272023-12-310001825384One Digital Borrower Llc First Lien Delayed Draw Term Loan Due 9/16/20242023-12-310001825384none_cnst_string_AmerilifeGroupLlcFirstLienDelayedDrawTermLoanDue83020242023-12-310001825384NextGen Healthcare, First Lien Term Loan, Due 11/11/20302023-12-310001825384Next Holdco, LLC First Lien Revolving Loan, Due 11/9/20292023-12-310001825384Next Holdco, Llc First Lien Delayed Draw Term Loan Due 11/10/20252023-12-310001825384Neptune Flood Incorporated, First Lien Term Loan, Due 5/8/20292023-12-310001825384Neptune Flood Incorporated, First Lien Revolving Loan, Due 5/8/20292023-12-310001825384Neptune BidCo US Inc, Second Lien Term Loan, Due 10/11/20292023-12-310001825384More Cowbell II LLC, First Lien Term Loan, Due 9/2/20302023-12-310001825384More Cowbell II LLC, First Lien Revolving Loan, Due 9/3/20292023-12-310001825384More Cowbell II LLC, First Lien Delayed Draw Term Loan, Due 9/1/20252023-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Term Loan, Due 7/29/20262023-12-310001825384Mirra-PrimeAccess Holdings, LLC, First Lien Revolving Loan, Due 7/29/20262023-12-310001825384Ministry Brands Purchaser, LLC, First Lien Term Loan, Due 12/28/20282023-12-310001825384Ministry Brands Purchaser, LLC, First Lien Revolving Loan, Due 12/24/20272023-12-310001825384Ministry Brands Purchaser, LLC, First Lien Delayed Draw Term Loan, Due 12/28/20282023-12-310001825384Millennium Trust Co., LLC, First Lien Term Loan, Due 3/27/20262023-12-310001825384MBO Partners, Inc, First Lien Term Loan, Due 5/23/20282023-12-310001825384MBO Partners, Inc, First Lien Delayed Draw Term Loan, Due 5/23/20282023-12-310001825384MB2 Dental Solutions, LLC, First Lien Term Loan, One, Due 1/29/20272023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Two, Due 1/29/20272023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Three, Due 1/29/20272023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, One, Due 1/29/20272023-12-310001825384MB2 Dental Solutions, LLC, First Lien Delayed Draw Term Loan, Four, Due 1/29/20272023-12-310001825384Maverick 1 LLC, Second Lien Term Loan, Due 5/18/20292023-12-310001825384Mandolin Technology Intermediate Holdings, Inc, Second Lien Term Loan, Due 7/30/20292023-12-310001825384Kwol Acquisition Inc, First Lien Term Loan, Due 12/12/20292023-12-310001825384Kwol Acquisition Inc, First Lien Revolving Loan, Due 12/12/20292023-12-310001825384Imagine Acquisitionco, LLC, First Lien Term Loan, Due 11/16/20272023-12-310001825384Imagine Acquisitionco, LLC, First Lien Delayed Draw Term Loan, Due 11/16/20232023-12-310001825384IG Investments Holdings, LLC, First Lien Term Loan, Two, Due 9/22/20282023-12-310001825384IG Investments Holdings, LLC, First Lien Term Loan, One, Due 9/22/20282023-12-310001825384IG Investments Holdings, LLC, First Lien Revolving Loan, Due 9/22/20272023-12-310001825384Hyland Software, Inc, First Lien Term Loan, Due 9/19/20302023-12-310001825384Hyland Software, Inc, First Lien Revolving Loan, Due 9/19/20292023-12-310001825384Helpsystems Holdings, Inc, Second Lien Term Loan, Due 11/19/20272023-12-310001825384Harbor Purchaser Inc, Second Lien Term Loan, Due 4/8/20302023-12-310001825384GS Acquisitionco, Inc, First Lien Term Loan, Due 5/22/20262023-12-310001825384GraphPAD Sofware, LLC, First Lien Term Loan, Three, Due 4/27/20272023-12-310001825384GraphPAD Sofware, LLC, First Lien Term Loan, One, Due 4/27/20272023-12-310001825384GraphPAD Software, LLC, First Lien Term Loan, Two, Due 4/27/20272023-12-310001825384GraphPAD Software, LLC, First Lien Term Loan, Four, Due 4/27/20272023-12-310001825384GraphPAD Software, LLC, First Lien Delayed Draw Term Loan, Due 4/27/20272023-12-310001825384GovDelivery Holdings, LLC, First Lien Term Loan, Due 1/29/20272023-12-310001825384GovDelivery Holdings, LLC, First Lien Revolving Loan, Due 1/29/20272023-12-310001825384GovDelivery Holdings, LLC, First Lien Delayed Draw Term Loan, Due 1/29/20272023-12-310001825384Giving Home Health Care, First Lien Term Loan, Due 8/19/20272023-12-310001825384Giving Home Health Care, First Lien Revolving Loan, Due 8/19/20272023-12-310001825384Geosyntec Consultants, Inc, First Lien Term Loan, Due 5/18/20292023-12-310001825384Geosyntec Consultants, Inc, First Lien Revolving Loan, Due 5/18/20272023-12-310001825384Geosyntec Consultants Inc First Lien Delayed Draw Term Loan Due 5/18/20292023-12-310001825384Galway Borrower, LLC, First Lien Term Loan, Two, Due 9/29/20282023-12-310001825384Galway Borrower, LLC, First Lien Term Loan, Due 9/29/20282023-12-310001825384Galway Borrower, LLC, First Lien Revolving Loan, One, Due 9/30/20272023-12-310001825384Galway Borrower, LLC, First Lien Delayed Draw Term Loan, Due 10/28/20242023-12-310001825384Foundation Risk Partners, Corp, First Lien Term Loan, Due 10/27/20282023-12-310001825384Foundation Risk Partners, Corp, First Lien Delayed Draw Term Loan, Due 10/27/20282023-12-310001825384FINThrive Software Intermediate Holdings, Inc, Second Lien Term Loan, Due, 12/17/20292023-12-310001825384Explorer Investor, Inc, First Lien Term Loan, Due 6/28/20292023-12-310001825384Euclid Transactional, LLC, First Lien Term Loan, Due 10/2/20282023-12-310001825384Ensono, Inc, Second Lien Term Loan, Due 5/28/20292023-12-310001825384Ellkay, LLC, First Lien Term Loan, Due 9/14/20272023-12-310001825384Ellkay, LLC, First Lien Revolving Loan, Due 9/14/20272023-12-310001825384Edelman Financial Center, Second Lien Term Loan, Due 7/20/20262023-12-310001825384Diligent Corporation, First Lien Term Loan, Two, Due 8/4/20252023-12-310001825384Diligent Corporation, First Lien Term Loan, One, Due 8/4/20252023-12-310001825384Diligent Corporation, First Lien Revolving Loan, Due 8/4/20252023-12-310001825384Dcert Buyer, Inc, Second Lien Term Loan, Due 2/19/20292023-12-310001825384CORA Health Holdings Corp, First Lien Term Loan, Due 6/15/20272023-12-310001825384CORA Health Holdings Corp, First Lien Delayed Draw Term Loan, Due 6/15/20272023-12-310001825384CNSI Holdings, LLC, First Lien Term Loan, Due 12/15/20282023-12-310001825384CNSI Holdings, LLC, First Lien Revolving Loan, Due 12/17/20272023-12-310001825384Cliffwater, LLC, First Lien Term Loan, Due 10/7/20302023-12-310001825384Cliffwater, LLC, First Lien Revolving Loan, Due 10/7/20302023-12-310001825384Cherry Bekaert Advisory LLC, First Lien Term Loan, Due 6/30/20282023-12-310001825384Cherry Bekaert Advisory LLC, First Lien Delayed Draw Term Loan, Due 6/30/20242023-12-310001825384Captive Resources Midco, LLC, First Lien Term Loan, Due 6/29/20292023-12-310001825384Captive Resources Midco, LLC, First Lien Revolving Loan, Due 7/1/20282023-12-310001825384Bottomline Technologies, Inc, First Lien Term Loan, Due 5/14/20292023-12-310001825384Bottomline Technologies, Inc, First Lien Revolving Loan, Due 5/15/20282023-12-310001825384Belmont Buyer, Inc., First Lien Term Loan, Due 6/21/20292023-12-310001825384Belmont Buyer, Inc., First Lien Revolving Loan, Due 6/21/20292023-12-310001825384Belmont Buyer, Inc., First Lien Delayed Draw Term Loan, Due 6/21/20292023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Term Loan, Due 12/29/20282023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Revolving Loan, Due 12/29/20272023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Two, Due 12/29/20282023-12-310001825384Beacon Pointe Harmony, LLC, First Lien Delayed Draw Term Loan, Due 12/29/20282023-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, Two, Due 10/5/20282023-12-310001825384Auctane Holdings, LLC, First Lien Term Loan, One, Due 10/5/20282023-12-310001825384ARMStrong Receivable Management, First Lien Term Loan, Due 10/5/20292023-12-310001825384ARMStrong Receivable Management, First Lien Revolving Loan, Due 10/5/20292023-12-310001825384ARMStrong Receivable Management, First Lien Delayed Draw Term Loan, Due 10/6/20252023-12-310001825384Anaplan, Inc, First Lien Term Loan, Due 6/21/20292023-12-310001825384Anaplan, Inc, First Lien Revolving Loan, Due 6/21/20282023-12-310001825384AmeriLife Group LLC, First Lien Term Loan, Due 8/31/20292023-12-310001825384AmeriLife Group LLC, First Lien Revolving Loan, Due 8/31/20282023-12-310001825384ALKU Intermediate Holdings, LLC, First Lien term Loan, Due 5/23/20292023-12-310001825384Accuserve, First Lien Term Loan, Due 8/13/20292023-12-310001825384Accuserve, First Lien Delayed Draw Term Loan, Due 8/13/20242023-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan, Two, Due 8/29/20292023-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan, One Due, 8/29/20292023-12-310001825384Accordion Partners LLC, First Lien Delayed Draw Term Loan Three, Due, 8/29/20292023-12-310001825384Accordion Partners LLC First Lien Term Loan Due 8/29/20292023-12-310001825384Accordion Partners LLC First Lien Revolving Loan Due 8/31/20282023-12-310001825384Accordion Partners LLC First Lien Delayed Draw Term Loan Due 8/29/20292023-12-310001825384THL Fund IX Investors (Plymouth), L.P, Equity Investment2024-01-012024-12-310001825384Spirit RR Holdings, Inc., Equity Investment2024-01-012024-12-310001825384RSC Topco, Inc.2024-01-012024-12-310001825384Resolute Investment Managers, Inc. Equity Investment2024-01-012024-12-310001825384New Giving Acquisition, Inc., Equity Investment2024-01-012024-12-310001825384Imagine Acquisitionco, LLC, Equity Investment2024-01-012024-12-310001825384GT Polaris Holdings, Inc, Preferred Equity Investment2024-01-012024-12-310001825384Galway Borrower, LLC, Equity Investment One2024-01-012024-12-310001825384Eclipse Buyer, Inc. Preferred Equity 9/6/20242024-01-012024-12-310001825384ACC Ultimate Holdings, L.P., Equity Investment2024-01-012024-12-310001825384THL Fund IX Investors (Plymouth), L.P, Equity Investment2023-01-012023-12-310001825384Spirit RR Holdings, Inc., Equity Investment2023-01-012023-12-310001825384RSC Topco, Inc, Equity Investment2023-01-012023-12-310001825384Resolute Investment Managers, Inc. Equity Investment2023-01-012023-12-310001825384Imagine Acquisitionco, LLC, Equity2023-01-012023-12-310001825384GT Polaris Holdings, Inc., Equity Investment2023-01-012023-12-310001825384Giving Home Health Care, Warrants2023-01-012023-12-310001825384Galway Borrower, LLC, Equity Investment2023-01-012023-12-310001825384none:AffiliatedBrokerDealerMember2024-01-012024-12-310001825384none:AffiliatedBrokerDealerMember2023-01-012023-12-310001825384none:AffiliatedBrokerDealerMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMember2023-12-310001825384us-gaap:FairValueInputsLevel3Member2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMember2022-12-310001825384us-gaap:FairValueInputsLevel3Member2022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2021-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2021-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2021-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2021-12-310001825384us-gaap:FairValueInputsLevel3Member2021-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMember2024-01-012024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMember2023-01-012023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:CommonEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:CommonEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:CommonEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputEbitdaMultipleMembernone:ValuationTechniqueEnterpriseValueAnalysisMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:PreferredEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:CommonEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:PreferredEquityMemberus-gaap:MeasurementInputEbitdaMultipleMembernone:ValuationTechniqueEnterpriseValueAnalysisMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:CommonEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:PreferredEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:CommonEquityMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:CommonEquityAndWarrantsMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputRecoveryRateMembernone:ValuationRecoveryAnalysisMember2024-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2024-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:MinimumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2023-12-310001825384srt:MaximumMemberus-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMembernone:MeasurementInputMarketTransactionMemberus-gaap:MarketApproachValuationTechniqueMember2023-12-310001825384none:TwoThousandTwentyNineNotesMember2024-09-170001825384none:TwoThousandTwentyFiveNotesMember2022-05-190001825384us-gaap:SecuredDebtMember2024-12-310001825384us-gaap:RevolvingCreditFacilityMember2024-12-310001825384none:TwoThousandTwentyNineNotesMember2024-12-310001825384none:CapitalCallFacilityMember2024-12-310001825384us-gaap:SecuredDebtMember2023-12-310001825384us-gaap:RevolvingCreditFacilityMember2023-12-310001825384none:CapitalCallFacilityMember2023-12-310001825384us-gaap:SecuredDebtMemberus-gaap:SubsequentEventMember2025-03-032025-03-030001825384none:CapitalCallFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2024-12-272024-12-270001825384none:CapitalCallFacilityMemberus-gaap:FederalFundsEffectiveSwapRateMember2024-12-272024-12-270001825384none:CapitalCallFacilityMember2024-12-272024-12-270001825384none:CapitalCallFacilityMembernone:LetterAgreementForThirdAmendmentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-12-222023-12-220001825384none:CapitalCallFacilityMembernone:LetterAgreementForThirdAmendmentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-12-212023-12-210001825384none:CapitalCallFacilityMembernone:LetterAgreementForThirdAmendmentMember2023-12-212023-12-210001825384us-gaap:SecuredDebtMember2023-08-142023-08-140001825384none:CapitalCallFacilityMembernone:LetterAgreementForSecondAmendmentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-12-272022-12-270001825384none:CapitalCallFacilityMembernone:LetterAgreementForSecondAmendmentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-12-262022-12-260001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-01-282022-01-280001825384us-gaap:RevolvingCreditFacilityMember2022-01-282022-01-280001825384currency:GBPus-gaap:RevolvingCreditFacilityMember2021-06-282021-06-280001825384currency:EURus-gaap:RevolvingCreditFacilityMember2021-06-282021-06-2800018253842022-12-3100018253842021-12-3100018253842020-12-310001825384none:AdministrationAgreementMember2024-01-012024-12-310001825384none:AdministrationAgreementMember2023-01-012023-12-310001825384none:AdministrationAgreementMember2022-01-012022-12-310001825384none:TransferAgentServicingAgreementMember2024-12-310001825384none:TransferAgentServicingAgreementMember2023-12-310001825384none:WorldwideInsuranceNetworkLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:WilliamsMartsonLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:WilliamsMartsonLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:VitalCareBuyerLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:TstIntermediateHoldingsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:TstIntermediateHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:TrinityPartnersHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:TitanHomeImprovementLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:TitanHomeImprovementLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ThgAcquisitionLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ThgAcquisitionLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:TaWegIntermediateHoldingsLlcMembernone:FirstLienRevolvingLoanTwoMember2024-12-310001825384none:TaWegIntermediateHoldingsLlcMembernone:FirstLienRevolvingLoanOneMember2024-12-310001825384none:TaWegIntermediateHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:TamarackIntermediateLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:SteppingStonesHealthcareServicesLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:SteppingStonesHealthcareServicesLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:SpecialtycareInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:SouthpawApBuyerLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:SouthpawApBuyerLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:SimplifiHoldingsInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ProjectKBuyercoInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:PetraBorrowerLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:PetraBorrowerLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:PasParentInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:PasParentInc.Membernone:FirstLienDelayedDrawTermLoanTwoMember2024-12-310001825384none:PasParentInc.Membernone:FirstLienDelayedDrawTermLoanOneMember2024-12-310001825384none:OrionAdvisorSolutionsLlcMembernone:SecondLienDelayedDrawTermLoanMember2024-12-310001825384none:OnezeroFinancialSystemsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:OnezeroFinancialSystemsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:NxgenBuyerInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:NextgenHealthcareMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:NextgenHealthcareMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:NewMountainCapitalLlcMembernone:UnsecuredNoteTwoMember2024-12-310001825384none:NewMountainCapitalLlcMembernone:UnsecuredNoteThreeMember2024-12-310001825384none:NewMountainCapitalLlcMembernone:UnsecuredNoteOneMember2024-12-310001825384none:NewMountainCapitalLlcMembernone:UnsecuredNoteFourMember2024-12-310001825384none:MoreCowbellIiLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:MoreCowbellIiLlcMembernone:FirstLienDelayedDrawTermLoanOneMember2024-12-310001825384none:MirraPrimeAccessHoldingsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:MinotaurAcquisitionIncMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:MinotaurAcquisitionIncMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:MinistryBrandsPurchaserLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:Mb2DentalSolutionsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:Mb2DentalSolutionsLlcMembernone:FirstLienDelayedDrawTermLoanOneMember2024-12-310001825384none:MaiCapitalManagementIntermediateLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:MaiCapitalManagementIntermediateLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:LendingtreeInc.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:KwolAcquisitionInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:KrivAcquisitionInc.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ImagineAcquisitioncoLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:IgInvestmentsHoldingsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:HylandSoftwareInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:HbwmIntermediateIiLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:HbwmIntermediateIiLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:GuardianRestorationPartnersBuyersLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:GuardianRestorationPartnersBuyersLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:GsAcquisitioncoIncMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:GsAcquisitioncoIncMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:GovdeliveryHoldingsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:GalwayBorrowerLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:GalwayBorrowerLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:FoundationRiskPartnersCorp.Membernone:FirstLienRevolvingLoanOneMember2024-12-310001825384none:FoundationRiskPartnersCorp.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ExeterMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ElkayLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:EclipseBuyerInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:EclipseBuyerInc.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:DiligentCorporationMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:DiligentCorporationMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ContinentalBuyerInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ContinentalBuyerInc.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:CliffwaterLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ChoreoBuyerLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:CherryBekaertAdvisoryLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ChartisGroupLlcMembernone:FirstLienRevolvingLoanTwoMember2024-12-310001825384none:ChartisGroupLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:CaptiveResourcesMidcoLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:BottomlineTechnologiesInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:BelmontBuyerInc.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:BelmontBuyerInc.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:BeaconPointeHarmonyLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:BeaconPointeHarmonyLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:BakerTillyAdvisoryGroupL.p.Membernone:FirstLienRevolvingLoanMember2024-12-310001825384none:BakerTillyAdvisoryGroupL.p.Membernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ArmstrongReceivableManagementMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ArmstrongReceivableManagementMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ArdenInsuranceServicesLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AprioAdvisoryGroupLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AprioAdvisoryGroupLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:AnaplanIncMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AmerilifeHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:AmerilifeGroupLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AlkemeIntermediaryHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:ActionBehaviorCentersTherapyLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:ActionBehaviorCentersTherapyLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:AcentraHoldingsLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AcentraHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:AccuserveMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AccuserveMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:AccordionPartnersLlcMembernone:FirstLienRevolvingLoanMember2024-12-310001825384none:AccordionPartnersLlcMembernone:FirstLienDelayedDrawTermLoanMember2024-12-310001825384none:WilliamsMartsonLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:WilliamsMartsonLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:TwoTenHoldcoIncMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:TstIntermediateHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:TrinityPartnersHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:TaWegIntermediateHoldingsLlcMembernone:FirstLienRevolvingLoanOneMember2023-12-310001825384none:TaWegIntermediateHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:TamarackIntermediateLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:SyntaxSystemsLimitedMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:SteppingStonesHealthcareServicesLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:SteppingStonesHealthcareServicesLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:SpecialtycareInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:SimplifiHoldingsInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:RscAcquisitionInc.Membernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:ProjectKBuyercoInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:PetraBorrowerLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:PetraBorrowerLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:PasParentInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:PasParentInc.Membernone:FirstLienDelayedDrawTermLoanOneMember2023-12-310001825384none:OnedigitalBorrowerLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:NextgenHealthcareMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:NextgenHealthcareMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:NeptuneFloodIncorporatedMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:MoreCowbellIiLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:MoreCowbellIiLlcMembernone:FirstLienDelayedDrawTermLoanOneMember2023-12-310001825384none:MirraPrimeAccessHoldingsLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:MinistryBrandsPurchaserLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:Mb2DentalSolutionsLlcMembernone:FirstLienDelayedDrawTermLoanOneMember2023-12-310001825384none:KwolAcquisitionInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:ImagineAcquisitioncoLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:IgInvestmentsHoldingsLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:HylandSoftwareInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:GovdeliveryHoldingsLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:GivingHomeHealthCareMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:GeosyntecConsultantsInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:GeosyntecConsultantsInc.Membernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:GaphpadSoftwareLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:GalwayBorrowerLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:GalwayBorrowerLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:ElkayLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:DiligentCorporationMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:CnsiHoldingsLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:CliffwaterLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:CherryBekaertAdvisoryLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:CaptiveResourcesMidcoLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:BottomlineTechnologiesInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:BelmontBuyerInc.Membernone:FirstLienRevolvingLoanMember2023-12-310001825384none:BelmontBuyerInc.Membernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:BeaconPointeHarmonyLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:BeaconPointeHarmonyLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:ArmstrongReceivableManagementMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:ArmstrongReceivableManagementMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:AnaplanIncMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:AmerilifeHoldingsLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:AmerilifeGroupLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:AccuserveMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384none:AccordionPartnersLlcMembernone:FirstLienRevolvingLoanMember2023-12-310001825384none:AccordionPartnersLlcMembernone:FirstLienDelayedDrawTermLoanMember2023-12-310001825384us-gaap:PrivatePlacementMember2024-01-012024-12-310001825384us-gaap:PrivatePlacementMember2023-01-012023-12-310001825384us-gaap:PrivatePlacementMember2022-01-012022-12-310001825384none:InvestmentAdvisoryAgreementMember2024-01-012024-12-310001825384none:SubAdministrationAgreementMember2024-12-310001825384none:SubAdministrationAgreementMember2023-12-310001825384none:TransferAgentServicingAgreementMember2024-01-012024-12-310001825384none:TransferAgentServicingAgreementMember2023-01-012023-12-310001825384none:TransferAgentServicingAgreementMember2022-01-012022-12-310001825384none:CapitalCallFacilityMembernone:LetterAgreementForFourthAmendmentMember2024-12-272024-12-270001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForFourthAmendmentMember2024-06-272024-06-270001825384none:CertainCircumstancesToIncreaseSizeOfCreditFacilityMemberus-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-01-282022-01-280001825384us-gaap:RevolvingCreditFacilityMembernone:LetterAgreementForSecondAmendmentMember2022-01-282022-01-280001825384us-gaap:FairValueInputsLevel3Member2024-12-310001825384us-gaap:TechnologySectorMember2024-01-012024-12-310001825384us-gaap:RealEstateSectorMember2024-01-012024-12-310001825384us-gaap:NonUsMember2024-01-012024-12-310001825384us-gaap:InsuranceSectorMember2024-01-012024-12-310001825384us-gaap:HealthcareSectorMember2024-01-012024-12-310001825384us-gaap:FinancialServicesSectorMember2024-01-012024-12-310001825384us-gaap:ConsumerSectorMember2024-01-012024-12-310001825384none:UnsecuredNoteMember2024-01-012024-12-310001825384none:SoftwareSectorMember2024-01-012024-12-310001825384none:SecondLienLoansMember2024-01-012024-12-310001825384none:ProfessionalServicesSectorMember2024-01-012024-12-310001825384none:PreferredEquityMember2024-01-012024-12-310001825384none:HealthCareTechnologySectorMember2024-01-012024-12-310001825384none:FirstLienLoansMember2024-01-012024-12-310001825384none:ConsumerFinanceSectorMember2024-01-012024-12-310001825384none:CommonEquityAndWarrantsMember2024-01-012024-12-310001825384none:CapitalMarketSectorMember2024-01-012024-12-310001825384country:US2024-01-012024-12-310001825384us-gaap:TechnologySectorMember2023-01-012023-12-310001825384us-gaap:RealEstateSectorMember2023-01-012023-12-310001825384us-gaap:NonUsMember2023-01-012023-12-310001825384us-gaap:InsuranceSectorMember2023-01-012023-12-310001825384us-gaap:HealthcareSectorMember2023-01-012023-12-310001825384us-gaap:FinancialServicesSectorMember2023-01-012023-12-310001825384us-gaap:ConsumerSectorMember2023-01-012023-12-310001825384none:UnsecuredNoteMember2023-01-012023-12-310001825384none:SoftwareSectorMember2023-01-012023-12-310001825384none:SecondLienLoansMember2023-01-012023-12-310001825384none:ProfessionalServicesSectorMember2023-01-012023-12-310001825384none:PreferredEquityMember2023-01-012023-12-310001825384none:HealthCareTechnologySectorMember2023-01-012023-12-310001825384none:FirstLienLoansMember2023-01-012023-12-310001825384none:ConsumerFinanceSectorMember2023-01-012023-12-310001825384none:CommonEquityAndWarrantsMember2023-01-012023-12-310001825384none:CapitalMarketSectorMember2023-01-012023-12-310001825384country:US2023-01-012023-12-3100018253842021-01-012021-12-310001825384none:TwoThousandTwentyNineNotesMember2024-09-172024-12-310001825384us-gaap:SecuredDebtMember2024-01-012024-12-310001825384us-gaap:RevolvingCreditFacilityMember2024-01-012024-12-310001825384none:CapitalCallFacilityMember2024-01-012024-12-310001825384us-gaap:SecuredDebtMember2023-08-142023-12-310001825384us-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001825384none:TwoThousandTwentyFiveNotesMember2023-01-012023-12-310001825384none:CapitalCallFacilityMember2023-01-012023-12-310001825384us-gaap:RevolvingCreditFacilityMember2022-01-012022-12-310001825384none:CapitalCallFacilityMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2024-01-012024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2024-01-012024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2024-01-012024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2024-01-012024-12-310001825384us-gaap:FairValueInputsLevel3Member2024-01-012024-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2023-01-012023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2023-01-012023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2023-01-012023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2023-01-012023-12-310001825384us-gaap:FairValueInputsLevel3Member2023-01-012023-12-310001825384us-gaap:FairValueInputsLevel3Membernone:UnsecuredNoteMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:SecondLienLoansMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:PreferredEquityMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Membernone:FirstLienLoansMember2022-01-012022-12-310001825384us-gaap:FairValueInputsLevel3Member2022-01-012022-12-3100018253842022-01-012022-12-310001825384none:TwoThousandTwentyFiveNotesMember2024-12-310001825384none:TwoThousandTwentyFiveNotesMember2023-12-310001825384none:ScenarioTwoForIncreaseInInterestRateMembernone:TwoThousandTwentyNineNotesMember2024-09-172024-09-170001825384none:ScenarioOneForIncreaseInInterestRateMembernone:TwoThousandTwentyNineNotesMember2024-09-172024-09-170001825384none:ScenarioTwoForIncreaseInInterestRateMember2022-05-192022-05-190001825384none:ScenarioOneForIncreaseInInterestRateMember2022-05-192022-05-190001825384us-gaap:SecuredDebtMember2024-01-012024-12-310001825384us-gaap:RevolvingCreditFacilityMember2024-01-012024-12-310001825384none:TwoThousandTwentyNineNotesMember2024-01-012024-12-310001825384none:TwoThousandTwentyFiveNotesMember2024-01-012024-12-310001825384none:CapitalCallFacilityMember2024-01-012024-12-3100018253842023-01-012023-12-3100018253842024-12-3100018253842023-12-310001825384none:AdministrationAgreementMember2024-12-310001825384none:AdministrationAgreementMember2023-12-3100018253842024-10-012024-12-3100018253842025-03-2400018253842024-01-012024-12-31xbrli:sharesiso4217:USDxbrli:purenone:itemiso4217:USDxbrli:shares

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2024

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 814-01375

Stone Point Credit Corporation

(Exact name of registrant as specified in its charter)

Delaware

(State of Incorporation)

20 Horseneck Lane

Greenwich, Connecticut 06830

(Address of principal executive offices)

85-3149929

(I.R.S. Employer Identification No.)

(203) 862-2900

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading

Symbol

    

Name of each exchange

on which registered

None

 

None

 

None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.001 per share

(Title of class)

Indicate by check mark if the registrant is a well - known seasoned issuer, as defined in Rule 405 of the Securities Act Yes  No 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404 (b) of the Sarbanes - Oxley Act (15 U.S.C. 7262 (b)) by the registered public accounting firm that prepared or issued its audit report. 

If securities are registered pursuant to Section 12 (b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive - based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D - 1 (b).

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes      No  

The issuer had 63,054,004 shares of common stock, $0.001 par value per share, outstanding as of March 24, 2025.

Auditor Firm ID: 185 Auditor Name: KMPG LLP Auditor Location: New York, New York.

Table of Contents

Stone Point Credit Corporation

FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2024

TABLE OF CONTENTS

 

Index

    

Page No.

PART I.

Item 1.

Business

8

Item 1A.

Risk Factors

30

Item 1B.

Unresolved Staff Comments

57

Item 1C.

Cybersecurity

57

Item 2.

Properties

58

Item 3.

Legal Proceedings

58

Item 4.

Mine Safety Disclosures

58

PART II.

Item 5.

Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters

58

Item 6.

Reserved

60

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

60

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

82

Item 8.

Financial Statements and Supplementary Data

83

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

128

Item 9A.

Controls and Procedures

128

Item 9B.

Other Information

128

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

128

PART III.

Item 10.

Directors, Executive Officers and Corporate Governance

129

Item 11.

Executive Compensation

132

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

132

Item 13.

Certain Relationships and Related Transactions, and Director Independence

133

Item 14.

Principal Accounting Fees and Services

139

PART IV.

Item 15.

Exhibits and Financial Statement Schedules

141

Signatures

144

2

Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Unless indicated otherwise, the “Company,” “we,” “us,” and “our” refer to Stone Point Credit Corporation, and the “Adviser” refers to Stone Point Credit Adviser LLC, an affiliate of Stone Point Capital LLC (“Stone Point Capital” together with the Adviser and its credit-focused affiliates, as applicable, “Stone Point Credit”). This annual report on Form 10-K contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current and prospective portfolio investments, our industry, our beliefs and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” and variations of these words and similar expressions are intended to identify forward-looking statements.

The Company has based the forward-looking statements included in this annual report on information available to the Company on the date of this report, and the Company assumes no obligation to update any such forward-looking statements, unless the Company is required to do so by applicable law. However, you are advised to consult any additional disclosures that the Company may make directly to you or through reports that the Company in the future may file with the Securities and Exchange Commission (the “SEC”), including future annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including:

our future operating results;
our business prospects and the prospects of our portfolio companies;
risk associated with possible disruptions in our operations or the economy generally, including disruptions from the impact of any public health emergencies or crises;
interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;
the impacts of rising interest and inflation rates and the risk of recession on our business prospects and the prospects of our portfolio companies;
general economic, political and industry trends and other external factors, including uncertainty surrounding the financial and political stability of the United States, the United Kingdom, the European Union, China, Russia, Ukraine and the Middle East;
our contractual arrangements and relationships with third parties;
actual and potential conflicts of interest with our Adviser and its affiliates;
the dependence of our future success on the general economy and its effect on the industries in which we invest;
the ability of our portfolio companies to achieve their objectives;
the adequacy of our financing sources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies;
the ability of our Adviser to locate suitable investments for us and to monitor and administer our investments;
the ability of our Adviser and its affiliates to attract and retain highly talented professionals;

3

Table of Contents

our ability to maintain our qualification as a business development company (“BDC”) and as a regulated investment company (“RIC”) under the Internal Revenue Code of 1986, as amended (the “Code”);
the effect of changes in tax laws and regulations and interpretations thereof; and
the risks, uncertainties and other factors we identify under “Item 1A. Risk Factors” and elsewhere in this report.

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of the assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled “Item 1A. Risk Factors” and elsewhere in this report. You should not place undue reliance on these forward-looking statements.

You should understand that under Section 27A(b)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports we file under the Exchange Act.

4

Table of Contents

Summary of Risk Factors

Investing in the Company’s common stock (the “Common Stock”) involves a high degree of risk. Some, but not all, of the risks and uncertainties that the Company faces are summarized below. Please refer to “Item 1A Risk Factors” for a more fulsome description of each risk.

Risks Relating to the Company’s Business and Structure

The Company has limited operating history.
The success of the Company depends in substantial part on the experience and knowledge of the Adviser and its Investment Team.
Legal, tax and regulatory changes could occur that may adversely affect the Company at any time during its term.
The business of identifying and structuring investments of the types contemplated by the Company is highly competitive and involves a high degree of uncertainty.
Certain sectors targeted by the Company are cyclical and subject to significant fluctuation.
The information and technology systems of the Company, the Adviser and their respective service providers may be vulnerable to cyber-attacks.
The Common Stock is an illiquid investment for which there is not a secondary market nor is it expected that any such secondary market will develop in the future.
Stockholders of the Company (“Stockholders”) may be subject to significant adverse consequences in the event such a Stockholder defaults on its capital commitment to the Company.
The Adviser will not assume any responsibility to the Company other than to render the services described in its Investment Advisory Agreement with the Company, and it will not be responsible for any action of the Board in declining to follow the Adviser’s advice or recommendations.
If the Company does not maintain its status as a BDC, the Company might be regulated as a closed-end investment company under the 1940 Act, which would subject it to substantially more regulatory restrictions and correspondingly decrease the Company’s operating flexibility.
The Company is an “emerging growth company” as defined in the JOBS Act.
As a public entity, the Company is subject to the reporting requirements of the Exchange Act and requirements of the Sarbanes-Oxley Act.
We have elected to be treated as a RIC under Subchapter M of the Code, and we intend to operate in a manner so as to continue to qualify for the tax treatment applicable to RICs. To qualify for tax treatment as a RIC, we must, among other things, distribute to our Stockholders in each taxable year generally at least 90% of the sum of our investment company taxable income, as defined in the Code (without regard to the deduction for dividends paid), and net tax-exempt income, if any, for that taxable year.
Certain of the Company’s debt investments may contain provisions providing for the payment of paid-in-kind (“PIK”) interest.
The Company is subject to certain restrictions imposed by the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).

5

Table of Contents

Stockholders may experience dilution.
The net asset value and liquidity, if any, of the market for shares of the Common Stock may be significantly affected by numerous factors, some of which are beyond the Company’s control and may not be directly related to the Company’s operating performance.
The amount of any distributions the Company may make on the Common Stock is uncertain.
The Company’s business faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities.
The Company intends to operate as a non-diversified investment company within the meaning of the 1940 Act, which means that the Company will not be limited by the 1940 Act with respect to the proportion of its assets that it may invest in a single issuer.
There can be no assurance that there will be a sufficient number of suitable investment opportunities satisfying the investment objectives of the Company to enable the Company to invest all of its committed capital, or that such investment opportunities will lead to completed investments by the Company.
The Company may co-invest in portfolio companies with third parties (including, in certain circumstances, investment funds, accounts and investment vehicles managed by the Adviser and its affiliates) through partnerships, joint ventures or other arrangements.
The Company may make minority investments, or may make investments in “club” deals alongside entities sponsored by other private credit or private equity firms, in portfolio companies where the Company may not have the right to appoint a director or otherwise be able to control or effectively influence the business or affairs of such entities.
The Company may, subject to the limitations described herein, incur leverage in connection with its operations, collateralized by its assets and/or capital commitments.
General interest rate fluctuations may have a substantial negative impact on the Company’s investments, the value of the Company’s Common Stock and the Company’s rate of return on invested capital.
In connection with certain portfolio investments, the Company may employ hedging techniques designed to reduce the risk of adverse movements in interest rates, securities prices and currency exchange rates.
The Adviser and its affiliates may have actual and potential conflicts of interest.

6

Table of Contents

Risks Relating to the Company’s Investments

Increased interest rates and inflation will increase financing costs for portfolio companies.
The Company will acquire a significant percentage of its portfolio company investments from privately held companies in directly negotiated transactions.
Investments in private and middle-market companies involves a number of significant risks.
The Company’s investment portfolio may contain securities or instruments issued by publicly held companies.
The Company will accept subscriptions and will maintain books and records in dollars although the Company may invest a portion of capital outside of the United States (and in various foreign currencies).
The Company’s investments will be subject to various risks, particularly the risk that the Company will be unable to realize its investment objectives by sale or other disposition at attractive prices or be unable to complete any exit strategy.
Investing in the Company presents certain risks, including, but not limited to, risks associated with: credit, investments in loans, “higher-yielding” debt securities, stressed and distressed investments, investments in public companies, credit ratings, prepayment, and interest rates.

7

Table of Contents

PART I.

Item 1. Business

The Company – Stone Point Credit Corporation

Stone Point Credit Corporation (the “Company” or “we”) is a specialty finance company focused on lending to middle market companies. We are an externally-managed closed-end investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, for tax purposes we have elected to be treated and intend to qualify annually as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. No assurance can be given that our investment objective will be achieved, and investment results may vary substantially on a monthly, quarterly and annual basis. Stone Point Credit Adviser LLC (the “Adviser” or together with its credit-focused affiliates, as applicable “Stone Point Credit”) believes that our investment objective can be achieved by primarily investing in senior secured debt, including first lien, second lien and unitranche debt, or unsecured loans and, to a lesser extent, subordinated loans, mezzanine loans and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company’s common equity. We may invest without limit in originated or syndicated debt. The Adviser is an affiliate of Stone Point Capital LLC (“Stone Point Capital” and together with Stone Point Credit and Stone Point Capital’s other affiliates, as applicable, “Stone Point” or the “Firm”).

The instruments in which we invest typically are not rated by any rating agency, but the Adviser believes that if such instruments were rated, they would be below investment grade, which is an indication of having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. Investments that are rated below investment grade are sometimes referred to as “high yield bonds,” “junk bonds” or “leveraged loans.” Therefore, our investments may result in an above average amount of risk and volatility or loss of principal.

The Adviser believes that the current market environment presents an attractive investment opportunity for the Company. Private equity sponsors have significant levels of capital available for investment, which the Adviser believes will continue to drive demand for direct lending over the coming years as private equity firms seek to deploy capital through leveraged buyouts. In addition to favorable market dynamics, the Adviser believes the Investment Team’s extensive network of contacts, which includes financial sponsors, debt investors, banks and specialty lenders, as well as the Adviser’s targeted outbound search model, combined with Stone Point’s reputation and record as a leader in investing in the financial services industry, provides the Company with a significant competitive advantage in sourcing attractive investment opportunities. Stone Point has created a network in sourcing, monitoring and workouts/restructuring that may be utilized by the Adviser as needed in managing the Company’s investments.

Corporate Structure

The Company was formed as Stone Point Capital Credit LLC, a Delaware limited liability company, on September 8, 2020. On December 1, 2020, in connection with its election to be regulated as a BDC, the Company changed its name and converted to Stone Point Credit Corporation, a Delaware corporation, and the member of Stone Point Capital Credit LLC became the sole stockholder of Stone Point Credit Corporation.

On June 11, 2021, the Company formed SPCC Funding I LLC (the “SPV”), a wholly-owned financing subsidiary, for the purpose of holding pledged investments as collateral under a financing facility. On April 24, 2023, the Company formed SPCC Funding II LLC (“SPV II,” and together with the SPV, the “SPVs”), a wholly-owned financing subsidiary, for the purpose of holding pledged investments as collateral under a financing facility.

The Adviser – Stone Point Credit Adviser LLC

Subject to the supervision of the Board of Directors (the “Board”), pursuant to an investment advisory agreement between the Company and the Adviser dated December 1, 2020 (the “Investment Advisory Agreement”), the Adviser manages the day-to-day operations of the Company and provides the Company and other separately managed accounts (the “Credit Funds”) with investment advisory and management services. The Board, including a majority of the Independent Directors (as defined below), most recently approved the renewal of the Investment Advisory Agreement for a one-year term in November 2024. The Adviser is an affiliate of

8

Table of Contents

Stone Point, which is an alternative investment management platform specializing in investments within the global financial services industry and related sectors with an investment track record of over 25 years. As of December 31, 2024, Stone Point had over $65 billion of assets under management, including over $10 billion managed by the Adviser.

Pursuant to a resource sharing agreement between Stone Point Capital and the Adviser (the “Resource Sharing Agreement”), Stone Point Capital makes the investment professionals on the Stone Point Credit investment team (the “Stone Point Credit Investment Team”) available to the Adviser for purposes of originating and identifying investment opportunities, conducting research and due diligence on prospective investments, analyzing and underwriting investment opportunities, structuring investments and monitoring and servicing the Company’s investments in accordance with the services provided by the Adviser under the Investment Advisory Agreement (“Credit Activities”). On an as needed basis, certain other investment professionals on the Stone Point Capital private equity investment team (the “Stone Point Capital Private Equity Team” and together with the Stone Point Credit Investment Team, the “Investment Team”) contribute a portion of their time, effort and knowledge to support Credit Activities. The Stone Point Credit Investment Team employs a blend of top-down and bottom-up analysis. The senior members of the Stone Point Credit Investment Team have been actively involved in the alternative credit investing market for many years and have built strong relationships with private equity sponsors, banks and financial intermediaries. As of December 31, 2024, the Investment Team was comprised of more than 80 investment professionals. A majority of the Investment Team is focused on the private equity markets; however, Stone Point intends to continue to expand the dedicated Stone Point Credit Investment Team to support the ongoing growth of the Company and expansion of Credit Activities. As of December 31, 2024, the Stone Point Credit Investment Team was comprised of 28 dedicated investment professionals. In addition, the Investment Team is supported by finance, tax, operational, administrative, legal, compliance, investor relations, business development and information technology professionals. Certain of these individuals have additional responsibilities other than those relating to the Company, including the other Credit Funds and private equity products sponsored by Stone Point Capital, but allocate a portion of their time in support of the Company’s business and investment objective.

The Adviser’s investment committee servicing the Company is comprised of Scott J. Bronner, James D. Carey, Eric L. Rosenzweig, David J. Wermuth and Nicolas D. Zerbib (the “Credit Investment Committee”), who bring substantial private equity, investment banking, insurance, government and executive management experience. The Credit Investment Committee is responsible for making all investment and disposition decisions subject to the supervision of the Board, a majority of which is made up of Independent Directors.

The Adviser believes that the Investment Team’s and Credit Investment Committee’s extensive network of contacts, which includes financial sponsors, debt investors, banks and specialty lenders, as well as the Adviser’s targeted outbound search model and its reputation and record as a leader in investing in the financial services industry, provide the Company with a significant competitive advantage in sourcing and underwriting attractive investment opportunities. Stone Point has created a network in sourcing, monitoring and workouts/restructuring that may be utilized by the Adviser as needed in managing the Company’s investments.

The Board of Directors

The Company’s business and affairs are managed under the direction of its Board. The Board consists of five members, three of whom are not “interested persons” of the Company, the Adviser or their respective affiliates as defined in Section 2(a)(19) of the 1940 Act. These individuals are referred to as the “Independent Directors.” The Independent Directors compose a majority of the Board. Directors who are “interested persons,” as defined in Section 2(a)(19) of the 1940 Act, of the Company or the Adviser are referred to herein as “Interested Directors.” The Board elects the Company’s officers, who serve at the discretion of the Board. The responsibilities of the Board include oversight of the Adviser’s quarterly valuation of the Company’s assets, corporate governance activities, oversight of the Company’s financing arrangements and oversight of the Company’s investment activities.

1

Certain communications between professionals within the Stone Point Capital Private Equity Team and professionals within Stone Point Credit Investment Team may be restricted due to internal policy restrictions.

2

Includes one investment team professional whose focus is shared across Stone Point Credit and Stone Point Capital.

9

Table of Contents

History of Stone Point

Stone Point Capital has a history of successfully investing in the global financial services industry over a period of more than thirty years. The platform began in 1985 and operated as MMC Capital under the ownership of Marsh & McLennan Companies, Inc. until 2005. Current Managing Directors of Stone Point Capital led the management of MMC Capital from 1998 until 2005, when they formed Stone Point Capital to acquire the business from Marsh & McLennan. Between 1985 and 1993, Stone Point Capital continued to execute a strategy of investing in property & casualty underwriting businesses on an opportunistic basis as market opportunities were identified. In 1994, Stone Point Capital formed its first private equity fund with committed capital to invest in underwriting companies operating principally within the insurance industry. During the last twenty-six years, the scope of investment activities has broadened to include other financial services companies, including companies in the following sectors: insurance distribution, insurance services, healthcare and managed care services, human capital management, business services, wealth management and fund administration, asset management, real estate finance and services, insurance underwriting, and lending and markets. We believe that Stone Point Capital’s experience, reputation and contacts have enabled it to attract experienced management teams, to identify, evaluate and respond quickly to market opportunities, and to work actively in partnership with managers to enhance the value of portfolio companies in numerous segments within the financial services industry.

In 2020, certain Managing Directors of Stone Point Capital formed Stone Point Credit to assume responsibility for managing the corporate and consumer credit-focused investment vehicles managed by Stone Point Capital. Stone Point Credit has raised and manages a full suite of credit strategies, which are accessible through commingled funds and customized separately managed accounts. Stone Point Credit seeks to leverage the Firm’s deep industry knowledge and extensive network to pursue credit-oriented investment opportunities across the financial services, business services, software and technology, and healthcare services sectors.

Investment Objective and Strategy

The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. The Company seeks to invest primarily in senior secured or unsecured loans and, to a lesser extent, subordinated loans, mezzanine loans and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company’s common equity.

The Company generally expects to invest in middle market companies with earnings before interest expense, income tax expense, depreciation and amortization, or “EBITDA,” between $30 million and $250 million annually. Typical middle market senior loans may be issued by middle market companies in the context of leveraged buyouts, acquisitions, debt refinancings, recapitalizations, and other similar transactions. Notwithstanding the foregoing, the Adviser may determine whether companies qualify as “middle market” in its sole discretion, and the Company may from time to time invest in larger or smaller companies if an attractive opportunity presents itself, especially when there are dislocations in the capital markets, including the high yield and syndicated loan markets. The Company’s target credit investments typically have maturities between 3 and 6 years and generally range in size between $20 million and $100 million. The investment size will vary with the size of the Company’s capital base. The Company has adopted a non-fundamental policy to invest, under normal market conditions, at least 75% of the value of its total assets (measured at the time of each such investment taking into account certain initial assumptions regarding the expected amount of total assets of the Company once fully invested) in portfolio companies that are in the financial services, business services, software and technology or healthcare services sectors. The remaining 25% of the value of the Company’s total assets (measured at the time of each such investment taking into account certain initial assumptions regarding the expected amount of total assets of the Company once fully invested) may be invested across a wide range of sectors (although the Company expects to avoid businesses which at the time of the Company’s investment participate in certain sectors such as payday lending, pawn shops, automobile title and tax refund anticipation loans, credit repair services, strip mining, drug paraphernalia, marijuana related businesses, tax evasion gaming and pornography).

The Company expects to generate revenues primarily through receipt of interest income from its investments. In addition, the Company may generate income from capital gains on the sales of loans and debt and equity related securities and various loan origination and other fees and dividends on direct equity investments.

As a BDC, the Company must invest at least 70% of its assets in “qualifying assets,” which may include investments in “eligible portfolio companies.” Under the relevant SEC rules, the term “eligible portfolio company” includes all U.S. private operating companies and small U.S. public operating companies with a market capitalization of less than $250 million. See “Item 1. Business – Qualifying Assets.

10

Table of Contents

Market Opportunity and Competitive Advantages

The Adviser believes the Company presents an attractive investment opportunity for several reasons, including:

Increasing Demand for Debt Capital. Private equity sponsors have significant levels of capital available for investment, which the Adviser believes will continue to drive demand for direct lending over the coming years as private equity firms seek to deploy capital through leveraged buyouts. The Company believes this dynamic, coupled with the Adviser’s strong relationships in the middle market, will provide significant investment opportunities for the Company.

Proactive Sourcing and Relationship-Driven Deal Flow. The Adviser believes that focusing its activities on proactive, outbound, multi-year searches produces higher quality investment opportunities. The Adviser seeks investment opportunities in sectors that it believes are attractive using a focused three-prong origination strategy. In sourcing investments for the Company, the Adviser leverages (i) its dedicated team of origination professionals and Stone Point’s broker-dealer professionals focusing on sponsor communities and financial intermediaries within targeted sectors, (ii) its extensive network of private equity investment professionals, focused on more than 75 financial services-related end markets, and (iii) its longstanding relationships with commercial banks who may provide investment opportunities to the Company.

Disciplined Underwriting Process. The Adviser seeks investment opportunities that it believes are attractive using a rigorous “top-down” and “bottom-up” process. The Adviser regularly evaluates and selects sectors on which to focus based on an investment thesis (top-down approach) and designates a team of investment professionals to identify leading companies and managers in these sectors (bottom-up approach). For more than 75 identified sectors of the financial services industry, this process includes:

Firm-wide discussions to prioritize the identified sectors;
Dedicating small teams of investment professionals to study these sectors;
Interaction with industry experts and attendance at key industry conferences; and
Proactive outbound calling efforts and meetings with private equity sponsors and management teams.

The Adviser employs a “triangulation” approach in evaluating the quality of a credit, focused on borrower characteristics, loan structure and quality of sponsorship. The Adviser generally seeks to invest in companies that have experienced management teams, are recognized as market leaders by consumers and peers, operate in industries with high entry barriers for competitors, and generate consistent free cash flow. In structuring a loan, the Adviser generally focuses on determining appropriate leverage levels (with a significant focus on adjustments and free cash flow), ensuring sufficient minimum sponsor equity and seeking to mitigate downside risk through structural protections. Finally, the Adviser seeks to invest in companies with strong financial sponsor ownership, focused on underwriting a sponsor’s ability to support the borrower.

Sector Focus. The Company makes its investments primarily in sectors in which Stone Point has developed a longstanding network and can leverage real-time insights from private portfolio companies to provide a discernible origination and underwriting edge. The Adviser currently focuses the Company’s investments in the financial services, business services, software and technology, and healthcare services sectors. As a result of this specialization by the Investment Team, the Adviser believes that it is well positioned to source proprietary deals and evaluate a broad range of investments with a deep understanding of the market dynamics and cycles for these sectors.

Further, the Adviser believes the Company’s focus on the financial services, business services, software and technology, and healthcare services sectors provides strong downside protection, given the low default rates in these industries, as well as Stone Point’s investment experience. The Company’s targeted sectors have performed well across market cycles, consistently generating lower cumulative default rates compared with non-financial sectors, which should contribute to enhanced risk-adjusted returns.

Ability to Leverage Stone Point’s Experienced Investment Team. The Adviser intends to utilize Stone Point Capital’s significant experience and knowledge throughout the life cycle of each investment to support the Stone Point Credit Investment Team’s Credit Activities. On an as-needed basis, Stone Point Capital Private Equity Team contributes a portion of its time, effort and resources to support Credit Activities. Stone Point Capital has a long, successful record of making investments and managing businesses in the financial services industry. Stone Point Capital has raised nine private equity funds with an investment track record of over 25 years and a focus on investments in companies in the global financial services industry and related sectors. Stone Point

11

Table of Contents

Capital and its affiliates have invested in 26 asset management platforms over 16 years and Stone Point believes that its experience investing in and building businesses across a variety of credit strategies, positions the Company for success in the direct lending middle market. The Stone Point Credit Investment Team is responsible for making all investment and disposition recommendations to the Credit Investment Committee. The Credit Investment Committee makes all investment and disposition decisions, subject to Board oversight. As of December 31, 2024, the Investment Team is comprised of more than 80 investment professionals who bring to Stone Point considerable experience with Stone Point and/or from other leading private equity, private debt, investment banking, financial services, corporate law, and accounting firms. A majority of the Investment Team is focused on the private equity markets; however, Stone Point intends to continue to expand the Stone Point Credit Investment Team to support the ongoing growth of the Company and expansion of Credit Activities. As of December 31, 2024, the Credit Investment Team was comprised of 28 dedicated investment professionals3.

Experienced Investment Committee. The Credit Investment Committee servicing the Company is comprised of Scott J. Bronner, James D. Carey, Eric L. Rosenzweig, David J. Wermuth and Nicolas D. Zerbib. Additionally, Charles A. Davis and Stephen Friedman serve as advisors to the Credit Investment Committee. The Credit Investment Committee currently leads the investment activities of the Credit Funds and has worked together at Stone Point for more than ten years investing across multiple credit cycles and different investing environments.

Mr. Bronner is the President of the Company, Head of Stone Point Credit and Managing Director of Stone Point Capital, and a member of the Credit Investment Committee, Allocation Committee and Valuation Committee of the Adviser. Prior to joining the Firm in 2009, he was in the Private Equity Division at Lehman Brothers Inc.
Mr. Carey is Co-Chief Executive Officer of Stone Point Capital, a member of the Credit Investment Committee and the Investment Committee of the Trident Funds, and a member of the Allocation Committee of the Adviser. Prior to joining the Firm in 1997, he was in the Financial Institutions Investment Banking Group at Merrill Lynch & Co. and prior to that time was an attorney with Kelley Drye & Warren LLP.
Mr. Rosenzweig is a Managing Director of Stone Point Capital and a member of the Credit Investment Committee and Valuation Committee of the Adviser. Prior to joining the Firm in 2006, he was in the Financial Institutions Investment Banking Group at UBS Investment Bank.
Mr. Wermuth is the Chairman of the Company and is Co-President and Chief Operating Officer of Stone Point Capital, a member of the Credit Investment Committee and the Investment Committee of the Trident Funds, and a member of the Allocation Committee and Valuation Committee of the Adviser. Prior to joining the Firm in 1999, he was an attorney specializing in mergers and acquisitions at Cleary, Gottlieb, Steen & Hamilton LLP and prior to that time an auditor for KPMG Peat Marwick.
Mr. Zerbib is Co-President and Chief Investment Officer of Stone Point Capital, a member of the Credit Investment Committee and the Investment Committee of the Trident Funds, and a member of the Valuation Committee of the Adviser. Prior to joining the Firm in 1998, he was in the Financial Institutions Group at Goldman Sachs.

3

Includes one employee whose focus is shared across Stone Point Credit and Stone Point Capital.

12

Table of Contents

Mr. Davis is the Chairman and Co-Chief Executive Officer of Stone Point Capital, Advisor to the Credit Investment Committee and the Chairman of the Investment Committee of the Trident Funds. Prior to joining the Firm in 1998, Mr. Davis was with Goldman, Sachs & Co. for 23 years where he served as head of Investment Banking Services worldwide, co-head of the Americas Group, head of the Financial Services Industry Group, a member of the International Executive Committee and a General Partner.
Mr. Friedman is the Senior Chairman of Stone Point Capital, Advisor to the Credit Investment Committee and a member of the Investment Committee of the Trident Funds. Prior to joining the Firm in 1998, Mr. Davis was with Goldman, Sachs & Co., the Investment Committee of the Trident Funds. Prior to joining the Firm in 1998, Mr. Davis was with Goldman, Sachs & Co., where he served as Chairman. In addition, he previously served as Assistant to President George W. Bush for Economic Policy and Director of the National Economic Council, Chairman of the President’s Intelligence Advisory Board and Intelligence Oversight Board, and Chairman of the Board of Directors of the Federal Reserve Bank of New York. Mr. Friedman joined Goldman Sachs in 1966 and became a Partner in 1973. He was Vice Chairman and Co-Chief Operating Officer from 1987 to November 1990, and co-Chairman or Chairman from 1990 to 1994.

All investment and disposition decisions are reviewed and approved by the Credit Investment Committee, which has principal responsibility for approving new investments and overseeing the management of existing investments. This senior management team is supported by a team of investment professionals who bring to Stone Point considerable experience with Stone Point and/or from other leading private equity, investment banking, financial services, corporate law and accounting firms.

The following table sets forth the experience of the Credit Investment Committee.

    

Years in

    

Financial

Years at

The Credit Investment Committee

Services

Stone Point

Scott J. Bronner, Head of Stone Point Credit and Managing Director of Stone Point

Capital Member of the Credit Investment Committee

18

16

James D. Carey, Co-Chief Executive Officer of Stone Point Capital

 

Member of the Credit Investment Committee

31

 

28

Eric L. Rosenzweig, Managing Director of Stone Point Capital

 

Member of the Credit Investment Committee

21

 

19

David J. Wermuth, Co-President and Chief Operating Officer of Stone Point Capital

 

Member of the Credit Investment Committee

29

 

26

Nicolas D. Zerbib, Co-President and Chief Investment Officer of Stone Point Capital

Member of the Credit Investment Committee

29

26

Charles A. Davis, Chairman and Co-Chief Executive Officer of Stone Point Capital

Advisor to the Credit Investment Committee

30+

26

Stephen Friedman, Senior Chairman of Stone Point Capital

 

Advisor to the Credit Investment Committee

30+

 

24

Investment Advisory Agreement

The Company entered into the Investment Advisory Agreement dated December 1, 2020 with the Adviser. The Board, including a majority of the Independent Directors, most recently approved the renewal of the Investment Advisory Agreement for a one-year term in November 2024. Pursuant to the Investment Advisory Agreement, the Adviser manages the Company’s day-to-day operations and provides the Company with investment advisory services. Among other things, the Adviser (i) determines the composition and allocation of the Company’s investment portfolio, the nature and timing of the changes therein and the manner of implementing such changes; (ii) identifies, evaluates and negotiates the structure of the investments made by the Company; (iii) performs due diligence on prospective portfolio companies; (iv) executes, closes, services and monitors the Company’s investments; (v) determines the securities and other assets that the Company will purchase, retain or sell; (vi) arranges financings and borrowing facilities for the Company and (vii) provides the Company with such other investment advisory, research and related services as the Company may, from time to time, reasonably require for the investment of its funds and (viii) to the extent permitted under the 1940 Act and the Investment Advisers Act of 1940 (the “Advisers Act”), on the Company’s behalf, and in coordination with any sub-adviser and any administrator,

13

Table of Contents

provides significant managerial assistance to those portfolio companies to which the Company is required to provide such assistance under the 1940 Act, including utilizing appropriate personnel of the Adviser to, among other things, monitor the operations of the Company’s portfolio companies, participate in board and management meetings, consult with and advise officers of portfolio companies and provide other organizational and financial consultation. The Adviser’s services under the Investment Advisory Agreement are not exclusive, and the Adviser is generally free to furnish similar services to other entities so long as its performance under the Investment Advisory Agreement is not adversely affected.

Under the Investment Advisory Agreement, the Company pays the Adviser (i) a base management fee and (ii) an incentive fee as compensation for the investment advisory and management services it provides the Company thereunder.

Base Management Fee

The Company pays to the Adviser an asset-based fee (the “Management Fee”) for management services in an amount equal to an annual rate of 1.30% of the average value of the Company’s gross assets (excluding cash and cash equivalents) as of the last day of the most recently completed calendar quarter and the last day of the immediately preceding calendar quarter payable quarterly in arrears. The Management Fee for any partial quarter is appropriately prorated based on the actual number of days elapsed during such partial quarter as a fraction of the number of days in the relevant calendar year.

Incentive Fee

Beginning December 21, 2024, on the fourth anniversary of the date on which Stockholders are required to fund their initial drawdown (the “Incentive Commencement Date”), the Company will pay the Adviser an incentive fee (“Incentive Fee”) as set forth below. The Incentive Fee will consist of two parts. The first part (the “Investment Income Incentive Fee”) will be calculated and payable following the Incentive Commencement Date on a quarterly basis, in arrears, and will equal 15% of “pre-incentive fee net investment income” for the immediately preceding calendar quarter, subject to a quarterly preferred return of 1.75% (i.e., 7% annualized) measured on a quarterly basis and a “catch-up feature”. For purposes of computing the initial installment of the Investment Income Incentive Fee, because the Incentive Commencement Date does not fall on the first day of a calendar quarter, the initial payment of the Investment Income Incentive Fee shall be payable for the period that commences on the Incentive Commencement Date through the last day of the first complete calendar quarter immediately following the Incentive Commencement Date (March 31, 2025), and, thereafter, at the end of each subsequent calendar quarter as described above. The second part (the “Capital Gains Incentive Fee”) will be an annual fee that will also commence with the period beginning on the Incentive Commencement Date and will be determined and payable following the Incentive Commencement Date, in arrears, as of the end of each calendar year (or upon termination of the Investment Advisory Agreement) in an amount equal to 15% of realized capital gains, if any, determined on a cumulative basis from the Incentive Commencement Date through the end of such calendar year (or upon termination of the Investment Advisory Agreement), computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis from the Incentive Commencement Date (based on the fair market value of each investment as of such date) through the end of such calendar year (or upon termination of the Investment Advisory Agreement), less the aggregate amount of any previously paid Capital Gains Incentive Fees. For the purpose of computing the Capital Gains Incentive Fees, the calculation methodology will look through derivative financial instruments or swaps as if the Company owned the reference assets directly.

Pre-incentive fee net investment income means interest income, dividend income and any other income accrued during the calendar quarter, minus operating expenses for the quarter, including the base Management Fee, expenses payable to the Administrator under the Administration Agreement, any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding (x) the Incentive Fee and (y) any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as debt instruments with payment-in-kind (“PIK”) interest and zero-coupon securities), accrued income that the Company has not yet received in cash. The Adviser is not obligated to return to the Company the Incentive Fee it receives on PIK interest that is later determined to be uncollectible in cash.

14

Table of Contents

The following is a graphical representation of the calculation of the income incentive fee:

Incentive Fee on

Pre-Incentive Fee Net Investment Income

Beginning on the Incentive Commencement Date

(expressed as a percentage of average adjusted capital)

Graphic

Percentage of Pre-Incentive Fee Net Investment Income

Allocated to Quarterly Incentive Fee

The second component of the Incentive Fee is the Capital Gains Incentive Fee. The Capital Gains Incentive Fee is payable at the end of each calendar year in arrears and equals, commencing on the Incentive Commencement Date, 15.0% of cumulative realized capital gains, net of all realized capital losses and unrealized capital depreciation on a cumulative basis from the Incentive Commencement Date to the end of each calendar year. Each year, the Capital Gains Incentive Fee will be paid net of the aggregate amount of any previously paid Capital Gains Incentive Fee for prior periods. The Company will accrue, but will not pay, a Capital Gains Incentive Fee with respect to unrealized appreciation because a Capital Gains Incentive Fee would be owed to the Adviser if the Company were to sell the relevant investment and realize a capital gain. The fees that are payable under the Investment Advisory Agreement for any partial period will be appropriately prorated. For the sole purpose of calculating the Capital Gains Incentive Fee, the cost basis as of the Incentive Commencement Date for all of the Company’s investments made prior to the date of the Exchange Listing will be equal to the fair market value of such investments as of the last day of the calendar quarter in which the date of the Exchange Listing occurs; provided, however, that in no event will the Capital Gains Incentive Fee payable pursuant to the Investment Advisory Agreement exceed the amount permitted by the Advisers Act, including Section 205 thereof.

Indemnification

Pursuant to the Investment Advisory Agreement, the Adviser and its directors, officers, stockholders, members, agents, representatives, employees, controlling persons, and any other person or entity affiliated with, or acting on behalf of the Adviser will not be liable to the Company for their acts under the Investment Advisory Agreement, absent willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties. The Company will also agree to indemnify, defend and protect the Adviser and its directors, officers, stockholders, members, agents, representatives, employees, controlling persons and any other person or entity affiliated with, or acting on behalf of the Adviser with respect to all damages, liabilities, costs and expenses resulting from acts of the Adviser not arising out of willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties.

The Administrator; Sub-Administrator

Stone Point Credit Adviser LLC also serves as the administrator of the Company (in such capacity, the “Administrator”). Subject to the supervision of the Board, the Administrator provides the administrative services necessary for the Company to operate and the Company utilizes the Administrator’s office facilities, equipment and recordkeeping services. In addition, the Company will reimburse the Administrator for the fees and expenses associated with performing compliance functions, and the Company’s allocable portion of the compensation of certain of the Company’s officers, including the Company’s Chief Financial Officer, Chief Compliance Officer and any support staff. The Company reimburses the Administrator for all reasonable costs and expenses incurred by the Administrator

15

Table of Contents

in providing these services, facilities and personnel, as provided by the administration agreement by and between the Company and the Administrator (the “Administration Agreement”). There is no separate fee paid in connection with the services provided under the Administration Agreement. In addition, the Administrator is permitted to delegate its duties under the Administration Agreement to affiliates or third parties, and the Company reimburses the expenses of these parties incurred directly and/or paid by the Administrator on the Company’s behalf. The Administrator may elect to waive certain charges that would have otherwise been eligible for reimbursement under the terms of the Administration Agreement which will not be subject to recoupment.

The Administrator has entered into a sub-administration agreement (the “Sub-Administration Agreement”) with U.S. Bank Global Fund Services (the “Sub-Administrator”) under which the Sub-Administrator provides various accounting and other administrative services with respect to the Company. The Company pays the Sub-Administrator fees for services the Adviser determines are commercially reasonable in its sole discretion. The Company also reimburses the Sub-Administrator for all reasonable expenses. To the extent that the Sub-Administrator outsources any of its functions, the Sub-Administrator pays any compensation associated with such functions. The cost of such compensation, and any other costs or expenses under the Sub-Administration Agreement, is in addition to the cost of any services borne by the Company under the Administration Agreement.

Expenses

The Company’s primary operating expenses include the payment of fees to the Adviser under the Investment Advisory Agreement, the Company’s allocable portion of overhead expenses under the Administration Agreement, and all other costs and expenses relating to the Company’s operations and transactions, including: operational and organizational costs; the costs of any public offerings of the Company’s Common Stock and other securities, including registration and listing fees; the cost of calculating the Company’s net asset value, including the cost and expenses of third-party valuation services; fees and expenses payable to third parties relating to evaluating, making and disposing of investments, including the Adviser’s or its affiliates’ travel expenses, research costs and out-of-pocket fees and expenses associated with performing due diligence and reviews of prospective investments, monitoring investments and, if necessary, enforcing the Company’s rights; interest payable on debt and other borrowing costs, if any, incurred to finance the Company’s investments; costs of effecting sales and repurchases of the Company’s Common Stock and other securities; the base Management Fee and any incentive fee; distributions on the Company’s Common Stock; transfer agent and custody fees and expenses; the allocated costs incurred by the Administrator in providing managerial assistance to those portfolio companies that request it; other expenses incurred by the Administrator, the Adviser or the Company in connection with administering the Company’s business, including payments made to third-party providers of goods or services; brokerage fees and commissions; federal and state registration fees; U.S. federal, state and local taxes; Independent Directors’ fees and expenses; costs associated with the Company’s reporting and compliance obligations under the 1940 Act and applicable U.S. federal and state securities laws; costs of any reports, proxy statements or other notices to Stockholders, including printing costs; costs of holding Stockholders meetings; the Company’s fidelity bond; directors’ and officers’ errors and omissions liability insurance, and any other insurance premiums; litigation, indemnification and other non-recurring or extraordinary expenses; direct costs and expenses of administration and operation, including printing, mailing, long distance telephone, staff, audit, compliance, tax and legal costs; fees and expenses associated with marketing efforts; dues, fees and charges of any trade association of which the Company is a member; and all other expenses reasonably incurred by the Company, the Administrator or the Sub-Administrator in connection with administering the Company’s business.

The Company makes use of certain “mixed-use” services, products and resources that are utilized by the Adviser to provide investment advisory and administrative services to other clients or for proprietary purposes, including but not limited to research and information services, information technology services and software platforms, and third-party service providers. To the extent that the cost of such services may be borne in part by the Company as an operating expense, the Administrator may use various methodologies to determine the Company’s allocable portion of the total cost of such service, product or resource, including but not limited to allocating between the Company and other clients pro rata based on number of clients receiving such services, proportionately in accordance with asset size, or on such other basis that the Administrator determines to be fair and equitable under the circumstances.

The Company will reimburse the Administrator for the allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including furnishing the Company with office facilities, equipment and clerical, bookkeeping and recordkeeping services at such facilities, as well as providing the Company with other administrative services. In addition, the Company will reimburse the Administrator for the fees and expenses associated with performing compliance functions, and the Company’s allocable portion of the compensation of certain of the Company’s officers, including the Company’s Chief Financial Officer, Chief Compliance Officer and any support staff.

16

Table of Contents

Dividend Reinvestment Plan

The Company has adopted an “opt out” dividend reinvestment plan (“DRIP”), under which a Stockholder’s distributions would automatically be reinvested under the DRIP in additional whole and fractional Shares, unless the Stockholder “opts out” of the DRIP, thereby electing to receive cash dividends.

Prior to an Exchange Listing, the Company uses newly issued shares of Common Stock to implement the DRIP. Shares of Common Stock are issued at a price per share equal to the most recent net asset value per share determined by the Board.

After an Exchange Listing, if any, the number of shares of Common Stock to be issued to a Stockholder is expected to be determined by dividing the total dollar amount of the distribution payable to such Stockholder by the market price per share of the Company’s Common Stock at the close of regular trading on the national securities exchange on which the Company’s Common Stock is traded on the date of such distribution. However, in the event the market price per share on the date of such distribution exceeds the most recently computed net asset value per share, the Company would expect to issue shares of Common Stock at the greater of the most recently computed net asset value per share or 95% of the current market price per share (or such lesser discount to the current market price per share that still exceeds the most recently computed net asset value per share). The market price per share on that date would be the closing price for the shares of Common Stock on the national securities exchange on which the Common Stock is traded or, if no sale is reported for such day, at the average of their reported bid and asked prices.

Stockholders who receive distributions in the form of additional shares of Common Stock generally will be subject to the same U.S. federal, state and local tax consequences as Stockholders who elect not to reinvest distributions. Participation in the DRIP will not in any way reduce the amount of a Stockholder’s Capital Commitment.

Regulation as a Business Development Company

The Company has elected to be treated as a BDC under the 1940 Act. As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. The 1940 Act contains prohibitions and restrictions relating to transactions between BDCs and their affiliates (including any investment advisers or sub-advisers), principal underwriters and affiliates of those affiliates or underwriters and requires that a majority of the directors be persons other than “interested persons,” as that term is defined in the 1940 Act.

In addition, the 1940 Act provides that the Company may not change the nature of the Company’s business so as to cease to be, or to withdraw the Company’s election as a BDC unless approved by a majority of the Company’s outstanding voting securities. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (i) 67% or more of the voting securities present at such meeting, if the holders of more than 50% of the outstanding voting securities of such company are present or represented by proxy or (ii) more than 50% of the outstanding voting securities of such company.

Any issuance of preferred stock must comply with the requirements of the 1940 Act. The 1940 Act requires, among other things, that (1) immediately after issuance and before any dividend or other distribution is made with respect to the Company’s Common Stock and before any purchase of Common Stock is made, such preferred stock together with all other senior securities must not exceed an amount equal to 50% of the Company’s total assets after deducting the amount of such dividend, distribution or purchase price, as the case may be, and (2) the holder of shares of preferred stock, if any are issued, must be entitled as a class to elect two directors at all times and to elect a majority of the directors if dividends on such preferred stock are in arrears by two full years or more.

Certain other matters under the 1940 Act require a separate class vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would be entitled to vote separately as a class from the holders of Common Stock on a proposal involving a plan of reorganization adversely affecting such securities.

The Company may invest up to 100% of the Company’s assets in securities acquired directly from issuers in privately negotiated transactions. With respect to such securities, the Company may, for the purpose of public resale, be deemed a “principal underwriter” as that term is defined under the Securities Act. The Company may purchase or otherwise receive warrants which offer an opportunity (not a requirement) to purchase equity of a portfolio company in connection with an acquisition financing or other investments. Similarly, the Company may acquire rights that obligate an issuer of acquired securities or their affiliates to repurchase the securities at certain times, under certain circumstances.

17

Table of Contents

The Company does not intend to acquire securities issued by any investment company whereby the Company’s investment would exceed the limits imposed by the 1940 Act. Under those limits, the Company generally cannot acquire more than (i) 3% of the total outstanding voting stock of any investment company, (ii) invest more than 5% of the value of the Company’s total assets in the securities of one investment company, or (iii) invest more than 10% of the value of the Company’s total assets in the securities of investment companies in general. These limitations do not apply where the Company (i) makes investments through a subsidiary or (ii) acquires interests in a money market fund as long as the Company does not pay a sales charge or service fee in connection with the purchase. In October 2020, the SEC adopted certain regulatory changes related to the ability of investment companies, including BDCs, to invest in other investment companies in excess of the limits imposed by the 1940 Act. These changes include, among other things, the adoption of Rule 12d1-4 under the 1940 Act. Under Rule 12d1-4, the Company may acquire securities issued by any investment company in excess of the limits imposed by the 1940 Act as long as the Company complies with the conditions of Rule 12d1-4, which include, among other things, certain post-acquisition limits on control and voting of any acquired RIC. The portion of the Company’s portfolio invested in securities issued by investment companies, if any, ordinarily will subject Stockholders to additional expenses. The Company’s investment portfolio is also subject to diversification requirements by virtue of the Company’s intention to be a RIC for U.S. tax purposes.

None of the Company’s policies described above are fundamental and each such policy may be changed without Stockholder approval, subject to any limitations imposed by the 1940 Act.

Private funds that are excluded from the definition of “investment company” pursuant to either Section 3(c)(1) or 3(c)(7) of the 1940 Act are also subject to certain of the limits under the 1940 Act noted above. Specifically, such private funds generally may not acquire directly or through a controlled entity more than 3% of the Company’s total outstanding voting stock (measured at the time of the acquisition). As a result, such private funds would be required to hold a smaller position in the Company’s stock than if they were not subject to this restriction.

Qualifying Assets

The Company may invest up to 30% of the Company’s portfolio opportunistically in “non-qualifying assets”, which are driven primarily through opportunities sourced through the Adviser. However, under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as “qualifying assets,” unless, at the time the acquisition is made, qualifying assets represent at least 70% of the BDC’s total assets. The principal categories of qualifying assets relevant to the Company’s proposed business are the following:

1.Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act and rules adopted pursuant thereto as any issuer which:
a.is organized under the laws of, and has its principal place of business in, the United States;
b.is not an investment company (other than a small business investment company wholly owned by the BDC) or a company that would be an investment company but for certain exclusions under the 1940 Act; and
c.satisfies any of the following:
i.does not have any class of securities that is traded on a national securities exchange;
ii.has a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and non-voting common equity of less than $250 million;
iii.is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company; or
iv.is a small and solvent company having total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million.

18

Table of Contents

2.Securities of any eligible portfolio company which the Company controls.
3.Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities, was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.
4.Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and the Company already owns 60% of the outstanding equity of the eligible portfolio company.
5.Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of warrants or rights relating to such securities.
6.Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment.

In addition, a BDC must have been organized and have its principal place of business in the United States and must be operated for the purpose of making investments in the types of securities described in 1., 2., 3. or 4. above.

If at any time less than 70% of the Company’s gross assets are comprised of qualifying assets, including as a result of an increase in the value of any non-qualifying assets or decrease in the value of any qualifying assets, the Company would generally not be permitted to acquire any additional non-qualifying assets, other than office furniture and equipment, interests in real estate and leasehold improvements and facilities maintained to conduct the business operations of the BDC, deferred organizational and operating expenses, and other non-investment assets necessary and appropriate to its operations as a BDC, until such time as 70% of the Company’s then current gross assets were comprised of qualifying assets. The Company would not be required, however, to dispose of any non-qualifying assets in such circumstances.

Managerial Assistance to Portfolio Companies

A BDC must have been organized under the laws of, and have its principal place of business in, any state or states within the United States and must be operated for the purpose of making investments in the types of securities described in 1., 2. or 3. above. However, in order to count portfolio securities as qualifying assets for the purpose of the 70% test, the BDC must either control the issuer of the securities or must offer to make available to the issuer of the securities (other than small and solvent companies described above) significant managerial assistance; except that, where the BDC purchases such securities in conjunction with one or more other persons acting together, one of the other persons in the group may make available such managerial assistance. Making available managerial assistance means, among other things, any arrangement whereby the BDC, through its directors or officers, offers to provide, and, if accepted, does so provide, significant guidance and counsel concerning the management, operations or business objectives and policies of a portfolio company.

Temporary Investments

The Company generally expects to call capital for investment purposes only at the time the Company identifies an investment opportunity. Notwithstanding the foregoing, the Company expects to deploy all proceeds from each capital call for investment purposes within two years of calling such capital. Until such time as the Company invests the proceeds of such capital calls in portfolio companies and while new investments are pending, the Company’s investments may consist of cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment, referred to herein, collectively, as “temporary investments,” so that 70% of the Company’s assets are qualifying assets. The Company may invest in U.S. Treasury bills or in repurchase agreements, provided that such agreements are fully collateralized by cash or securities issued by the U.S. government or its agencies. A repurchase agreement involves the purchase by an investor, such as the Company, of a specified security and the simultaneous agreement by the seller to repurchase it at an agreed-upon future date and at a price which is greater than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction on the proportion of the Company’s assets that may be invested in such repurchase agreements. However, if more than 25% of the Company’s net assets constitute repurchase agreements from a single counterparty, the Company may not meet the diversification tests in order to qualify as a RIC. Thus, the Company does not intend to enter into repurchase agreements with a single counterparty in excess of this limit. The

19

Table of Contents

Adviser will monitor the creditworthiness of the counterparties with which the Company enters into repurchase agreement transactions.

Code of Ethics

The Company and the Adviser have each adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain transactions by the Company’s personnel. Personnel subject to each code may invest in securities for their personal investment accounts, including securities that may be purchased or held by the Company, so long as such investments are made in accordance with the code’s requirements. The Company has also adopted a code of ethics which applies to, among others, our senior officers, including our chief executive officer and chief financial officer, as well as all of our officers and directors. The Company’s code of ethics is attached as an exhibit to this Annual Report on Form 10-K.

Compliance Policies and Procedures

The Company and the Adviser have adopted and implemented written policies and procedures reasonably designed to detect and prevent violation of the federal securities laws and are required to review these compliance policies and procedures annually for their adequacy and the effectiveness of their implementation and designate a Chief Compliance Officer to be responsible for administering the policies and procedures. Brian J. Rooder currently serves as the Company’s Chief Compliance Officer.

Sarbanes-Oxley Act of 2002

The Sarbanes-Oxley Act imposes a wide variety of regulatory requirements on publicly-held companies and their insiders. Many of these requirements will affect the Company. For example:

pursuant to Rule 13a-14 of the Exchange Act, the Company’s Principal Executive Officer and Principal Financial Officer must certify the accuracy of the financial statements contained in the Company’s periodic reports;
pursuant to Item 307 of Regulation S-K, the Company’s periodic reports must disclose the Company’s conclusions about the effectiveness of its disclosure controls and procedures;
pursuant to Rule 13a-15 of the Exchange Act, the Company’s management is required to prepare a report regarding its assessment of the Company’s internal control over financial reporting and (once the Company ceases to be an emerging growth company under the JOBS Act or, if later, for the year following the Company’s first annual report required to be filed with the SEC) must obtain an audit of the effectiveness of internal control over financial reporting performed by its independent registered public accounting firm; and
pursuant to Item 308 of Regulation S-K and Rule 13a-15 of the Exchange Act, the Company’s periodic reports must disclose whether there were significant changes in the Company’s internal control over financial reporting or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

The Sarbanes-Oxley Act requires the Company to review its current policies and procedures to determine whether the Company complies with the Sarbanes-Oxley Act and the regulations promulgated thereunder. The Company will continue to monitor its compliance with all regulations that are adopted under the Sarbanes-Oxley Act and will take actions necessary to ensure that the Company is in compliance therewith.

Proxy Voting Policies and Procedures

The Company has delegated its proxy voting responsibility to the Adviser. As a fiduciary, the Adviser has a duty to monitor corporate events and to vote proxies, as well as a duty to cast votes in the best interest of the Company and not to subrogate Company interests to its own interests. To meet its fiduciary obligations, the Adviser seeks to ensure that it votes proxies in the best interest of the Company, and addresses how the Adviser will resolve any conflict of interest that may arise when voting proxies. The Adviser’s proxy voting policy attempts to generalize a complex subject and the Adviser may, from time to time, determine that it is in the best interests of the Company to depart from specific policies described therein.

20

Table of Contents

Stockholders may, without charge, obtain information regarding how the Company voted proxies with respect to the Company’s portfolio securities by making a written request for proxy voting information to: Chief Compliance Officer, 20 Horseneck Lane, Greenwich, Connecticut 06830 or by contacting the Company’s investor relations department at SPCreditIR@stonepoint.com.

Reporting Obligations

The Company will furnish the Stockholders with annual reports containing audited financial statements, quarterly reports, and such other periodic reports as the Company determines to be appropriate or as may be required by law. The Company is required to comply with all periodic reporting, proxy solicitation and other applicable requirements under the Exchange Act. Stockholders and the public may view materials the Company files with the SEC free of charge on its website (http://www.sec.gov) or by contacting the Company’s investor relations department at SPCreditIR@stonepoint.com.

Material U.S. Federal Income Tax Considerations

The following discussion is a general summary of certain material U.S. federal income tax considerations applicable to the Company and an investment in shares of Common Stock. The discussion is based upon the Code, the regulations of the U.S. Department of Treasury promulgated thereunder, referred to herein as the “Treasury regulations,” the legislative history of the Code, current administrative interpretations and practices of the Internal Revenue Service, referred to herein as the “IRS” (including administrative interpretations and practices of the IRS expressed in private letter rulings which are binding on the IRS only with respect to the particular taxpayers that requested and received those rulings) and judicial decisions, each as of the date of this Form 10-K and all of which are subject to change or differing interpretations, possibly retroactively, which could affect the continuing validity of this discussion. The Company has not sought, and will not seek, any ruling from the IRS regarding any matter discussed in this summary, and this summary is not binding on the IRS. Accordingly, there can be no assurance that the IRS will not assert, and a court will not sustain, a position contrary to any of the tax consequences discussed below.

Investors should note that this summary does not purport to be a complete description of all the tax aspects affecting the Company or the Stockholders. For example, this summary does not describe all of the U.S. federal income tax consequences that may be relevant to certain types of Stockholders subject to special treatment under the U.S. federal income tax laws, including Stockholders subject to the alternative minimum tax, tax-exempt organizations, insurance companies, partnerships or other pass-through entities and their owners, Non-U.S. Stockholders (as defined below) engaged in a trade or business in the United States or entitled to claim the benefits of an applicable income tax treaty, persons who have ceased to be U.S. citizens or to be taxed as residents of the United States, U.S. Stockholders (as defined below) whose functional currency is not the U.S. dollar, persons holding the Company’s Common Stock in connection with a hedging, straddle, conversion or other integrated transaction, dealers in securities, traders in securities that elect to use a mark-to-market method of accounting for securities holdings, pension plans and trusts, and financial institutions. This summary assumes that Stockholders hold shares of Common Stock as capital assets for U.S. federal income tax purposes (generally, assets held for investment). This summary does not discuss any aspects of U.S. estate or gift taxation, U.S. state or local taxation or non-U.S. taxation. It does not discuss the special treatment under U.S. federal income tax laws that could result if the Company invests in tax-exempt securities or certain other investment assets.

For purposes of this discussion, a “U.S. Stockholder” is a beneficial owner of shares of Common Stock that is, for U.S. federal income tax purposes:

an individual who is a citizen or resident of the United States;
a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state thereof, including, for this purpose, the District of Columbia;
a trust if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” (as defined in the Code) have the authority to control all substantive decisions of the trust, or (ii) the trust has in effect a valid election to be treated as a domestic trust for U.S. federal income tax purposes; or
an estate, the income of which is subject to U.S. federal income taxation regardless of its source.

21

Table of Contents

For purposes of this discussion, a “Non-U.S. Stockholder” is a beneficial owner of shares of Common Stock that is not a U.S. Stockholder or a partnership (or an entity or arrangement treated as a partnership) for U.S. federal income tax purposes.

If a partnership, or other entity or arrangement treated as a partnership for U.S. federal income tax purposes, holds shares of Common Stock, the U.S. federal income tax treatment of a partner in the partnership generally will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. A Stockholder that is a partnership holding shares of Common Stock, and each partner in such a partnership, should consult his, her or its own tax adviser with respect to the tax consequences of the purchase, ownership and disposition of shares of Common Stock.

Tax matters are very complicated and the tax consequences to each Stockholder of the ownership and disposition of shares of Common Stock will depend on the facts of such Stockholder’s particular situation. Investors should consult their own tax adviser regarding the specific tax consequences of the ownership and disposition of shares of Common Stock to them, including tax reporting requirements, the applicability of U.S. federal, state and local tax laws and non-U.S. tax laws, eligibility for the benefits of any applicable income tax treaty and the effect of any possible changes in the tax laws.

Election to be Taxed as a RIC

The Company has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. As a RIC, the Company generally will not pay corporate-level U.S. federal income taxes on any income or gains that the Company timely distributes as dividends to Stockholders. Rather, dividends the Company distributes generally will be taxable to Stockholders, and any net operating losses, foreign tax credits and other of the Company’s tax attributes generally will not pass through to Stockholders, subject to special rules for certain items such as net capital gains and qualified dividend income the Company recognizes. To qualify as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements (as described below). In addition, to qualify as a RIC, the Company must timely distribute dividends to Stockholders of an amount generally at least equal to 90% of the Company’s investment company taxable income (determined without regard to the dividends paid deduction), which is generally the Company’s net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses, if any, and 90% of the Company’s net tax-exempt income, if any, for each taxable year (the “Annual Distribution Requirement”).

Taxation as a RIC

If the Company qualifies as a RIC and satisfies the Annual Distribution Requirement, then the Company will not be subject to U.S. federal income tax on the portion of the Company’s investment company taxable income, net tax-exempt income, if any, and net capital gain (generally, net long-term capital gain in excess of net short-term capital loss) that the Company timely distributes (or is deemed to timely distribute) as dividends to Stockholders. The Company will be subject to U.S. federal income tax at the regular corporate rates on any income or capital gain not distributed (or deemed distributed) to Stockholders.

The Company generally will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income or gains in respect of any calendar year unless the Company distributes dividends in a timely manner to Stockholders of an amount at least equal to the sum of (1) 98% of the Company’s net ordinary income (taking into account certain deferrals and elections) for the calendar year, (2) 98.2% of the Company’s capital gain net income (adjusted for certain ordinary losses) generally for the one-year period ending October 31 in such calendar year and (3) any net ordinary income and capital gain net income recognized, but not distributed, in preceding years (the “Excise Tax Avoidance Requirement”). Any distribution declared by the Company during October, November or December of any calendar year, payable to Stockholders of record on a specified date in such a month and actually paid during January of the following calendar year, will be treated as if it had been paid by the Company, as well as received by U.S. Stockholders, on December 31 of the calendar year in which the distribution was declared. The Company will not be subject to the U.S. federal excise tax on amounts on which the Company is required to pay U.S. federal income tax (such as retained net capital gains). Depending upon the level of taxable income earned in a taxable year, the Company may choose to carry forward taxable income for distribution in the following taxable year and pay the applicable U.S. federal excise tax.

The Company may incur the 4% nondeductible U.S. federal excise tax in the future on a portion of its income and capital gains. While the Company intends to distribute income and capital gains to minimize exposure to 4% nondeductible U.S. federal excise tax, the Company may not be able to, or may choose not to, distribute amounts sufficient to avoid the imposition of the tax entirely. In that event, the Company generally will be liable for 4% nondeductible U.S. federal excise tax only on the amount by which the Company does not meet the Excise Tax Avoidance Requirement. The Company generally will endeavor in each taxable year to avoid any

22

Table of Contents

material U.S. federal excise tax on its earnings but there can be no assurance that the Company will be successful in entirely avoiding U.S. federal excise tax.

In order to qualify as a RIC for U.S. federal income tax purposes, the Company must, among other things:

qualify and have in effect an election to be treated as a BDC under the 1940 Act at all times during each taxable year;
derive in each taxable year at least 90% of the Company’s gross income from dividends, interest, payments with respect to loans of certain securities, gains from the sale of stock or other securities, net income derived from an interest in a “qualified publicly traded partnership” (as defined in the Code), or other income derived with respect to the Company’s business of investing in such stock or securities (the “90% Income Test”); and
diversify the Company’s holdings so that at the end of each quarter of the taxable year:
at least 50% of the value of the Company’s assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of the Company’s assets or more than 10% of the outstanding voting securities of the issuer; and
no more than 25% of the value of the Company’s assets is invested in (a) the securities, other than U.S. government securities or securities of other RICs, of one issuer or of two or more issuers that are controlled, as determined under applicable Code rules, by the Company and that are engaged in the same or similar or related trades or businesses or (b) the securities of one or more qualified publicly traded partnerships (the “Diversification Tests”).

A RIC is limited in its ability to deduct expenses in excess of its investment company taxable income. If the Company’s expenses in a given taxable year exceed its investment company taxable income, the Company may experience a net operating loss for that taxable year. However, a RIC is not permitted to carry forward net operating losses to subsequent taxable years and such net operating losses do not pass through to its shareholders. In addition, deductible expenses can be used only to offset investment company taxable income, not net capital gain. A RIC may not use any net capital losses (that is, the excess of realized capital losses over realized capital gains) to offset its investment company taxable income, but may carry forward such net capital losses, and use them to offset future capital gains, indefinitely. In the event that a RIC were to experience an ownership change as defined under the Code, the capital loss carryforwards and other favorable tax attributes of the RIC, if any, may be subject to limitation. Due to these limits on deductibility of expenses and net capital losses, the Company may for tax purposes have aggregate taxable income for several years that the Company is required to distribute and that is taxable to Stockholders even if such taxable income is greater than the net income the Company actually earns during those taxable years.

For U.S. federal income tax purposes, the Company will include in its taxable income certain amounts that it has not yet received in cash. For example, if the Company holds debt obligations that are treated under applicable U.S. federal income tax rules as having original issue discount (“OID”) (such as debt instruments with PIK interest or, in certain cases, that have increasing interest rates or are issued with warrants), the Company must include in its taxable income in each taxable year a portion of the OID that accrues over the life of the obligation, regardless of whether the Company receives cash representing such income in the same taxable year. The Company may also have to include in its taxable income other amounts that the Company has not yet received in cash, such as accruals on a contingent payment debt instrument or deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. Further, the Company may elect to amortize market discount on debt investments and currently include such amounts in its taxable income, instead of upon their sale or other disposition, as any failure to make such election would limit the Company’s ability to deduct interest expense for tax purposes. Because such OID or other amounts accrued will be included in the Company’s investment company taxable income for the taxable year of accrual, the Company may be required to make distributions to Stockholders in order to satisfy the Annual Distribution Requirement and/or the Excise Tax Avoidance Requirement, even though the Company will have not received any corresponding cash payments. Accordingly, to enable the Company to make distributions to Stockholders that will be sufficient to enable the Company to satisfy the Annual Distribution Requirement, the Company may need to sell some of its assets at times and/or at prices that it would not consider advantageous, the Company may need to raise additional equity or debt capital or the Company may need to forego new investment opportunities or otherwise take actions that are disadvantageous to its business (or be unable to take actions that are advantageous to its business). If the Company is unable to obtain cash from other sources to enable the Company to satisfy the Annual Distribution Requirement, the Company may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax (and any applicable state and local taxes).

23

Table of Contents

Because the Company expects to use a subscription facility, the Company may be prevented from making distributions to Stockholders in certain circumstances. In addition, under the 1940 Act, the Company is generally not permitted to make distributions to Stockholders while its debt obligations and other senior securities are outstanding unless certain “asset coverage” tests are met. Limits on the Company’s distributions to Stockholders may prevent the Company from satisfying the Annual Distribution Requirement and, therefore, may jeopardize the Company’s qualification for taxation as a RIC, or may cause the Company to be subject to the 4% nondeductible U.S. federal excise tax.

Although the Company does not presently expect to do so, the Company may borrow funds and sell assets in order to make distributions to Stockholders that are sufficient for the Company to satisfy the Annual Distribution Requirement. However, the Company’s ability to dispose of assets may be limited by (1) the illiquid nature of its portfolio and/or (2) other requirements relating to the Company’s status as a RIC, including the Diversification Tests. If the Company disposes of assets in order to meet the Annual Distribution Requirement or the Excise Tax Avoidance Requirement, the Company may make such dispositions at times that, from an investment standpoint, are not advantageous. Alternatively, although the Company currently does not intend to do so, to satisfy the Annual Distribution Requirement, the Company may declare a taxable dividend payable in the Company’s stock or cash at the election of each Stockholder. In such case, for U.S. federal income tax purposes, the amount of the dividend paid in the Company’s Common Stock will generally be equal to the amount of cash that could have been received instead of the Company’s stock.

Distributions the Company makes to Stockholders may be made from the Company’s cash assets or by liquidation of its investments, if necessary. The Company may recognize gains or losses from such liquidations. In the event the Company recognizes net capital gains from such transactions, Stockholders may receive a larger capital gain distribution than they would have received in the absence of such transactions.

Failure to Qualify as a RIC

If the Company failed to satisfy the 90% Income Test for any taxable year or the Diversification Tests for any quarter of a taxable year, the Company might nevertheless continue to qualify as a RIC for such taxable year if certain relief provisions of the Code applied (which might, among other things, require the Company to pay certain corporate-level U.S. federal taxes or to dispose of certain assets). If the Company failed to qualify for treatment as a RIC and such relief provisions did not apply to the Company, the Company would be subject to U.S. federal income tax on all of its taxable income at regular corporate U.S. federal income tax rates (and the Company also would be subject to any applicable state and local taxes), regardless of whether the Company makes any distributions to Stockholders. The Company would not be able to deduct distributions to Stockholders, nor would distributions to Stockholders be required to be made for U.S. federal income tax purposes. Any distributions the Company makes generally would be taxable to U.S. Stockholders as ordinary dividend income and, subject to certain limitations under the Code, would be eligible for the 20% maximum rate generally applicable to individuals and other non-corporate U.S. Stockholders, to the extent of the Company’s current or accumulated earnings and profits. Subject to certain limitations under the Code, U.S. Stockholders that are corporations for U.S. federal income tax purposes generally would be eligible for the dividends-received deduction. Distributions in excess of the Company’s current and accumulated earnings and profits would be treated first as a return of capital to the extent of the Stockholder’s adjusted tax basis, and any remaining distributions would be treated as a capital gain.

Subject to a limited exception applicable to RICs that qualified as such under Subchapter M of the Code for at least one taxable year prior to disqualification and that re-qualify as a RIC no later than the second consecutive taxable year following the non-qualifying taxable year, the Company could be subject to U.S. federal income tax on any unrealized net built-in gains in the assets held by the Company during the period in which the Company failed to qualify as a RIC that are recognized during the five-taxable year period after its requalification as a RIC, unless the Company made a special election to pay corporate-level U.S. federal income tax on such net built-in gains at the time of the Company’s requalification as a RIC. The Company may decide to be taxed as a regular corporation even if the Company would otherwise qualify as a RIC if the Company determines that treatment as a corporation for a particular taxable year would be in the Company’s best interests.

The Company’s Investments – General

Certain of the Company’s investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things, (1) treat dividends that would otherwise constitute qualified dividend income as non-qualified dividend income, (2) disallow, suspend or otherwise limit the allowance of certain losses or deductions, (3) convert lower-taxed long-term capital gain into higher-taxed short-term capital gain or ordinary income, (4) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited), (5) cause the Company to recognize income or gain without receipt of a corresponding cash payment, (6) adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (7) adversely alter

24

Table of Contents

the characterization of certain complex financial transactions and (8) produce income that will not be qualifying income for purposes of the 90% Income Test. The Company intends to monitor its transactions and may make certain tax elections to mitigate the potential adverse effect of these provisions, but there can be no assurance that the Company will be eligible for any such tax elections or that any adverse effects of these provisions will be mitigated.

The Company may invest a portion of its net assets in below investment grade instruments. Investments in these types of instruments may present special tax issues for the Company. U.S. federal income tax rules are not entirely clear about issues such as when the Company may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless instruments, how payments received on obligations in default should be allocated between principal and income and whether exchanges of debt obligations in a bankruptcy or workout context are taxable. The Company intends to address these and other issues to the extent necessary in order to seek to ensure that the Company distributes sufficient income to avoid any material U.S. federal income or the 4% nondeductible U.S. federal excise tax.

A portfolio company in which the Company invests may face financial difficulties that require the Company to work-out, modify or otherwise restructure the Company’s investment in the portfolio company. Any such transaction could, depending upon the specific terms of the transaction, result in unusable capital losses and future non-cash income. Any such transaction could also result in the Company receiving assets that give rise to non-qualifying income for purposes of the 90% Income Test or otherwise would not count toward satisfying the Diversification Tests. Furthermore, some of the income that the Company might otherwise earn, such as fees for providing managerial assistance, certain fees earned with respect to the Company’s investments, income recognized in a work-out or restructuring of a portfolio investment, or income recognized from an equity investment in an operating partnership, may not satisfy the 90% Income Test. To manage the risk that such income might disqualify the Company as a RIC for failure to satisfy the 90% Income Test, one or more subsidiary entities treated as U.S. corporations for entity-level income tax purposes may be employed to earn such income and (if applicable) hold the related asset. Such subsidiary entities will be required to pay entity-level income tax on their earnings, which ultimately will reduce the yield to Stockholders on such fees and income.

Gain or loss recognized by the Company from warrants or other securities acquired by the Company, as well as any loss attributable to the lapse of such warrants, generally will be treated as capital gain or loss. Such gain or loss generally will be long-term or short-term depending on how long the Company held a particular warrant or security.

The Company’s investment in non-U.S. securities may be subject to non-U.S. income, withholding and other taxes. In that case, the Company’s yield on those securities would be decreased. U.S. Stockholders generally will not be entitled to claim a U.S. foreign tax credit or deduction with respect to non-U.S. taxes paid by the Company.

If the Company acquires shares in a passive foreign investment company (“PFIC”), the Company may be subject to U.S. federal income tax on a portion of any “excess distribution” received on, or any gain from the disposition of, such shares even if the Company distributes such income as a taxable dividend to Stockholders. Additional charges in the nature of interest generally will be imposed on the Company in respect of deferred taxes arising from any such excess distribution or gain. If the Company invests in the shares of a PFIC and elects to treat the PFIC as a “qualified electing fund” under the Code (a “QEF”), in lieu of the foregoing requirements, the Company will be required to include in income each year the Company’s proportionate share of the ordinary earnings and net capital gain of the QEF, even if such income is not distributed by the QEF. Alternatively, the Company may be able to elect to mark its shares in a PFIC at the end of each taxable year to market; in this case, the Company will recognize as ordinary income any increase in the value of such shares, and as ordinary loss any decrease in such value to the extent that any such decrease does not exceed prior increases in such value included in the Company’s income. The Company’s ability to make either election will depend on factors beyond the Company’s control and is subject to restrictions which may limit the availability of the benefit of these elections. Under either election, the Company may be required to recognize in a taxable year income in excess of any distributions the Company receives from PFICs and any proceeds from dispositions of PFIC stock during that taxable year, and such income will nevertheless be subject to the Annual Distribution Requirement and will be taken into account for purposes of determining whether the Company satisfies the Excise Tax Avoidance Requirement. See “– Taxation as a RIC” above.

Under Section 988 of the Code, gains or losses attributable to fluctuations in exchange rates between the time the Company accrues income, expenses or other liabilities denominated in a foreign currency and the time the Company actually collects such income or pay such expenses or liabilities are generally treated as ordinary income or loss. Similarly, gains or losses on foreign currency-denominated forward, futures, and option contracts, as well as certain other financial instruments, and the disposition of debt obligations denominated in a foreign currency, to the extent attributable to fluctuations in exchange rates between the acquisition and disposition dates, are also treated as ordinary income or loss.

25

Table of Contents

Some of the income that the Company might otherwise earn, such as fees for providing managerial assistance, certain fees earned with respect to the Company’s investments, income recognized in a work-out or restructuring of a portfolio investment, or income recognized from an equity investment in an operating partnership, may not satisfy the 90% Income Test. To manage the risk that such income might disqualify the Company as a RIC for failure to satisfy the 90% Income Test, one or more subsidiary entities treated as U.S. corporations for U.S. federal income tax purposes may be employed to earn such income and (if applicable) hold the related asset. Such subsidiary entities will be required to pay U.S. federal income tax on their earnings, which ultimately will reduce the yield to Stockholders on such fees and income.

The remainder of this discussion assumes that the Company qualifies as a RIC for each taxable year.

Taxation of U.S. Stockholders

The following discussion only applies to U.S. Stockholders. Prospective Stockholders that are not U.S. Stockholders should refer to “– Taxation of Non-U.S. Stockholders” below.

Distributions

Distributions by the Company (including distributions where Stockholders can elect to receive cash or stocks) generally are taxable to U.S. Stockholders as ordinary income or capital gains. Distributions of the Company’s investment company taxable income will be taxable as ordinary income to U.S. Stockholders to the extent of the Company’s current or accumulated earnings and profits, whether paid in cash or stock. To the extent that such distributions paid by the Company to non-corporate U.S. Stockholders (including individuals) are attributable to dividends from U.S. corporations and certain qualified foreign corporations, such distributions (“Qualifying Dividends”) may be eligible for a reduced maximum U.S. federal income tax rate of 20%. In this regard, it is anticipated that the Company’s distributions generally will not be attributable to dividends received by the Company and, therefore, generally will not qualify for the 20% maximum rate applicable to Qualifying Dividends. Distributions of the Company’s net capital gain (which is generally the Company’s realized net long-term capital gains in excess of realized net short-term capital losses) properly designated by the Company as “capital gain dividends” will be taxable to U.S. Stockholders as long-term capital gains (currently taxable at a maximum U.S. federal income tax rate of 20% in the case of non-corporate U.S. Stockholders (including individuals)), regardless of the U.S. Stockholder’s holding period for his, her or its stocks and regardless of whether paid in cash or stock. Distributions in excess of the Company’s earnings and profits first will reduce a U.S. Stockholder’s adjusted tax basis in such Stockholder’s stocks and, after the adjusted tax basis is reduced to zero, will constitute capital gains to such U.S. Stockholder.

The Company may decide to retain some or all of the Company’s net capital gain for reinvestment, but designate the retained net capital gain as a “deemed distribution.” In that case, among other consequences, (i) the Company will pay tax on the retained amount, (ii) each U.S. Stockholder will be required to include his, her or its share of the deemed distribution in income as if it had been actually distributed to the U.S. Stockholder, and (iii) the U.S. Stockholder will be entitled to claim a credit equal to his, her or its allocable share of the tax paid thereon by the Company. Because the Company expects to pay tax on any retained net capital gains at the regular corporate U.S. federal income tax rate, and because that rate is in excess of the maximum U.S. federal income tax rate currently payable by individuals (and other non-corporate U.S. Stockholders) on long-term capital gains, the amount of tax that individuals (and other non-corporate U.S. Stockholders) will be treated as having paid will exceed the tax they owe on the capital gain distribution. Such excess generally may be claimed as a credit against the U.S. Stockholder’s other federal income tax obligations or may be refunded to the extent it exceeds the U.S. Stockholder’s U.S. federal income tax liability. The amount of the deemed distribution net of such tax will be added to the U.S. Stockholder’s tax basis for his, her or its stocks. In order to utilize the deemed distribution approach, the Company must provide written notice to Stockholders prior to the expiration of 60 days after the close of the relevant taxable year. The Company cannot treat any of its investment company taxable income as a “deemed distribution.”

For purposes of determining (1) whether the Annual Distribution Requirement is satisfied for any year and (2) the amount of capital gain dividends paid for that year, under certain circumstances, the Company may elect to treat a dividend that is paid during the following taxable year as if it had been paid during the taxable year in question. If the Company makes such an election, U.S. Stockholders will still be treated as receiving the dividend in the taxable year in which the distribution is made. However, any dividend declared by the Company in October, November or December of any calendar year, payable to Stockholders of record on a specified date in such a month and actually paid during January of the following calendar year, will be treated as if it had been received by U.S. Stockholders on December 31 of the calendar year in which the dividend was declared.

Until and unless the Company is treated as a publicly offered RIC as a result of either (1) shares of its common stock collectively being held by at least 500 persons at all times during a taxable year, (2) shares of its common stock being continuously offered

26

Table of Contents

pursuant to a public offering (within the meaning of Section 4 of the Securities Act) or (3) shares of its common stock being treated as regularly traded on an established securities market, each U.S. Stockholder that is an individual, trust or estate will be treated as having received a dividend for U.S. federal income tax purposes from the Company in the amount of such U.S. Stockholder’s allocable share of the management and incentive fees paid to the Adviser and certain of the Company’s other expenses for the calendar year, and these fees and expenses will be treated as miscellaneous itemized deductions of such U.S. Stockholder. For taxable years beginning before 2026, miscellaneous itemized deductions generally are not deductible by a U.S. Stockholder that is an individual, trust or estate. For taxable years beginning in 2026 or later, miscellaneous itemized deductions generally are deductible by a U.S. Stockholder that is an individual, trust or estate only to the extent that the aggregate of such U.S. Stockholder’s miscellaneous itemized deductions exceeds 2% of such U.S. Stockholder’s adjusted gross income for U.S. federal income tax purposes, are not deductible for purposes of the alternative minimum tax and are subject to the overall limitation on itemized deductions under Section 68 of the Code.

The Company’s U.S. Stockholders will receive, as promptly as possible after the end of each calendar year, a notice reporting the amounts includible in such U.S. Stockholder’s taxable income for such calendar year as ordinary income and as long-term capital gain. In addition, the U.S. federal tax status of each calendar year’s distributions from the Company generally will be reported to the IRS (including the amount of any dividends that are Qualifying Dividends eligible for the 20% maximum rate). Dividends paid by the Company generally will not be eligible for the dividends-received deduction or the preferential tax rate applicable to Qualifying Dividends because the Company’s income generally will not consist of dividends. Distributions may also be subject to additional state, local and non-U.S. taxes depending on a U.S. Stockholder’s particular situation.

Certain distributions reported by the Company as section 163(j) interest dividends may be treated as interest income by the U.S. Stockholders for purposes of the tax rules applicable to interest expense limitations under the Code section 163(j). Such treatment by the U.S. Stockholders is generally subject to holding period requirements and other potential limitations, although the holding period requirements are generally not applicable to dividends declared by money market funds and certain other funds that declare dividends daily and pay such dividends on a monthly or more frequent basis. The amount that the Company is eligible to report as a section 163(j) dividend for a tax year is generally limited to the excess of the Company’s business interest income over the Company’s (i) business interest expense and (ii) other deductions properly allocable to the Company’s business interest income.

Dispositions

A U.S. Stockholder generally will recognize taxable gain or loss if the U.S. Stockholder sells or otherwise disposes of his, her or its stock (except pursuant to a repurchase by the Company, as described below). The amount of gain or loss will be measured by the difference between such Stockholder’s adjusted tax basis in the stocks sold and the amount of the proceeds received in exchange. Any gain or loss arising from such sale or disposition generally will be treated as long-term capital gain or loss if the U.S. Stockholder has held his, her or its stocks for more than one year; otherwise, any such gain or loss will be classified as short-term capital gain or loss. However, any capital loss arising from the sale or disposition of stocks held for six months or less will be treated as long-term capital loss to the extent of the amount of capital gain dividends received, or undistributed capital gain deemed received, with respect to such stocks. In addition, all or a portion of any loss recognized upon a disposition of stocks may be disallowed if other stocks of the Company are purchased (whether through reinvestment of distributions or otherwise) within 30 days before or after the disposition.

In general, non-corporate U.S. Stockholders (including individuals) currently are subject to a maximum U.S. federal income tax rate of 20% on their net capital gain (i.e., the excess of realized net long-term capital gains over realized net short-term capital losses), including any long-term capital gain derived from an investment in stocks. Such rate is lower than the maximum rate on ordinary income currently payable by individuals. Corporate U.S. Stockholders currently are subject to U.S. federal income tax on net capital gain at the maximum 21% rate also applied to ordinary income. Non-corporate U.S. Stockholders (including individuals) incurring net capital losses (i.e., capital losses in excess of capital gains) for a taxable year generally may deduct up to $3,000 of such losses against their ordinary income each taxable year; any net capital losses of a non-corporate U.S. Stockholder (including an individual) in excess of $3,000 generally may be carried forward and used in subsequent taxable years as provided in the Code. Corporate U.S. Stockholders generally may not deduct any net capital losses for a taxable year, but may carry back such capital losses for three taxable years or carry forward such capital losses for five taxable years.

The Code and the related U.S. Treasury regulations require the Company to annually report the adjusted cost basis information of covered securities, which generally include shares of a RIC, to the IRS and to taxpayers. Stockholders should contact their financial intermediaries with respect to reporting of cost basis and available elections for their accounts.

27

Table of Contents

From time to time, the Company may offer to repurchase its outstanding stocks. Stockholders who tender all stocks of the Company held, or considered to be held, by them will be treated as having sold their stocks and generally will realize a capital gain or loss. If a Stockholder tenders fewer than all of its stocks or fewer than all stocks tendered are repurchased, such Stockholder may be treated as having received a taxable dividend upon the tender of its stocks. In such a case, there is a risk that non-tendering Stockholders, and Stockholders who tender some but not all of their stocks or fewer than all of whose stocks are repurchased, in each case whose percentage interests in the Company increase as a result of such tender, will be treated as having received a taxable distribution from the Company. The extent of such risk will vary depending upon the particular circumstances of the tender offer, and in particular whether such offer is a single and isolated event or is part of a plan for periodically redeeming stocks of the Company.

Medicare Tax on Net Investment Income

An additional 3.8% Medicare tax is imposed on certain net investment income (including ordinary dividends and capital gain distributions received from the Company and net gains from redemptions or other taxable dispositions of the Company’s stocks) of U.S. individuals, estates and trusts to the extent that such person’s “modified adjusted gross income” (in the case of an individual) or “adjusted gross income” (in the case of an estate or trust) exceeds certain threshold amounts.

Tax Shelter Reporting Regulations

Under applicable Treasury regulations, if a U.S. Stockholder recognizes a loss with respect to the Company’s stocks of $2 million or more for a non-corporate U.S. Stockholder or $10 million or more for a corporate U.S. Stockholder in any single taxable year (or a greater loss over a combination of years), the U.S. Stockholder must file with the IRS a disclosure statement on Form 8886. Direct owners of portfolio securities are in many cases excepted from this reporting requirement, but under current guidance, U.S. Stockholders of a RIC are not excepted. Future guidance may extend the current exception from this reporting requirement to U.S. Stockholders of most or all RICs. The fact that a loss is reportable under these regulations does not affect the legal determination of whether the taxpayer’s treatment of the loss is proper. Significant monetary penalties apply to a failure to comply with this reporting requirement. States may also have a similar reporting requirement. U.S. Stockholders should consult their own tax advisers to determine the applicability of these Treasury regulations in light of their individual circumstances.

Backup Withholding

The relevant withholding agent may be required to withhold U.S. federal income tax (“backup withholding”), at a current rate of 24%, from any taxable distribution to a U.S. Stockholder (other than a “C” corporation, a financial institution, or a Stockholder that otherwise qualifies for an exemption) (1) that fails to provide a correct taxpayer identification number or a certificate that such Stockholder is exempt from backup withholding or (2) with respect to whom the IRS notifies the withholding agent that such Stockholder has failed to properly report certain interest and dividend income to the IRS and to respond to notices to that effect. An individual’s taxpayer identification number is his or her social security number. Backup withholding is not an additional tax, and any amount withheld under the backup withholding rules is allowed as a credit against the U.S. Stockholder’s U.S. federal income tax liability, provided that proper information is timely provided to the IRS.

Taxation of Non-U.S. Stockholders

The following discussion applies only to Non-U.S. Stockholders. Whether an investment in stocks of the Company is appropriate for a Non-U.S. Stockholder will depend upon that Stockholder’s particular circumstances. An investment in stocks of the Company by a Non-U.S. Stockholder may have adverse tax consequences to such Non-U.S. Stockholder. Non-U.S. Stockholders should consult their own tax advisers before investing in the Company’s Stocks.

Distributions; Dispositions

Subject to the discussion below, distributions of the Company’s investment company taxable income to a Non-U.S. Stockholder that are not effectively connected with the Non-U.S. Stockholder’s conduct of a trade or business within the United States will be subject to withholding of U.S. federal income tax at a 30% rate (or lower rate provided by an applicable income tax treaty) to the extent of the Company’s current or accumulated earnings and profits.

Certain properly reported dividends are generally exempt from withholding of U.S. federal income tax where paid in respect of a RIC’s (i) “qualified net interest income” (generally, its U.S.-source interest income, other than certain contingent interest and interest from obligations of a corporation or partnership in which the RIC or the non-U.S. Stockholder are at least a 10% shareholder, reduced

28

Table of Contents

by expenses that are allocable to such income) or (ii) “qualified short-term capital gains” (generally, the excess of the RIC’s net short-term capital gain, other than short-term capital gains recognized on the disposition of U.S. real property interests, over the RIC’s long-term capital loss), as well as if certain other requirements are satisfied. Nevertheless, no assurance can be given as to whether any of the Company’s distributions will be eligible for this exemption from withholding of U.S. federal income tax or, if eligible, will be reported as such by the Company. Furthermore, in the case of the Company’s stock held through an intermediary, the intermediary may have withheld U.S. federal income tax even if the Company reported the payment as an interest-related dividend or short-term capital gain dividend. Since the Company’s stocks will be subject to significant transfer restrictions, and an investment in the Company’s stocks will generally be illiquid, non-U.S. Stockholders whose distributions on the Company’s stocks are subject to withholding of U.S. federal income tax may not be able to transfer their stocks easily or quickly or at all.

Distributions of the Company’s investment company taxable income to a Non-U.S. Stockholder that are effectively connected with the Non-U.S. Stockholder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment of the Non-U.S. Stockholder), generally will not be subject to withholding of U.S. federal income tax if the Non-U.S. Stockholder complies with applicable certification and disclosure requirements, although the distributions (to the extent of the Company’s current or accumulated earnings and profits) will be subject to U.S. federal income tax on a net basis at the rates and in the manner applicable to U.S. Stockholders generally.

Actual or deemed distributions of the Company’s net capital gains, other than any net capital gains recognized on the disposition of U.S. real property interests, to a Non-U.S. Stockholder, and gains realized by a Non-U.S. Stockholder upon the sale of the Company’s stocks, will not be subject to U.S. federal income tax or any withholding of such tax, unless (a) the distributions or gains, as the case may be, are effectively connected with the Non-U.S. Stockholder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, are attributable to a U.S. permanent establishment of the Non-U.S. Stockholder), in which case the distributions or gains will be subject to U.S. federal income tax on a net basis at the rates and in the manner applicable to U.S. Stockholders generally or (b) the Non-U.S. Stockholder is an individual who has been present in the United States for 183 days or more during the taxable year and satisfies certain other conditions, in which case, except as otherwise provided by an applicable income tax treaty, the distributions or gains, which may be offset by certain U.S.-source capital losses, generally will be subject to a flat 30% U.S. federal income tax, even though the Non-U.S. Stockholder is not considered a resident alien under the Code.

If the Company distributes net capital gains in the form of deemed rather than actual distributions, a Non-U.S. Stockholder will be entitled to a U.S. federal income tax credit or tax refund equal to the Stockholder’s allocable share of the tax the Company pays on the capital gains deemed to have been distributed. In order to obtain the refund, the Non-U.S. Stockholder must obtain a U.S. taxpayer identification number and file a U.S. federal income tax return, even if the Non-U.S. Stockholder would not otherwise be required to obtain a U.S. taxpayer identification number or file a U.S. federal income tax return.

For a corporate Non-U.S. Stockholder, both distributions (actual or deemed) and gains realized upon the sale of the Company’s stocks that are effectively connected with the Non-U.S. Stockholder’s conduct of a trade or business within the United States may, under certain circumstances, be subject to an additional “branch profits tax” at a 30% rate (or at a lower rate if provided for by an applicable income tax treaty).

Backup Withholding

A Non-U.S. Stockholder who is a non-resident alien individual, and who is otherwise subject to withholding of U.S. federal income tax, will be subject to information reporting and may be subject to backup withholding of U.S. federal income tax on taxable distributions unless the Non-U.S. Stockholder provides the applicable withholding agent with a U.S. nonresident withholding tax certificate (e.g., an IRS Form W-8BEN, IRS Form W-8BEN-E or an acceptable substitute form) or otherwise establishes an exemption from backup withholding.

Non-U.S. Stockholders should consult their own tax advisers with respect to the U.S. federal income and withholding tax consequences, and state, local and non-U.S. tax consequences, of an investment in stocks of the Company.

Withholding and Information Reporting on Foreign Financial Accounts

Numerous jurisdictions have enacted, or have committed to enact, legislation and administrative guidance requiring the collection and sharing of certain information in order to combat tax avoidance. Pursuant to these regimes, entities such as the Company may be required to collect information concerning their owners and may be required to share such information with the taxing authorities of

29

Table of Contents

jurisdictions in which the Company invests or holds a financial account. The Company will be subject to one or more of these reporting regimes during the course of its life.

The United States Foreign Account Tax Compliance Act (“FATCA”) aims to combat tax evasion by U.S. tax residents using foreign accounts. Pursuant to the FATCA regime, the applicable withholding agent generally will be required to withhold 30% of U.S. source interest and dividends paid to (i) a non-U.S. financial institution (whether such financial institution is the beneficial owner or an intermediary) unless such non-U.S. financial institution agrees to verify, report and disclose its U.S. accountholders and meets certain other specified requirements or (ii) a non-financial non-U.S. entity (whether such entity is the beneficial owner or an intermediary) unless such entity certifies that it does not have any substantial U.S. owners or provides the name, address and taxpayer identification number of each substantial U.S. owner and such entity meets certain other specified requirements. Additionally, although FATCA withholding with respect to gross proceeds of a disposition of stock had been scheduled to begin on January 1, 2019, proposed regulations, which can be relied on until final regulations are issued, suspended such withholding indefinitely. If payment of this withholding tax is made, Non-U.S. Stockholders that are otherwise eligible for an exemption from, or a reduction in, withholding of U.S. federal income taxes with respect to such dividends or proceeds will be required to seek a credit or refund from the IRS to obtain the benefit of such exemption or reduction. The Company will not pay any additional amounts in respect to any amounts withheld.

Item 1A. Risk Factors

Investing in shares of the Company’s Common Stock involves a number of significant risks. Before you invest in shares of the Company’s Common Stock, you should be aware of various risks, including those described below. The risks set out below are not the only risks the Company faces. Additional risks and uncertainties not presently known to the Company or not presently deemed material by the Company may also impair the Company’s operations and performance. If any of the following events occur, the Company’s business, financial condition, results of operations and cash flows could be materially and adversely affected. In such case, the Company’s net asset value could decline, and you may lose all or part of your investment. The risk factors described below are the principal risk factors associated with an investment in the Company as well as those factors generally associated with an investment company with investment objectives, investment policies, capital structure or trading markets similar to the Company.

Risks Relating to the Company’s Business and Structure

Limited Operating History

The Company has limited operating history upon which to evaluate the Company’s performance and the Adviser and its affiliates have not previously sponsored a BDC. The performance of the Investment Team’s past portfolio investments associated with the funds managed by Stone Point (the “Stone Point Funds”) is not necessarily indicative of the results that will be achieved by the Company. The Company is subject to all of the business risks and uncertainties associated with any new business, including the risk that the Company will not achieve its investment objective, or that the Company will not qualify or maintain the Company’s qualification to be treated as a RIC under Subchapter M of the Code, and that the value of any Stockholder’s investment could decline substantially.

The Adviser and its affiliates have limited experience managing a BDC, and the investment philosophy and techniques used by the Adviser to manage a BDC may differ from the investment philosophy and techniques previously employed by the Stone Point Funds in identifying and managing past investments. In addition, the 1940 Act and the Code impose numerous constraints on the operations of BDCs and RICs that do not apply to the other types of investment vehicles. For example, under the 1940 Act, BDCs are required to invest at least 70% of their total assets primarily in securities of qualifying U.S. private companies or thinly traded public companies, cash, cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less from the time of investment. The Adviser’s limited experience in managing a portfolio of assets under such constraints may hinder its ability to take advantage of attractive investment opportunities and, as a result, achieve the Company’s investment objective.

Based on the amount of proceeds raised in the Initial or Subsequent Closings, it could take some time to invest substantially all of the capital the Company expects to raise due to market conditions generally and the time necessary to identify, evaluate, structure, negotiate and close suitable investments. In order to comply with the RIC diversification requirements during the startup period, the Company may invest proceeds in temporary investments, such as cash, cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less from the time of investment, which the Company expects will earn yields substantially lower than the interest, dividend or other income that the Company seeks to receive in respect of suitable portfolio investments. The Company may not be able to pay any significant distributions during this period, and any such distributions may be substantially lower than the distributions the Company expects to pay when the Company’s portfolio is fully invested. The Company

30

Table of Contents

will pay management fees to the Adviser throughout this interim period irrespective of the Company’s performance. If the management fees and the Company’s other expenses exceed the return on the temporary investments, the Company’s equity capital will be eroded.

Dependence on Key Personnel and Adviser

The success of the Company depends in substantial part on the experience and knowledge of the Adviser and its Investment Team. There can be no assurance that any individual will continue to be employed by the Adviser throughout the term of the Company. The loss of key personnel could have a material adverse effect on the Company.

Business and Regulatory Risks of Alternative Asset Investments

Legal, tax and regulatory changes could occur that may adversely affect the Company at any time during its term. The legal, tax and regulatory environment for BDCs and other vehicles that invest in alternative investments is evolving, and changes in the legislation or regulation and market perception of such vehicles, including changes to existing laws and regulations and increased criticism of the BDC, private credit, private equity and other sectors within the alternative asset industry by some politicians, government representatives, regulators and market commentators, may adversely affect the ability of the Company to pursue its investment strategy, its ability to obtain leverage and financing and the value of investments held by the Company. In recent years, market disruptions and the dramatic increase in the capital allocated to alternative investment strategies have led to increased governmental as well as self-regulatory scrutiny of the alternative investment fund industry in general, and certain legislation proposing greater regulation of the industry periodically is considered by the governing bodies of both U.S. and non-U.S. jurisdictions. It is impossible to predict what, if any, changes may be instituted with respect to the legislation or regulations applicable to the Company, the Adviser, their respective affiliates, the markets in which they trade and invest, the Stockholders or the counterparties with which they do business, or what other effect such legislation or regulations might have. There can be no assurance that the Company, the Adviser or their respective affiliates will be able, for financial reasons or otherwise, to comply with future laws and regulations, and any regulations that restrict the ability of the Company to implement its investment strategy could have a material adverse impact on the Company’s portfolio. To the extent that the Company or its investments are or may become subject to regulation by various agencies in the United States or other non-U.S. jurisdictions, certain costs of compliance will be borne by the Company.

The SEC and other various U.S. federal, state and local agencies may conduct examinations and inquiries into, and bring enforcement and other proceedings against, the Company, the Adviser or their respective affiliates. The Company, the Adviser or their respective affiliates may receive requests for information or subpoenas from the SEC and other state, federal and non-U.S. regulators from time to time in connection with such inquiries and proceedings and otherwise in the ordinary course of business. These requests may relate to a broad range of matters, including specific practices of the Company, the Adviser, the securities in which the Adviser invests on behalf of the Company and/or clients, or industry-wide practices. Certain costs of any such increased reporting, registration and compliance requirements may be borne by the Company and may furthermore place the Company at a competitive disadvantage to the extent that the Company or the Adviser is required to disclose sensitive business information.

Competitive Nature of the Adviser’s Business

The business of identifying and structuring investments of the types contemplated by the Company is highly competitive and involves a high degree of uncertainty. The Adviser expects to encounter competition from other entities having similar investment objectives, including other BDCs, private equity and credit funds, strategic industry acquirers, registered investment companies, specialty finance companies, banks, broker-dealers, investment partnerships and corporations, and other financial investors. Some of these competitors may have more relevant experience and contacts or better resources than the Adviser or may not be subject to the regulatory restrictions that the 1940 Act imposes on the Company as a BDC and that the Code imposes on the Company as a RIC. Such other investors may make competing offers for investment opportunities that are identified, and even after an agreement in principle has been reached with the board of directors or owners of an acquisition target, consummating the transaction will be subject to myriad uncertainties, only some of which are foreseeable or within the control of the Adviser. To the extent that the Adviser encounters competition with respect to the Company’s investments, yields to Stockholders may be reduced. In addition to competition from other investors, the availability of investment opportunities generally will be subject to market conditions as well as, in many cases, the prevailing regulatory or political climate.

31

Table of Contents

Financial Services Industry Risks

Many financial services companies have asset and liability structures that are essentially monetary in nature and are directly affected by many factors, including domestic and international economic and political conditions, broad trends in business and finance, legislation and regulation affecting the national and international business and financial communities, monetary and fiscal policies, interest rates, inflation, currency values, market conditions, the availability and cost of short-term and long-term funding and capital, the credit capacity or perceived creditworthiness of customers and counterparties and the level and volatility of trading markets. Such factors can adversely impact financial institutions and their customers, suppliers, service providers and counterparties, all of whom are potential investment targets for the Company. Moreover, the financial services industry is highly dependent on technology and communications and information systems, is exposed to many types of operational risks and operates in a highly regulated environment; each of these factors could have an adverse impact on financial institutions and their customers and counterparties.

Cyclicality

Certain sectors targeted by the Company are cyclical and subject to significant fluctuation due to competition, the high level of government regulation, general economic conditions, the level of interest rates, the state of the public equity markets and other factors. The returns on the Company’s investments may therefore be lower in certain periods. For example, the financial performance of credit-related investments, which includes both regulated institutions, such as depositories, as well as specialty finance and asset management investments, are susceptible to the cyclicality associated with the sector. Although an individual credit platform’s financial performance depends in part upon its own specific business characteristics, there are macroeconomic factors that could result in more benign or severe investment environments. The Company is expected to continue to experience the effects of this cyclicality.

Systems Risk; Cyber Security Breaches and Identity Theft

The Company and the Adviser rely extensively on computer programs and systems (and could rely on new systems and technology in the future) for various purposes, including trading, clearing, and settling transactions, evaluating certain investments, monitoring their portfolios and net capital, and generating risk management and other reports that are critical to oversight of the Company’s activities. Certain of the Company’s and the Adviser’s operations will be dependent upon systems operated by third parties, including prime brokers, administrators, market counterparties and their sub-custodians and other service providers, though the Adviser could perform certain of these functions internally in reliance on their own systems (the cost of which could be borne by the Company). The Company’s service providers could also depend on information technology systems that could or could not be controlled by them and, notwithstanding the diligence that the Company could perform on its service providers, the Company could not be able to verify the risks or reliability of such information technology systems.

The Company, the Adviser, and their affiliates and their service providers are subject to risks associated with a breach in cybersecurity. Cybersecurity is a generic term used to describe the technology, processes and practices designed to protect networks, systems, computers, programs, and data from both intentional cyber-attacks and hacking by other computer users, as well as unintentional damage or interruption that, in either case, can result in damage and disruption to hardware and software systems, loss or corruption of data and/or misappropriation of confidential information. Cybersecurity incidents and cyber-attacks have been occurring globally at a more frequent and severe level and will likely continue to increase in frequency in the future. The Adviser and its service providers’ information and technology systems may be vulnerable to damage or interruption from computer viruses and other malicious code, network failures, computer and telecommunication failures, infiltration by unauthorized persons and security breaches, usage errors by their respective professionals or service providers, power, communications or other service outages and catastrophic events such as fires, tornadoes, floods, hurricanes, and earthquakes.

Cybersecurity threats may involve unauthorized access to sensitive information, including, without limitation, information regarding the Adviser’s or the Company’s investment activities, or could render data or systems unusable, any of which could result in significant losses. Any cybersecurity attacks against the Adviser, the Company, or the Company’s portfolio companies could lead to the loss of sensitive information essential to such entity’s operations, could have a material adverse effect on such entity’s reputations, financial positions or cash flows, could lead to financial losses from remedial actions or loss of business, or could lead to potential liability. Neither the Adviser nor the Company control the cybersecurity plans and systems put in place by third-party service providers, and such third-party service providers may have limited indemnification obligations to the Adviser and the Company, each of whom could be negatively impacted as a result. Breaches such as those involving covertly introduced malware, attempts to induce Stone Point Credit personnel (or third-party agents) to provide data or payments under false pretenses (e.g., via a falsified email), unauthorized release of confidential or otherwise protected information, including personal information relating to the Company, and

32

Table of Contents

corruption of data, and other electronic security breaches could lead to disruptions in critical systems, potentially resulting in further harm and could require the Adviser, the Company, or any such portfolio company to make a significant investment to fix or replace such systems. Cyberattacks may also be carried out in a manner that does not require gaining unauthorized access, such as causing denial-of-service attacks on systems or websites, rendering them unavailable. If unauthorized parties gain access to such information and technology systems, they could be able to steal, publish, delete, or modify private and sensitive information. If the information and technology systems of the Adviser and the Company and their respective service providers are compromised, become inoperable for extended periods of time or cease to function properly, the Adviser, the Company, and/or their service providers may have to make a significant investment to fix or replace such systems. The failure of these systems and/or of disaster recovery plans for any reason could cause significant interruptions in the Adviser’s, the Company’s, and/or a portfolio company’s operations and result in a failure to maintain the security, confidentiality, or privacy of sensitive data, including personal information relating to investors of the Company (and their beneficial owners), material non-public information relating to, and the intellectual property and trade secrets of the Adviser, the Company, and/or its portfolio companies. Such a failure or unauthorized disclosure of data could harm the Adviser, the Company, and/or a portfolio company’s reputation, subject any such entity and their respective affiliates to legal claims, regulatory action, increased costs, financial losses, data privacy breaches or enforcement actions arising out of applicable privacy or other laws and adverse publicity and otherwise affect their business and financial performance. The costs related to cyber or other security threats or disruptions may not be fully insured or indemnified by other means.

FOIA/Public Disclosure

As a result of the U.S. Freedom of Information Act (“FOIA”), any governmental public records access law, any state or other jurisdiction’s laws similar in intent or effect to FOIA, or any other similar statutory or regulatory requirement, the Company, the Adviser, the Stockholders or any of their respective services providers or their affiliates may be required to disclose information relating to the Company, or their affiliates, and/or any entity in which an investment is made, which disclosure could, for example, affect the Company’s competitive advantage in finding attractive investment opportunities. In addition, some of the shares of Common Stock may be held by Stockholders that are subject to public disclosure requirements, such as public pension plans and listed investment vehicles. The amount of information about their investments that is required to be disclosed has increased in recent years, and that trend may continue. While the Adviser may, in seeking to prevent any such potential disclosure, withhold all or any part of the information otherwise to be provided to certain or all Stockholders, such information may not be withheld in many circumstances. To the extent that disclosure of confidential information relating to the Company or its investments results from shares of Common Stock being held by such Stockholders, the Company may be adversely affected.

Duties of the Adviser and the Stockholders’ Rights

The Adviser is engaged to provide the Company (and not any individual Stockholder) with portfolio management and certain administrative services. As such, and to the fullest extent permitted by law, none of the Stockholders will have direct rights against the Adviser and the Adviser does not represent or owe any duty to any individual Stockholder in the Company in connection with its appointment to provide such services.

Interpretation of Governing Agreements and Legal Requirements

The governing and related documents of the Company (the “Governing Agreements”) are detailed agreements that establish complex arrangements among the Adviser, the Company and its investors, and other entities and individuals. Questions will arise from time to time under the Governing Agreements regarding the parties’ rights and obligations in certain situations, some of which the parties may not have considered while drafting and executing the Governing Agreements. In these instances, the applicable provisions of the Governing Agreements, if any, may be broad, general, ambiguous, or conflicting, and may permit more than one reasonable interpretation. At times, there may not be provisions directly applicable to the situation at hand. While the Company will construe the provisions set forth in the Governing Agreements (including any “hedge clauses” discussed below) in good faith and in a manner consistent with its legal obligations, the interpretations it adopts may not necessarily be, and need not be, the most favorable interpretations for its Stockholders.

The Governing Agreements contain provisions (sometimes referred to as “hedge clauses”) that provide that the Adviser and its agents have no responsibility or liability for any loss incurred by the Company or any Stockholder arising in connection with their activities on behalf of, or their association with, the Company provided that such exculpation will not apply where such person committed certain bad acts (including fraud, willful misfeasance or gross negligence). Hedge clauses are limited by, among other things, Section 206 of the Advisers Act, which the SEC has interpreted to impose certain duties on investment advisers that are not waivable.

33

Table of Contents

Restrictions on Transfer and Withdrawal

The Common Stock has not been and may never be registered under the Securities Act and, unless so registered, may not be offered or sold except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Common Stock is an illiquid investment for which there is not a secondary market, nor is it expected that any such secondary market will develop in the future. Stockholders generally may not sell, assign or transfer their shares without prior written consent of the Adviser (unless the transfer is to an affiliate), which the Adviser may grant or withhold in its sole discretion. Except in limited circumstances for legal or regulatory purposes, Stockholders are not entitled to redeem their shares of Common Stock. Stockholders must be prepared to bear the economic risk of an investment in the Company for an indefinite period. The Company is generally not able to issue or sell Common Stock at a price below net asset value per share. The Company may, however, sell Common Stock, or warrants, options or rights to acquire Common Stock, at a price below the then-current net asset value per share of Common Stock, if the Board determines that such sale is in the Company’s best interests, and if Stockholders approve the sale. In any such case, the price at which the Company’s securities are to be issued and sold may not be less than a price that, in the determination of the Board, closely approximates the market value of such securities (less any distributing commission or discount). If the Company raises additional funds by issuing Common Stock or senior securities convertible into, or exchangeable for, Common Stock, then the percentage ownership of Stockholders at that time will decrease, and Stockholders may experience dilution.

The Adviser does not know at this time what circumstances will exist in the future and therefore does not know what factors the Board will consider in determining whether to do an Exchange Listing. If the Company does undertake an Exchange Listing, there can be no assurances that a public trading market will develop or, if one develops, that such trading market can be sustained. Shares of companies offered in an initial public offering often trade at a discount to the initial offering price due to underwriting discounts and related offering expenses. Also, shares of closed-end investment companies and BDCs frequently trade at a discount from their net asset value. This characteristic of closed-end investment companies is separate and distinct from the risk that the Company’s net asset value per share of Common Stock may decline. The Company cannot predict whether the Common Stock, if listed on a national securities exchange, will trade at, above or below net asset value.

No Right to Control the Company’s Operations

Stockholders in the Company will have no opportunity to control the day-to-day operations of the Company, including investment and disposition decisions. In order to safeguard their limited liability from the liabilities and obligations of the Company, Stockholders must rely on the Adviser’s ability to identify, structure and implement investments consistent with the investment objectives and policies of the Company.

Consequences of Default

Stockholders may be subject to significant adverse consequences in the event such a Stockholder defaults on its capital commitment to the Company. In addition to losing its right to participate in future Drawdowns, a defaulting Stockholder may be forced to transfer its shares of Common Stock to a third party for a price that is less than the net asset value of such shares of Common Stock.

Board Participation

Employees of the Adviser may serve as directors of some portfolio companies and, as such, may have duties to persons other than the Company, including other shareholders of such portfolio companies. Although holding board positions may be important to the Company’s investment strategy and may improve the Adviser’s management ability, board positions could impair the Company’s ability to sell the relevant securities and/or loans when and upon the terms it wants, and may subject the Company and the Adviser to claims they would otherwise not be subject to as an investor, including claims of breach of duty of loyalty, corporate waste, securities claims and other director-related claims.

Indemnification Obligations

The Adviser will not assume any responsibility to the Company other than to render the services described in its Investment Advisory Agreement with the Company, and it will not be responsible for any action of the Board in declining to follow the Adviser’s advice or recommendations. Pursuant to the Investment Advisory Agreement, the Adviser and its directors, officers, shareholders, members, agents, representatives, employees, controlling persons, and any other person or entity affiliated with, or acting on behalf of the Adviser will not be liable to the Company for their acts under the Investment Advisory Agreement, absent willful misfeasance, bad

34

Table of Contents

faith, gross negligence or reckless disregard in the performance of their duties. The Company will also agree to indemnify, defend and protect the Adviser and its directors, officers, shareholders, members, agents, representatives, employees, controlling persons and any other person or entity affiliated with, or acting on behalf of the Adviser with respect to all damages, liabilities, costs and expenses resulting from acts of the Adviser not arising out of willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties. These protections may lead the Adviser to act in a riskier manner when acting on the Company’s behalf than it would when acting for its own account.

Possibility of Fraud and Other Misconduct of Employees of the Adviser and Service Providers

Misconduct by employees of the Adviser, service providers and/or their respective affiliates could cause significant losses. Misconduct could include entering into transactions without authorization, the failure to comply with operational and risk procedures, including due diligence procedures, misrepresentations as to investments being considered by the Company, the improper use or disclosure of confidential or material non-public information, which could result in litigation, regulatory enforcement or serious financial harm, including limiting the business prospects or future marketing activities of the Company, and noncompliance with applicable laws or regulations (including in the workplace via inappropriate or unlawful behavior or actions directed to other employees) and the concealing of any of the foregoing. Such activities could result in reputational damage, litigation, business disruption and/or financial losses to the Company. Stone Point has controls and procedures through which it seeks to minimize the risk of such misconduct occurring. However, no assurances can be given that Stone Point will be able to identify or prevent such misconduct.

Qualifying Assets

As a BDC, the 1940 Act prohibits the Company from acquiring any assets other than certain qualifying assets unless, at the time of and after giving effect to such acquisition, at least 70% of the Company’s total assets are qualifying assets. Therefore, the Company may be precluded from investing in what the Adviser believes are attractive investments if such investments are not qualifying assets. Conversely, if the Company fails to invest a sufficient portion of its assets in qualifying assets, the Company could lose its status as a BDC, which would have a material adverse effect on the Company’s business, financial condition, and results of operations. Similarly, these rules could prevent the Company from making additional investments in existing portfolio companies, which could result in the dilution of the Company’s position or could require the Company to dispose of investments at an inopportune time to comply with the 1940 Act. If the Company is forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments.

Status as Business Development Company

If the Company does not maintain its status as a BDC, the Company might be regulated as a closed-end investment company under the 1940 Act, which would subject it to substantially more regulatory restrictions and correspondingly decrease the Company’s operating flexibility.

Emerging Growth Company Status

The Company expects to qualify as an “emerging growth company” as defined in the JOBS Act until the earlier of (a) the last day of the fiscal year (i) following the fifth anniversary of the completion of the Company’s initial public offering of common equity securities, (ii) in which the Company has total annual gross revenue of at least $1.235 billion, or (iii) in which the Company is deemed to be a large accelerated filer, which means the market value of the Common Stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (b) the date on which the Company has issued more than $1.0 billion in non-convertible debt during the prior three-year period. For so long as the Company remains an “emerging growth company,” it will likely take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). It is not possible to predict if prospective investors will find the Common Stock less attractive because the Company will rely on some or all of these exemptions.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company may take advantage of such extended transition periods.

35

Table of Contents

Because of the exemptions from various reporting requirements provided to the Company as an “emerging growth company” and because the Company may have an extended transition period for complying with new or revised financial accounting standards, the Company may be less attractive to investors and it may be difficult for the Company to raise additional capital as and when needed. Potential investors may be unable to compare the Company with other companies in the same industry if they believe that the Company’s financial accounting is not as transparent as other companies in the industry. If the Company is perceived as being not as transparent as other companies in the industry, the Company’s financial condition and results of operations may be materially and adversely affected.

The Company is a Public Entity

The Company is subject to the reporting requirements of the Exchange Act and requirements of the Sarbanes-Oxley Act. The Exchange Act will require the Company to file annual, quarterly and current reports with respect to the Company’s business and financial condition which will cause the Company to incur certain legal, accounting and other expenses. The Sarbanes-Oxley Act will require the Company to maintain effective disclosure controls and procedures and internal control over financial reporting, which are discussed below. In order to maintain and improve the effectiveness of the Company’s disclosure controls and procedures and internal controls, significant resources and management oversight will be required. The Company has implemented procedures, processes, policies and practices for the purpose of addressing the standards and requirements applicable to public companies. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

The systems and resources necessary to comply with public company reporting requirements will increase further once the Company ceases to be an “emerging growth company” under the JOBS Act. As long as the Company remains an emerging growth company, it intends to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act.

Exchange Act Filing Requirements

Because the Company is subject to the reporting requirements under the Exchange Act, ownership information for any person who beneficially owns 5% or more of the Common Stock will have to be disclosed in a Schedule 13G, Schedule 13D or other filings with the SEC. Beneficial ownership for these purposes is determined in accordance with the rules of the SEC and includes having voting or investment power over the securities. In some circumstances, Stockholders who choose to reinvest their dividends may see their percentage stake in the Company increase to more than 5%, thus triggering this filing requirement. Each Stockholder is responsible for determining their filing obligations and preparing the filings. In addition, Stockholders who hold more than 10% of a class of the Company’s shares may be subject to Section 16(b) of the Exchange Act, which recaptures for the benefit of the Company’s profits from the purchase and sale, or sale and purchase, of registered stock within a six-month period.

Internal Controls

The Company will not be required to comply with the requirements of the Sarbanes-Oxley Act, including the internal control evaluation and certification requirements of Section 404 of that statute (“Section 404”), and will not be required to comply with all of those requirements until the Company has been subject to the reporting requirements of the Exchange Act for a specified period or the date the Company is no longer an emerging growth company under the JOBS Act. Accordingly, the Company’s internal control over financial reporting will not initially meet all of the standards contemplated by Section 404 that the Company may eventually be required to meet. The Company will need to undertake the process of building out its internal control over financial reporting and establishing formal procedures, policies, processes and practices related to financial reporting and to the identification of key financial reporting risks, assessment of their potential impact and linkage of those risks to specific areas and activities within the Company.

Additionally, the Company has undertaken the process of documenting its internal control procedures to satisfy the requirements of Section 404, which requires annual management assessments of the effectiveness of its internal control over financial reporting. Additionally, the Company’s independent registered public accounting firm is required to formally attest to the effectiveness of the internal control over financial reporting. If the Company is not able to adequately implement the requirements of Section 404, the Company’s operations, financial reporting or financial results could be adversely affected. Matters impacting the Company’s internal controls may cause the Company to be unable to report its financial information on a timely basis and thereby subject the Company to adverse regulatory consequences, including sanctions by the SEC or violations of applicable stock exchange listing rules, and may result in a breach of the covenants under the agreements governing any of its financing arrangements, if any. There could also be a

36

Table of Contents

negative reaction in the financial markets due to a loss of investor confidence in the Company and the reliability of its financial statements. Confidence in the reliability of the Company’s financial statements could also suffer if the Company or its independent registered public accounting firm were to report a material weakness in the Company’s internal control over financial reporting. This could materially adversely affect the Company and, following an Exchange Listing, lead to a decline in the market price of the Common Stock.

RIC related Tax Risks

The Company has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. To qualify for and maintain RIC tax treatment under the Code, the Company must meet, amongst other requirements, requirements related to annual distributions, source of income and asset diversification. Failure to meet these requirements may result in the Company having to dispose of certain investments quickly in order to prevent the loss of RIC status. If the Company fails to qualify for or maintain RIC tax treatment for any reason and is subject to corporate federal income tax, the resulting corporate taxes could substantially reduce its net assets, the amount of income available for distribution, and the amount of its distributions. See “Material U.S. Federal Income Tax Considerations – Taxation as a RIC.”

As a result of the “Annual Distribution Requirement” (i.e., the requirements that the Company must distribute to its Stockholders, for each taxable year, at least 90% of the Company’s “investment company taxable income,” which is generally the Company’s ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses, and 90% of the Company’s net tax-exempt income, if any) to qualify for tax treatment as a RIC, the Company may need to access the capital markets periodically to raise cash to fund new investments in portfolio companies. The Company expects to be able to issue “senior securities,” including borrowing money from banks or other financial institutions only in amounts such that the ratio of the Company’s total assets (less total liabilities other than indebtedness represented by senior securities) to its total indebtedness represented by senior securities plus preferred stock, if any, equals at least 150% after such incurrence or issuance. If the Company issues senior securities, it will be exposed to risks associated with leverage, including an increased risk of loss. The Company’s ability to issue different types of securities is also limited. Compliance with RIC distribution requirements may unfavorably limit the Company’s investment opportunities and reduce its ability in comparison to other companies to profit from favorable spreads between the rates at which the Company can borrow and the rates at which it can lend. Therefore, the Company intends to seek to continuously issue equity securities, which may lead to Stockholder dilution.

The Company may borrow to fund investments. If the value of the Company’s assets declines, the Company may be unable to satisfy the asset coverage test under the 1940 Act, which would prohibit the Company from paying distributions and could prevent it from qualifying for tax treatment as a RIC, which would generally result in a corporate-level U.S. federal income tax on any income and net gains. If the Company cannot satisfy the asset coverage test, it may be required to sell a portion of its investments and, depending on the nature of the Company’s debt financing, repay a portion of its indebtedness at a time when such sales may be disadvantageous.

Until and unless the Company is treated as a publicly offered RIC as a result of either (1) shares of its Common Stock and preferred stock collectively being held by at least 500 persons at all times during a taxable year, (2) shares of its Common Stock being continuously offered pursuant to a public offering (within the meaning of Section 4 of the Securities Act) or (3) shares of its Common Stock being treated as regularly traded on an established securities market, each U.S. Stockholder that is an individual, trust or estate will be treated as having received a dividend for U.S. federal income tax purposes from the Company in the amount of such U.S. Stockholder’s allocable share of the management and incentive fees paid to the Adviser and certain of the Company’s other expenses for the calendar year, and these fees and expenses will be treated as miscellaneous itemized deductions of such U.S. Stockholder. For taxable years beginning before 2026, miscellaneous itemized deductions generally are not deductible by a U.S. Stockholder that is an individual, trust or estate. For taxable years beginning in 2026 or later, miscellaneous itemized deductions generally are deductible by a U.S. Stockholder that is an individual, trust or estate only to the extent that the aggregate of such U.S. Stockholder’s miscellaneous itemized deductions exceeds 2% of such U.S. Stockholder’s adjusted gross income for U.S. federal income tax purposes, are not deductible for purposes of the alternative minimum tax and are subject to the overall limitation on itemized deductions under Section 68 of the Code.

Phantom Income

For U.S. federal income tax purposes, the Company will include in its taxable income certain amounts that it has not yet received in cash. For example, if the Company holds debt obligations that are treated under applicable U.S. federal income tax rules as having OID (such as debt instruments with PIK interest or, in certain cases, that have increasing interest rates or are issued with warrants), the

37

Table of Contents

Company must include in its taxable income in each taxable year a portion of the OID that accrues over the life of the obligation, regardless of whether the Company receives cash representing such income in the same taxable year. The Company may also have to include in its taxable income other amounts that the Company has not yet received in cash, such as accruals on a contingent payment debt instrument or deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. Further, the Company may elect to amortize market discount on debt investments and currently include such amounts in its taxable income, instead of upon their sale or other disposition, as any failure to make such election would limit the Company’s ability to deduct interest expense for tax purposes. Because such OID or other amounts accrued are included in the Company’s investment company taxable income for the taxable year of accrual, the Company may be required to make distributions to Stockholders in order to satisfy the Annual Distribution Requirement (as defined below) and/or excise tax avoidance requirement, even though the Company will have not received any corresponding cash payments. Accordingly, to enable the Company to make distributions to Stockholders that will be sufficient to enable the Company to satisfy the Annual Distribution Requirement, the Company may need to sell some of its assets at times and/or at prices that it would not consider advantageous, the Company may need to raise additional equity or debt capital or the Company may need to forego new investment opportunities or otherwise take actions that are disadvantageous to its business (or be unable to take actions that are advantageous to its business). If the Company is unable to obtain cash from other sources to enable the Company to satisfy the Annual Distribution Requirement, the Company may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax (and any applicable state and local taxes).

Stock Dividend

Although the Company currently does not intend to do so, the Company may declare a large portion of a dividend in shares of the Company’s stock at the election of each Stockholder. An IRS Revenue Procedure allows a publicly offered RIC to distribute its own stock as a dividend for the purpose of fulfilling its distribution requirements, if certain conditions are satisfied. Among other things, the aggregate amount of cash available to be distributed to all Stockholders is required to be at least 20% of the aggregate declared distribution. The Internal Revenue Service has also issued private letter rulings on cash/stock dividends paid by RICs and real estate investment trusts where the cash component is limited to 20% of the total distribution if certain requirements are satisfied. Stockholders receiving such dividends will be required to include the full amount of the dividend (including the portion payable in stock) as ordinary income (or, in certain circumstances, long-term capital gain) to the extent of the Company’s current and accumulated earnings and profits for federal income tax purposes. As a result, Stockholders may be required to pay income taxes with respect to such dividends in excess of the cash dividends received. It is unclear whether the Company will be a publicly offered RIC and to what extent the Company will be able to pay taxable dividends in cash and Common Stock (whether pursuant to IRS Revenue Procedure, a private letter ruling or otherwise).

Dividend Reinvestment

Stockholders that participate in the Company’s dividend reinvestment plan will be deemed to have received, and for U.S. federal income tax purposes will be taxed on, the amount reinvested in the Company’s Common Stock to the extent the amount reinvested was not a tax-free return of capital. As a result, unless a Stockholder is a tax-exempt entity, the Stockholder may have to use funds from other sources to pay the tax liability on the value of the Company’s Common Stock received as a result of the distribution.

Certain ERISA Considerations

In general, the fiduciary responsibility standards and prohibited transaction restrictions of ERISA apply to a variety of employee retirement and welfare benefit plans maintained by private employers (“ERISA Plans”). Although ERISA does not (with certain exceptions) apply to individual retirement accounts, “Keogh” plans and certain other plans, such plans (collectively with ERISA Plans, “Plans”), are generally subject to Section 4975 of the Code, which contains prohibited-transaction provisions that are similar to those contained in ERISA.

Investment Considerations

The assets of the Company are invested in accordance with the investment objective and policies described in its registration statement. The fiduciary of an ERISA Plan (and not the Adviser) will be solely responsible for the ERISA Plan’s decision to invest in the Company, including, without limitation, the role that an investment in the Company would play in the ERISA Plan’s portfolio and whether an investment in the Company is reasonably designed as part of the overall investment of the ERISA Plan’s assets. Accordingly, an authorized fiduciary of an ERISA Plan proposing to invest in the Company should, in consultation with its own advisors, consider whether such investment is consistent with the terms of the ERISA Plan’s governing documents (including any

38

Table of Contents

investment guidelines) and applicable law. Neither the Adviser nor the Company or any of their respective affiliates is responsible for determining, and none of them makes any representation regarding, whether the Company’s Common Stock is an appropriate investment for Plans generally or any particular Plan.

Prohibited Transactions

Section 406 of ERISA and Section 4975 of the Code prohibit certain transactions involving the assets of Plans and certain persons, referred to as “parties in interest” under ERISA or “disqualified persons” under Section 4975 of the Code, having certain relationships to such Plans, unless a statutory or administrative exemption is applicable to the transaction. A purchase of the Company’s Common Stock by an ERISA Plan having a relationship with the Adviser or the Company, or any of their respective affiliates could, under certain circumstances, be considered a transaction prohibited under ERISA or Section 4975 of the Code. Accordingly, an authorized fiduciary of an investing Plan will be deemed to have represented and agreed, among other things, that the ERISA Plan’s purchase and holding of the Company’s Common Stock are not and will not constitute or otherwise result in a non-exempt prohibited transaction. In addition, as discussed below, other issues under the rules governing prohibited transactions may arise to the extent that the assets of the Company constitute “plan assets.”

Certain “Plan Asset” Considerations

U.S. Department of Labor regulations (as modified by Section 3(42) of ERISA (together, the “Plan Assets Regulation”)) describes when the assets of an entity are to be treated as “plan assets” for purposes of ERISA and Section 4975 of the Code. The Plan Assets Regulation provides that, if a “benefit plan investor” (as defined under the Plan Assets Regulation (“Benefit Plan Investor”)) acquires an “equity interest” in an entity, and if Benefit Plan Investors in the aggregate hold 25% or more of the value of any class of equity interests in the entity, the entity’s assets will be treated as “plan assets” for purposes of ERISA and Section 4975 of the Code, unless the Company’s Common Stock constitutes a “publicly-offered security” (as defined in the Plan Assets Regulation (“Publicly-Offered Security”)) or another exception under the Plan Assets Regulation applies.

In order to attempt to prevent the assets of the Company from constituting “plan assets” for purposes of ERISA and/or Section 4975 of the Code, based upon representations from investors, the Company will endeavor to restrict the sale and transfer of the Company’s Common Stock to Benefit Plan Investors such that at all times less than 25% of the Company’s Common Stock, as determined for purposes of the Plan Assets Regulation, will be held by Benefit Plan Investors and, therefore, the Company’s assets will not be expected to constitute “plan assets” for purposes of ERISA or Section 4975 of the Code and the Adviser would not be expected to be considered a fiduciary under ERISA with respect to investing ERISA Plans. In order to prevent Benefit Plan Investors from owning (or be at substantial likelihood of owning) 25% or more of any class of equity interest of the Company, the Company may also exercise its right to cause a compulsory withdrawal of Benefit Plan Investors. Notwithstanding any of the foregoing, if the Company determines that the Common Stock can be considered a “publicly-offered security” for purposes of the Plan Assets Regulation, the Company may thereupon decide to operate on the basis that its assets are not “plan assets” pursuant to the Publicly-Offered Security exception regardless of the number of Benefit Plan Investors owning the Common Stock.

If, notwithstanding the foregoing, the Company’s assets are treated as “plan assets” for purposes of ERISA and/or Section 4975 of the Code, the Company may be prevented from making certain otherwise desirable investments and engaging in certain other transactions that might otherwise be permitted and, if a non-exempt prohibited transaction occurs, may result in various liabilities and penalties for any “party-in-interest” under ERISA or “disqualified person” under the Code engaging in such transaction.

Takeover Attempts

The Company’s charter, as well as certain statutory and regulatory requirements, contains certain provisions that may have the effect of discouraging a third party from attempting to acquire the Company. The Board is comprised of directors with staggered terms, which is intended to prevent Stockholders from removing a majority of directors in any given election. This, along with other anti-takeover provisions, may inhibit a change of control in circumstances that could give Stockholders the opportunity to realize a premium over the value of shares of the Common Stock.

Dilution

The Company’s charter authorizes the issuance of additional shares of Common Stock without requiring the approval of the Stockholders. Stockholders will not have preemptive rights to purchase any shares issued by the Company in the future. The Company’s charter authorizes the issue of up to 250,000,000 shares of Common Stock. The Board may elect to sell additional shares

39

Table of Contents

in the future or issue equity interests in private offerings. To the extent the Company issues additional equity interests at or below net asset value, an existing Stockholder’s percentage ownership interest in the Company may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of the Company’s investments, Stockholders may also experience dilution in the book value and fair value of their shares.

Under the 1940 Act, the Company is generally prohibited from issuing or selling Common Stock at a price below net asset value per share, which may be a disadvantage as compared with certain public companies. The Company may, however, sell Common Stock, or warrants, options, or rights to acquire Common Stock, at a price below the current net asset value of the Common Stock if the Board and Independent Directors determine that such sale is in the Company’s best interests and the best interests of Stockholders, and the Stockholders, including a majority of those Stockholders that are not affiliated with the Company, approve such sale. In any such case, the price at which the Company’s securities are to be issued and sold may not be less than a price that, in the determination of the Board, closely approximates the fair value of such securities (less any distributing commission or discount). If the Company raises additional funds by issuing Common Stock or senior securities convertible into, or exchangeable for, Common Stock, then the percentage ownership of existing Stockholders at that time will decrease and such Stockholders will experience dilution.

All distributions declared in cash payable to Stockholders that are participants in the DRIP will generally be automatically reinvested in shares of Common Stock unless the investor opts out of the plan. As a result, Stockholders who opt out of participating in the DRIP may experience accretion to the net asset value of their shares if the Company’s Common Stock is trading at a premium to net asset value and dilution if the Company’s Common Stock is trading at a discount to net asset value. The level of accretion or discount would depend on various factors, including the proportion of Stockholders who participate in the DRIP, the level of premium or discount at which shares of Common Stock are trading and the amount of the distribution payable to Stockholders.

Outstanding Shares Prior to an Exchange Listing

The ability of Stockholders to liquidate their investments will be limited. If the Company conducts an Exchange Listing in the future, a large volume of sales of shares could decrease the prevailing market prices of the Common Stock and could impair the Company’s ability to raise additional capital through the sale of equity securities in the future. The ability of Stockholders to liquidate their investments could further depress the market price of Common Stock and have a negative effect on the Company’s ability to raise capital in the future. In addition, anticipated downward pressure on the Common Stock price due to actual or anticipated sales of Common Stock from this market overhang could cause some institutions or individuals to engage in short sales of the Common Stock, which may itself cause the price of the Common Stock to decline.

Net Asset Value

The net asset value and liquidity, if any, of the market for shares of the Common Stock may be significantly affected by numerous factors, some of which are beyond the Company’s control and may not be directly related to the Company’s operating performance. These factors include any, or a combination of any, of the following:

changes in the value of the Company’s portfolio of investments and derivative instruments as a result of changes in market factors, such as interest rate shifts, and also portfolio specific performance, such as portfolio company defaults, among other reasons;
changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs;
loss of RIC tax treatment or BDC status;
distributions that exceed the Company’s net investment income and net income as reported according to U.S. generally accepted accounting principles (“GAAP”);
changes in earnings or variations in operating results;
changes in accounting guidelines governing valuation of the Company’s investments;
any shortfall in revenue or net income or any increase in losses from levels expected by the Stockholders;

40

Table of Contents

departure of the Adviser or certain of its key personnel;
general economic trends and other external factors; and
loss of a major funding source.

Preferred Stock

The Board may be authorized to issue shares of preferred stock in one or more series without Stockholder approval, which could potentially adversely affect the interests of existing Stockholders.

The Company cannot assure Stockholders that the issuance of preferred stock, debt securities and/or convertible debt securities would result in a higher yield or return to the holders of shares of Common Stock. The issuance of preferred stock, debt securities or convertible debt would likely cause the net asset value of the Common Stock to become more volatile. If the dividend rate on the preferred stock, or the interest rate on the debt securities and/or the convertible debt securities, were to approach the net rate of return on the Company’s investment portfolio, the benefit of such leverage to the holders of the Common Stock would be reduced. If the dividend rate on the preferred stock, or the interest rate on the debt securities and/or convertible debt securities, were to exceed the net rate of return on the Company’s portfolio, the use of leverage would result in a lower rate of return to the holders of Common Stock than if the Company had not issued the preferred stock, debt securities or convertible debt securities. Any decline in the net asset value of the Company’s investment would be borne entirely by the holders of Common Stock. Therefore, if the market value of the Company’s portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of Common Stock than if the Company was not leveraged through the issuance of preferred stock, debt securities or convertible debt securities. This decline in net asset value would also tend to cause a greater decline in the market price, if any, for the Common Stock.

There is also a risk that, in the event of a sharp decline in the value of the Company’s net assets, the Company would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred stock, debt securities or convertible debt, or the Company’s current investment income might not be sufficient to meet the dividend requirements on the preferred stock or the interest payments on the debt securities and/or the convertible debt securities. In order to counteract such an event, the Company might need to liquidate investments in order to fund the redemption of some or all of the preferred stock, debt securities or convertible debt. In addition, the Company would pay (and the holders of Common Stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, debt securities, convertible debt, or any combination of these securities. Holders of preferred stock, debt securities or convertible debt may have different interests than holders of Common Stock and may at times have disproportionate influence over the Company’s affairs.

The 1940 Act requires that holders of shares of preferred stock must be entitled as a class to elect two directors at all times and to elect a majority of the directors if dividends on such preferred stock are in arrears by two years or more, until such arrearage is eliminated. In addition, certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock, including changes in fundamental investment restrictions and conversion to open-end status and, accordingly, preferred shareholders could veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of Common Stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies, might impair the Company’s ability to maintain its tax treatment as a RIC for U.S. federal income tax purposes.

Unrealized Depreciation

Under Rule 2a-5 of the 1940 Act, the Company is required to carry investments at market value or, if no quotation is readily available, at the fair value as determined in good faith in accordance with procedures established by the Adviser. Pursuant to Rule 2a-5, the Board has designated the Adviser as “Valuation Designee”. The Adviser, with the assistance of its Valuation Committee, subject to oversight by the Board, is responsible for determining the fair value of the Company’s investments in accordance with valuation policies and procedures approved by the Board. Decreases in the market values or fair values of the Company’s investments relative to amortized cost are recorded as unrealized depreciation. Any unrealized losses in the Company’s portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to the Company with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of the Company’s income available for distribution in future periods. In addition, decreases in the market value or fair value of the Company’s investments will reduce the Company’s net asset value.

41

Table of Contents

Pre-incentive fee net income does not include any realized or unrealized capital gains or losses or unrealized capital appreciation or depreciation. Because of the structure of the incentive fee, it is possible that the Company may pay an incentive fee in a quarter where the Company incurs a loss. For example, this may occur if the Company receives pre-incentive fee net income even if the Company has incurred a loss in that quarter due to realized and unrealized capital losses.

PIK Interest Payments

Certain of the Company’s debt investments may contain provisions providing for the payment of PIK interest. Because PIK interest results in an increase in the size of the loan balance of the underlying loan, the receipt by the Company of PIK interest will have the effect of increasing the Company’s assets under management. As a result, because the base Management Fee that the Company pays to the Adviser is based on the average value of the Company’s gross assets, the receipt by the Company of PIK interest will result in an increase in the amount of the base Management Fee. In addition, any such increase in a loan balance due to the receipt of PIK interest will cause such loan to accrue interest on the higher loan balance, which will result in an increase in the Company’s pre-incentive fee net investment income and, as a result, an increase in incentive fees that are payable by the Company to the Adviser.

To the extent original issue discount instruments, such as zero coupon bonds and PIK loans, constitute a significant portion of the Company’s income, investors will be exposed to typical risks associated with such income being required to be included in taxable and accounting income prior to receipt of cash, including the following: (a) the higher interest rates of PIK loans reflect the payment deferral and increased credit risk associated with these instruments, and PIK instruments generally represent a significantly higher credit risk than coupon loans; (b) PIK loans may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral; (c) market prices of zero-coupon or PIK securities are affected to a greater extent by interest rate changes and may be more volatile than securities that pay interest periodically and in cash, and PIKs are usually less volatile than zero-coupon bonds, but more volatile than cash pay securities; (d) because original issue discount income is accrued without any cash being received by the Company, required cash distributions may have to be paid from offering proceeds or the sale of Company assets without investors being given any notice of this fact; (e) the deferral of PIK interest increases the loan-to-value ratio, which is a measure of the riskiness of a loan; (f) even if the accounting conditions for income accrual are met, the borrower could still default when the Company’s actual payment is due at the maturity of the loan; and (g) original issue discount creates risk of non-refundable cash payments to the Adviser based on non-cash accruals that may never be realized.

Distributions

The amount of any distributions the Company may make on the Common Stock is uncertain. The Company may not be able to pay distributions, or be able to sustain distributions at any particular level, and the Company’s distributions per share, if any, may not grow over time, and the Company’s distributions per share may be reduced. The Company has not established any limit on the extent to which it may use borrowings, if any, and the Company may use offering proceeds to fund distributions (which may reduce the amount of capital the Company ultimately invests in portfolio companies).

Subject to the Board’s discretion and applicable legal restrictions, the Company generally intends to authorize and declare cash distributions on a quarterly basis and pay such distributions on a quarterly basis. The Company expects to pay distributions out of assets legally available for distribution. However, the Company cannot assure Stockholders that the Company will achieve investment results that will allow the Company to make a consistent targeted level of cash distributions or year-to-year increases in cash distributions. The Company’s ability to pay distributions might be adversely affected by the impact of the risks described herein. In addition, the inability to satisfy the asset coverage test applicable to the Company as a BDC under the 1940 Act can limit the Company’s ability to pay distributions. Distributions from offering proceeds also could reduce the amount of capital the Company ultimately invests in debt or equity securities of portfolio companies. The Company cannot assure Stockholders that the Company will pay distributions to Stockholders in the future.

Distributions on the Common Stock may exceed the Company’s taxable earnings and profits, particularly during the period before the Company has substantially invested the net proceeds from this offering. Therefore, portions of the distributions that the Company pay may represent a return of capital to Stockholders. A return of capital is a return of a portion of Stockholders’ original investment in shares of the Company’s Common Stock. As a result, a return of capital will (i) lower Stockholders’ tax basis in their shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds the Company has for investment in portfolio companies. The Company has not established any limit on the extent to which the Company may use offering proceeds to fund distributions.

42

Table of Contents

The Company may pay distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of Stockholders’ capital and will lower Stockholders’ tax basis in their shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value. Distributions from offering proceeds also could reduce the amount of capital the Company ultimately has available to invest in portfolio companies.

Responsible Investment Considerations

Stone Point Credit maintains what it refers to as a separate Responsible Investment Policy and seeks to integrate certain ESG diligence into its investment process in accordance with the relevant policy and subject to its fiduciary duty and any applicable legal, regulatory, or contractual requirements. There is no guarantee that the Adviser will be able to successfully implement the Responsible Investment Policy or to identify ESG risks while achieving the Company’s investment strategy. While the Adviser will attempt to gather information regarding a portfolio company on a pre-investment basis, there are certain transactions that make it more difficult to gather relevant information. There is no guarantee that all ESG information will be available for all types of transactions. In addition, applying ESG factors to investment decisions is qualitative and subjective by nature, and there is no guarantee that the criteria utilized by the Adviser, or any judgment exercised by the Adviser, will reflect the beliefs or values of any particular investor. There are also significant differences in interpretations of what critical ESG characteristics mean by region, industry, and topic. The Adviser’s interpretations and decisions are expected to differ from others’ views and could also evolve over time. In addition, in evaluating an investment, the Adviser expects to depend upon information and data provided by several sources, including the relevant target companies and/or various reporting sources which could be incomplete, inaccurate, or unavailable, and which could cause the Adviser to incorrectly assess a company’s ESG practices and/or related risks. The Adviser does not intend independently to verify all ESG information reported by target companies or third parties. Further, considering ESG qualities when evaluating an investment could result in the selection or exclusion of certain investments based on the Adviser’s view of certain ESG-related and other factors and could cause the Company not to make an investment that it would have made or to make a management decision with respect to an investment differently than it would have made in the absence of a Responsible Investment Policy, which could negatively impact the Company’s performance.

Further, ESG practices are evolving rapidly and there are different principles, frameworks, methodologies, and tracking tools being implemented by other asset managers, and the Adviser’s adoption and adherence to various such principles, frameworks, methodologies, and tools is expected to vary over time. There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement, and disclosure of ESG factors. Stone Point Credit’s Responsible Investment Policy could become subject to additional regulation in the future, and Stone Point Credit cannot guarantee that its current approach will meet future regulatory requirements.

Non-Diversified Investment Company

The Company intends to operate as a non-diversified investment company within the meaning of the 1940 Act, which means that the Company will not be limited by the 1940 Act with respect to the proportion of its assets that it may invest in a single issuer. However, the Company from time to time in the future may be considered a diversified management investment company within the meaning of the 1940 Act. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC for U.S. federal income tax purposes, the Company does not have fixed guidelines for diversification. While the Company is not targeting any specific industries, its investments may be focused on relatively few industries. To the extent that the Company holds large positions in a small number of issuers, or within a particular industry, the Company’s net asset value may be subject to greater fluctuation. The Company may also be more susceptible to any single economic or regulatory occurrence or a downturn in particular industry.

Difficulty of Locating Suitable Investments

There can be no assurance that there will be a sufficient number of suitable investment opportunities satisfying the investment objectives of the Company to enable the Company to invest all of its committed capital, or that such investment opportunities will lead to completed investments by the Company. Identification of attractive investment opportunities is difficult and the availability of investment opportunities generally will be subject to market conditions and the prevailing regulatory and economic climate.

Co-investment with Third Parties

The Company may co-invest in portfolio companies with third parties (including Stone Point Credit and certain of its affiliates) through partnerships, joint ventures or other arrangements. Such investments may involve risks not present in investments where a

43

Table of Contents

third party is not involved, including the possibility that a third party co-venturer or partner may at any time have economic or business interests or goals that are inconsistent with those of the Company or may be in a position to take action contrary to the Company’s investment objectives or may default on its obligations. In addition, the Company may under certain circumstances be liable for actions of their third-party co-venturers or partners.

The Company may be prohibited under the 1940 Act from participating in certain transactions with its affiliates without the prior approval of the directors who are not interested persons and, in some cases, the prior approval of the SEC. On June 14, 2022, the SEC granted the Company exemptive relief (the “Order”) that permits the Company to co-invest alongside other funds/vehicles managed by the Adviser or certain of its affiliates, or alongside the Adviser or certain of its affiliates in a principal capacity, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors (the “Order”). The Order provides that, in connection with any co-investment transaction, the Company will receive its pro rata share of any transaction fees, based on its relative share of the amount invested or committed, as applicable, in the transaction. The Adviser’s investment allocation policy seeks to ensure equitable allocation of investment opportunities between the Company and other Credit Funds and certain affiliates of the Adviser. While an affiliated broker-dealer or other financial affiliate (“Financial Affiliate”) of the Adviser from time to time may be permitted, subject to the terms of the Order, to participate as principal in a co-investment transaction in which the Company also participates, in no event will the Financial Affiliate acquire any such investment at a price more favorable than that offered to the Company. As a result of the exemptive relief, there could be significant overlap in the Company’s investment portfolio and the investment portfolio of other Credit Funds that could avail themselves of the exemptive relief.

In situations when co-investment with other Credit Funds is not permitted under the 1940 Act and related rules, existing or future staff guidance, or the terms and conditions the Order, the Adviser and/or its affiliates will need to decide which client or clients will proceed with the investment.

Minority Investments

The Company may make minority investments, or may make investments in “club” deals alongside entities sponsored by other private credit or private equity firms, in portfolio companies where the Company may not have the right to appoint a director or otherwise be able to control or effectively influence the business or affairs of such entities. The entity in which a Company investment is made may have economic or business interests or goals that are inconsistent with those of the Company, and the Company may not be able to limit or otherwise protect the value of its investment in the portfolio company. In addition, although the Company may seek board representation in connection with certain investments, there is no assurance that such representation, if sought, will be obtained. In all such cases, the Company will rely significantly on the existing management and boards of directors of portfolio companies, which may include representatives of investors with whom the Company is not affiliated and whose interests may conflict with the interests of the Company.

Follow-On Investments

The Company may make follow-on investments in certain portfolio companies or have the opportunity to increase an investment in certain portfolio companies. There can be no assurance that the Company will wish to make follow-on investments or that it will have sufficient funds to do so. Any decision by the Company not to make follow-on investments or its inability to make them may have a substantial negative impact on a portfolio company in need of such an investment or may diminish the Company’s ability to influence the portfolio company’s future development. The Company’s ability to make follow-on investments may also be limited by the Adviser’s allocation policies and procedures. In situations where co-investment with other clients of the Adviser or its affiliates is not permitted under the 1940 Act and related rules, existing or future staff guidance, or the terms and conditions of the Order, the Adviser will need to decide which client or clients will proceed with the investment. Under the Adviser’s allocation policy, the Adviser is required to allocate follow-on investments in portfolio companies based on the order in which the Company invested in such portfolio companies, with priority to the Company’s earlier investments.

Limitations on Leverage

The Company may, subject to the limitations described below, incur leverage in connection with its operations, collateralized by its assets and/or capital commitments. The amount of leverage that the Company employs will depend on the Adviser’s and the Board’s assessment of market and other factors at the time of any proposed borrowing. The use of leverage by the Company may have important consequences to the Stockholders, including, but not limited to, the following: (a) greater fluctuations in the net asset value of the Company; (b) use of cash flow for debt service and related costs and expenses, rather than for additional investments,

44

Table of Contents

distributions or other purposes; (c) increased interest expense if interest rate levels were to increase significantly; (d) limitation on the flexibility of the Company to make distributions to the Stockholders (and investors should specifically note in this regard that, for the avoidance of doubt, in connection with one or more credit facilities entered into by the Company, distributions to the investors may be subordinated to payments required in connection with any indebtedness contemplated thereby); (e) in certain circumstances, the Company may be required to dispose of investments at a loss or otherwise on unattractive terms in order to service its debt obligations or meet its det covenants; (f) the amount and timing of contributions and distributions to Stockholders may be affected in a manner that may have potentially adverse consequences to Stockholders; (g) result in lower multiples of cost (but enhanced IRRs) for equity investments; and (h) in the case of certain tax-exempt entities, tax on UBTI in respect of acquisition indebtedness. There can be no assurance that the Company will have sufficient cash flow to meet its debt service obligations. As a result, the Company’s exposure to losses may be increased due to the illiquidity of its investments generally.

In addition, the Company may need to refinance its outstanding debt as the debt matures. There is a risk that the Company may not be able to refinance existing debt or that the terms of any refinancing may not be as favorable as the terms of the existing loan agreements. If prevailing interest rates or other factors at the time of refinancing result in higher interest rates upon refinancing, then the interest expense relating to that refinanced indebtedness would increase. These risks could adversely affect the Company’s financial condition, cash flows and return on its investments. A credit agreement or borrowing facility frequently will contain other terms that restrict the activities of the Company and the Stockholders or impose additional obligations on them. For example, certain lenders or facilities are expected to impose restrictions on the Company’s ability to consent to the transfer of a Stockholder’s interest in the Company or impose concentration or other limits on the Company’s investments, and/or financial or other covenants, that could affect the implementation of the Company’s investment strategy. The Company and any other parallel investment entities, alternative investment vehicles and/or co-investment vehicles may be jointly and severally liable for all credit support obligations in respect of investments or under any Company-related credit facility. Therefore, in the event that one or more investors of the Company and/or investors of any other parallel investment entities, alternative investment vehicles and/or co-investment vehicles fail to satisfy a drawdown or otherwise default on their contribution obligations pursuant to the credit support, such amount would be drawn on a pro rata basis from non-defaulting investors and/or investors of any other parallel investment entities, alternative investment vehicles and/or co-investment vehicles up to the remaining amount of their respective unfunded capital commitments. As a result of the incurrence of indebtedness on a joint and several or cross-collateralized basis, the Company may be required to contribute amounts in excess of its pro rata share, including additional capital to make up for any shortfall if such vehicles are unable to repay their pro rata share of such indebtedness. However, subject to the terms on borrowing under the Company’s Governing Agreements, only the Company’s pro rata share (based on the amounts invested or proposed to be invested in the investment or the proposed investment) of any such indebtedness will be counted for purposes of the limitations on borrowing. Finally, the Management Fee will be payable based on the average value of the Company’s gross assets (excluding cash and cash equivalents), which may give the Adviser an incentive to use leverage to make additional investments.

In connection therewith, credit facilities may be secured by an assignment of the Stockholders’ unfunded capital commitments or the Company’s portfolio investments and assets. Stockholders may be required to acknowledge their obligation to pay their share of such indebtedness up to the amount of their unfunded capital commitments or to acknowledge the right of such lender to call on such Stockholders to fund their commitments. The Governing Agreements may provide a lender with the right to receive detailed due diligence and credit-related information regarding the Stockholders. The Adviser reserves the right, in its sole discretion, to waive these requirements for certain Stockholders, which may have an adverse effect on the Company’s ability to obtain such credit facility or terms thereof. In addition, subject to the limitations in the Governing Agreements, the Company’s financing arrangements could be structured generally as a portfolio financing where multiple investments are cross-collateralized and are subject to the risk of loss. As a result, the Company could lose its interests in one or more performing investments in the event any investment is cross-collateralized with poorly performing or non-performing investments. The Company’s assets, including any investments made by the Company and any capital held by the Company, are available to satisfy all liabilities and other obligations of the Company. If the Company defaults on secured indebtedness, the lender could foreclose and the Company could lose its entire investment in the collateral for such loan. If the Company itself becomes subject to a liability, parties seeking to have the liability satisfied could have recourse to the Company’s assets generally and not be limited to any particular asset, such as the investment giving rise to the liability. In the event of a sudden, precipitous drop in the value of the Company’s assets, the Company might not be able to dispose of assets quickly enough to pay off its debt, resulting in a foreclosure or other total loss of some or all of the pledged assets. Company-level debt facilities typically include other covenants such as, but not limited to, covenants against the Company incurring or being in default under other recourse debt, including certain fund level guarantees of asset-level debt, which, if triggered, could cause adverse consequences to the Company if it is unable to cure or otherwise mitigate such breach. Also any bankruptcy, insolvency or default by a counterparty to the Company could result in a loss of the Company’s investments, including, for example, where fund assets and securities are re-hypothecated or otherwise held by such counterparties and become subject to general claims of their creditors.

45

Table of Contents

As a BDC, generally, the ratio of the Company’s total assets (less total liabilities other than indebtedness represented by senior securities) to the Company’s total indebtedness represented by senior securities plus any preferred stock, if any, must be at least 200%; however, legislation enacted in March 2018 has modified the 1940 Act by allowing a BDC to increase the maximum amount of leverage it may incur from an asset coverage ratio of 200% to an asset coverage ratio of 150%, if certain requirements are met. This means that generally, the Company can borrow up to $1 for every $1 of investor equity (or, if certain conditions are met, the Company can borrow up to $2 for every $1 of investor equity). The Company may reduce its asset coverage ratio to 150% and, in connection with their subscription agreements, the Stockholders are required to acknowledge the Company’s ability to operate with an asset coverage ratio that may be as low as 150%. If this ratio declines below 150%, the Company cannot incur additional debt and could be required to sell a portion of its investments to repay some indebtedness when it may be disadvantageous to do so. This could have a material adverse effect on the Company’s operations, and the Company may not be able to service its debt or make distributions.

In addition, as market conditions permit, the Company may securitize its loans to generate cash for funding new investments. To securitize loans, the Company may create a wholly owned subsidiary, contribute a pool of loans to the subsidiary and have the subsidiary issue primarily investment grade debt securities to purchasers who would be expected to be willing to accept a substantially lower interest rate than the loans earn. The Company would retain all or a portion of the equity in the securitized pool of loans. The Company’s retained equity would be exposed to any losses on the portfolio of loans before any of the debt securities would be exposed to such losses.

Leverage magnifies the potential for loss on investments in the Company’s indebtedness and on invested equity capital. As the Company uses leverage to partially finance its investments, Stockholders will experience increased risks of investing in the Company’s securities. If the value of the Company’s assets increases, then leveraging would cause the net asset value attributable to the Common Stock to increase more sharply than it would have had the Company not leveraged. Conversely, if the value of the Company’s assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had the Company not leveraged its business. Similarly, any increase in the Company’s income in excess of interest payable on the borrowed funds would cause the Company’s net investment income to increase more than it would without the leverage, while any decrease in the Company’s income would cause net investment income to decline more sharply than it would have had the Company not borrowed. Such a decline could negatively affect the Company’s ability to pay dividends on its Common Stock, scheduled debt payments or other payments related to the Company’s securities.

Benchmark Rate Risks for Floating Rate Loans

LIBOR, the London Interbank Offered Rate, was a leading floating rate benchmark used in loans, notes, derivatives and other instruments or investments. As a result of benchmark reforms, publication of all LIBOR settings has ceased. Various financial industry groups and certain regulators have taken actions to establish alternative reference rates (e.g., the Secured Overnight Financing Rate (“SOFR”), which measures the cost of overnight borrowings through repurchase agreement transactions collateralized with U.S. Treasury securities and is intended to replace U.S. dollar LIBOR with certain adjustments). At this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates (and the nature of such alternative reference rates) or other reforms to such alternative reference rates that may be enacted in the United States, United Kingdom or elsewhere. There also remains uncertainty regarding the effects of the transition away from LIBOR to alternative reference rates on the Company or on certain instruments in which the Company invests which have transitioned from LIBOR.

We generally expect to use an alternative reference rate as the reference rate in term loans we extend to portfolio companies such that the interest due to us pursuant to a term loan extended to a portfolio company is calculated using the alternative reference rate. The terms of our debt investments generally include minimum interest rate floors which are calculated based on the applicable alternative reference rate.

Changes or reforms to the determination or supervision of any reference rate could have an adverse impact on the market for or value of any securities, loans, and other financial obligations or extensions of credit held by or due to the Company linked to any such reference rate or on the Company’s overall financial condition or results of operations. Any such change may have an adverse effect on the Company’s overall financial condition or results of operations.

Hedging Policies/Risks

In connection with certain portfolio investments, the Company may employ hedging techniques designed to reduce the risk of adverse movements in interest rates, securities prices and currency exchange rates. While such transactions may reduce certain risks, such transactions themselves may entail certain other risks. Thus, while the Company may benefit from the use of these hedging

46

Table of Contents

mechanisms, unanticipated changes in interest rates, securities prices, currency exchange rates and other factors may result in a poorer overall performance for the Company than if it had not entered into such hedging transactions. The successful utilization of hedging and risk management transactions requires skills that are separate from the skills used in selecting and monitoring investments.

Derivatives and Financial Commitment Transactions

The Company may invest in derivatives and other assets that are subject to many of the same types of risks related to the use of leverage. In October 2020, the SEC adopted Rule 18f-4 under the 1940 Act that governs the use of derivatives, (defined to include any swap, security-based swap, futures contract, forward contract, option or any similar instrument) as well as financial commitment transactions (defined to include reverse repurchase agreements, short sale borrowings and any firm or standby commitment agreement or similar agreement) by BDCs. Under Rule 18f-4, the Company is required to trade derivatives and other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions) subject to a value-at-risk (“VaR”) leverage limit and certain derivatives risk management program and reporting requirements. Generally, these requirements apply unless the Company satisfies a “limited derivatives users” exception that is included in Rule 18f-4. Under Rule 18f-4, when the Company trades reverse repurchase agreements or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing indebtedness when calculating the Company’s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation of whether the Company satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions or not. These requirements may limit the ability of the Company to use derivatives, short sales, and reverse repurchase agreements and similar financing transactions as part of its investment strategies. These requirements may increase the cost of the Company’s investments and cost of doing business, which could adversely affect investors.

The Company has adopted updated policies and procedures in compliance with Rule 18f-4. The Company expects to qualify as a “limited derivatives user.” Future legislation or rules may modify how the Company treats derivatives and other financial arrangements for purposes of the Company’s compliance with the leverage limitations of the 1940 Act. Future legislation or rules may modify how leverage is calculated under the 1940 Act and, therefore, may increase or decrease the amount of leverage currently available to the Company under the 1940 Act, which may be materially adverse to the Company and the Company’s investors.

Portfolio Company Management

Each portfolio company’s day-to-day operations are the responsibility of such company’s management team. Although the Adviser is responsible for monitoring the performance of each portfolio investment there can be no assurance that the existing management team, or any successor, will be able to successfully operate the portfolio company in accordance with the Company’s plans. The success of each portfolio company depends in substantial part upon the skill and knowledge of each portfolio company’s management team.

Operating and Financial Risks of Portfolio Companies

Companies in which the Company invests could deteriorate as a result of, among other factors, an adverse development in their business, a change in the competitive environment, or an economic downturn. As a result, companies which the Company expects to be stable may operate, or expect to operate, at a loss or have significant variations in operating results, may require substantial additional capital to support their operations or to maintain their competitive position, or may otherwise have a weak financial condition or be experiencing financial distress. In some cases, the success of the Company’s investment strategy will depend, in part, on the ability of the Company to restructure and/or effect improvements in the operations of a portfolio company. The activity of identifying and implementing restructuring programs and operating improvements at portfolio companies entails a high degree of uncertainty. There can be no assurance that the Company will be able to successfully identify and implement such restructuring programs and improvements.

Projections and Third-Party Reports

The Company will generally make investments based on projections of the operating results of portfolio companies, the market environment and views/assumptions on default rates, recoveries, interest rate movements and technical market factors. Projected operating results will normally be based primarily on the guidance of the company’s management and be justified by the Adviser’s

47

Table of Contents

judgments or third-party advice and reports. In all cases, projections are only estimates of future results that are based upon assumptions made at the time that the projections are developed. There can be no assurance that the projected results will be achieved and actual results may vary significantly from the projections. General economic, natural and other conditions, which are not predictable, can have an adverse impact on the reliability of such projections.

Risks Relating to the Company’s Investments

Interest Rates

Because the Company may borrow money to make investments, the Company’s net investment income will depend, in part, upon the difference between the rate at which the Company borrows funds and the rate at which the Company invests those funds. As a result, the Company can offer no assurance that a significant change in market interest rates will not have a material adverse effect on the Company’s net investment income.

A reduction in interest rates on new investments relative to interest rates on current investments could have an adverse impact on the Company’s net investment income. However, an increase in interest rates could decrease the value of any investments which earn fixed interest rates and also could increase the Company’s interest expense, thereby decreasing the Company’s net income. Also, an increase in interest rates available to investors could make an investment in shares of Common Stock less attractive if the Company is not able to increase its dividend rate, which could reduce the value of the Common Stock. Further, rising interest rates could also adversely affect the Company’s performance if such increases cause its borrowing costs to rise at a rate in excess of the rate that the Company’s investments yield.

The recent increases in interest rates have made it more expensive to finance our investments and to refinance our current financing arrangements. In addition, certain of our financing arrangements provide for adjustments in the loan interest rate along with changes in market interest rates. Therefore, in periods of rising interest rates, to the extent the Company borrows money subject to a floating interest rate, the Company’s cost of funds would increase, which could reduce the Company’s net investment income. Further, rising interest rates could also adversely affect the Company’s performance if it holds investments with floating interest rates, subject to specified minimum interest rates (such as an applicable reference rate floor), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase the Company’s interest expense, even though its interest income from investments is not increasing in a corresponding manner as a result of such minimum interest rates.

If general interest rates continue to rise, there is a risk that the portfolio companies in which the Company hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with the Company. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on the Company to provide fixed rate loans to the Company’s portfolio companies, which could adversely affect the Company’s net investment income, as increases in the Company’s cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

Risks Related to Investments in Loans

The Company invests primarily by making loans, either through primary issuances or in secondary transactions, including potentially on a syndicated basis (i.e., through the use of derivatives, participations or assignments). The value of such loans may be detrimentally affected to the extent a borrower defaults on its obligations. There can be no assurance that the value assigned by the Company to collateralize an underlying loan can be realized upon liquidation, nor can there be any assurance that any such collateral will retain its value. Furthermore, circumstances could arise (such as in the bankruptcy of a borrower) that could cause the Company’s security interest in the loan’s collateral to be invalidated. Also, much of the collateral will be subject to restrictions on transfers intended to satisfy securities regulations, which will limit the number of potential purchasers if the Company intends to liquidate such collateral. The amount realizable with respect to a loan may be detrimentally affected if a guarantor, if any, fails to meet its obligations under a guarantee. Finally, there may be a monetary, as well as a time, cost involved in collecting on defaulted loans and, if applicable, taking possession of various types of collateral.

48

Table of Contents

Investments in Privately Held Companies

The Company will acquire a significant percentage of its portfolio company investments from privately held companies in directly negotiated transactions. Substantially all of these investments are subject to legal and other restrictions on resale or are otherwise less liquid than exchange-listed securities or other securities for which there is an active trading market. The Company typically would be unable to exit these investments unless and until the portfolio company has a liquidity event such as a sale, refinancing, or initial public offering.

The illiquidity of the Company’s investments may make it difficult or impossible for the Company to sell such investments if the need arises. In addition, if the Company is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which the Company has previously recorded its investments, which could have a material adverse effect on the Company’s business, financial condition and results of operations.

Moreover, investments purchased by the Company that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer, market events, economic conditions or investor perceptions.

Investments in Private and Middle-Market Companies

Investments in private and middle-market companies involve a number of significant risks. Generally, little public information exists about these companies, and the Company will rely on the ability of the Adviser’s investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If the Adviser is unable to uncover all material information about these companies, it may not make a fully informed investment decision, and the Company may lose money on its investments. Middle-market companies generally have less predictable operating results and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. Middle-market companies may have limited financial resources, may have difficulty accessing the capital markets to meet future capital needs and may be unable to meet their obligations under their debt securities held by the Company, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of the Company realizing any guarantees it may have obtained in connection with its investment. In addition, such companies typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns. Additionally, middle-market companies are more likely to depend on the management talents and efforts of a small group of persons. Therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on a portfolio company and, in turn, on the Company. Middle-market companies also may be parties to litigation and may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence. In addition, the Company’s executive officers, directors and the Adviser may, in the ordinary course of business, be named as defendants in litigation arising from the Company’s investments in the portfolio companies.

Investments in Publicly Traded Companies

The Company’s investment portfolio may contain securities or instruments issued by publicly held companies. Such investments may subject the Company to risks that differ in type or degree from those involved with investments in privately held companies. Such risks include, without limitation, greater volatility in the valuation of such companies, increased obligations to disclose information regarding such companies, limitations on the ability of the Company to dispose of such securities or instruments at certain times, increased likelihood of shareholder litigation against such companies’ board members and increased costs associated with each of the aforementioned risks. Moreover, the Company may not have the same access to information in connection with investments in public securities, either when investing in a potential investment or after making an investment, as compared to privately negotiated investments. Furthermore, the Company may be limited in its ability to make investments, and to sell existing investments, in public securities because the Adviser and/or Stone Point may be deemed to have material, non-public information regarding the issuers of those securities or as a result of other internal policies.

Investments in the Health Care Sector

The Company could make investments in the health care sector. Investing in health care companies involves substantial risks, including, but not limited to, the following: limited operating histories and limited experience instituting compliance policies, rapidly changing technologies and the obsolescence of products, change in government policies and governmental investigations, potential litigation alleging negligence, products liability torts, breaches of warranty, intellectual property infringement and other legal theories, extensive and evolving government regulation, disappointing results from preclinical testing, indications of safety concerns,

49

Table of Contents

insufficient clinical trial data to support the safety or efficacy of the product candidate, difficulty in obtaining all necessary regulatory approvals in each proposed jurisdiction, inability to manufacture sufficient quantities of the product candidate for development or commercialization in a timely or cost-effective manner, and the fact that, even after regulatory approval has been obtained, the product and its manufacturer are subject to continual regulatory review, and any discovery of previously unknown problems with the product or the manufacturer could result in restrictions or recalls. Each of these risks could have a material adverse effect on the direct and indirect investments of the Company.

Foreign Investments

The Company will accept subscriptions and will maintain books and records in U.S. dollars although the Company may invest a portion of capital outside of the United States (and in various foreign currencies). Investment in foreign securities involves certain factors not typically associated with investing in U.S. securities, including risks relating to: (i) currency exchange matters, including fluctuations in the rate of exchange between the dollar and the various foreign currencies in which the Company’s foreign investments are denominated, and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including potential price volatility in and relative liquidity of some foreign securities markets, the absence of uniform accounting, auditing and financial reporting standards, practices and disclosure requirements and less government supervision and regulation; (iii) certain economic, social and political risks, including potential exchange control regulations and restrictions on foreign investment and repatriation of capital, the risks of political, economic or social instability and the possibility of expropriation or confiscatory taxation; and (iv) the possible requirement of financing and structuring alternatives and exit strategies that differ substantially from those commonly used in the United States. In addition, the Company and the Stockholders could become subject to additional or unforeseen taxation in foreign jurisdictions in which the Company invests, and changes to taxation treaties (or their interpretation) between the jurisdiction of a Stockholder and the countries in which the Company invests may adversely affect the tax treatment of such Stockholder. The foregoing factors may increase transaction costs and adversely impact the value of the Company’s investments in non-U.S. portfolio companies.

Difficulties Upon Exit

The Company’s investments are subject to various risks, particularly the risk that the Company will be unable to realize its investment objectives by sale or other disposition at attractive prices or be unable to complete any exit strategy. Dispositions of investments may be subject to contractual and other limitations on transfer or other restrictions that would interfere with subsequent sales of such investments or adversely affect the terms that could be obtained upon any disposition thereof. There can be no assurance that a public market will develop for any of the Company’s investments or that the Company will otherwise be able to realize such investments. Therefore, there can be no assurance that the Company will realize net profits or achieve returns commensurate with the risks associated with the investments, or that the Company will not experience losses in its investments, which may be substantial.

Risks of Investing in a Credit Vehicle

In addition to the foregoing risks, investing in the Company presents certain risks, including, but not limited to, risks associated with: credit, investments in loans, “higher-yielding” debt securities, stressed and distressed investments, investments in public companies, credit ratings, prepayment, and interest rates.

The Company has a very broad mandate with respect to the type and nature of securities in which it may invest. While some of the loans in which the Company will invest may be secured, the Company may also invest in debt or preferred equity securities that are either unsecured or subordinated to substantial amounts of senior indebtedness, or a significant portion of which may be unsecured. In such instances, the ability of the Company to influence a portfolio company’s affairs, especially during periods of financial distress or following an insolvency, is likely to be substantially less than that of senior creditors. For example, under terms of subordination agreements, senior creditors are typically able to block the acceleration of the debt or other exercises by the Company of its rights as a creditor. Accordingly, the Company may not be able to take the steps necessary to protect its investments in a timely manner or at all. In addition, the debt securities in which the Company will invest may not be protected by financial covenants or limitations upon additional indebtedness, may have limited liquidity and may not be rated by a credit rating agency.

Credit Risk

One of the fundamental risks associated with investments by the Company is credit risk, which is the risk that an issuer will be unable to make principal and interest payments on its outstanding debt obligations when due. The return to Stockholders would be adversely impacted if an issuer of debt in which the Company invests becomes unable to make such payments when due. Although the

50

Table of Contents

Company may make investments that are believed to be secured by specific collateral, the value of which may initially exceed the principal amount of such investments or the fair value of such investments, there can be no assurance that the liquidation of any such collateral would satisfy the borrower’s obligation in the event of non-payment of scheduled interest or principal payments with respect to such investment, or that such collateral could be readily liquidated. The Company may also invest in unsecured loans, which involves a higher degree of risk than senior secured loans. Furthermore, the Company’s right to payment and its security interest, if any, may be subordinated to the payment rights and security interests of a senior lender, to the extent applicable. Certain of these investments may have an interest-only payment schedule, with the principal amount remaining outstanding and at risk until the maturity of the investment. In addition, loans may provide for payments-in-kind, which have a similar effect of deferring current cash payments. In such cases, a portfolio company’s ability to repay the principal of an investment may depend on a liquidity event or the long-term success of the company, the occurrence of which is uncertain.

With respect to the Company’s investments in any number of credit products, if the borrower or issuer breaches any of the covenants or restrictions under the credit agreement that governs loans of such issuer or borrower, it could result in a default under the applicable indebtedness as well as the indebtedness held by the Company. Such default may allow the creditors to accelerate the related debt and may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies. This could result in an impairment or loss of the Company’s investment or a pre-payment (in whole or in part) of the Company’s investment.

Similarly, while the Company generally targets investing in companies it believes are of high quality, these companies could still present a high degree of business and credit risk. Companies in which the Company invests could deteriorate as a result of, among other factors, an adverse development in their business, a change in the competitive environment or the continuation or worsening of the current (or any future) economic and financial market downturns and dislocations. As a result, companies that the Company expected to be stable or improve may operate, or expect to operate, at a loss or have significant variations in operating results, may require substantial additional capital to support their operations or maintain their competitive position, or may otherwise have a weak financial condition or experience financial distress. In addition, exogenous factors such as fluctuations of the equity markets also could result in warrants and other equity securities or instruments owned by the Company becoming worthless.

Risks Related to Loan Prepayments

The loans in the Company’s investment portfolio generally may be prepaid at any time, mostly with little advance notice. Whether a loan is prepaid will depend both on the continued positive performance of the portfolio company and the existence of favorable financing market conditions that allow such company the ability to replace existing financing with less expensive capital. As market conditions change, the Company does not know when, and if, prepayment may be possible for each portfolio company. In some cases, the prepayment of a loan may reduce the Company’s achievable yield if the capital returned cannot be invested in transactions with equal or greater expected yields, which could have a material adverse effect on the Company’s business, financial condition and results of operations.

Risks Associated with Covenant-Lite Loans

A significant number of leveraged loans in the market may consist of loans that either have no financial maintenance covenants or have financial maintenance covenants that apply to a revolving credit facility, as applicable (“Covenant-Lite Loans”). While the Company does not intend to invest in Covenant-Lite Loans as part of its principal investment strategy, it is possible that such loans may comprise a portion of the Company’s portfolio. Such loans do not require the borrower to maintain debt service or other financial ratios. Ownership of Covenant-Lite Loans may expose the Company to different risks, including with respect to liquidity, price volatility, ability to restructure loans, credit risks and less protective loan documentation than is the case with loans that also contain financial maintenance covenants.

Potential Material and Adverse Effects of Market Conditions on Debt and Equity Capital Markets

From time to time, capital markets may experience periods of disruption and instability. For example, from 2008 to 2009, the global capital markets were unstable as evidenced by the lack of liquidity in the debt capital markets, significant write-offs in the financial services sector, the repricing of credit risk in the broadly syndicated credit market and the failure of major financial institutions. Despite actions of the U.S. federal government and various foreign governments, these events contributed to worsening general economic conditions that materially and adversely impacted the broader financial and credit markets and reduced the availability of debt and equity capital for the market as a whole and financial services firms in particular. While market conditions have improved from the beginning of the disruption, there have been recent periods of volatility, such as during the coronavirus

51

Table of Contents

(“COVID-19”) pandemic, and there can be no assurance that adverse market conditions will not repeat themselves in the future. If these adverse and volatile market conditions continue, the Company and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital in order to grow. Equity capital may be particularly difficult to raise during periods of adverse or volatile market conditions because, subject to some limited exceptions, as a BDC, the Company is generally not able to issue additional shares of Common Stock at a price less than net asset value per share without first obtaining approval for such issuance from Stockholders and the Company’s Independent Directors.

Moreover, the re-appearance of market conditions similar to those experienced from 2008 through 2009 for any substantial length of time could make it difficult for the Company to borrow money or to extend the maturity of or refinance any indebtedness the Company may have under similar terms and any failure to do so could have a material adverse effect on the Company’s business. The debt capital that will be available to the Company in the future, if any, may be at a higher cost and on less favorable terms and conditions than what the Company is currently able to access. If the Company is unable to raise or refinance debt, the Company may be limited in its ability to make new commitments or to fund existing commitments to its portfolio companies.

Given the extreme volatility and dislocation in the capital markets over the past several years, many BDCs have faced, and may in the future face, a challenging environment in which to raise or access capital. In addition, significant changes in the capital markets, including the extreme volatility and disruption over the past several years, has had, and may in the future have, a negative effect on the valuations of the Company’s investments and on the potential for liquidity events involving these investments.

As a BDC, the Company needs the ability to raise additional capital for investment purposes on an ongoing basis. Without sufficient access to the capital markets, the Company may be forced to curtail business operations or may not be able to pursue new investment opportunities. An inability to raise capital or access debt financing could negatively affect the Company’s business, inhibit the Company’s ability to scale operations, and lead to an increase in operating expenses as a percentage of the Company’s net assets. Disruptive conditions in the financial industry and any new legislation in response to those conditions could restrict the Company’s business operations and could adversely impact the Company’s results of operations and financial condition.

Use of Expert Networks and Data Analytics

In connection with the evaluation of potential investment opportunities, the Adviser engages expert networks and uses data analytics, including data provided by third-party vendors. The Adviser seeks to avoid inadvertently obtaining confidential information from expert networks and data analytics and has therefore implemented policies and procedures to mitigate the risk that the use of expert networks (in the case of Stone Point Credit) or data analytics could result in the receipt of confidential information by investment professionals. However, because the Adviser’s business operates on an integrated platform without information barriers, if such controls fail and an investment professional obtains material nonpublic information, the Adviser could be restricted in acquiring or disposing of investments on behalf of the Company, which could impact the returns generated for the Company.

General Risk Factors

Market Risks

General economic conditions may affect the Company’s activities. Interest rates, the price of securities and participation by other investors in the financial markets may also affect the value of securities purchased by and the number of investments made by the Company.

Inflation Risks

Typically, as inflation rises, a portfolio company will earn more revenue but also will incur higher expenses; as inflation declines, a portfolio company might be unable to reduce expenses in line with any resulting reduction in revenue. A rise in real interest rates would likely result in higher financing costs for portfolio companies and could therefore result in a reduction in the amount of cash available for distribution to investors or the value of the portfolio company. If a portfolio company is unable to increase its revenue or pass any increases in its costs along to its customers during times of higher inflation, its profitability and its ability to pay interest and principal on its loans could be adversely affected, particularly if interest rates rise in response to increases in inflation rates.

52

Table of Contents

Economic and Political Environment

Turmoil such as that recently experienced by the U.S. and global financial markets illustrates the risk that the financial markets can experience uncertainty, volatility and instability, potentially for protracted periods of time. Global financial markets have experienced considerable and prolonged declines in the valuations of equity and debt securities and periodic acute contractions in the availability of credit. There can be no assurances that conditions in the U.S. or global financial markets will not worsen and/or adversely affect one or more of the Company’s portfolio companies (including with respect to performing under or refinancing their existing obligations), its access to capital or leverage, its ability to effectively deploy its capital or realize investments on favorable terms or its overall performance. The Company’s investment strategy and the availability of opportunities satisfying the Company’s risk-adjusted return parameters. The implementation of the investment activities of the Company relies in part on the continuation of certain trends and conditions observed in the financial markets and in some cases the improvement of such conditions. Trends and historical events do not imply, forecast or predict future events and, in any event, past performance is not necessarily indicative of future results. There can be no assurance that the assumptions made or the beliefs and expectations currently held by Stone Point will prove correct and actual events and circumstances may vary significantly.

The activities of the Company could be materially adversely affected by the instability in the U.S. and/or global financial markets and supply chains and/or changes in market, economic, political, and/or regulatory conditions, as well as by numerous other factors outside the control of the Company, the investors in the Company and their respective affiliates.

Many of the portfolio companies in which the Company makes investments could be susceptible to economic slowdowns or recessions and could be unable to meet their debt obligations during these periods. Therefore, non-performing assets may increase, and the value of the Company’s portfolio may decrease during these periods as the Company is required to record the investments at their current fair value. Adverse economic conditions could also decrease the value of the collateral securing some of the loans in the Company’s portfolio and the value of its equity investments. Economic slowdowns or recessions could lead to financial losses in the Company’s portfolio and a decrease in revenues, net income, and assets. Unfavorable economic conditions also could increase portfolio companies’ funding costs, limit portfolio companies’ access to the capital markets or result in a decision by lenders not to extend credit to such portfolio company. These events could prevent the Company from making more investments that it otherwise would have made and harm the Company’s operating results.

A portfolio company’s failure to satisfy financial or operating covenants under its debt agreements could lead to defaults and, potentially, acceleration of the time when the loans are due and eventual foreclosure on its assets to repay its debts, which could itself trigger cross-defaults under other agreements and ultimately jeopardize the portfolio company’s ability to repay the debt investment that the Company holds. The Company may incur additional expenses to the extent necessary to seek recovery in these scenarios or to negotiate new terms with a defaulting portfolio company. In addition, if one of the portfolio companies were to go bankrupt, depending on the facts and circumstances, including the extent to which the Company will actually provide significant managerial assistance to that portfolio company, a bankruptcy court might subordinate all or a portion of the Company’s claim to that of other creditors.

53

Table of Contents

Public Health Emergencies

Any public health emergency, including any outbreak of COVID - 19, SARS, H1N1/09 flu, avian flu, other coronavirus, Ebola or other existing or new epidemic diseases, or the threat thereof, could adversely impact global commercial activity and contribute to significant volatility in certain equity, debt, derivative, and commodities markets. Such outbreaks could negatively impact the Company and its portfolio companies and could meaningfully affect the Company’s ability to fulfill its investment objectives. In addition to these developments potentially having adverse consequences for certain portfolio companies and other issuers in or through which the Company invests and the value of the Company’s investments therein, the operations of Stone Point (including those relating to the Stone Point investment professionals) could be disrupted if any of its or its affiliates’ key personnel contracts COVID-19 and/or any other infectious disease. Any of the foregoing events could materially and adversely affect the Company’s ability to source, manage and divest its investments and its ability to fulfill its investment objectives. Similar consequences could arise with respect to other comparable infectious diseases. The impact of a public health crisis, such as COVID-19 (or any future pandemic, epidemic or other similar outbreak of a contagious disease), is difficult to predict, which presents material uncertainty and risk with respect to the performance of the Company.

Russo-Ukrainian Conflict

Instability within Eastern Europe, particularly the commencement of open hostilities between the Ukraine and Russia may have an adverse impact on the Company. On February 21, 2022, the Russian Federation recognized the sovereignty of the “Donetsk People’s Republic” and “Luhansk People’s Republic” in the Donbas region of Eastern Ukraine. Shortly thereafter, tension has increased with the Russian Federation advancing troops and commencing large scale military operations in the Ukraine. The United States, the United Kingdom (the “UK”) and the European Union (the “EU”) have imposed a series of sanctions against certain financial institutions, businesses, key members and personnel associated with the Russian Federation. It is currently unclear what the outcome and impact will be of (a) the military activities and encroachment by the Russian Federation in the Ukraine and (b) the sanctions that have been imposed against key members and personnel of the Russian Federation, however, it is possible that the escalation of hostilities between the Russian Federation, the Ukraine, NATO member states and other states and the imposition of further economic sanctions may have an adverse impact on European and global markets and result in political and economic instability, increased sanctions, reduced investment activities and adverse effects on economies generally. It is currently unclear whether such open hostilities may spread to other geographies beyond the current conflict region and any such geopolitical and economic ramifications may, in turn, have an impact on the ability of the Company to achieve its investment objectives. Sanctions from the United States, the UK and the European Union and potential counter sanctions from Russia may affect prospective market counterparties of the Company. Capital markets may be impacted and international investors may seek to move capital to other regions.

Israel-Gaza Conflict

The assault on Israel by Hamas (the Islamic terrorist group that controls the Palestinian territory of Gaza) in early October 2023 and Israel’s subsequent declaration of war against Hamas may have severe adverse effects on regional and global economic markets. The war between Hamas and Israel and the varying involvement of the United States and other countries, as well as political and civil unrest related to the foregoing, makes it difficult to predict the conflict’s impact on global economic and market conditions and, as a result, the situation presents material uncertainty and risk with respect to the Company and its portfolio companies, and the ability of the Company and its portfolio companies to achieve their investment objectives.

Risks of Conflicts

Recently, various countries have seen significant internal conflicts and, in some cases, civil wars may have had an adverse impact on the securities markets of the countries concerned. In addition, the occurrence of new disturbances due to acts of war or terrorism or other political developments cannot be excluded. Apparently stable systems may experience periods of disruption or improbable reversals of policy. Nationalization, expropriation or confiscatory taxation, currency blockage, political changes, government regulation, political, regulatory or social instability or uncertainty or diplomatic developments, including the imposition of sanctions or other similar measures, could adversely affect the Company’s investments. The transformation from a centrally planned, socialist economy to a more market oriented economy has also resulted in many economic and social disruptions and distortions. Moreover, there can be no assurance that the economic, regulatory and political initiatives necessary to achieve and sustain such a transformation will continue or, if such initiatives continue and are sustained, that they will be successful or that such initiatives will continue to benefit foreign (or non-national) investors. Certain instruments, such as inflation index instruments, may depend upon measures compiled by governments (or entities under their influence) which are also the obligors.

54

Table of Contents

Recent examples of the above include conflict, loss of life and disaster connected to ongoing armed conflict between Russia and Ukraine in Europe and Hamas and Israel in the Middle East, and an example of a country undergoing transformation is Venezuela. The extent, duration and impact of these conflicts, related sanctions and retaliatory actions are difficult to ascertain, but could be significant and have severe adverse effects on the region, including significant adverse effects on the regional or global economies and the markets for certain securities and commodities. These impacts could negatively affect the Company’s investments in securities and instruments that are economically tied to the applicable region, and include (but are not limited to) declines in value and reductions in liquidity. In addition, to the extent new sanctions are imposed or previously relaxed sanctions are reimposed (including with respect to countries undergoing transformation), complying with such restrictions may prevent the Company from pursuing certain investments, cause delays or other impediments with respect to consummating such investments or divestments, require divestment or freezing of investments on unfavorable terms, render divestment of underperforming investments impracticable, negatively impact the Company’s ability to achieve its investment objective, prevent the Company from receiving payments otherwise due it, increase diligence and other similar costs to the Company, render valuation of affected investments challenging, or require the Company to consummate an investment on terms that are less advantageous than would be the case absent such restrictions. Any of these outcomes could adversely affect the Company’s performance with respect to such investments, and thus the Company’s performance as a whole.

UK’s Exit from the EU

Following the UK’s withdrawal from the EU (“Brexit”), the UK and the EU entered into a free trade agreement on January 1, 2021 to govern their future relationship on a number of areas (the “Treaty”). Although the EU and the UK agreed to the Treaty, trade in goods and services between the UK and the EU may be disrupted through the imposition of new customs checks and processes at the border. The UK’s departure from the customs union and the single market has rendered its access to EU markets significantly more restricted than had previously been the case.

The Treaty does not cover the UK’s future relationship with the EU on financial services. The EU and the UK have agreed on a memorandum of understanding establishing a framework for regulatory cooperation in financial services, which does not include a new framework for mutual market access. While some EU directives contemplate access to EU markets by financial services firms established in countries deemed to have equivalent standards, even if UK domestic law continues to be equivalent to EU law (which is not guaranteed), there is no certainty that the EU will facilitate equivalence decisions. Where the EU makes such equivalence decisions, it could unilaterally revoke them at short notice.

Notwithstanding the foregoing, the longer term economic, legal, political and social framework to be put in place between the UK and the EU are likely to lead to ongoing political and economic uncertainty and periods of exacerbated volatility in both the UK and in wider European markets for some time.

Data Privacy Regulation

The U.S. is in a period of active adoption and/or consideration of additional data privacy and cybersecurity laws. These include the California Consumer Privacy Act, effective since January 1, 2020, as amended by the California Privacy Rights Act, effective January 1, 2023 (the “CCPA”); the Virginia Consumer Data Privacy Act, enacted in 2021 and effective January 1, 2023; the New York SHIELD Act, aspects of which took effect on October 23, 2019 and March 21, 2020, respectively; a range of additional laws in effect in states, including Colorado, Connecticut, and Delaware, as well as a range of proposed additional laws in other states; and a range of proposed additional laws at the federal level. The cumulative effects of the CCPA and other recently adopted laws, and active enforcement of existing privacy and consumer protection laws by the Federal Trade Commission and various state attorneys general – and the likely effect of additional laws that might be enacted – include an increased ability of individuals, relative to companies, to control the use of their personal information; increased obligations of companies to maintain the security of personal information; and increased exposure to fines or damages for companies that do not accord individuals their specified privacy rights, that experience data breaches, or that do not maintain reasonable security safeguards, procedures and practices. Companies may also be subject to purported class action and other litigation claims based on alleged violations of privacy laws. The Company will endeavor to maintain systems that promote compliance with applicable laws, but there can be no assurance that these systems will be effective in mitigating the business impact of individuals’ increased privacy rights or in ensuring compliance with such laws. In the event of fines or damages due to noncompliance or alleged noncompliance with such data privacy and cybersecurity laws, or related expenses such as the cost of investigation or legal defense, there may be a business impact on the Company.

55

Table of Contents

Artificial Intelligence

Artificial intelligence, including machine learning and similar tools and technologies that collect, aggregate, analyze or generate data or other materials (collectively, “AI”), and its current and potential future applications including in the private investment and financial industries, as well as the legal and regulatory frameworks within which AI operates, continue to rapidly evolve. While Stone Point does not use AI at this time to make investment recommendations, the use of AI could exacerbate or create new and unpredictable risks to Stone Point’s business, including by potentially significantly disrupting the markets in which the Company operates or subjecting Stone Point and the Company to increased competition and regulation, which could materially and adversely affect business, financial condition or results of operations of Stone Point and the Company. In addition, the use of AI by bad actors could heighten the sophistication and effectiveness of cyber and security attacks experienced by Stone Point.

Sanctions Laws

Economic sanction laws in the United States and other jurisdictions prohibit Stone Point and the Company from transacting with certain countries, individuals, and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) administers and enforces laws, Executive Orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of services to, certain foreign countries, territories, entities, and individuals. These types of trade sanctions significantly restrict or completely prohibit certain investment activities in regions outside the United States, and if the Company or its portfolio companies were to violate any such laws or regulations, it could face significant legal and monetary penalties. Some of these regulations provide that penalties can be imposed on Stone Point and the Company for the conduct of a portfolio company, even if such person has not violated any regulation.

Terrorism, Natural Disasters and Major Events

The threats of terrorist strikes, and the fear of prolonged global conflict have exacerbated volatility in the financial markets and caused consumer, corporate and financial confidence to weaken, increasing the risk of a “self-reinforcing” economic downturn. While new opportunities for portfolio companies may arise in the insurance and reinsurance industries as a result of catastrophic events and financial market problems, the climate of uncertainty may have an adverse effect upon the portfolio companies in which the Company makes investments. Economic and political uncertainty also increases the difficulty of modeling market conditions, which may reduce the accuracy of the Adviser’s financial projections. The performance of the portfolio companies in which the Company makes investments may be affected by additional catastrophic events.

The performance of the portfolio companies in which the Company invests may be affected by additional catastrophic events. A major disruption to the operations of the Company and the portfolio companies in which the Company invests as a result of force majeure events (including, without limitation, severe weather, earthquakes, landslides or other natural disasters, strikes or war or the outbreak of disease, epidemics or pandemics or any other serious public health concern, war, terrorism, labor strikes, major plant breakdowns, pipeline or electricity line ruptures, failure of technology, defective design and construction, accidents, demographic changes, government macroeconomic policies, social instability, etc.) may cause the Company or their portfolio companies to suffer losses due to damage to the Company or its portfolio companies’ operations as a result of any of the foregoing.

Banking Sector and Financial Markets Instability

While there have been no recent high-profile U.S. or European bank failures, it is possible that instability in the banking sector could return, resulting in (among other things) the loss of uninsured deposits by private funds, their investors, their portfolio companies and/or their counterparties. Such losses, or even concerns about the potential for such losses, could result in significant impairment of the ability of any of the foregoing parties to effectively operate, resulting in potentially material and adverse effects on the Company and its investments. Instability may also result in a deterioration in the broader global financial markets, resulting in declines in equity, debt and other asset prices together with other (potentially unexpected) adverse impacts, all of which could have a material and adverse effect on the Company, its investments and their operations beyond the impacts specifically associated with bank failures.

In addition, bank failures could result in the adoption of new and/or different regulations affecting the banking sector and potentially the financial sector more generally. For example, federal banking regulators have recently proposed rules surrounding capital, long term debt and resolution planning, each referencing the bank failures in their releases. Although such regulations (if adopted) could result in greater stability of the financial system, the actual impact of any such regulations on financial markets and

56

Table of Contents

their participants is unknown, and it is possible that any such regulations could adversely impact the Company, and its operations and investments.

Item 1B. Unresolved Staff Comments

None.

Item 1C. Cybersecurity

Cybersecurity

The Company has processes in place to assess, identify, and manage material risks from cybersecurity threats. The Company’s business is dependent on the communications and information systems of the Adviser and other third-party service providers. The Adviser manages the Company’s day-to-day operations and has implemented a cybersecurity program that applies to the Company and its operations.

Cybersecurity Program Overview

The Adviser has instituted a cybersecurity program designed to identify, assess, and mitigate cyber risks applicable to the Company. The cyber risk management program involves risk assessments, implementation of security measures, and ongoing monitoring of systems and networks, including networks on which the Company relies. The Adviser actively monitors the current threat landscape in an effort to identify material risks arising from new and evolving cybersecurity threats, including material risks faced by the Company.

The Company relies on the Adviser to engage external experts, including cybersecurity assessors, consultants, and auditors to evaluate cybersecurity measures and risk management processes, including those applicable to the Company.

The Company relies on the Adviser’s risk management program and processes, which include cyber risk assessments.

The Company depends on and engages various third parties, including suppliers, vendors, and service providers, to operate its business. The Company relies on the knowledge of information technology, legal and compliance personnel of the Adviser when identifying and overseeing risks from cybersecurity threats associated with our use of such entities.

Board Oversight of Cybersecurity Risks

The Board provides strategic oversight on cybersecurity matters, including risks associated with cybersecurity threats. The Board receives periodic updates from the Company’s Chief Compliance Officer and Adviser’s Director of IT regarding the overall state of the Adviser’s cybersecurity program, information on the current threat landscape, and risks from cybersecurity threats and any cybersecurity incidents impacting the Company.

Management’s Role in Cybersecurity Risk Management

The Adviser’s Director of IT and internal cybersecurity team are responsible for the cybersecurity program applicable to the Company (including enterprise-wide cybersecurity strategy, policies, standards, engineering, architecture, and processes), and along with the Company’s CCO, are responsible for assessing and managing material risks from cybersecurity threats that impact the Company. The Adviser’s Director of IT has more than 25 years of experience advising on and managing risks from cybersecurity. The Adviser’s Director of IT works closely with Company management to administrator, assess, discuss, and prioritize the Company’s cybersecurity efforts. The Company’s Chief Compliance Officer oversees the Company’s oversight function generally and relies on the Adviser’s Director of IT to assist with assessing and managing material risks from cybersecurity threats. The Company’s Chief Compliance Officer has been responsible for this oversight function as Chief Compliance Officer since his appointment and has worked in the financial services industry for more than 15 years, during which time the Chief Compliance Officer has gained expertise in assessing and managing risk applicable to the Company.

The Company’s management is informed about and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents impacting the Company, including through the receipt of notifications from service providers and reliance on communications with information technology, legal and compliance personnel of the Adviser.

57

Table of Contents

Assessment of Cybersecurity Risk

The potential impact of risks from cybersecurity threats on the Company are assessed on an ongoing basis, and how such risks could materially affect the Company’s business strategy, operational results, and financial condition are regularly evaluated as part of the Adviser’s program. During the reporting period, the Company has not identified any risks from cybersecurity threats, including as a result of previous cybersecurity incidents, that the Company believes have materially affected, or are reasonably likely to materially affect, the Company, including its business strategy, operational results, and financial condition.

Item 2. Properties

We do not own any real estate or other properties materially important to our operations. Our principal executive offices are located at 20 Horseneck Lane, Greenwich, Connecticut 06830. We believe that our office facilities are suitable and adequate for our business as it is contemplated to be conducted.

Item 3. Legal Proceedings

Neither we nor the Adviser are currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us or the Adviser. From time to time, we or the Adviser may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of these legal or regulatory proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

Item 4. Mine Safety Disclosures

Not applicable.

PART II.

Item 5. Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters

Market Information

The Company’s Common Stock is offered in private placements (“Private Offerings”) and has not been registered under the Securities Act or the securities laws of any other jurisdiction. Accordingly, the Company is offering the Company’s Common Stock only (1) to “accredited investors” (as defined in Rule 501 under the Securities Act) and (2) outside the United States in compliance with Regulation S, in reliance upon exemptions from the registration requirements of the Securities Act.

Each purchaser of the Company’s Common Stock is required to complete and deliver to the Company, prior to the acceptance of any order, a subscription agreement substantiating the purchaser’s investor status and including other limitations on resales and transfers of the Company’s Common Stock.

Purchasers of shares of the Company’s Common Stock will not be permitted to transfer their shares without the Company’s prior written consent (unless the transfer is to an affiliate) until a date to be established by the Company. While the Company expects not to unreasonably withhold its prior written consent to transfers by the Company’s Stockholders, the Company may withhold its consent if any such transfer would have adverse tax, regulatory or other consequences. Additionally, to the extent the Company approves any transfers or the foregoing restriction lapses, investors are subject to restrictions on resale and transfer associated with securities sold pursuant to Regulation D, Regulation S and other exemptions from registration under the Securities Act. Unless and until the Company’s Common Stock were to become registered under the Securities Act, it may be transferred only in transactions that are exempt from registration under the Securities Act and the applicable securities laws of other jurisdictions.

Any transfers of shares of the Company’s Common Stock in violation of the foregoing provisions will be void, and any intended recipient of the Company’s Common Stock will acquire no rights in such shares and will not be treated as the Company’s Stockholder for any purpose.

58

Table of Contents

Holders of the Company’s Common Stock

As of March 24, 2025, there were 196 holders of record of the Company’s Common Stock.

Valuation of Portfolio Securities

In accordance with Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company’s “Valuation Designee”. The Adviser, with the assistance of its Valuation Committee, subject to oversight by the Board, is responsible for determining the fair value of the Company’s investments in accordance with valuation policies and procedures approved by the Board (“Valuation Policy”) in instances where there is no readily available market quotation. Investments for which market quotations are readily available may be priced by independent pricing services. The Company generally retains an external, independent valuation firm to provide data and valuation analyses on the Company’s portfolio companies.

The Company’s investment portfolio is recorded at fair value as determined in good faith in accordance with the Valuation Policy and, as a result, there is and will be uncertainty as to the value of the Company’s portfolio investments. Under the 1940 Act, the Company is required to carry its portfolio investments at market value or, if there is no readily available market quotation, at fair value as determined in accordance with procedures established by the Adviser. There is not a public market or active secondary market for many of the types of investments in privately held companies that the Company intends to hold and make. The Company’s investments may not be publicly traded or actively traded on a secondary market but, instead, may be traded on a privately negotiated over-the-counter secondary market for institutional investors, if at all. As a result, these investments are valued quarterly at fair value as determined in good faith in accordance with the Valuation Policy approved by the Board.

The determination of fair value, and thus the amount of unrealized appreciation or depreciation the Company may recognize in any reporting period, is to a degree subjective, and the Adviser has a conflict of interest in making fair value determinations. The types of factors that may be considered in determining the fair values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow, current market interest rates, precedent transactions and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, the valuations may fluctuate significantly over short periods of time due to changes in current market conditions. The determinations of fair value in accordance with the Valuation Policy may differ materially from the values that would have been used if an active market and market quotations existed for such investments. The Company’s net asset value could be adversely affected if the determinations regarding the fair value of the investments were materially higher than the values that the Company ultimately realizes upon the disposal of such investments.

Distributions

The Company intends to pay quarterly distributions to the Company’s Stockholders out of assets legally available for distribution. The Company has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. To obtain and maintain the Company’s ability to be subject to tax as a RIC, the Company must, among other things, timely distribute to the Company’s Stockholders at least 90% of the Company’s investment company taxable income for each taxable year. Please refer to “Item 1. Business – Material U.S. Federal Income Tax Consequences” for further information.

Reports to Stockholders

We plan to furnish our Stockholders with an annual report for each fiscal year ending December 31 containing financial statements audited by our independent public accounting firm. Additionally, we intend to continue to comply with the periodic reporting requirements of the Exchange Act.

Unregistered Sales of Equity Securities

Except as previously reported by the Company on its current reports on Form 8-K, the Company did not sell any securities during the period covered by this Annual Report that were not registered under the Securities Act.

59

Table of Contents

Item 6. Reserved.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this Annual Report on Form 10-K. Unless indicated otherwise, the “Company,” “we,” “us,” and “our” refer to Stone Point Credit Corporation, and the “Adviser” refers to Stone Point Credit Adviser LLC, an affiliate of Stone Point Capital LLC (“Stone Point Capital”) (together with the Adviser and their other affiliates, collectively, “Stone Point”).

Overview

We were incorporated under the laws of the State of Delaware on September 8, 2020. The Company has elected to be treated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”) and has elected to be treated, and intends to qualify annually, as a RIC for federal income tax purposes. As such, we are required to comply with various regulatory requirements, such as the requirement to invest at least 70% of our assets in “qualifying assets” and tax requirements such as source of income limitations, asset diversification requirements, and the requirement to distribute annually at least 90% of our taxable income and tax-exempt interest.

As of December 31, 2024, the Company has called equity capital in the amount of $1,176.4 million. See “Subscriptions and Drawdowns” under “Financial Condition, Liquidity and Capital Resources” below for further details. Management anticipates calling additional equity capital for investment purposes through drawdowns in respect of capital commitments made by investors pursuant to Private Offerings.

Investment Objective and Strategy

The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. The Company seeks to invest primarily in senior secured or unsecured loans and, to a lesser extent, subordinated loans, mezzanine loans and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company’s common equity. The Company may invest without limit in originated or syndicated debt.

The Company generally expects to invest in middle market companies with earnings before interest expense, income tax expense, depreciation and amortization, or “EBITDA,” between $30 million and $250 million annually. Typical middle market senior loans may be issued by middle market companies in the context of leveraged buyouts, acquisitions, debt refinancings, recapitalizations, and other similar transactions. Notwithstanding the foregoing, the Adviser may determine whether companies qualify as “middle market” in its sole discretion, and the Company may from time to time invest in larger or smaller companies if an attractive opportunity presents itself, especially when there are dislocations in the capital markets, including the high yield and syndicated loan markets. The Company’s target credit investments typically have maturities between 3 and 6 years and generally range in size between $20 million and $100 million. The investment size will vary with the size of the Company’s capital base. The Company has adopted a non-fundamental policy to invest, under normal market conditions, at least 75% of the value of its total assets (measured at the time of each such investment taking into account certain initial assumptions regarding the expected amount of total assets of the Company once fully invested) in portfolio companies that are in the financial services, business services, software and technology or healthcare services sectors. The remaining 25% of the value of the Company’s total assets (measured at the time of each such investment taking into account certain initial assumptions regarding the expected amount of total assets of the Company once fully invested) may be invested across a wide range of sectors (although the Company expects to avoid businesses which at the time of the Company’s investment participate in certain sectors such as payday lending, pawn shops, automobile title and tax refund anticipation loans, credit repair services, strip mining, drug paraphernalia, marijuana related businesses, tax evasion gaming and pornography).

Key Components of Operations

Investments

Our level of investment activity can and will vary substantially from period to period depending on many factors, including the amount of debt available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the type of investments we make.

60

Table of Contents

As a BDC, the Company must invest at least 70% of its assets in “qualifying assets,” which may include investments in “eligible portfolio companies.” Under the relevant SEC rules, the term “eligible portfolio company” includes all U.S. private operating companies and small U.S. public operating companies with a market capitalization of less than $250 million.

As a BDC, we may also invest up to 30% of our portfolio opportunistically in “non-qualifying” portfolio investments, such as investments in non-U.S. companies.

Revenues

The Company expects to generate revenues primarily through receipt of interest income from its investments. In addition, the Company may generate income from capital gains on the sales of loans and debt and equity related securities and various loan origination and other fees and dividends on direct equity investments.

Expenses

The Company’s day-to-day investment operations are managed by the Adviser, and services necessary for the Company’s business, including the origination and administration of its investment portfolio, are provided by individuals who are employees of the Adviser, Administrator, and Sub-Administrator, pursuant to the terms of the Investment Advisory Agreement, the Administration Agreement, and Sub-Administration Agreement. The Company will reimburse the Administrator for its allocable portion of expenses incurred by it in performing its obligations under the Administration Agreement, including its allocable portion of the cost of certain of the Company’s officers and their respective staff, and the Adviser for certain expenses under the Investment Advisory Agreement. The Company bears its allocable portion of the compensation paid by Stone Point to the Company’s Chief Compliance Officer and Chief Financial Officer and their respective staff (based on a percentage of time such individuals devote, on an estimated basis, to the Company’s business affairs). The Company bears all other costs and expenses of the Company’s operations, administration and transactions, including, but not limited to (i) investment advisory fees, including management fees and incentive fees, to the Adviser, pursuant to the Investment Advisory Agreement; (ii) the Company’s allocable portion of overhead and other expenses incurred by Administrator in performing its administrative obligations under the Administration Agreement, (iii) fees for services rendered by the Sub-Administrator that the Administrator determines are commercially reasonable; and (iv) all other expenses of its operations and transactions including, without limitation, those relating to:

the cost of calculating the Company’s net asset value, including the cost of any third-party valuation services;
the cost of effecting sales and repurchases of shares of the Common Stock and other securities, including, as otherwise noted below, in connection with the Private Offering;
fees payable to third parties relating to making investments, including the Adviser’s or its affiliates’ travel expenses, research costs and out-of-pocket fees and expenses associated with performing due diligence and reviews of prospective investments;
interest expense and other costs associated with the Company’s indebtedness;
transfer agent, dividend reinvestment plan administrator, sub-administrator and custodial fees;
out-of-pocket fees and expenses associated with marketing efforts;
federal and state registration fees and any stock exchange listing fees;
U.S. federal, state and local taxes;
Independent Directors’ fees and expenses;
brokerage commissions and markups;
fidelity bond, directors’ and officers’ liability insurance and other insurance premiums;

61

Table of Contents

direct costs, such as printing, mailing, long distance telephone and staff;
fees and expenses associated with independent audits and outside legal costs;
costs associated with the Company’s reporting and compliance obligations U.S. federal and state securities laws, including, the Securities Act, the Exchange Act, and the 1940 Act; and
other expenses incurred by the Administrator or the Company in connection with administering the Company’s business, including payments under the Administration Agreement that will be based upon the Company’s allocable portion (subject to the review and approval of the Board) of overhead.

The Administrator can waive any amounts owed to it under the Administration Agreement, at its discretion. From time to time, the Adviser or its affiliates may pay third-party providers of goods or services. The Company will subsequently reimburse the Adviser for such amounts paid on the Company’s behalf. The Adviser has agreed to bear the aggregate organizational and offering costs in connection with the Private Offering in excess of $1.3 million.

The Company has entered into credit facilities to partially fund the Company’s operations, and may incur costs and expenses including commitment, origination, legal and/or structuring fees and the related interest costs associated with any amounts borrowed. See “Revolving Credit Facility” under “Financial Condition, Liquidity and Capital Resources” below for further details.

Leverage

The amount of leverage that the Company employs will depend on the Adviser’s and the Board’s assessment of market and other factors at the time of any proposed borrowing. In accordance with the 1940 Act, with certain limitations, BDCs are allowed to borrow amounts such that their asset coverage ratios, as defined in the 1940 Act, are at least 200% (or 150% if certain conditions are met) after such borrowing. As a result of complying with the requirements set forth in the Small Business Credit Availability Act, the Company is able to borrow amounts such that its asset coverage ratio is at least 150%, rather than 200%. As of December 31, 2024 and 2023, the Company’s asset coverage ratio was 194% and 193%, respectively.

In any period, our interest expense will depend largely on the extent of our borrowing and we expect interest expense will increase as we increase our leverage over time within the limits of the 1940 Act. In addition, we may dedicate assets or capital commitments as collateral to financing facilities.

Financial and Operating Highlights

    

Year Ended

    

Year Ended

    

Year Ended

December 31,

December 31,

December 31,

($ in thousands, except per share amounts)

 

 2024

 

 2023

 

 2022

Total investment income

$

277,502

$

226,063

$

129,950

Total expenses

 

132,574

 

108,834

 

65,034

Net investment income (loss)

$

144,928

 

117,229

 

64,916

Total net realized gains (losses)

 

(5,762)

 

(133)

 

1,072

Total net change in unrealized appreciation (depreciation)

 

14,434

 

16,375

 

(34,138)

Net increase (decrease) in net assets resulting from operations

$

153,600

$

133,471

$

31,850

Per share information - basic and diluted:

 

 

 

Net investment income (loss)

$

2.53

$

2.62

$

1.94

Net increase (decrease) in net assets resulting from operations

$

2.68

$

2.99

$

0.95

62

Table of Contents

($ in thousands, except per share amounts)

As of December 31,

As of December 31,

As of December 31, 

 

Consolidated balance sheet data

    

2024

    

2023

    

2022

Cash and cash equivalents

$

51,760

$

41,629

$

33,791

Investments at fair value

 

2,504,242

 

1,999,625

 

1,688,521

Total assets

 

2,597,264

 

2,067,897

 

1,744,124

Total debt (net of unamortized deferred financing and debt issuance costs)

 

1,317,926

 

1,061,253

 

905,451

Total liabilities

 

1,345,767

 

1,076,476

 

926,939

Total net assets

$

1,251,497

$

991,422

$

817,186

Net asset value per share

$

19.85

$

19.71

$

19.32

Other data:

 

 

 

Number of portfolio companies

 

100

 

74

 

66

Distributions declared per share

 

2.55

 

2.57

 

1.89

Total return based on net asset value 1

 

14.34

%  

 

16.21

%  

 

5.35

%

1

Total return is based upon the change in net asset value per share between the opening and ending net asset values per share, assuming reinvestment of any distributions during the period. Total return is not annualized and does not include a sales load.

Selected Quarterly Financial Data (Unaudited)

The tables below set forth certain quarterly financial data for the years ended December 31, 2024 and 2023

    

Quarter Ended

($ in thousands, except per share amounts)

    

December 31, 2024

    

September 30, 2024

    

June 30, 2024

    

March 31, 2024

Total investment income

$

72,944

$

69,648

$

71,277

$

63,633

Net investment income (loss)

 

37,384

34,898

38,801

33,845

Net realized gains (losses) and unrealized appreciation (depreciation)

 

(934)

4,765

(2,567)

7,408

Net increase (decrease) in net assets resulting from operations

 

36,450

39,663

36,234

41,253

Net investment income (loss) per common share

 

0.66

0.57

0.71

0.67

Basic and diluted earnings (loss) per common share

 

0.55

0.64

0.67

0.82

Net asset value per common stock at end of quarter

 

19.85

19.86

19.87

19.86

    

Quarter Ended

($ in thousands, except per share amounts)

    

December 31, 2023

    

September 30, 2023

    

June 30, 2023

    

March 31, 2023

Total investment income

$

63,359

$

59,111

$

54,467

$

49,126

Net investment income (loss)

 

31,933

31,232

28,624

25,440

Net realized gains (losses) and unrealized appreciation (depreciation)

 

5,380

9,008

(1,403)

3,258

Net increase (decrease) in net assets resulting from operations

 

37,313

40,240

27,220

28,698

Net investment income (loss) per common share

 

0.67

0.69

0.66

0.60

Basic and diluted earnings (loss) per common share

 

0.80

0.89

0.62

0.68

Net asset value per common stock at end of quarter

 

19.71

19.60

19.38

19.40

63

Table of Contents

Portfolio and Investment Activity

Our investment activity for the years ended December 31, 2024 and 2023 is presented below (information presented herein is at par value unless otherwise indicated).

    

Year Ended

Year Ended

 

($ in thousands)

    

December 31, 2024

    

December 31, 2023

 

New investment commitments:

 

  

 

  

Total new investment commitments

$

1,477,558

$

514,004

Principal amount of investments funded:

 

 

First lien loans

$

1,059,439

$

468,930

Second lien loans

 

161,209

 

Unsecured notes

 

89,322

 

27,396

Total principal amount of investments funded

$

1,309,970

$

496,326

Principal amount of investments sold or repaid:

 

 

First lien loans

 

620,959

 

163,135

Second lien loans

 

183,381

 

16,854

Unsecured notes

 

59,735

 

53,649

Total principal amount of investments sold or repaid

$

864,074

$

233,638

Number of new investment commitments

 

72

 

29

Average new investment commitment

 

20,522

 

17,724

Percentage of new investment commitments at floating rates

 

97.9

%

 

97.6

%

Percentage of new investment commitments at fixed rates

 

2.1

%

 

2.4

%

Weighted average yield to maturity on purchased or funded investments during the period1

 

10.3

%

 

12.3

%

Weighted average yield to maturity on investments sold or repaid during the period

 

12.1

%

 

11.5

%

1

Weighted average yield to maturity is calculated by weighting the yield to maturity of each investment by its ending funded par amount. Yield to maturity is calculated inclusive of a portfolio company’s spread, reference rate floor (if any) or actual reference rate in effect and original issue discount through maturity and excludes any upfront fees.

As of December 31, 2024, the Company had 254 debt investments in 100 portfolio companies with an aggregate fair value of $2,504.2 million. As of December 31, 2023, the Company had 161 debt investments in 72 portfolio companies with an aggregate value of $1,999.6 million.

As of December 31, 2024 and 2023, the Company’s investments consisted of the following:

December 31, 2024

December 31, 2023

 

($ in thousands)

    

Amortized

    

Fair

Percent of Total

Amortized

    

Fair

    

Percent of Total

 

Investments:

Cost

Value

    

 Portfolio at Fair Value

Cost

Value

Portfolio at Fair Value

 

First Lien Loans

$

2,207,578

$

2,209,392

88.2

%

$

1,732,531

$

1,727,610

86.3

%

Second Lien Loans

 

157,690

151,362

6.0

%

178,040

165,870

8.3

%

Unsecured Notes

 

90,353

91,375

3.7

%

66,198

68,012

3.4

%

Preferred Equity

 

34,833

36,226

1.5

%

27,272

27,540

1.4

%

Common Equity and Warrants

 

12,353

15,887

0.6

%

8,584

10,593

0.6

%

Total Investments

$

2,502,807

$

2,504,242

100.0

%

$

2,012,625

$

1,999,625

100.0

%

64

Table of Contents

The industry composition of investments based on fair value as of December 31, 2024 and 2023 was as follows:

    

December 31, 2024

    

December 31, 2023

 

Capital Markets

5.0

%

4.7

%

Diversified Consumer Services

0.7

0.6

Financial Services

9.5

10.8

Health Care Providers & Services

16.8

13.0

Health Care Technology

3.1

6.2

Insurance

21.9

22.3

IT Services

7.8

12.1

Professional Services

16.5

13.0

Real Estate Management & Development

4.6

2.5

Software

12.6

14.8

Consumer Finance

1.5

0.0

Total

100.0

%

100.0

%

The geographic composition of investments based on fair value as of December 31, 2024 and 2023 was as follows:

    

December 31, 2024

    

December 31, 2023

 

U.S.

98.9

%

98.4

%

Non-U.S.

1.1

1.6

Total

100.0

%

100.0

%

The following table presents certain selected information regarding our investment portfolio as of December 31, 2024 and 2023:

    

As of

    

As of

 

December 31, 2024

December 31, 2023

 

Number of portfolio companies

100

74

Median EBITDA (based on par)

$

110.7 million

$

102.0 million

Percentage of performing debt bearing a floating rate

96.2

%

96.5

%

Percentage of performing debt bearing a fixed rate

3.8

%

3.5

%

Weighted average yield to maturity on investments1

10.6

%

12.2

%

1

Weighted average yield to maturity is calculated by weighting the yield to maturity of each investment by its ending funded par amount. Yield to maturity is calculated inclusive of a portfolio company’s spread, reference rate floor (if any) or actual reference rate in effect and original issue discount through maturity and excludes any upfront fees.

65

Table of Contents

The following table presents the maturity schedule of our debt investments based on fair value as of December 31, 2024 and 2023:

($ in thousands)

    

December 31, 2024

    

December 31, 2023

 

Percentage of

Percentage of 

Maturity Year

Fair Value

    

 Portfolio

Fair Value

    

Portfolio

 

2024

$

%

$

(377)

0.0

%

2025

(84)

40,131

2.0

2026

66,463

2.7

137,339

7.0

2027

273,196

11.1

445,317

22.7

2028

670,886

27.4

634,662

32.4

2029

527,977

21.5

540,982

27.6

2030

468,942

19.1

131,936

6.7

2031

362,966

14.8

20,219

1.0

2032

30,113

1.2

2033

13,974

0.6

11,283

0.6

2034

14,939

0.6

2035

2036

11,355

0.5

2037

11,402

0.5

2038

Total

$

2,452,129

100.0

%

$

1,961,492

100.0

%

Our Adviser monitors our portfolio companies on an ongoing basis. The Adviser believes that actively managing an investment allows it to identify problems early and work with companies to develop constructive solutions when necessary. The Adviser will monitor our portfolio with a focus toward anticipating negative credit events. In seeking to maintain portfolio company performance and help to ensure a successful exit, the Adviser will work closely with, as applicable, the lead equity sponsor, portfolio company management, consultants, advisers and other security holders to discuss financial position, compliance with covenants, financial requirements and execution of the company’s business plan. In addition, the Adviser’s personnel may occupy a seat or serve as an observer on a portfolio company’s board of directors or similar governing body.

Typically, the Adviser receives financial reports detailing operating performance, sales volumes, margins, cash flows, financial position and other key operating metrics on a quarterly basis from portfolio companies. The Adviser will use this data, combined with the knowledge gained through due diligence of the company’s customers, suppliers, competitors, market research and other methods, to conduct an ongoing assessment of the company’s operating performance and prospects.

As part of the monitoring process, the Adviser rates the risk of all portfolio investments on a scale of 1 to 5, no less frequently than quarterly. This internal performance rating is primarily intended to assess the underlying risk of a portfolio investment relative to such investments’ cost taking into account the performance of the portfolio company’s business, the collateral coverage of the investment and other relevant factors. The Adviser’s internal performance ratings do not constitute any rating of investments by a

66

Table of Contents

nationally recognized rating organization or reflect any third-party assessment. The Adviser’s internal performance rating scale is as follows:

Investment
Performance
Rating

    

Description

1

The portfolio company is performing above expectations, and the business trends and risk factors for this investment since origination or acquisition are generally favorable.

2

The portfolio company is generally performing as expected and the risk factors are neutral to favorable. All investments or acquired investments in new portfolio companies are initially assessed a rating of 2.

3

The portfolio company is performing below expectations and the investment’s risk has increased somewhat since origination or acquisition. For debt investments rated 3, the portfolio company could be out of compliance with debt covenants; however, loan payments are generally not past due.

4

The portfolio company is performing materially below expectations and indicates that the investment’s risk has increased materially since origination or acquisition. For debt investments rated 4, in addition to the portfolio company being generally out of compliance with debt covenants, loan payments may be past due.

5

The portfolio company is performing substantially below expectations and indicates that the investment’s risk has increased substantially since origination or acquisition. For debt investments rated 5, most or all of the debt covenants are out of compliance and payments are substantially delinquent. It is anticipated that we will not recoup our initial cost basis and may realize a substantial loss upon exit of the investment.

It is possible that the rating of a portfolio investment may change over time. For investments rated 3, 4 or 5, the Adviser enhances its level of scrutiny over the monitoring of such portfolio company.

The following table shows the composition of our portfolio investments on the Adviser’s internal performance rating scale:

($ in thousands)

December 31, 2024

December 31, 2023

 

Percentage

Percentage

 

Investment Rating

    

Fair Value

    

of Portfolio

    

Fair Value

    

of Portfolio

 

1

$

439,290

17.5

%

$

233,138

11.7

%

2

1,949,232

77.9

%

1,684,406

84.2

%

3

93,237

3.7

%

80,865

4.0

%

4

22,483

0.9

%

1,216

0.1

%

5

Total

$

2,504,242

100.0

%

$

1,999,625

100.0

%

The following table presents the amortized cost of our performing and non-accrual investments as of December 31, 2024 and 2023:

December 31, 2024

    

December 31, 2023

 

($ in thousands)

Amortized Cost

    

Percentage

Amortized Cost

    

Percentage

 

Performing

$

2,502,807

100.0

%

$

2,012,625

100.0

%

Non-accrual

 

Total

$

2,502,807

100.0

%

$

2,012,625

100.0

%

The following table presents the fair value of our performing and non-accrual investments as of December 31, 2024 and 2023:

    

December 31, 2024

    

December 31, 2023

 

($ in thousands)

Fair Value

    

Percentage

    

Fair Value

    

Percentage

 

Performing

$

2,504,242

100.0

%

$

1,999,625

100.0

%

Non-accrual

Total

$

2,504,242

100.0

%

$

1,999,625

100.0

%

67

Table of Contents

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. Accrued interest is generally reversed when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may make exceptions to this treatment and determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Results of Operations

The following table presents the operating results for the years ended December 31, 2024, 2023, and 2022:

    

Year Ended

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Total investment income

$

277,502

$

226,063

$

129,950

Less: total expenses

132,574

108,834

65,034

Net investment income (loss)

144,928

117,229

64,916

Total net realized gains (losses)

(5,762)

(133)

1,072

Net change in unrealized appreciation (depreciation) on investments

14,434

16,375

(34,138)

Net increase (decrease) in net assets resulting from operations

$

153,600

$

133,471

$

31,850

Investment Income

Total investment income consisted of interest income from investments, dividend income from investments, interest from cash and cash equivalents and fee income. For the years ended December 31, 2024, 2023, and 2022, total investment income was comprised of the following:

    

Year Ended

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Interest income from investments

$

271,385

$

223,951

$

128,975

Dividend income from investments

3,719

1,422

600

Interest from cash and cash equivalents

3

2

1

Fee income

2,395

688

374

Total investment income

$

277,502

$

226,063

$

129,950

For the years ended December 31, 2024 and 2023, total investment income increased to $277.5 million from $226.1 million primarily due to an increase in the size of our debt portfolio, which at par, increased to $2,489.7 million from $2,012.0 million. For the year ended December 31, 2024, the weighted average yield on our portfolio decreased to 10.6% from 12.2% for the year ended December 31, 2023.

For the years ended December 31, 2023 and 2022, total investment income increased to $226.1 million from $129.9 million primarily due to an increase in the weighted average yield on our portfolio as well as an increase in the size of our debt portfolio, which at par, increased to $2,012.0 million from $1,745.4 million. For the year ended December 31, 2023, weighted average yield on our portfolio increased to 12.2% from 11.1% for the year ended December 31, 2022.

68

Table of Contents

Expenses

Operating expenses for the years ended December 31, 2024, 2023, and 2022 were as follows:

    

Year Ended

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Base management fees

$

30,071

$

24,304

$

18,937

Interest and credit facility fees

94,465

77,361

40,044

Offering costs

56

97

116

Professional fees

7,552

6,642

5,500

Directors fees

368

368

367

Insurance expenses

62

62

70

Total expenses

$

132,574

$

108,834

$

65,034

Under the Administration Agreement, we will reimburse the Administrator for all reasonable costs and expenses incurred for services performed for us. In addition, the Administrator is permitted to delegate its duties under the Administration Agreement to affiliates or third parties, and we will reimburse the expenses of these parties incurred directly and/or paid by the Administrator on the Company’s behalf. The Adviser can waive any amounts owed to it under the Administration Agreement, at its discretion.

For the years ended December 31, 2024, 2023, and 2022, the Company incurred $1.0 million, $1.3 million and $1.0 million of administrative overhead expenses, respectively. As of December 31, 2024, 2023, and 2022, administrator expenses of $0.2 million, $0.3 million and $0.2 million, respectively, remained payable to the Administrator. For the years ended December 31, 2024 and 2023, the Administrator has not elected to waive any charges that would have been eligible for reimbursement under the terms of the Administration Agreement. For the year ended December 31, 2022, the Administrator elected to waive additional charges that would have otherwise been eligible for reimbursement under the terms of the Administration Agreement which are not subject to recoupment.

For the years ended December 31, 2024 and 2023, total expenses increased to $132.6 million from $108.8 million primarily due to an increase in interest and credit facility fees and base management fees. For the year ended December 31, 2024, the weighted average borrowings and interest rate was $920.1 million and 7.9% compared to weighted average borrowings and an interest rate of $763.0 million and 7.8% for the year ended December 31, 2023. For the years ended December 31, 2024 and 2023, management fees increased due to an overall increase in total assets.

For the years ended December 31, 2023 and 2022, total expenses increased to $108.8 million from $65.0 million primarily due to an increase in interest and credit facility fees and base management fees. For the year ended December 31, 2023, the weighted average borrowings and interest rate was $763.0 million and 7.8% compared to weighted average borrowings and an interest rate of $675.5 million and 4.3% for the year ended December 31, 2022. For the years ended December 31, 2023 and 2022, management fees increased due to an overall increase in total assets.

Income Taxes, Including Excise Taxes

We have elected to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), and we intend to operate in a manner so as to continue to qualify for the tax treatment applicable to RICs. To qualify for tax treatment as a RIC, we must, among other things, distribute to our Stockholders in each taxable year generally at least 90% of the sum of our investment company taxable income, as defined by the Code (without regard to the deduction for dividends paid), and net tax-exempt income, if any, for that taxable year. To maintain our tax treatment as a RIC, we, among other things, intend to make the requisite distributions to our stockholders, which generally relieve us from corporate-level U.S. federal income taxes to the extent of such distributions.

69

Table of Contents

Net Realized Gains (Losses) and Unrealized Appreciation (Depreciation) on Investments

The following table summarizes our net realized gains (losses) and unrealized appreciation (depreciation) for the years ended December 31, 2024, 2023, and 2022:

    

Year Ended

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Net realized gains (losses) and unrealized appreciation (depreciation) on investments

Total net realized gains (losses)

$

(5,762)

$

(133)

$

1,072

Total net change in unrealized appreciation (depreciation)

$

14,434

$

16,375

$

(34,138)

Net realized gains (losses) and unrealized appreciation (depreciation) on investments

$

8,672

$

16,242

$

(33,066)

For the year ended December 31, 2024, we had net realized losses on investments of $5.8 million. For the year ended December 31, 2023, we had net realized losses on investments of $0.1 million. For the year ended December 31, 2022, we had net realized gains on investments of $1.1 million.

The Adviser determines the fair value of our portfolio investments quarterly and any changes in fair value are recorded as unrealized appreciation or depreciation. During the year ended December 31, 2024 we had net change in unrealized appreciation on our investment portfolio of $14.4 million driven primarily by an increase in the fair value of our debt instruments as a percentage of principal compared to December 31, 2023. During the year ended December 31, 2023 we had net change in unrealized appreciation on our investment portfolio of $16.4 million driven primarily by an increase in the fair value of our debt instruments as a percentage of principal compared to December 31, 2022. During the year ended December 31, 2022, we had a net change in unrealized depreciation on our investment portfolio of $34.1 million, driven primarily by a decrease in the fair value of our debt instruments as a percentage of principal compared to December 31, 2021. As of December 31, 2024, 2023, and 2022, the fair value of our debt investments as a percentage of principal was 98.5%, 97.5%, and 96.0%, respectively.

Financial Condition, Liquidity and Capital Resources

The Company intends to generate further cash from (1) future offerings of the Company’s common or preferred stock, (2) cash flows from operations and (3) borrowings from banks or other lenders. The Company will seek to enter into bank debt, credit facility or other financing arrangements on at least customary market terms; however, the Company cannot assure you it will be able to do so.

The Company’s primary use of cash will be for (1) investments in portfolio companies and other investments to comply with certain portfolio diversification requirements, (2) the cost of operations (including paying the Adviser), (3) debt service of any borrowings and (4) cash distributions to the holders of the Company’s stock.

Equity

Subscriptions and Drawdowns

On November 17, 2020, the Adviser committed to contribute $1,000 of capital to the Company. In exchange for this contribution, the Adviser received 50 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).

70

Table of Contents

For the years ended December 31, 2024, 2023, and 2022, the Company has completed the following share issuances:

($in thousands)

    

Number of Common

    

Aggregate Offering 

Common Stock Issuance Date

 

Stock Issued

Price

December 31, 2024

 

81,918

$

1,625

December 31, 2024(1)

 

565,762

11,223

September 27, 2024(1)

 

647,722

12,833

September 27, 2024

 

117,353

2,325

July 2, 2024

 

282,309

5,600

June 28, 2024

 

6,539,426

129,521

June 28,2024(1)

 

634,347

12,564

April 2, 2024

 

12,684

250

March 28, 2024

 

3,402,804

66,893

March 26, 2024(1)

 

461,503

9,072

December 28, 2023

 

2,305,457

45,037

December 26, 2023(1)

 

264,628

5,169

September 29, 2023

 

2,578,558

49,900

September 27, 2023(1)

 

218,518

4,229

June 28, 2023

 

1,126,918

21,800

June 26, 2023(1)

 

252,293

4,881

April 3, 2023

 

56,599

1,094

March 29, 2023

 

980,749

18,906

March 27, 2023(1)

 

229,681

4,428

December 30, 2022

 

2,467,892

48,500

December 27, 2022(1)

 

186,283

3,666

September 28, 2022

 

5,000,901

99,900

September 26, 2022(1)

 

138,540

2,768

June 29, 2022

 

2,498,950

50,000

June 27, 2022(1)

 

100,633

2,013

March 29, 2022

 

1,986,561

40,000

March 25, 2022

2,734,196

55,000

March 24, 2022(1)

 

87,065

1,751

(1)

Shares were issued to stockholders participating in the Company’s DRIP.

For information related to the Company’s share issuances from its date of inception through December 31, 2021, see “Subscriptions and Drawdowns” under “Financial Condition, Liquidity and Capital Resources” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

The sales of Common Stock were made pursuant to subscription agreements entered into by the Company and its investors. Under the terms of the subscription agreements, investors are required to fund drawdowns to purchase shares of Common Stock up to the amount of their respective capital commitments on an as-needed basis with a minimum of ten business days’ prior notice to the funding date.

Each of the sales of Common Stock is exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) thereof and Regulation D thereunder. The Company is still accepting new commitments. The Company has not engaged in general solicitation or advertising with regard to the issuance and sale of the Common Stock and has not offered securities to the public in connection with such issuance and sale. The Company relied, in part, upon representations from the investors in the subscription agreements that each investor was an accredited investor as defined in Regulation D under the Securities Act.

71

Table of Contents

Debt

Financing Facilities

The following tables show the Company’s outstanding debt as of December 31, 2024 and 2023:

    

December 31, 2024

Aggregate Principal 

    

Outstanding 

    

Amount 

    

Net Carrying

($ in thousands)

Committed

Principal

Available (1)

 Value(2)

Capital Call Facility

$

65,000

$

27,000

$

38,000

$

26,757

Revolving Credit Facility

850,000

680,000

170,000

671,821

Secured Credit Facility

300,000

200,000

100,000

197,076

2025 Notes

225,000

225,000

224,612

2029 Notes

200,000

200,000

197,660

Total

$

1,640,000

$

1,332,000

$

308,000

$

1,317,926

December 31, 2023

    

Aggregate Principal

    

Outstanding

    

Amount

    

Net Carrying

($ in thousands)

    

 Committed

 Principal

 Available (1)

 Value(2)

Capital Call Facility

$

85,000

$

52,000

$

33,000

$

51,663

Revolving Credit Facility

750,000

666,000

84,000

661,933

Secured Credit Facility

300,000

126,000

174,000

124,000

2025 Notes

225,000

225,000

223,657

Total

$

1,360,000

$

1,069,000

$

291,000

$

1,061,253

(1)The amount available may be subject to limitations related to the borrowing base under the Financing Facilities, outstanding letters of credit issued and asset coverage requirements.
(2)As of December 31, 2024 and 2023, all of the Company’s outstanding debt was categorized as Level 3 within the fair value hierarchy.

Capital Call Facility

Effective as of December 29, 2020 (the “Initial Closing Date”), the Company entered into a revolving credit facility (as amended, the “Capital Call Facility”) by and among, inter alios, the Company as the initial borrower, the lenders from time-to-time party thereto (collectively, the “Lenders”) and Capital One, National Association, as the administrative agent (the “Administrative Agent”), sole lead arranger and a Lender. On December 27, 2022, the Company executed a letter agreement (the “Second Amendment”) to amend its revolving credit agreement (as amended, the “Revolving Credit Agreement”), by and among, inter alios, the Company as the borrower, the Lenders and Capital One, National Association, as the administrative agent, sole lead arranger and a Lender.

The Second Amendment, among other things, reduced the maximum borrowing capacity of the Company under the Capital Call Facility to $125.0 million from $200.0 million and changed the applicable margin for advances under the Capital Call Facility to SOFR plus 1.95% from SOFR plus 1.85%. The Second Amendment extended the scheduled maturity date of the loans under the Capital Call Facility from December 28, 2022 to December 27, 2023. The other material terms of the Capital Call Facility were unchanged.

On December 22, 2023, the Company amended the Capital Call Facility (the “Third Amendment”). The Third Amendment, among other things, extended the maturity date to December 27, 2024, reduced the maximum borrowing capacity of the Company under the Capital Call Facility to $85.0 million and increased the applicable margin for advances under the Capital Call Facility to SOFR plus 2.35% per annum from SOFR plus 1.95% per annum with respect to SOFR Loans (as defined in the Capital Call Facility) and to 1.35% per annum with respect to Reference Rate Loans (as defined in the Capital Call Facility). The other material terms of the Capital Call Facility were unchanged.

On December 27, 2024, the Company amended the Capital Call Facility (the “Fourth Amendment”). The Fourth Amendment, among other things, extended the maturity date to December 26, 2026, reduced the maximum borrowing capacity of the Company under the Capital Call Facility to $65.0 million, and bifurcated the unused fee such that if the average unused portion of the

72

Table of Contents

commitment of the Lenders during any calendar month is more than 50% of the amount of the commitment of the Lenders, the unused fee increased to .50% per annum multiplied by the daily unused portion of the commitment of the Lenders.

The proceeds of the loans under the Capital Call Facility may be used to acquire portfolio investments and such other uses as permitted under the Capital Call Facility. At the Company’s option, the Capital Call Facility will accrue interest at a rate per annum based on (i) a daily simple SOFR plus an applicable margin of 2.35% or (ii) the greatest of (1) the prime rate or (2) the federal funds effective rate plus 0.5% plus an applicable margin of 1.35%.

The maturity date is the earliest of: (a) December 26, 2025; (b) the date upon which the Administrative Agent declares the Company’s obligations under the Capital Call Facility (the “Obligations”) due and payable after the occurrence of an event of default under the Capital Call Facility; (c) 45 days prior to the termination of the Company’s Operative Documents (as defined in the Capital Call Facility); (d) 45 days prior to the date on which the Company’s ability to call capital commitments for the purpose of repaying the Obligations is terminated, and (e) the date upon which the Company terminates the commitments of the Lenders pursuant to Section 3.6 of the Capital Call Facility or otherwise.

The Capital Call Facility includes customary covenants as well as usual and customary events of default for revolving credit facilities of this nature.

As of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the Capital Call Facility approximated its fair value. As of December 31, 2024 and 2023, unamortized financing costs of $243 and $337, respectively, are being deferred and amortized over the remaining term of the Capital Call Facility. As of December 31, 2024 and 2023, the Company had an outstanding balance of $27,000 and $52,000, respectively. The Capital Call Facility is presented in the Consolidated Statements of Assets and Liabilities net of unamortized financing costs, which results in an outstanding balance totaling $26,757 as of December 31, 2024 and $51,663 as of December 31, 2023.

The following table shows additional information about the interest and financing costs related to the Capital Call Facility for the years ended December 31, 2024, 2023, and 2022:

    

Year Ended

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Interest expenses related to the Capital Call Facility

$

2,666

$

2,994

$

2,927

Financing expenses related to the Capital Call Facility

354

454

556

Total interest and financing expenses related to the Capital Call Facility

$

3,020

$

3,448

$

3,483

Revolving Credit Facility

On June 28, 2021, SPV I entered into a senior secured revolving credit facility (as amended, the “Revolving Credit Facility”) with JPMorgan Chase Bank, National Association (“JPM”). JPM serves as administrative agent and lender, U.S. Bank, National Association, serves as collateral agent, securities intermediary and collateral administrator, and Stone Point Credit Adviser LLC serves as portfolio manager under the Revolving Credit Facility.

Advances under the Revolving Credit Facility bear interest at a per annum rate equal to: (a) for advances denominated in USD, Term SOFR, (b) for advances denominated in CAD, the average rate applicable to CAD bankers’ acceptances for a three-month period, (c) for advances denominated in GBP, the daily simple Sterling Overnight Index Average for each day, (d) for advances denominated in AUD, the three-month average bid reference rate administered by the Australian Financial Markets Association for Australian dollar bills, and (e) for advances denominated in Euros, the three-month Euro interbank offered rate, in each case, in effect, plus the applicable margin of 2.45% per annum (or, for advances denominated in GBP, 2.5693% per annum). SPV I paid and will pay, as applicable, a commitment fee of (x) initially, to but excluding September 28, 2021, 0.25% per annum, (y) from and including September 28, 2021 to but excluding the first anniversary of the Revolving Credit Facility, 0.50% per annum, and (z) from and including the first anniversary of the Revolving Credit Facility, 0.60% per annum, in each case, on the average daily unused amount of the financing commitments until the third anniversary of the Revolving Credit Facility.

On June 30, 2023, SPV I executed a letter agreement (the “Third Amendment”) to amend the Revolving Credit Facility. The Third Amendment revises the Revolving Credit Agreement to provide that all borrowings in U.S. dollars now bear interest at a rate based on Term SOFR. The Third Amendment also amends the accordion feature of the Revolving Credit Agreement to increase the

73

Table of Contents

maximum borrowing capacity of SPV I under the Revolving Credit Agreement to an aggregate of $1.0 billion. The other material terms of the Revolving Credit Facility were unchanged.

On June 27, 2024, SPV I executed a letter agreement (the “Fourth Amendment”) to amend the Revolving Credit Facility. The Fourth Amendment revises the Revolving Credit Agreement to effect an extension of the reinvestment period to June 27, 2027, and of the scheduled termination date to June 27, 2029. The amended Revolving Credit Agreement includes a non-call period from the effective date of the Fourth Amendment until June 27, 2026. The Fourth Amendment also increases the financing commitment from $750.0 million to $850.0 million and reduces the applicable margin from 2.55% per annum to 2.45% per annum with respect to SOFR loans, as well as changing the rate for Canadian Dollar advances from the Canadian Dollar Offered Rate (CDOR) to a three-month term rate based on the Canadian Overnight Repo Rate Average (CORRA). In connection with the Fourth Amendment, SPV I paid an upfront fee of $5.6 million. The other material terms of the Revolving Credit Facility were unchanged.

On September 12, 2024, SPV I executed a letter agreement (the “Fifth Amendment”) to amend the Revolving Credit Facility. Under the Fifth Amendment, JPM and each other lender party and each of their respective successors and permitted assigns have agreed to make Tranche A Advances and Tranche B Advances to the Company as specified according to a transaction schedule. The other material terms of the Revolving Credit Facility were unchanged. SPV I’s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in all of SPV I’s portfolio of investments and cash. The obligations of SPV I under the Revolving Credit Facility are non-recourse to the Company, and the Company’s exposure under the Revolving Credit Facility is limited to the value of the Company’s investment in SPV I.

The Revolving Credit Facility is secured by a security interest in the assets of SPV I and on any payments received by SPV I in respect of those assets. Assets pledged to the lenders under the Revolving Credit Facility will not be available to pay the debts of the Company if such assets have been used to repay or otherwise satisfy the obligations owed under the Revolving Credit Facility.

In connection with the Revolving Credit Facility, SPV I made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. The Revolving Credit Facility contains customary events of default for similar financing transactions, including if a change of control of SPV I occurs. Upon the occurrence and during the continuation of an event of default, the lenders may declare the outstanding advances and all other obligations under the Revolving Credit Facility immediately due and payable.

The occurrence of an event of default (as described above) or a Market Value Event (as defined in the Revolving Credit Facility) triggers a requirement that SPV I obtain the consent of JPM prior to entering into any sale or disposition with respect to portfolio assets, and the occurrence of a Market Value Event triggers the right of JPM to direct SPV I to enter into sales or dispositions with respect to any portfolio assets, in each case in JPM’s sole discretion.

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the Revolving Credit Facility approximated its fair value. As of December 31, 2024 and 2023, unamortized financing costs of $8,179 and $4,067, respectively, are being deferred and amortized over the remaining term of the Revolving Credit Facility. As of December 31, 2024 and 2023, the Revolving Credit Facility had an outstanding balance of $680,000 and $666,000, respectively. As of December 31, 2024 and 2023, the Revolving Credit Facility is presented in the Consolidated Statements of Assets and Liabilities net of unamortized financing costs, which results in an outstanding balance, totaling $671,821 and $661,933, respectively.

The following table shows additional information about the interest and financing costs related to the Revolving Credit Facility for the years ended December 31, 2024, 2023, and 2022:

    

Year Ended

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Interest expenses related to the Revolving Credit Facility

$

54,436

$

54,030

$

27,106

Financing expenses related to the Revolving Credit Facility

1,507

1,782

1,627

Total interest and financing expenses related to the Revolving Credit Facility

$

55,943

$

55,812

$

28,733

Secured Credit Facility

On August 14, 2023, SPV II entered into a $300.0 million Credit Agreement (the “Secured Credit Facility”), with the lenders from time to time parties thereto, Goldman Sachs Bank USA, as syndication agent and administrative agent (the “Administrative

74

Table of Contents

Agent”), U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, and U.S. Bank National Association, as collateral custodian.

The Secured Credit Facility is comprised of (i) a $250.0 million asset-based revolving loan facility (the “ABL Facility”) and (ii) a $50.0 million asset-based revolving loan facility (the “Revolver Facility”), each of which has its own borrowing base (comprised of its respective eligible assets, as approved by the Administrative Agent from time to time) but both of which are generally subject to the same terms under the Secured Credit Facility. No gain or loss is recognized on any purchases or sales to or from SPV II and the Company.

The Secured Credit Facility is secured by a security interest in the assets of SPV II and on any payments received by SPV II in respect of those assets. Assets pledged to the lenders under the Secured Credit Facility will not be available to pay the debts of the Company if such assets have been used to repay or otherwise satisfy the obligations owed under the Secured Credit Facility.

The Secured Credit Facility will mature on August 14, 2028, unless terminated earlier as provided in the Secured Credit Facility. For each of the ABL Facility and the Revolver Facility, SPV II may draw and redraw loans in U.S. dollars, euros or British pound sterling under the Secured Credit Facility during a commitment period ending on August 14, 2026, unless the commitments are terminated earlier as provided in the Secured Credit Facility. Loans drawn under the Secured Credit Facility will bear interest at Term SOFR plus 3.10% per annum and, in the case of loans drawn in euros or British pound sterling, an additional currency benchmark adjustment will apply. The Secured Credit Facility contains customary covenants, including certain limitations on the activities of SPV II, and customary events of default.

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the Secured Credit Facility approximated its fair value. As of December 31, 2024 and 2023, unamortized financing costs of $2,924 and $2,000, respectively, are being deferred and amortized over the remaining term of the Secured Credit Facility. As of December 31, 2024 and 2023, the Secured Credit Facility had an outstanding balance of $200,000 and $126,000, respectively. The Secured Credit Facility is presented in the Consolidated Statements of Assets and Liabilities net of unamortized financing costs, which results in an outstanding balance, totaling $197,076 as of December 31, 2024 and $124,000 as of December 31, 2023.

The following table shows additional information about the interest and financing costs related to the Secured Credit Facility for the year ended December 31, 2024 and the period ended from August 14, 2023 to December 31, 2023:

    

Year Ended

    

Period from August 14, 2023 to

($ in thousands)

December 31, 2024

December 31, 2023

Interest expenses related to the Secured Credit Facility

$

17,002

$

3,782

Financing expenses related to the Secured Credit Facility

576

165

Total interest and financing expenses related to the Secured Credit Facility

$

17,578

$

3,947

2025 Notes

On May 19, 2022, the Company entered into a Note Purchase Agreement (the “NPA”) governing the issuance of $225.0 million in aggregate principal amount of senior unsecured notes due May 19, 2025 (the “2025 Notes”) to qualified institutional investors in a private placement. $150.0 million of the 2025 Notes were delivered and paid for on May 19, 2022, and $75.0 million of the 2025 Notes were delivered and paid for on August 18, 2022.

The 2025 Notes have a fixed interest rate of 5.83% per year, subject to a step up of (1) 1.00% per year, to the extent and for so long as the 2025 Notes fail to satisfy certain investment grade rating conditions and/or (2) 1.50% per year, to the extent and for so long as either the ratio of the Company’s secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter-end, or the Company fails to deliver the required quarterly or annual consolidated financial statements and related certificates when due.

The 2025 Notes mature on May 19, 2025 unless redeemed, purchased or prepaid prior to such date by the Company in accordance with the terms of the NPA. Interest on the 2025 Notes is due semiannually in May and November of each year, beginning in November 2022. In addition, the Company is obligated to offer to repay the 2025 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the NPA, the Company may redeem the 2025 Notes in whole or in part at any time or from time to time at the Company’s option at par plus accrued interest to the prepayment date and, if redeemed on or before February 17, 2025, at a make-whole premium.

75

Table of Contents

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the 2025 Notes approximated its fair value. For the years ended December 31, 2024 and 2023, unamortized debt issuance costs of $388 and $1,343, respectively, are being deferred and amortized over the remaining term of the 2025 Notes. As of each of December 31, 2024 and 2023, the 2025 Notes had an outstanding balance of $225,000. For the years ended December 31, 2024 and 2023, the 2025 Notes are presented in the Consolidated Statements of Assets and Liabilities net of unamortized debt issuance costs, which results in an outstanding balance, totaling $224,612 and $223,657, respectively.

The following table shows additional information about the interest and financing costs related to the 2025 Notes for the years ended December 31, 2024 and 2023:

    

Year Ended

    

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

Interest expenses related to the 2025 Notes

$

13,118

$

13,118

Financing costs related to the 2025 Notes

 

1,055

1,037

Total interest and financing costs related to the 2025 Notes

$

14,173

$

14,155

2029 Notes

On September 17, 2024, the Company entered into a Note Purchase Agreement (the “September 2024 NPA”) governing the issuance of $200.0 million in aggregate principal amount of senior unsecured notes due September 15, 2029 (the “2029 Notes”) to qualified institutional investors in a private placement.

The 2029 Notes have a fixed interest rate of 6.70% per year, subject to a step up of (1) 1.00% per year, to the extent and for so long as the 2029 Notes fail to satisfy certain investment grade rating conditions and/or (2) 1.50% per year, to the extent and for so long as either the ratio of the Company’s secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter-end, or the Company fails to deliver the required quarterly or annual financial statements and related certificates when due. The Company intends to use the net proceeds from the offering of the 2029 Notes to repay existing Indebtedness and for general corporate purposes.

The 2029 Notes will mature on September 15, 2029 unless redeemed, purchased or prepaid prior to such date by the Company in accordance with the terms of the September 2024 NPA. Interest on the 2029 Notes will be due semiannually in April and October of each year, beginning in April 2025. In addition, the Company is obligated to offer to repay the 2029 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the September 2024 NPA, the Company may redeem the 2029 Notes in whole or in part at any time or from time to time at the Company’s option at par plus accrued interest to the prepayment date and, if redeemed on or before June 16, 2029, a make-whole premium.

As of December 31, 2024 the carrying amount of the Company’s borrowings under the 2029 Notes approximated its fair value. As of December 31, 2024 unamortized debt issuance costs of $2,340 are being deferred and amortized over the remaining term of the 2029 Notes. As of December 31, 2024 the 2029 Notes had an outstanding balance of $200,000. The 2029 Notes are presented on the Consolidated Statements of Assets and Liabilities net of unamortized debt issuance costs, which results in an outstanding balance, totaling $197,660 as of December 31, 2024.

76

Table of Contents

The following table shows additional information about the interest and financing costs related to the 2029 Notes for the period ended September 17, 2024 to December 31, 2024:

    

For the period from

September 17,2024 to

($ in thousands)

December 31, 2024

Interest expense related to the 2029 Notes

$

3,611

Financing expenses related to the 2029 Notes

139

Total interest and financing expenses related to the 2029 Notes

$

3,750

Liquidity

Operating liquidity is our ability to meet our short-term liquidity needs. The following table presents our operating liquidity position as of December 31, 2024 and 2023:

As of

($ in thousands)

    

December 31, 2024

    

December 31, 2023

Cash and cash equivalents

    

$

51,760

$

41,629

Unused borrowing capacity (1)

 

243,000

206,000

Unfunded portfolio company commitments

 

(402,618)

(226,542)

Undrawn capital commitments

 

336,596

311,945

Total operational liquidity

$

228,738

$

333,032

(1)Unused borrowing capacity has been adjusted to remove the maximum borrowing capacity under the Capital Call Facility given the Capital Call Facility would need to be repaid in full if the Company were to draw the remaining capital commitments.

Distributions

For the years ended December 31, 2024 and 2023, the Company declared the following distributions:

($ in thousands, except per share amounts)

Distribution

Annualized

Record Date

    

Payment Date

    

 Rate per Share

    

 Distribution Yield1

    

Distribution Paid

December 27, 2024

December 31, 2024

$

0.600

12.0

%

$

37,444

September 26, 2024

September 27, 2024

$

0.650

13.0

%

$

40,067

June 26, 2024

June 28, 2024

$

0.650

13.1

%

$

35,220

March 25, 2024

March 26, 2024

$

0.650

13.2

%

$

32,700

December 22, 2023

December 26, 2023

$

0.670

13.5

%

$

31,985

September 25, 2023

September 27, 2023

$

0.655

13.4

%

$

29,436

June 23, 2023

June 26, 2023

$

0.640

13.2

%

$

27,880

March 24, 2023

March 27, 2023

$

0.600

12.6

%

$

25,377

1

Annualized distribution yield is calculated as annualized quarterly declared distribution divided by weighted average net asset value over the period. Weighted average net asset value is based on the net asset value at the beginning of the quarter plus capital called and distributions reinvested during the quarter.

Commitments and Off-Balance Sheet Arrangements

Litigation and Regulatory Matters

From time to time, the Company may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Company’s rights under contracts with the Company’s portfolio companies. The Company and the Adviser are not currently a party to any material legal proceedings.

77

Table of Contents

Unfunded Portfolio Company Commitments

From time to time, the Company may enter into commitments to fund investments. As of December 31, 2024 and 2023, the Company had the following unfunded portfolio company commitments under loan and financing agreements:

78

Table of Contents

($ in thousands)

    

    

December 31, 2024

    

December 31, 2023

Portfolio Company

    

Type of Investment

    

Par

    

Par

2-10 Holdco, Inc.

First Lien Revolving Loan

$

$

2,778

Accordion Partners LLC

 

First Lien Delayed Draw Term Loan

 

5,454

 

2,075

Accordion Partners LLC

 

First Lien Revolving Loan

 

3,636

 

2,034

Accuserve

 

First Lien Delayed Draw Term Loan

 

4,876

 

2,690

Accuserve

 

First Lien Revolving Loan

 

6,573

 

Acentra Holdings, LLC

 

First Lien Revolving Loan

 

1,287

 

Acentra Holdings, LLC

 

First Lien Delayed Draw Term Loan

 

8,715

 

Action Behavior Centers Therapy LLC

 

First Lien Revolving Loan

 

3,071

 

Action Behavior Centers Therapy LLC

 

First Lien Delayed Draw Term Loan

 

5,722

 

Alkeme Intermediary Holdings, LLC

 

First Lien Delayed Draw Term Loan

 

12,511

 

Amerilife Holdings LLC

 

First Lien Delayed Draw Term Loan

 

4,753

 

1,768

AmeriLife Group LLC

 

First Lien Revolving Loan

 

6,891

 

5,273

Anaplan, Inc.

 

First Lien Revolving Loan

 

1,546

 

1,546

Aprio Advisory Group, LLC

 

First Lien Delayed Draw Term Loan

 

4,741

 

Aprio Advisory Group, LLC

 

First Lien Revolving Loan

 

2,994

 

Arden Insurance Services LLC

First Lien Revolving Loan

1,463

ARMStrong Receivable Management

 

First Lien Delayed Draw Term Loan

 

1,020

 

4,955

ARMStrong Receivable Management

 

First Lien Revolving Loan

 

299

 

299

Baker Tilly Advisory Group, L.P.

 

First Lien Delayed Draw Term Loan

 

2,736

 

Baker Tilly Advisory Group, L.P.

 

First Lien Revolving Loan

 

3,835

 

Beacon Pointe Harmony, LLC

 

First Lien Delayed Draw Term Loan

 

9,390

 

9,874

Beacon Pointe Harmony, LLC

 

First Lien Revolving Loan

 

3,000

 

3,000

Belmont Buyer, Inc.

 

First Lien Revolving Loan

 

1,453

 

2,180

Belmont Buyer, Inc.

 

First Lien Delayed Draw Term Loan

 

4,235

 

2,616

Bottomline Technologies, Inc.

 

First Lien Revolving Loan

 

7,365

 

7,365

Captive Resources Midco, LLC

 

First Lien Revolving Loan

 

2,203

 

2,203

Chartis Group, LLC

 

First Lien Delayed Draw Term Loan

 

2,517

 

Chartis Group, LLC

 

First Lien Revolving Loan

 

1,259

 

Cherry Bekaert Advisory LLC

 

First Lien Delayed Draw Term Loan

 

638

 

5,625

Choreo Buyer, LLC

 

First Lien Delayed Draw Term Loan

 

15,560

 

Cliffwater, LLC

 

First Lien Revolving Loan

 

2,857

 

2,857

CNSI Holdings, LLC

 

First Lien Revolving Loan

 

 

912

Continental Buyer Inc.

 

First Lien Delayed Draw Term Loan

 

8,153

 

Continental Buyer Inc.

 

First Lien Revolving Loan

 

3,057

 

Diligent Corporation

 

First Lien Delayed Draw Term Loan

 

4,124

 

Diligent Corporation

 

First Lien Revolving Loan

 

5,997

 

2,300

Eclipse Buyer, Inc.

 

First Lien Revolving Loan

 

1,083

 

Eclipse Buyer, Inc.

 

First Lien Delayed Draw Term Loan

 

2,134

 

Ellkay, LLC

 

First Lien Revolving Loan

 

2,167

 

3,611

Exeter

First Lien Revolving Loan

8,797

Foundation Risk Partners, Corp.

 

First Lien Revolving Loan

 

4,407

 

Foundation Risk Partners, Corp.

 

First Lien Delayed Draw Term Loan

 

4,686

 

Galway Borrower LLC

 

First Lien Delayed Draw Term Loan

 

10,596

 

21,000

Galway Borrower, LLC

 

First Lien Revolving Loan

 

2,767

 

4,098

GaphPAD Software, LLC

 

First Lien Revolving Loan

 

 

1,250

Geosyntec Consultants, Inc.

 

First Lien Delayed Draw Term Loan

 

 

2,187

Geosyntec Consultants, Inc.

 

First Lien Revolving Loan

 

 

1,609

Giving Home Health Care

 

First Lien Revolving Loan

 

 

3,125

GovDelivery Holdings, LLC

 

First Lien Revolving Loan

 

2,193

 

1,910

GS Acquisitionco, Inc.

 

First Lien Revolving Loan

 

1,080

 

GS Acquisitionco, Inc.

 

First Lien Delayed Draw Term Loan

 

1,109

 

Guardian Restoration Partners Buyers, LLC

First Lien Revolving Loan

2,057

Guardian Restoration Partners Buyers, LLC

First Lien Delayed Draw Term Loan

9,082

HBWM Intermediate II, LLC

First Lien Revolving Loan

1,017

HBWM Intermediate II, LLC

First Lien Delayed Draw Term Loan

5,498

Hyland Software, Inc

 

First Lien Revolving Loan

 

1,199

 

1,199

IG Investments Holdings, LLC

 

First Lien Revolving Loan

 

3,509

 

5,058

Imagine Acquisitionco, LLC

 

First Lien Revolving Loan

 

4,399

 

4,630

KRIV Acquisition Inc.

 

First Lien Delayed Draw Term Loan

 

24,923

 

Kwol Acquisition Inc

 

First Lien Revolving Loan

 

329

 

230

LendingTree, Inc.

 

First Lien Delayed Draw Term Loan

 

3,000

 

MAI Capital Management Intermediate LLC

 

First Lien Revolving Loan

 

1,331

 

MAI Capital Management Intermediate LLC

 

First Lien Delayed Draw Term Loan

 

2,782

 

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

8,932

 

3,200

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

 

MB2 Dental Solutions, LLC

 

First Lien Revolving Loan

 

2,244

 

Ministry Brands Purchaser, LLC

 

First Lien Revolving Loan

 

1,695

 

791

Minotaur Acquisition, Inc.

 

First Lien Delayed Draw Term Loan

 

3,401

 

Minotaur Acquisition, Inc.

 

First Lien Revolving Loan

 

2,041

 

79

Table of Contents

Mirra-Prime Access Holdings, LLC

 

First Lien Revolving Loan

 

685

 

2,055

More Cowbell II LLC

 

First Lien Delayed Draw Term Loan

 

5,444

 

5,444

More Cowbell II LLC

 

First Lien Revolving Loan

 

4,247

 

5,771

Neptune Flood Incorporated

First Lien Revolving Loan

750

New Mountain Capital LLC

Unsecured Notes

350

New Mountain Capital LLC

Unsecured Notes

557

New Mountain Capital LLC

Unsecured Notes

1,942

New Mountain Capital LLC

Unsecured Notes

2,657

OneDigital Borrower LLC

First Lien Delayed Draw Term Loan

9,771

Orion Advisor Solutions, LLC

Second Lien Delayed Draw Term Loan

6,524

NextGen Healthcare

First Lien Delayed Draw Term Loan

2,370

2,370

NextGen Healthcare

First Lien Revolving Loan

889

889

NXGen Buyer, Inc.

First Lien Revolving Loan

326

oneZero Financial Systems, LLC

First Lien Delayed Draw Term Loan

4,712

oneZero Financial Systems, LLC

First Lien Revolving Loan

3,365

PAS Parent Inc.

First Lien Delayed Draw Term Loan

1,476

9,000

PAS Parent Inc.

First Lien Revolving Loan

1,000

1,000

PAS Parent Inc.

First Lien Delayed Draw Term Loan

5,625

Petra Borrower, LLC

First Lien Delayed Draw Term Loan

3,193

6,875

Petra Borrower, LLC

First Lien Revolving Loan

2,456

2,750

Project K BuyerCo, Inc.

First Lien Revolving Loan

7,727

7,727

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

19,663

Simplifi Holdings, Inc.

First Lien Revolving Loan

2,892

2,349

Syntax Systems Limited

First Lien Revolving Loan

459

Southpaw AP Buyer, LLC

First Lien Delayed Draw Term Loan

260

Southpaw AP Buyer, LLC

First Lien Revolving Loan

868

SpecialtyCare, Inc.

First Lien Revolving Loan

446

914

Stepping Stones Healthcare Services, LLC

First Lien Revolving Loan

3,500

3,500

Stepping Stones Healthcare Services, LLC

First Lien Delayed Draw Term Loan

6,300

1,545

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

2,000

2,000

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

5,602

3,941

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

1,135

Tamarack Intermediate, L.L.C.

First Lien Revolving Loan

3,516

3,516

THG Acquisition, LLC

First Lien Revolving Loan

2,706

THG Acquisition, LLC

First Lien Delayed Draw Term Loan

5,847

Titan Home Improvement, LLC

First Lien Delayed Draw Term Loan

4,605

Titan Home Improvement, LLC

First Lien Revolving Loan

3,837

Trinity Partners Holdings, LLC

First Lien Delayed Draw Term Loan

6,625

7,447

TST Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

5,817

5,769

TST Intermediate Holdings, LLC

First Lien Revolving Loan

890

Vital Care Buyer LLC

First Lien Revolving Loan

874

Williams Martson, LLC

 

First Lien Delayed Draw Term Loan

 

2,554

 

2,554

Williams Martson, LLC

 

First Lien Revolving Loan

 

2,235

 

2,235

Worldwide Insurance Network, LLC

 

First Lien Delayed Draw Term Loan

 

12,174

 

Total Par.

 

  

$

402,618

$

226,542

We believe that we maintain sufficient liquidity in the form of cash, financing capacity and undrawn capital commitments from our investors to cover any outstanding unfunded portfolio company commitments we may be required to fund.

Investor Commitments

As of December 31, 2024, the Company has received capital commitments totaling $1,512.9 million, of which, $336.6 million remains unfunded.

Recent Developments

On March 3, 2025, (the “First Amendment Date”), SPV II entered into an amendment to its Secured Credit Facility which, among other things, reduces the spread to 2.00% per annum, extends the reinvestment period to three years after the First Amendment Date, and extends the maturity date to five years after the First Amendment Date.

80

Table of Contents

Contractual Obligations

Our payment obligations for repayment of debt, which total our contractual obligations on December 31, 2024, include the following:

Payments Due by Period

Less Than

1 - 3

3 - 5

More Than

    

Total

    

1 Year

    

Years

    

Years

    

5 Years

Capital Call Facility

$

65,000

$

65,000

$

$

$

Revolving Credit Facility

850,000

850,000

Secured Credit Facility

300,000

300,000

2025 Notes

225,000

225,000

2029 Notes

200,000

200,000

Total Contractual Obligations

$

1,640,000

$

290,000

$

$

1,350,000

$

Hedging

In connection with certain portfolio investments, the Company may employ hedging techniques designed to reduce the risk of adverse movements in interest rates, securities prices and currency exchange rates. While such transactions may reduce certain risks, such transactions themselves may entail certain other risks. Thus, while the Company may benefit from the use of these hedging mechanisms, unanticipated changes in interest rates, securities prices, currency exchange rates and other factors may result in a poorer overall performance for the Company than if it had not entered into such hedging transactions. The successful utilization of hedging and risk management transactions requires skills that are separate from the skills used in selecting and monitoring investments. There were no hedging transactions through the year ended December 31, 2024.

Critical Accounting Policies

This discussion of the Company’s operating plan is based upon the Company’s financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these financial statements requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ. In addition to the discussion below, the Company describes its critical accounting policies in the notes to the Company’s financial statements.

Valuation of Investments

The Board has designated the Adviser as the Company’s “Valuation Designee” under Rule 2a-5 under the 1940 Act. The Adviser determines the value of the Company’s investments in accordance with fair value accounting guidance promulgated under U.S. GAAP, which establishes a hierarchical disclosure framework which ranks the observability inputs used in measuring financial instruments at fair value. See the Notes to Financial Statements for a description of the hierarchy for fair value measurements and a description of the Company’s valuation procedures.

Revenue Recognition

The Company records interest income on an accrual basis to the extent that the Company expects to collect such amounts. Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. Certain investments may have contractual payment-in-kind (“PIK”) interest or dividends. PIK interest and dividends represent accrued interest or dividends that are added to the principal amount or liquidation amount of the investment on the respective interest or dividend payment dates rather than being paid in cash and generally becomes due at maturity or at the occurrence of a liquidation event. The Company does not accrue as a receivable interest on loans and debt securities for accounting purposes if the Company has reason to doubt the Company’s ability to collect such interest. OIDs, market discounts or premiums are accreted or amortized over the life of the respective security using the

81

Table of Contents

effective interest method as interest income. The Company records prepayment premiums on loans and debt securities as interest income.

U.S. Federal Income Taxes

The Company has elected to be treated, and intends to qualify annually, to be taxed as a RIC under Subchapter M of the Code. As a RIC, the Company generally will not be subject to corporate-level U.S. federal income taxes on any ordinary income or capital gains distributed to Stockholders. To qualify as a RIC, the Company must, among other things, maintain an election under the 1940 Act to be regulated as a BDC, meet specified source-of-income and asset diversification requirements as well as distribute each taxable year dividends for U.S. federal income tax purposes generally of an amount at least equal to 90% of the Company’s “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses and is determined without regard to any deduction for dividends paid. See “Note 11. Taxes.”

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

The Company is subject to financial market risks, including valuation risk and interest rate risk.

Valuation Risk

The Company plans to invest primarily in illiquid debt securities of private companies. Most of the Company’s investments will not have a readily available market price, and the Adviser will value these investments at fair value as determined in good faith in accordance with procedures approved by the Board. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments the Company makes.

Interest Rate Risk

We are subject to financial market risks, most significantly changes in interest rates. Interest rate sensitivity refers to the change in our earnings that may result from changes in the level of interest rates. Because we expect to fund a portion of our investments with borrowings, our net investment income is expected to be affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

As of December 31, 2024, 99.4% of the Company’s debt investments based on fair value were at floating rates. Our credit facilities, including our Capital Call Facility and Revolving Credit Facility, also bear interest at floating rates.

Based on our Consolidated Statement of Assets and Liabilities as of December 31, 2024, the following table shows the approximate annualized impact of hypothetical base rate changes in interest rates (considering interest rate floors and assuming no changes in our investment portfolio and borrowing structure):

Change in

($ in thousands)

Net Investment

Basis point change

    

Interest Income (1)

    

Interest Expense

    

Income (Loss)

300

$

70,718

$

(27,210)

$

43,508

200

47,146

(18,140)

29,006

100

23,573

(9,070)

14,503

(100)

(23,573)

9,070

(14,503)

(200)

(47,146)

18,140

(29,006)

(300)

(70,718)

27,210

(43,508)

(1)

Assumes no defaults or prepayments by portfolio companies over the next twelve months.

We may in the future hedge against interest rate fluctuations by using hedging instruments such as interest rate swaps, futures, options and forward contracts, subject to the requirements of the 1940 Act and applicable commodities laws. While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of changes in interest rates with respect to our portfolio investments. During the periods covered by this Form 10-K, we did not engage in interest rate hedging activities.

82

Table of Contents

Item 8. Financial Statements and Supplementary Data

Index to Financial Statements

 

Page

Report of Independent Registered Public Accounting Firm

84

Consolidated Statements of Assets and Liabilities as of December 31, 2024 and 2023

85

Consolidated Statements of Operations for the years ended December 31, 2024, 2023, and 2022

86

Consolidated Statements of Changes in Net Assets for the years ended December 31, 2024, 2023, and 2022

87

Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023, and 2022

88

Consolidated Schedules of Investments as of December 31, 2024 and 2023

89

Notes to Consolidated Financial Statements

101

83

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Stockholders and Board of Directors

Stone Point Credit Corporation:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated statements of assets and liabilities of Stone Point Credit Corporation and subsidiaries (the Company), including the consolidated schedules of investments as of December 31, 2024 and 2023, the related consolidated statements of operations, changes in net assets, and cash flows for each of the years in the three year period ended December 31, 2024, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations, and its cash flows for each of the years in the three year period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.

Basis for Opinions

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Such procedures also included confirmation of securities owned as of December 31, 2024 and 2023, by correspondence with the custodians, portfolio companies, agents, or by other appropriate auditing procedures. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ KPMG LLP

We have served as the Company’s auditor since 2020.

New York, New York

March 24, 2025

84

Table of Contents

Stone Point Credit Corporation

Consolidated Statements of Assets and Liabilities

(in thousands, except share and per share amounts)

    

December 31, 2024

    

December 31, 2023

Assets:

Investments at fair value:

Non-controlled/non-affiliated investments (amortized cost $2,502,807 and $2,012,625, respectively)

$

2,504,242

$

1,999,625

Cash and cash equivalents

 

51,760

 

41,629

Interest receivable

 

23,453

 

21,422

Dividend receivable

367

Unsettled trades receivable

 

15,471

 

3,551

Paydown receivable

 

2,247

 

1,204

Deferred offering expenses

 

25

 

34

Prepaid expenses and other assets

 

66

 

66

Total assets

$

2,597,264

$

2,067,898

Liabilities:

 

 

  

Revolving credit facilities payable (net of deferred financing costs of $11,346 and $6,404 respectively) (Note 6)

$

895,654

$

837,596

Notes payable (net of debt issuance costs of $2,728 and $1,343 respectively)

 

422,272

 

223,657

Unsettled trades payable

 

69

 

1,000

Base management fees payable (Note 3)

 

8,013

 

6,532

Accounts payable and accrued expenses

 

2,434

 

2,548

Interest and financing fees payable

 

17,325

 

5,143

Total liabilities

$

1,345,767

$

1,076,476

Commitments and contingencies (Note 5)

$

$

Net assets:

 

 

  

Preferred stock, $0.001 par value, 1,000 shares authorized, 0 shares issued and outstanding at December 31, 2024 and December 31, 2023

$

$

Common stock, $0.001 par value, 250,000 shares authorized, 63,054,004 and 50,308,175 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively

 

63

 

50

Paid in capital in excess of par

 

1,251,041

 

999,354

Distributable earnings (accumulated losses)

 

393

 

(7,982)

Total net assets

 

1,251,497

 

991,422

Total liabilities and net assets

$

2,597,264

$

2,067,898

Net asset value per common share

$

19.85

$

19.71

The accompanying notes are an integral part of these consolidated financial statements.

85

Table of Contents

Stone Point Credit Corporation

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

For the Year Ended

For the Year Ended

Year Ended

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

Investment income:

Interest income from non-controlled/non-affiliated investments

$

271,385

$

223,951

$

128,975

Dividend income from non-controlled/non-affiliated investments

 

3,719

 

1,422

 

600

Interest income from cash and cash equivalents

 

3

 

2

 

1

Total interest and dividend income

275,107

225,375

129,576

Fee income

2,395

688

374

Total fee income

2,395

688

374

Total investment income

277,502

226,063

129,950

Operating expenses:

 

 

 

Base management fees (Note 3)

$

30,071

$

24,304

$

18,937

Interest and financing fees (Note 6)

 

94,465

 

77,361

 

40,044

Offering costs (Note 4)

 

56

 

97

 

116

Professional fees

 

7,552

 

6,642

 

5,500

Directors fees

 

368

 

368

 

367

Insurance expense

 

62

 

62

 

70

Total expenses

 

132,574

 

108,834

 

65,034

Net investment income (loss)

$

144,928

$

117,229

$

64,916

Net realized gains (losses) and unrealized appreciation (depreciation) on investments

 

 

 

Net realized gains (losses):

 

 

 

Non-controlled/non-affiliated investments

$

(5,762)

$

(133)

$

1,072

Total net realized gains (losses)

$

(5,762)

$

(133)

$

1,072

Net change in unrealized appreciation (depreciation):

 

 

 

Non-controlled/non-affiliated investments

$

14,434

$

16,375

$

(34,138)

Total net change in unrealized appreciation (depreciation)

$

14,434

$

16,375

$

(34,138)

Net increase (decrease) in net assets resulting from operations

$

153,600

$

133,471

$

31,850

Per share informationbasic and diluted:

 

 

 

Net investment income (loss)

$

2.53

$

2.62

$

1.94

Net increase (decrease) in net assets resulting from operations

$

2.68

$

2.99

$

0.95

Weighted average shares outstanding

 

57,255,840

 

44,712,958

 

33,466,524

The accompanying notes are an integral part of these consolidated financial statements.

86

Table of Contents

Stone Point Credit Corporation

Consolidated Statements of Changes in Net Assets

(in thousands, except shares and per share amounts)

For the Year Ended

For the Year Ended

For the Year Ended

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

Increase (decrease) in net assets resulting from operations:

Net investment income (loss)

$

144,928

$

117,229

$

64,916

Total net realized gains (losses)

 

(5,762)

 

(133)

 

1,072

Total net change in unrealized appreciation (depreciation)

 

14,434

 

16,375

 

(34,138)

Net increase (decrease) in net assets resulting from operations

 

153,600

 

133,471

 

31,850

Decrease in net assets resulting from stockholder distributions:

 

 

 

Shares distributed pursuant to dividend reinvestment plan

 

(45,692)

 

(18,706)

 

(10,199)

Distributions to stockholders

 

(99,739)

 

(95,971)

 

(53,634)

Net decrease in net assets resulting from stockholder distributions

 

(145,431)

 

(114,677)

 

(63,833)

Increase in net assets resulting from capital share transactions:

 

 

 

Issuance of shares of Common Stock pursuant to dividend reinvestment plan

 

45,692

 

18,706

 

10,199

Issuance of shares of Common Stock

 

206,214

 

136,737

 

293,400

Net increase in net assets resulting from capital share transactions

 

251,906

 

155,443

 

303,599

Total increase in net assets

 

260,075

 

174,237

 

271,616

Net assets, beginning of period

 

991,422

 

817,185

 

545,569

Net assets, end of period

$

1,251,497

$

991,422

$

817,185

Net asset value per share

$

19.85

$

19.71

$

19.32

Common stock outstanding at the end of the period

 

63,054,004

 

50,308,175

 

42,294,773

The accompanying notes are an integral part of these consolidated financial statements.

87

Table of Contents

Stone Point Credit Corporation

Consolidated Statements of Cash Flows

(in thousands)

    

For the Year Ended

For the Year Ended

    

For the Year Ended

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022*

Cash flows from operating activities:

Net increase (decrease) in net assets resulting from operations

$

153,600

$

133,471

$

31,850

Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:

 

 

Total net change in unrealized (appreciation) depreciation

 

(14,434)

(16,375)

 

34,138

Total net realized (gains) losses

 

5,762

133

 

(1,072)

Net amortization and accretion of premiums and discounts

 

(13,645)

(9,574)

 

(6,832)

Purchases of investments, net

 

(1,275,526)

(507,020)

 

(779,690)

Sales and repayments of investments, net

793,282

221,830

223,921

Amortization of deferred financing costs

2,438

2,401

2,178

Amortization of debt issuance costs

 

1,194

1,037

 

591

Changes in operating assets and liabilities:

 

 

Interest receivable

 

(2,031)

(2,289)

 

(10,628)

Dividend receivable

 

367

(366)

 

Unsettled trades receivable

 

(11,920)

(3,081)

 

(471)

Paydown receivable

 

(1,043)

510

 

(1,294)

Deferred offering expenses

 

(47)

(79)

 

(11)

Prepaid expenses and other assets

 

377

 

(416)

Base management fees payable

 

1,481

983

 

2,730

Organizational and offering expenses payable

 

 

(41)

Accounts payable and accrued expenses

 

(114)

166

 

92

Interest and financing fees payable

 

12,182

(6,871)

 

9,198

Unsettled trades payable

(931)

(544)

1,544

Net cash used in operating activities

 

(349,385)

(185,291)

 

(494,213)

Cash flows from financing activities:

 

 

Borrowings under revolving credit facilities

 

971,500

633,200

 

912,000

Payments on revolving credit facilities

 

(908,500)

(478,200)

 

(858,000)

Deferred financing costs

 

(7,380)

(2,536)

 

(2,987)

Borrowings under notes payable

 

200,000

 

225,000

Debt issuance costs

 

(2,579)

(100)

 

(2,871)

Distributions paid in cash

 

(99,739)

(95,971)

 

(53,634)

Proceeds from issuance of Common Stock

 

206,214

136,737

 

293,400

Net cash provided by financing activities

 

359,516

193,130

 

512,908

Net increase (decrease) in cash and cash equivalents

 

10,131

7,839

 

18,695

Cash and cash equivalents, beginning of period

 

41,629

33,791

 

15,096

Cash and cash equivalents, end of period

$

51,760

$

41,629

$

33,791

Supplemental and Non-Cash Information

 

 

Cash paid during the year for interest

$

78,650

$

86,975

$

22,366

Reinvestment of distributions during the year

$

45,692

$

18,706

$

10,199

Non-Cash purchases of Investments

$

$

(4,914)

$

Non-Cash proceeds from investments

$

$

4,914

$

*Prior period presentation was updated to conform with current period presentation by showing the breakout of amortization of deferred financing and debt issuance costs from new deferred financing and debt issuance costs.

The accompanying notes are an integral part of these consolidated financial statements.

88

Table of Contents

Stone Point Credit Corporation

Consolidated Schedule of Investments

As of December 31, 2024

(in thousands)

    

    

    

    

    

Par

    

    

    

    

    

Percentage

 

Reference Rate

Amount /

Fair

of Net

 

Portfolio Company 1 2 3 4

Type of Investment

    

Footnotes

    

and Spread

Interest Rate

Maturity 5

Units

Cost 6

Value

Assets 7

 

Non-Controlled/Non-Affiliated Investments

 

  

 

  

 

  

 

  

 

  

 

 

  

 

 

  

 

  

Debt Investments – 195.9%

  

 

  

 

  

 

  

 

  

 

 

  

 

 

  

 

  

Capital Markets

 

  

 

  

 

  

 

  

 

  

 

 

  

 

 

  

 

  

Cliffwater, LLC

First Lien Term Loan

(10)

SOFR +

4.50

%,

0.75

% Floor

8.86

%

10/7/2030

17,014

$

16,680

$

17,014

1.4

%

Cliffwater, LLC

First Lien Revolving Loan

(9)

SOFR +

4.50

%,

0.75

% Floor

8.86

%

10/7/2030

(47)

0.0

%

NXGen Buyer, Inc.

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.11

%

10/29/2027

14,877

14,705

14,707

1.2

%

NXGen Buyer, Inc.

Second Lien Term Loan

(10)

SOFR +

8.00

%,

1.00

% Floor

12.36

%

4/28/2028

1,250

1,206

1,236

0.1

%

NXGen Buyer, Inc.

Second Lien Term Loan

(10)

SOFR +

8.00

%,

1.00

% Floor

12.36

%

4/28/2028

2,500

2,500

2,471

0.2

%

NXGen Buyer, Inc.

 

First Lien Revolving Loan

(9)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.11

%

10/29/2027

 

 

(3)

 

(4)

 

0.0

%

Project K Buyerco, INC.

 

First Lien Term Loan

(10)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.43

%

12/10/2027

 

74,955

 

 

74,126

 

 

75,644

 

6.0

%

Project K Buyerco, INC.

 

First Lien Revolving Loan

(9)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.43

%

12/10/2027

 

 

 

(76)

 

 

71

 

0.0

%

Wharf Street Ratings Acquisition LLC

 

Unsecured Note

 

N/A

 

8.00

%

12/8/2028

 

13,813

 

 

13,185

 

 

13,130

 

1.0

%

Total Capital Markets

 

 

122,276

124,269

Consumer Finance

ACM ASOF VIII LCLUB LLC

First Lien Term Loan

N/A

13.00

%

6/30/2030

14,065

13,995

13,995

1.1

%

Exeter Short Term Funding LLC

First Lien Revolving Loan

(9)(10)

SOFR +

6.10

%,

2.00

% Floor

10.65

%

2/9/2026

23,758

23,595

23,595

1.9

%

Total Consumer Finance

37,590

37,590

Diversified Consumer Services

Harbor Purchaser, Inc.

 

Second Lien Term Loan

(8)(10)

 

SOFR +

8.50

%,

0.50

% Floor

 

12.86

%

4/8/2030

 

12,500

 

 

12,306

 

 

12,438

 

1.0

%

Houghton Mifflin Harcourt Co

First Lien Term Loan

(8)(10)

SOFR +

5.25

%,

0.50

% Floor

9.71

%

4/9/2029

4,987

4,888

4,925

0.4

%

Total Diversified Consumer Services

 

 

 

 

17,194

 

 

17,363

 

 

  

 

  

 

  

 

  

Financial Services

Advisor Group Holdings, Inc.

 

Unsecured Note

(8)(11)

 

N/A

 

10.75

%

8/1/2027

 

826

 

 

809

 

 

852

 

0.1

%

ALP CFO 2024, L.P.

Unsecured Note

N/A

10.04

%

10/15/2036

11,355

11,355

11,355

0.9

%

Beacon Pointe Harmony, LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.11

%

12/29/2028

 

23,228

 

 

22,925

 

 

23,228

 

1.9

%

Beacon Pointe Harmony, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.49

%

12/29/2028

 

11,061

 

 

10,831

 

 

11,061

 

0.9

%

Beacon Pointe Harmony, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.49

%

12/29/2028

 

11,194

 

 

11,116

 

 

11,194

 

0.9

%

Beacon Pointe Harmony, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

4.75

%,

0.75

% Floor

9.20

%

12/29/2028

2,603

2,552

2,603

0.2

%

Beacon Pointe Harmony, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.11

%

12/29/2027

 

 

 

(30)

 

 

 

0.0

%

Choreo Buyer LLC.

First Lien Term Loan

(10)

SOFR +

5.00

%,

1.00

% Floor

9.36

%

2/18/2028

5,151

5,080

5,121

0.4

%

Choreo Buyer LLC.

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.36

%

3/20/2026

 

 

 

(102)

 

 

(92)

 

0.0

%

Edelman Financial Center

Second Lien Term Loan

(8)(10)

SOFR +

5.25

%

9.61

%

10/6/2028

12,500

12,472

12,629

1.0

%

HBWM Intermediate II, LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.90

%

11/17/2031

 

4,582

 

 

4,560

 

 

4,559

 

0.4

%

HBWM Intermediate II, LLC

First Lien Delayed Draw Term Loan

(9)

SOFR +

4.50

%,

0.75

% Floor

8.90

%

11/16/2026

(14)

(27)

0.0

%

HBWM Intermediate II, LLC

First Lien Revolving Loan

(9)(10)

SOFR +

4.50

%,

0.75

% Floor

8.88

%

8/18/2031

82

72

77

0.0

%

Ivy Hill Asset Management, L.P.

 

Unsecured Note

 

N/A

 

9.00

%

6/29/2028

 

4,300

 

 

4,300

 

 

4,430

 

0.4

%

LendingTree, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

1.50

% Floor

 

10.11

%

3/27/2031

 

6,938

 

 

6,774

 

 

6,938

 

0.6

%

LendingTree, Inc.

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.75

%,

1.50

% Floor

 

10.11

%

3/27/2025

 

 

 

(41)

 

 

 

0.0

%

MAI Capital Management Intermediate LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.08

%

8/29/2031

 

6,893

 

 

6,826

 

 

6,827

 

0.5

%

MAI Capital Management Intermediate LLC

 

First Lien Delayed Draw Term Loan

(9)(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.08

%

8/29/2031

 

1,289

 

 

1,264

 

 

1,251

 

0.1

%

MAI Capital Management Intermediate LLC

First Lien Revolving Loan

(9)(10)

SOFR +

4.75

%,

0.75

% Floor

9.08

%

8/29/2031

205

190

190

0.0

%

Minotaur Acquisition, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.36

%

5/10/2030

 

20,356

 

 

19,976

 

 

20,187

 

1.6

%

Minotaur Acquisition, Inc.

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.36

%

5/11/2026

 

 

 

(31)

 

 

(28)

 

0.0

%

Minotaur Acquisition, Inc.

First Lien Delayed Draw Term Loan

(10)

SOFR +

5.00

%,

1.00

% Floor

9.36

%

5/10/2030

3,401

3,337

3,371

0.3

%

Minotaur Acquisition, Inc.

First Lien Revolving Loan

(9)

SOFR +

5.00

%,

1.00

% Floor

9.36

%

5/10/2030

(37)

(17)

0.0

%

New Mountain Guardian IV Income Rated Feeder II, Ltd.

Unsecured Note

(9)(10)

SOFR +

8.40

%

12.92

%

4/3/2037

650

650

668

0.1

%

New Mountain Guardian IV Rated Feeder III, Ltd.

Unsecured Note

(9)(10)

SOFR +

5.10

%

9.43

%

8/28/2037

1,132

1,132

1,164

0.1

%

New Mountain Guardian IV Rated Feeder III, Ltd.

Unsecured Note

(9)(10)

SOFR +

7.50

%

11.83

%

8/28/2037

5,394

5,394

5,530

0.4

%

New Mountain Guardian IV Rated Feeder III, Ltd.

Unsecured Note

(9)(10)

SOFR +

8.02

%

12.35

%

8/28/2037

3,943

3,884

4,040

0.3

%

Nexus Buyer LLC

Second Lien Term Loan

(8)(10)

SOFR +

6.25

%

10.71

%

11/5/2029

19,998

20,007

20,012

1.6

%

TA/WEG Intermediate Holdings, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.50

%

10/4/2027

 

21,739

 

 

21,549

 

 

21,487

 

1.7

%

TA/WEG Intermediate Holdings, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.57

%

10/4/2027

 

2,430

 

 

2,404

 

 

2,402

 

0.2

%

TA/WEG Intermediate Holdings, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.57

%

10/4/2027

 

2,435

 

 

2,383

 

 

2,407

 

0.2

%

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

(10)

SOFR +

5.00

%,

1.00

% Floor

9.57

%

10/4/2027

25,650

25,564

25,352

2.0

%

TA/WEG Intermediate Holdings, LLC

 

First Lien Delayed Draw Term Loan

(9)(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.50

%

10/4/2027

 

14,255

 

 

14,006

 

 

14,025

 

1.1

%

TA/WEG Intermediate Holdings, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.57

%

10/4/2027

 

 

 

(6)

 

 

(23)

 

0.0

%

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

(9)

SOFR +

5.00

%,

1.00

% Floor

9.50

%

10/4/2027

(24)

(13)

0.0

%

WEG Sub Intermediate Holdings, LLC

Unsecured Note

N/A

13.00

%

5/26/2033

13,962

13,760

13,974

1.1

%

Total Financial Services

234,887

236,734

89

Table of Contents

    

    

    

    

    

Par

    

    

    

Percentage

 

Type of

Reference Rate

Interest

Amount /

of Net

 

Portfolio Company 1 2 3 4

Investment

    

Footnotes

    

and Spread

Rate

Maturity 5

Units

Cost 6

Fair Value

Assets 7

 

Health Care Providers & Services

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Acentra Holdings, LLC

First Lien Term Loan

(10)

SOFR +

5.50

%,

0.50

% Floor

9.83

%

12/17/2029

14,856

14,362

14,654

1.2

%

Acentra Holdings, LLC

First Lien Term Loan

(10)

SOFR +

5.50

%,

0.50

% Floor

9.83

%

12/17/2029

2,876

2,837

2,837

0.2

%

Acentra Holdings, LLC

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.50

%,

0.50

% Floor

9.83

%

3/19/2026

(57)

(119)

0.0

%

Acentra Holdings, LLC

First Lien Revolving Loan

(9)(10)

SOFR +

5.50

%,

0.50

% Floor

9.82

%

12/17/2029

154

124

134

0.0

%

Action Behavior Centers Therapy LLC

First Lien Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.84

%

7/2/2031

33,786

33,294

33,502

2.7

%

Action Behavior Centers Therapy LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.25

%,

0.75

% Floor

9.80

%

7/2/2031

421

375

370

0.0

%

Action Behavior Centers Therapy LLC

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

0.75

% Floor

9.84

%

7/2/2031

(43)

(26)

0.0

%

Belmont Buyer, Inc.

First Lien Term Loan

(10)

SOFR +

5.25

%,

1.00

% Floor

9.88

%

6/21/2029

16,450

16,267

16,204

1.3

%

Belmont Buyer, Inc.

First Lien Term Loan

(10)

SOFR +

6.50

%,

1.00

% Floor

10.84

%

6/21/2029

18,182

17,735

18,261

1.5

%

Belmont Buyer, Inc.

First Lien Delayed Draw Term Loan

(10)

SOFR +

6.50

%,

1.00

% Floor

10.93

%

6/21/2029

4,316

4,207

4,334

0.3

%

Belmont Buyer, Inc.

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.25

%,

1.00

% Floor

9.88

%

1/26/2026

(29)

(63)

0.0

%

Belmont Buyer, Inc.

First Lien Revolving Loan

(9)(10)

SOFR +

6.50

%,

1.00

% Floor

10.95

%

6/21/2029

727

678

727

0.1

%

Chartis Group, LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.85

%

9/17/2031

 

8,224

 

8,147

 

8,146

 

0.7

%

Chartis Group, LLC

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.85

%

9/17/2026

 

 

(12)

 

(24)

 

0.0

%

Chartis Group, LLC

First Lien Revolving Loan

(9)

SOFR +

4.50

%,

0.75

% Floor

8.85

%

9/17/2031

(12)

(12)

0.0

%

Continental Buyer Inc.

First Lien Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.50

%

4/2/2031

20,738

20,442

20,448

1.6

%

Continental Buyer Inc.

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.25

%,

0.75

% Floor

9.50

%

4/2/2026

(55)

(114)

0.0

%

Continental Buyer Inc.

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

0.75

% Floor

9.50

%

4/2/2031

(41)

(43)

0.0

%

CORA Health Holdings Corp.

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.74

%

6/15/2027

 

14,300

 

14,204

 

13,201

 

1.1

%

CORA Health Holdings Corp.

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.74

%

6/15/2027

 

236

 

235

 

218

 

0.0

%

Covetrus, Inc.

 

First Lien Term Loan

(8)(10)

 

SOFR +

5.00

%,

0.50

% Floor

 

9.33

%

10/12/2029

 

8,258

 

7,887

 

7,965

 

0.6

%

Kwol Acquisition Inc

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.08

%

12/12/2029

 

2,403

 

2,397

 

2,395

 

0.2

%

Kwol Acquisition Inc

First Lien Revolving Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.08

%

12/12/2029

(1)

(1)

0.0

%

Giving Home Health Care

First Lien Term Loan

(10)

SOFR +

6.00

%,

1.00

% Floor

10.62

%

4/26/2029

48,125

48,036

47,778

3.8

%

MB2 Dental Solutions, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.86

%

2/13/2031

 

54,392

 

53,908

 

54,681

 

4.4

%

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

(9)(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.86

%

2/13/2031

 

2,289

 

2,267

 

2,349

 

0.2

%

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

10.02

%

2/13/2031

 

4,645

 

4,613

 

4,670

 

0.4

%

MB2 Dental Solutions, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.86

%

2/13/2031

 

 

(20)

 

 

0.0

%

Mirra-PrimeAccess Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

6.50

%,

1.00

% Floor

 

11.09

%

7/29/2026

 

24,188

 

23,998

 

19,664

 

1.6

%

Mirra-PrimeAccess Holdings, LLC

 

First Lien Revolving Loan

(9)(10)

 

SOFR +

6.50

%,

1.00

% Floor

 

11.09

%

7/29/2026

 

2,055

 

1,995

 

1,543

 

0.1

%

NextGen Healthcare

First Lien Term Loan

(10)

SOFR +

5.75

%,

0.75

% Floor

10.27

%

11/11/2030

9,172

9,051

9,146

0.7

%

NextGen Healthcare

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.75

%,

0.75

% Floor

10.27

%

11/10/2025

(15)

(7)

0.0

%

NextGen Healthcare

First Lien Revolving Loan

(9)

SOFR +

5.75

%,

0.75

% Floor

10.27

%

11/9/2029

(11)

(2)

0.0

%

One Call Corp

First Lien Term Loan

(8)(10)

SOFR +

5.50

%,

0.75

% Floor

10.39

%

4/22/2027

16,373

15,703

15,881

1.3

%

Project Ruby Ultimate Parent Corp.

Second Lien Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.72

%

3/12/2029

15,000

14,927

14,925

1.2

%

SpecialtyCare, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.60

%

6/19/2028

 

13,313

 

13,083

 

12,847

 

1.0

%

SpecialtyCare, Inc.

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.66

%

6/19/2028

 

104

 

103

 

100

 

0.0

%

SpecialtyCare, Inc.

 

First Lien Revolving Loan

(9)(10)

 

SOFR +

4.00

 

8.67

%

6/18/2026

 

616

 

607

 

579

 

0.0

%

Stepping Stones Healthcare Services, LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.08

%

1/2/2029

 

23,826

 

23,591

 

23,826

 

1.9

%

Stepping Stones Healthcare Services, LLC

 

First Lien Delayed Draw Term Loan

(9)(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.08

%

1/2/2029

 

697

 

644

 

696

 

0.1

%

Stepping Stones Healthcare Services, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.33

%

1/2/2029

 

5,348

 

5,300

 

5,348

 

0.4

%

Stepping Stones Healthcare Services, LLC

First Lien Revolving Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.08

%

12/29/2026

(21)

0.0

%

Trinity Partners Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%

12/21/2028

 

26,795

 

26,559

 

26,795

 

2.1

%

Trinity Partners Holdings, LLC

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%

6/21/2025

 

 

(66)

 

 

0.0

%

TST Intermediate Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.50

%,

1.00

% Floor

 

10.19

%

12/31/2028

 

15,885

 

15,826

 

15,647

 

1.3

%

TST Intermediate Holdings, LLC

 

First Lien Delayed Draw Term Loan

(9)(10)

 

SOFR +

5.50

%,

1.00

% Floor

 

10.19

%

12/31/2028

 

12,813

 

12,623

 

12,533

 

1.0

%

TST Intermediate Holdings, LLC

First Lien Revolving Loan

(9)

SOFR +

5.50

%,

1.00

% Floor

10.19

%

12/31/2028

(13)

(13)

0.0

%

Vital Care Buyer LLC

First Lien Term Loan

(10)

SOFR +

4.50

%,

0.75

% Floor

8.83

%

7/30/2031

6,626

6,561

6,563

0.5

%

Vital Care Buyer LLC

First Lien Revolving Loan

(9)

SOFR +

4.50

%,

0.75

% Floor

8.83

%

7/30/2031

(8)

(8)

0.0

%

Total Health Care Providers & Services

 

  

 

  

 

 

 

422,182

 

418,535

 

Health Care Technology

 

  

 

  

 

 

 

 

 

  

 

  

Ellkay, LLC

 

First Lien Term Loan

(10)

 

SOFR +

7.50

%,

1.00

% Floor

 

12.55

%  

9/14/2027

 

28,377

 

27,987

 

24,608

 

2.0

%

Ellkay, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

7.50

%,

1.00

% Floor

 

12.55

%  

9/14/2027

 

 

(28)

 

(288)

 

0.0

%

Homecare Software Solutions LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.55

%,

0.75

% Floor

 

9.93

%  

6/16/2031

 

11,782

 

11,672

 

11,670

 

0.9

%

Homecare Software Solutions LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.55

%,

0.75

% Floor

 

9.93

%  

6/16/2031

 

5,026

 

4,977

 

4,978

 

0.4

%

Homecare Software Solutions LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.55

%,

0.75

% Floor

 

9.93

%  

6/16/2031

 

4,376

 

4,335

 

4,335

 

0.3

%

Imagine Acquisitionco, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.59

%  

11/16/2027

 

28,071

 

27,857

 

28,071

 

2.2

%

Imagine Acquisitionco, LLC

First Lien Revolving Loan

(9)(10)

 

SOFR +

5.00

%,

1.00

% Floor

 

9.55

%  

11/16/2027

 

232

 

198

 

232

 

0.0

%

Total Health Care Technology

 

76,998

73,606

90

Table of Contents

    

    

    

    

    

Par

    

    

    

Percentage

 

Type of

Reference Rate

Interest

Amount /

of Net

 

Portfolio Company 1 2 3 4

Investment

    

Footnotes

    

and Spread

Rate

Maturity 5

Units

Cost 6

Fair Value

Assets 7

 

Insurance

 

 

  

 

  

 

 

 

 

 

  

Alkeme Intermediary Holdings, LLC

First Lien Term Loan

(10)

SOFR +

5.75

%,

1.00

% Floor

10.11

%  

10/28/2026

11,638

11,493

11,490

0.9

%

Alkeme Intermediary Holdings, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.75

%,

1.00

% Floor

10.11

%  

10/28/2026

10,822

10,597

10,526

0.8

%

Amerilife Holdings LLC

First Lien Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

9.70

%  

8/31/2029

68,480

67,880

68,179

5.4

%

Amerilife Holdings LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.00

%,

0.75

% Floor

9.70

%  

8/31/2029

4,476

4,374

4,435

0.4

%

Amerilife Holdings LLC

First Lien Delayed Draw Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

9.70

%  

8/31/2029

180

179

180

0.0

%

Amerilife Holdings LLC

First Lien Revolving Loan

(9)

SOFR +

5.00

%,

0.75

% Floor

9.70

%  

8/31/2028

(64)

(30)

0.0

%

AP Highlands Holdings, L.P.

 

Unsecured Note

 

N/A

 

9.25

%  

10/16/2028

 

4,965

 

4,918

 

4,915

 

0.4

%

AP Highlands Co-Invest, L.P.

 

Unsecured Note

 

N/A

 

9.25

%  

10/16/2028

 

3,035

 

3,007

 

3,005

 

0.2

%

Arden Insurance Services LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

1.00

% Floor

 

9.58

%  

11/27/2030

 

13,171

 

12,975

 

12,973

 

1.0

%

Arden Insurance Services LLC

 

First Lien Revolving Loan

(9)(10)

 

SOFR +

5.25

%,

1.00

% Floor

 

9.58

%  

11/27/2030

 

366

 

339

 

338

 

0.0

%

Ardonagh Finco B.V.

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.50

% Floor

 

9.90

%  

2/18/2031

 

4,410

 

4,350

 

4,428

 

0.4

%

ARMStrong Receivable Management

First Lien Term Loan

(10)

SOFR +

5.00

%,

1.00

% Floor

9.43

%  

10/5/2029

14,599

14,581

14,542

1.2

%

ARMStrong Receivable Management

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.00

%,

1.00

% Floor

9.69

%  

10/5/2029

392

390

387

0.0

%

ARMStrong Receivable Management

First Lien Revolving Loan

(9)

SOFR +

5.00

%,

1.00

% Floor

9.43

%  

10/5/2029

(1)

0.0

%

Babylon Buyer, Inc.

First Lien Term Loan

(10)

SOFR +

5.75

%,

0.75

% Floor

10.15

%  

3/8/2030

36,339

35,513

35,866

2.9

%

Babylon Buyer, Inc.

First Lien Revolving Loan

(10)

SOFR +

5.75

%,

0.75

% Floor

10.13

%  

3/8/2030

1,479

1,447

1,459

0.1

%

Captive Resources Midco, LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.11

%  

7/2/2029

 

30,945

 

30,529

 

30,945

 

2.5

%

Captive Resources Midco, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.11

%  

7/1/2028

 

 

(26)

 

 

0.0

%

Euclid Transactional, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

11.27

%  

10/2/2028

 

71,561

 

70,575

 

71,561

 

5.7

%

Foundation Risk Partners, Corp.

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.58

%  

10/29/2030

 

4,569

 

4,569

 

4,526

 

0.4

%

Foundation Risk Partners, Corp.

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.58

%  

10/29/2030

 

41,751

 

40,640

 

41,359

 

3.3

%

Foundation Risk Partners, Corp.

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.25

%,

0.75

% Floor

9.58

%  

10/29/2030

4,877

4,809

4,787

0.4

%

Foundation Risk Partners, Corp.

First Lien Delayed Draw Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.58

%  

10/29/2030

5,657

5,657

5,604

0.4

%

Foundation Risk Partners, Corp.

First Lien Delayed Draw Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.58

%  

10/29/2030

19,512

19,092

19,329

1.5

%

Foundation Risk Partners, Corp.

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

0.75

% Floor

9.58

%  

10/29/2029

(193)

(41)

0.0

%

Galway Borrower LLC

 

First Lien Term Loan

(10)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.83

%  

9/29/2028

 

33,977

 

33,656

 

34,032

 

2.7

%

Galway Borrower LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.83

%  

9/29/2028

 

17,826

 

17,474

 

17,697

 

1.4

%

Galway Borrower LLC

 

First Lien Delayed Draw Term Loan

(9)(10)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.82

%  

9/29/2028

 

194

 

161

 

120

 

0.0

%

Galway Borrower LLC

 

First Lien Revolving Loan

(9)(10)

 

SOFR +

4.50

%,

0.75

% Floor

 

8.82

%  

10/2/2028

 

253

 

244

 

253

 

0.0

%

OneDigital Borrower LLC

Second Lien Term Loan

(8)(10)

SOFR +

5.25

%,

0.50

% Floor

9.61

%  

7/2/2032

20,000

19,903

19,956

1.6

%

RSC Acquisition, Inc

 

First Lien Term Loan

(10)

 

SOFR +

4.75

%,

0.75

% Floor

 

9.34

%  

10/30/2029

 

5,940

 

5,940

 

5,912

 

0.5

%

RSC Acquisition, Inc

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.34

%  

10/30/2029

2,243

2,243

2,232

0.2

%

RSC Acquisition, Inc

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.08

%  

10/30/2029

4,297

4,298

4,277

0.3

%

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.26

%  

10/30/2029

21,358

21,358

21,257

1.7

%

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.26

%  

10/30/2029

15,911

15,911

15,836

1.3

%

THG Acquisition, LLC

First Lien Term Loan

(10)

SOFR +

4.75

%

9.11

%  

10/31/2031

26,229

25,969

25,967

2.1

%

THG Acquisition, LLC

First Lien Delayed Draw Term Loan

(9)

SOFR +

4.75

%

9.11

%  

10/31/2026

(29)

(58)

0.0

%

THG Acquisition, LLC

First Lien Revolving Loan

(9)(10)

SOFR +

4.75

%

9.11

%  

10/31/2031

217

189

188

0.0

%

Worldwide Insurance Network, LLC

First Lien Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

10.22

%  

5/28/2030

24,100

23,761

23,761

1.9

%

Worldwide Insurance Network, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.00

%,

0.75

% Floor

10.32

%  

5/28/2030

7,070

6,939

6,799

0.5

%

Total Insurance

525,648

528,991

IT Services

 

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Auctane Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

0.75

% Floor

 

10.94

%  

10/5/2028

 

38,900

 

38,417

 

38,398

 

3.1

%

Auctane Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

0.75

% Floor

 

10.94

%  

10/5/2028

 

12,764

 

12,605

 

12,599

 

1.0

%

Bottomline Technologies, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.61

%  

5/14/2029

 

76,421

 

75,327

 

75,650

 

6.0

%

Bottomline Technologies, Inc.

 

First Lien Revolving Loan

(9)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.61

%  

5/15/2028

 

 

(83)

 

(74)

 

0.0

%

DCert Buyer, Inc.

 

Second Lien Term Loan

(8)(10)

 

SOFR +

7.00

%

 

11.36

%  

2/19/2029

 

8,259

 

8,157

 

6,731

 

0.5

%

DS Admiral Bidco LLC

First Lien Term Loan

(8)(10)

SOFR +

4.25

%

8.61

%  

6/26/2031

4,988

4,789

4,863

0.4

%

Evergreen Services Group PIK Holdco, LLC

Unsecured Note

N/A

13.75

%  

4/7/2031

7,071

6,923

6,965

0.6

%

Evergreen Services Group PIK Holdco, LLC

 

Unsecured Note

 

N/A

 

13.75

%  

4/7/2031

 

3,883

 

3,800

 

3,825

 

0.3

%

Helpsystems Holdings, Inc.

 

Second Lien Term Loan

(10)

 

SOFR +

6.75

%,

0.75

% Floor

 

11.44

%  

11/19/2027

 

10,000

 

10,000

 

8,100

 

0.6

%

Lytx, Inc.

First Lien Term Loan

(10)

SOFR +

5.00

%,

1.00

% Floor

9.48

%  

2/28/2028

19,661

19,661

19,661

1.6

%

Ministry Brands Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%  

12/28/2028

 

17,170

 

17,061

 

16,966

 

1.4

%

Ministry Brands Holdings, LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%  

12/28/2028

 

1,736

 

1,730

 

1,716

 

0.1

%

Ministry Brands Holdings, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%  

12/30/2027

 

 

(8)

 

(20)

 

0.0

%

Total IT Services

 

  

 

  

 

198,379

 

195,380

 

91

Table of Contents

    

    

    

    

    

Par

    

    

    

Percentage

 

Type of

Reference Rate

Interest

Amount /

of Net

 

Portfolio Company 1 2 3 4

Investment

    

Footnotes

    

and Spread

Rate

Maturity 5

Units

Cost 6

Fair Value

Assets 7

 

Professional Services

Accordion Partners Holdings LLC

Unsecured Note

N/A

12.75

%

11/15/2034

15,244

14,944

14,939

1.2

%

Accordion Partners LLC

First Lien Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.58

%  

11/17/2031

32,723

32,504

32,396

2.6

%  

Accordion Partners LLC

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.58

%  

11/16/2026

 

(27)

 

(55)

 

0.0

%  

Accordion Partners LLC

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

0.75

% Floor

9.58

%  

11/17/2031

(24)

(36)

0.0

%  

ALKU Intermediate Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

6.25

%,

0.75

% Floor

 

10.50

%  

5/23/2029

3,649

 

3,576

3,665

 

0.3

%  

ALKU Intermediate Holdings, LLC

First Lien Term Loan

(10)

SOFR +

5.50

%,

0.50

% Floor

9.75

%  

5/23/2029

403

396

 

396

0.0

%  

Aprio Advisory Group, LLC

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.32

%  

8/1/2031

20,251

20,053

20,059

1.6

%  

Aprio Advisory Group, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

4.75

%,

0.75

% Floor

9.08

%  

8/1/2031

4,063

4,002

3,980

0.3

%  

Aprio Advisory Group, LLC

First Lien Revolving Loan

(9)(10)

SOFR +

4.75

%,

0.75

% Floor

9.32

%  

8/1/2031

1,409

1,367

1,367

0.1

%

Baker Tilly Advisory Group, L.P.

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

6/3/2031

18,134

17,876

17,871

1.4

%  

Baker Tilly Advisory Group, L.P.

First Lien Delayed Draw Term Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

6/3/2026

(23)

(40)

0.0

%  

Baker Tilly Advisory Group, L.P.

First Lien Revolving Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

6/3/2030

(53)

(54)

0.0

%  

BDO USA, P.C.

First Lien Term Loan

(10)

SOFR +

5.00

%,

2.00

% Floor

9.52

%  

8/31/2028

13,365

13,144

13,311

1.1

%  

Cherry Bekaert Advisory LLC

First Lien Term Loan

(10)

SOFR +

5.25

%,

0.75

% Floor

9.61

%  

6/30/2028

4,320

4,251

4,266

0.3

%

Cherry Bekaert Advisory LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.25

%,

0.75

% Floor

9.61

%  

6/30/2028

4,984

4,894

4,913

0.4

%

Explorer Investor, Inc

 

First Lien Term Loan

(10)

 

SOFR +

6.00

%,

0.50

% Floor

 

10.51

%  

6/28/2029

28,336

 

27,130

 

26,655

 

2.1

%  

IG Investments Holdings, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.57

%  

9/22/2028

47,083

 

46,543

 

46,782

 

3.7

%  

IG Investments Holdings, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.57

%  

9/22/2028

 

(51)

 

(22)

 

0.0

%  

KRIV Acquisition Inc.

First Lien Term Loan

(10)

SOFR +

5.75

%,

1.00

% Floor

10.11

%  

7/6/2029

13,837

13,837

13,833

1.1

%  

KRIV Acquisition Inc.

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.75

%,

1.00

% Floor

10.11

%  

9/25/2026

(118)

(7)

0.0

%  

KRIV Acquisition Inc.

First Lien Delayed Draw Term Loan

(10)

SOFR +

5.75

%,

1.00

% Floor

10.11

%  

7/6/2029

1,670

1,670

1,669

0.1

%  

MBO Partners, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

7.75

%,

1.00

% Floor

 

12.23

%  

5/23/2028

43,763

 

42,788

 

43,369

 

3.5

%  

MBO Partners, Inc.

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

7.75

%,

1.00

% Floor

 

12.56

%  

5/23/2028

12,300

 

12,174

 

12,189

 

1.0

%  

OMNIA Partners LLC

Second Lien Term Loan

(10)

SOFR +

5.00

%

9.62

%  

5/31/2032

10,000

9,952

10,157

0.8

%  

PAS Parent Inc.

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

12/29/2028

1,861

1,861

1,844

0.1

%

PAS Parent Inc.

First Lien Delayed Draw Term Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

6/26/2026

(24)

(52)

0.0

%

PAS Parent Inc.

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

12/29/2028

7,481

7,343

7,399

0.6

%  

PAS Parent Inc.

First Lien Revolving Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.11

%  

12/30/2027

(15)

(9)

0.0

%  

People 2.0, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

7.50

%,

1.00

% Floor

 

11.83

%  

7/12/2028

44,476

 

43,862

 

43,533

 

3.5

%  

Petra Borrower, LLC

First Lien Term Loan

(10)

SOFR +

5.75

%,

1.00

% Floor

10.32

%  

11/15/2030

15,845

15,492

15,646

1.3

%  

Petra Borrower, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.75

%,

1.00

% Floor

10.19

%  

11/15/2030

2,947

2,847

2,870

0.2

%  

Petra Borrower, LLC

First Lien Revolving Loan

(9)

SOFR +

5.75

%,

1.00

% Floor

10.32

%  

11/15/2029

(51)

(31)

0.0

%  

More Cowbell II LLC

First Lien Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

8.89

%  

9/2/2030

49,478

48,421

49,478

4.0

%  

More Cowbell II LLC

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.00

%,

0.75

% Floor

8.89

%  

9/1/2025

(23)

0.0

%  

More Cowbell II LLC

First Lien Revolving Loan

(9)(10)

SOFR +

5.00

%,

0.75

% Floor

9.26

%  

9/3/2029

2,831

2,693

2,831

0.2

%  

Williams Marston, LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.36

%  

8/25/2028

15,602

 

15,134

 

15,133

 

1.2

%  

Williams Marston, LLC

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.36

%  

8/25/2025

 

(32)

 

(77)

 

0.0

%  

Williams Marston, LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

5.75

%,

1.00

% Floor

 

10.36

%  

8/25/2028

 

(41)

 

(67)

 

0.0

%  

Total Professional Services

 

 

408,272

 

410,101

 

Real Estate Management & Development

 

 

  

 

  

 

 

 

 

  

 

Accuserve Solutions, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

1.00

% Floor

 

10.03

%  

3/15/2030

64,629

 

64,189

 

63,679

 

5.1

%  

Accuserve Solutions, Inc.

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.25

%,

1.00

% Floor

 

10.03

%  

3/16/2026

 

(9)

 

(72)

 

0.0

%  

Accuserve Solutions, Inc.

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

1.00

% Floor

10.03

%  

3/15/2030

(97)

0.0

%  

Freedom Mortgage Corp

Unsecured Note

(8)(11)

N/A

12.25

%  

10/1/2030

2,333

2,292

2,583

0.2

%  

Guardian Restoration Partners Buyers, LLC

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.75

% Floor

9.08

%  

11/3/2031

8,229

8,128

8,126

0.6

%  

Guardian Restoration Partners Buyers, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

4.75

%,

0.75

% Floor

10.02

%  

11/3/2031

4,632

4,526

4,461

0.4

%  

Guardian Restoration Partners Buyers, LLC

First Lien Revolving Loan

(9)

SOFR +

4.75

%,

0.75

% Floor

9.08

%  

11/3/2031

(25)

(26)

0.0

%  

Southpaw AP Buyer, LLC

First Lien Term Loan

(10)

SOFR +

5.25

%,

1.00

% Floor

9.99

%  

3/2/2028

10,679

10,545

10,610

0.8

%  

Southpaw AP Buyer, LLC

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.25

%,

1.00

% Floor

9.76

%  

3/2/2028

607

600

601

0.0

%  

Southpaw AP Buyer, LLC

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

1.00

% Floor

9.99

%  

3/2/2028

(12)

(6)

0.0

%  

Titan Home Improvement, LLC

First Lien Term Loan

(10)

SOFR +

5.75

%,

1.00

% Floor

10.26

%  

5/31/2030

24,497

24,037

24,031

1.9

%  

Titan Home Improvement, LLC

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.75

%,

1.00

% Floor

10.26

%  

6/2/2026

(42)

(87)

0.0

%  

Titan Home Improvement, LLC

First Lien Revolving Loan

(9)

SOFR +

5.75

%,

1.00

% Floor

10.26

%  

5/31/2030

(69)

(73)

0.0

%  

Total Real Estate Management & Development

 

 

 

114,160

 

113,730

 

Software

 

 

  

 

  

 

 

 

 

  

 

Anaplan Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.58

%  

6/21/2029

20,672

 

20,364

 

20,672

 

1.7

%  

Anaplan Inc.

 

First Lien Revolving Loan

(9)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.58

%  

6/21/2028

 

(18)

0.0

%  

92

Table of Contents

    

    

    

    

    

Par

    

    

    

    

    

Percentage

 

Type of

Reference Rate

Interest

Amount /

of Net

 

Portfolio Company 1 2 3 4

Investment

Footnotes

and Spread

Rate

Maturity 5

Units

Cost 6

Fair Value

Assets 7

 

Diligent Corporation

First Lien Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

10.09

%  

8/6/2030

45,568

45,422

45,249

3.6

%

Diligent Corporation

First Lien Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

10.09

%  

8/6/2030

7,812

7,471

7,757

0.6

%

Diligent Corporation

 

First Lien Delayed Draw Term Loan

(9)

 

SOFR +

5.00

%,

0.75

% Floor

 

10.09

%  

4/30/2026

 

 

 

(28)

 

 

(29)

 

0.0

%

Diligent Corporation

First Lien Revolving Loan

(9)

SOFR +

5.00

%,

0.75

% Floor

10.09

%  

8/6/2030

(55)

(42)

0.0

%

Eclipse Buyer, Inc.

First Lien Term Loan

(10)

SOFR +

4.75

%,

0.50

% Floor

9.26

%  

9/8/2031

12,590

12,469

12,474

1.0

%

Eclipse Buyer, Inc.

First Lien Delayed Draw Term Loan

(9)

SOFR +

4.75

%,

0.50

% Floor

9.26

%  

9/7/2026

(10)

(20)

0.0

%

Eclipse Buyer, Inc.

First Lien Revolving Loan

(9)

SOFR +

4.75

%,

0.50

% Floor

9.26

%  

9/8/2031

(10)

(10)

0.0

%

GovDelivery Holdings LLC

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

0.75

% Floor

 

10.34

%  

1/17/2031

 

15,682

 

 

15,547

 

 

15,682

 

1.3

%

GovDelivery Holdings LLC

 

First Lien Delayed Draw Term Loan

(10)

 

SOFR +

5.25

%,

0.75

% Floor

 

9.84

%  

1/17/2031

 

2,323

 

 

2,297

 

 

2,301

 

0.2

%

GovDelivery Holdings LLC

 

First Lien Revolving Loan

(9)

 

SOFR +

5.75

%,

0.75

% Floor

 

10.34

%  

1/17/2031

 

 

 

(19)

 

 

 

0.0

%

GS Acquisitionco, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.25

%,

1.00

% Floor

 

9.58

%  

5/25/2028

 

39,247

 

 

39,131

 

 

39,247

 

3.1

%

GS Acquisitionco, Inc.

First Lien Delayed Draw Term Loan

(9)(10)

SOFR +

5.25

%,

1.00

% Floor

9.58

%  

5/25/2028

316

310

316

0.0

%

GS Acquisitionco, Inc.

First Lien Revolving Loan

(9)

SOFR +

5.25

%,

1.00

% Floor

9.58

%  

5/25/2028

(4)

0.0

%

Hyland Software, Inc

First Lien Term Loan

(10)

SOFR +

6.00

%,

0.75

% Floor

 

10.36

%  

9/19/2030

 

25,048

 

 

24,723

 

 

24,980

 

2.0

%

Hyland Software, Inc

First Lien Revolving Loan

(9)

SOFR +

6.00

%,

0.75

% Floor

 

10.36

%  

9/19/2029

 

 

 

(14)

 

 

(3)

 

0.0

%

Mandolin Technology Intermediate Holdings, Inc.

 

Second Lien Term Loan

(10)

 

SOFR +

6.50

%,

1.00

% Floor

 

10.98

%  

7/30/2029

 

17,500

 

 

17,374

 

 

14,012

 

1.1

%

Maverick 1 LLC

 

Second Lien Term Loan

(10)

 

SOFR +

6.75

%,

0.75

% Floor

 

11.49

%  

5/18/2029

 

9,000

 

 

8,968

 

 

8,739

 

0.7

%

oneZero Financial Systems, LLC

First Lien Term Loan

(10)

SOFR +

5.00

%,

0.75

% Floor

9.59

%  

10/7/2031

26,923

26,658

26,654

2.1

%

oneZero Financial Systems, LLC

First Lien Delayed Draw Term Loan

(9)

SOFR +

5.00

%,

0.75

% Floor

9.59

%  

10/7/2026

(23)

(47)

0.0

%

oneZero Financial Systems, LLC

First Lien Revolving Loan

(9)

SOFR +

5.00

%,

0.75

% Floor

9.59

%  

10/7/2031

(33)

(34)

0.0

%

Orion Advisor Solutions, Inc.

 

Second Lien Term Loan

(10)

 

SOFR +

7.50

%,

1.00

% Floor

 

12.09

%  

9/24/2028

 

16,623

 

 

16,535

 

 

16,573

 

1.3

%

Orion Advisor Solutions, Inc.

Second Lien Delayed Draw Term Loan

(9)(10)

SOFR +

7.50

%,

1.00

% Floor

12.09

%  

9/24/2028

3,413

3,383

3,383

0.3

%

Simplifi Holdings, Inc.

 

First Lien Term Loan

(10)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%  

10/1/2027

 

26,295

 

 

26,003

 

 

26,295

 

2.1

%

Simplifi Holdings, Inc.

 

First Lien Revolving Loan

(9)

 

SOFR +

5.50

%,

0.75

% Floor

 

9.96

%  

10/1/2027

 

 

 

(20)

 

 

 

0.0

%

Syntax Systems Limited

 

First Lien Term Loan

(10)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.58

%  

10/30/2028

 

541

 

 

536

 

 

542

 

0.0

%

Syntax Systems Limited

 

First Lien Term Loan

(10)

 

SOFR +

5.00

%,

0.75

% Floor

 

9.46

%  

10/30/2028

 

10,480

 

 

10,417

 

 

10,480

 

0.8

%

Tamarack Intermediate, L.L.C.

 

First Lien Term Loan

(10)

 

SOFR +

5.75

%,

0.75

% Floor

 

10.30

%  

3/13/2028

 

20,947

 

 

20,698

 

 

20,700

 

1.7

%

Tamarack Intermediate, L.L.C.

 

First Lien Revolving Loan

(9)

 

SOFR +

5.75

%,

0.75

% Floor

 

10.30

%  

3/13/2028

 

 

 

(37)

 

 

(41)

 

0.0

%

Total Software

 

 

  

 

  

 

 

298,035

 

 

295,830

 

Total Debt Investments

 

 

  

 

  

 

2,455,621

 

2,452,129

 

93

Table of Contents

    

    

    

    

Par 

    

    

    

Percentage 

    

Type of

Interest 

Amount 

of Net 

Portfolio Company 1 2 3

 Investment

Rate

Acquisition Date

/ Units

Cost 4

Fair Value

Assets 5

Preferred Equity - 2.9%

  

  

  

Health Care Technology

Imagine Acquisitionco, LLC

 

Preferred Equity

 

N/A

 

11/16/2021

 

2,000

 

2,000

 

3,140

 

0.3

%  

Total Health Care Technology

 

 

  

 

  

 

2,000

 

3,140

 

Insurance

Galway Borrower, LLC

Preferred Equity

14.00

%

4/28/2023

12,601

12,370

12,679

1.0

%  

RSC Topco, Inc.

Preferred Equity

13.25

%

8/14/2023

6,004

5,873

5,968

0.5

%  

Total Insurance

18,243

18,647

Software

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Eclipse Buyer, Inc.

Preferred Equity

12.50

%  

9/6/2024

3,490

3,422

3,423

0.3

%  

GT Polaris Holdings, Inc

 

Preferred Equity

 

12.50

%  

6/6/2022

 

11,304

 

11,168

11,016

 

0.9

%  

Total Software

 

 

  

  

 

14,590

14,439

 

Total Preferred Equity Investments

34,833

36,226

Common Equity and Warrants - 1.3%

Capital Markets

Resolute Investment Managers, Inc.

Equity

 

N/A

12/29/2023

 

55

 

1,236

1,276

 

0.1

%  

Total Capital Markets

1,236

1,276

 

 

  

  

 

Health Care Providers & Services

New Giving Acquisition, Inc.

Equity

N/A

8/19/2022

2

998

0.1

%  

Total Health Care Providers & Services

998

Professional Services

THL Fund IX Investors (Plymouth), L.P.12

Equity

N/A

9/1/2023

3,732

3,732

4,191

0.3

%  

Total Professional Services

3,732

4,191

Real Estate Management & Development

ACC Ultimate Holdings, L.P.

Equity

N/A

5/8/2024

375

3,750

3,750

0.3

%  

Total Real Estate Management & Development

3,750

3,750

Software

Spirit RR Holdings, Inc.

Equity

 

N/A

 

9/19/2022

 

3,586

 

3,635

 

5,672

 

0.5

%  

Total Software

 

  

 

  

 

3,635

 

5,672

 

Total Common Equity and Warrants Investments

12,353

15,887

Total Non-Controlled/Non-Affiliated Investments

 

  

 

  

 

$

2,502,807

$

2,504,242

(1)All of the Company’s investments are domiciled in the United States except for Ardonagh Finco B.V., New Mountain Guardian, and Syntax Systems Limited, which are domiciled in the United Kingdom, Bermuda, and Canada, respectively.
(2)Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of ASC 820 fair value hierarchy.
(3)All investments were qualifying assets as defined under Section 55(a) of the Investment Company Act of 1940 except for Ardonagh Finco B.V., New Mountain Guardian, Syntax Systems Limited, Exeter Short Term Funding LLC, and ALP CFO 2024, L.P.
(4)As of December 31, 2024, all investments are pledged as collateral unless otherwise stated.
(5)The date disclosed represents the expiration of the commitment period of the unfunded term loan. Upon expiration of the commitment period, the funded portion of the term loan may be subject to a longer maturity date.
(6)Cost represents the original cost adjusted for amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.
(7)Percentage is based on net assets of $1,251,497 as of December 31, 2024.
(8)Represents securities categorized as Level 2 assets under the definition of ASC 820 fair value hierarchy.
(9)This investment has an unfunded commitment as of December 31, 2024. For further details, see Note 5. Fair value includes an analysis of the unfunded commitment.
(10)The interest rate on this security is subject to the Secured Overnight Financing Rate, which at December 31, 2024 was 4.49%.
(11)Securities are exempt from registration under Rule 144A of the Securities Act of 1933. These securities represent a fair value of $3,435 or 0.3% of net assets as of December 31, 2024 and are considered restricted.
(12)Investment measured at net asset value (“NAV”).

The accompanying notes are an integral part of these consolidated financial statements.

94

Table of Contents

Stone Point Credit Corporation

Consolidated Schedule of Investments

As of December 31, 2023

(in thousands)

    

    

    

    

    

Par 

    

    

    

Percentage 

 

Type of 

Reference Rate 

Interest 

Amount / 

 

of Net 

 

Portfolio Company 1 2 3 4

Investment

and Spread

Rate

Maturity 5

Units

Cost 6

Fair Value

Assets 7

 

Non-Controlled/Non-Affiliated Investments

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Debt Investments – 198.0%

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Capital Markets

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Project K BuyerCo, Inc.

 

First Lien Term Loan

 

SOFR +

6.00

%,

0.75

% Floor 10

 

11.46

%  

12/10/2027

 

75,727

$

74,643

$

75,864

 

7.7

%

Project K BuyerCo, Inc.

 

First Lien Revolving Loan

 

SOFR +

6.00

%,

0.75

% Floor 9

 

11.46

%  

12/10/2027

 

-

 

(102)

 

14

 

0.0

%

Project K BuyerCo, Inc.

 

Unsecured Note

 

N/A

 

10.00

%  

12/11/2028

 

13,813

 

13,059

 

12,531

 

1.3

%

Resolute Investment Managers, Inc.

 

First Lien Term Loan

 

SOFR +

6.50

%,

1.00

% Floor 10

 

12.11

%  

4/30/2027

 

3,403

 

3,403

 

3,403

 

0.3

%

Total Capital Markets

 

 

 

  

 

  

 

91,003

 

91,812

 

Diversified Consumer Services

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Harbor Purchaser, Inc.

 

Second Lien Term Loan

 

SOFR +

8.50

%,

0.50

% Floor 10

 

13.86

%  

4/8/2030

 

12,500

 

12,280

 

11,838

 

1.2

%

Total Diversified Consumer Services

 

 

 

  

 

  

 

12,280

 

11,838

 

Financial Services

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Advisor Group Holdings, Inc. 8 11

 

Unsecured Note

 

N/A

 

10.75

%  

8/1/2027

 

826

803

836

 

0.1

%

Beacon Pointe Harmony, LLC

 

First Lien Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

10.86

%

12/29/2028

 

28,493

 

28,047

 

28,493

 

2.9

%

Beacon Pointe Harmony, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

10.86

%

12/29/2028

 

11,175

 

10,894

 

11,175

 

1.1

%

Beacon Pointe Harmony, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.50

%,

0.75

% Floor 9 10

 

10.86

%

12/29/2028

3,207

3,177

3,207

0.3

%

Beacon Pointe Harmony, LLC

 

First Lien Revolving Loan

 

SOFR +

5.50

%,

0.75

% Floor 9

10.86

%

12/29/2027

 

 

(40)

 

 

0.0

%

Cliffwater, LLC

First Lien Term Loan

SOFR +

6.00

%,

0.75

% Floor 10

11.36

%

10/7/2030

17,143

16,808

16,800

1.7

%

Cliffwater, LLC

First Lien Revolving Loan

SOFR +

6.00

%,

0.75

% Floor 9

11.36

%

10/7/2030

(55)

(57)

0.0

%

Edelman Financial Center 8

 

Second Lien Term Loan

 

SOFR +

6.75

% 10

12.22

%

7/20/2026

 

5,121

 

4,820

 

5,131

 

0.5

%

GC Two Intermediate Holdings, Inc. 8 11

 

Unsecured Note

 

N/A

7.50

%

4/1/2029

 

11,721

 

10,042

 

10,549

 

1.1

%

Ivy Hill Asset Management, L.P.

Unsecured Note

N/A

9.00

%

6/29/2028

4,300

4,300

4,300

0.4

%

Millennium Trust Co., LLC 8

First Lien Term Loan

SOFR +

4.75

%,

0.75

% Floor 10

10.21

%

3/27/2026

3,928

3,847

3,934

0.4

%

More Cowbell II LLC

First Lien Term Loan

SOFR +

6.25

%,

0.75

% Floor 10

11.73

%

9/2/2030

49,978

48,774

49,350

5.0

%

More Cowbell II LLC

First Lien Delayed Draw Term Loan

SOFR +

6.25

%,

0.75

% Floor 9

11.73

%

9/1/2025

(57)

(68)

0.0

%

More Cowbell II LLC

First Lien Revolving Loan

SOFR +

6.25

%,

0.75

% Floor 9 10

11.64

%

9/3/2029

1,307

1,140

1,218

0.1

%

Petra Borrower, LLC

First Lien Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

11.13

%

11/15/2030

17,875

17,431

17,428

1.8

%

Petra Borrower, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 9

11.13

%

5/15/2025

(85)

(172)

0.0

%

Petra Borrower, LLC

First Lien Revolving Loan

SOFR +

5.75

%,

1.00

% Floor 9

11.13

%

11/15/2029

(67)

(69)

0.0

%

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

11.23

%

10/4/2027

21,964

21,840

21,778

2.2

%

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

11.23

%

10/4/2027

2,455

2,426

2,434

0.2

%

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

11.23

%

10/4/2027

2,460

2,398

2,439

0.2

%

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 9 10

11.23

%

10/4/2027

21,937

21,897

21,717

2.2

%

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

SOFR +

5.75

%,

1.00

% Floor 9

11.23

%

10/4/2027

1,500

(13)

0.0

%

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

SOFR +

5.75

%,

1.00

% Floor 9

11.23

%

10/4/2027

(1,500)

(1)

(4)

0.0

%

TA/WEG Intermediate Holdings, LLC

Unsecured Note

N/A

15.00

%

5/26/2033

11,591

11,266

11,283

1.1

%

Total Financial Services

209,605

211,689

95

Table of Contents

    

    

    

    

    

Par 

    

    

    

Percentage 

 

 

Type of 

 

Reference Rate 

 

Interest 

 

Amount / 

 

Fair 

 

of Net 

Portfolio Company 1 2 3 4

 

Investment

 

and Spread

 

Rate

 

Maturity

 

Units

 

Cost 4

 

Value

 

Assets 7

Health Care Providers & Services

 

  

 

  

 

  

 

  

 

  

  

  

 

  

Belmont Buyer, Inc.

First Lien Term Loan

SOFR +

6.50

%,

1.00

% Floor 10

11.97

%

6/21/2029

18,367

17,848

18,222

1.8

%

Belmont Buyer, Inc.

First Lien Delayed Draw Term Loan

SOFR +

6.50

%,

1.00

% Floor 9 10

11.97

%

6/21/2029

1,735

1,650

1,701

0.2

%

Belmont Buyer, Inc.

First Lien Revolving Loan

SOFR +

6.50

%,

1.00

% Floor 9

11.97

%

6/21/2029

(60)

(17)

0.0

%

CNSI Holdings, LLC

 

First Lien Term Loan

 

SOFR +

6.50

%,

0.50

% Floor 10

 

11.85

%

12/15/2028

 

15,008

14,595

14,718

 

1.5

%

CNSI Holdings, LLC

 

First Lien Revolving Loan

 

SOFR +

6.50

%,

0.50

% Floor 9 10

 

11.85

%

12/17/2027

 

528

489

500

 

0.1

%

CORA Health Holdings Corp.

 

First Lien Term Loan

 

SOFR +

5.75

%,

1.00

% Floor 10

 

11.39

%

6/15/2027

 

14,219

 

14,084

 

12,258

 

1.2

%

CORA Health Holdings Corp.

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.75

%,

1.00

% Floor 10

 

11.39

%

6/15/2027

 

238

237

205

 

0.0

%

Giving Home Health Care

 

First Lien Term Loan

 

SOFR +

6.50

%,

1.00

% Floor 10

 

11.95

%

8/19/2027

 

32,480

32,627

32,805

 

3.3

%

Giving Home Health Care

 

First Lien Revolving Loan

 

SOFR +

6.50

%,

1.00

% Floor 9

 

11.95

%

8/19/2027

 

 

0.0

%

Giving Home Health Care

 

Second Lien Term Loan

 

N/A

 

12.50

%

2/18/2028

 

4,500

4,433

4,499

 

0.5

%

Kwol Acquisition Inc

 

First Lien Term Loan

 

SOFR +

6.25

%,

0.75

% Floor 10

 

11.43

%

12/12/2029

 

2,421

2,361

2,361

 

0.2

%

Kwol Acquisition Inc

 

First Lien Revolving Loan

 

SOFR +

6.25

%,

0.75

% Floor 9 10

 

11.43

%

12/12/2029

 

99

90

90

 

0.0

%

MB2 Dental Solutions, LLC

 

First Lien Term Loan

 

SOFR +

6.00

%,

1.00

% Floor 10

 

11.46

%

1/29/2027

 

10,729

10,584

10,523

 

1.1

%

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

6.00

%,

1.00

% Floor 10

 

11.46

%

1/29/2027

 

3,869

3,848

3,794

 

0.4

%

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

6.00

%,

1.00

% Floor 10

 

11.46

%

1/29/2027

 

26,497

26,151

25,988

 

2.6

%

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

6.00

%,

1.00

% Floor 10

 

11.46

%

1/29/2027

 

4,948

4,872

4,853

 

0.5

%

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

6.50

%,

1.00

% Floor 9 10

 

11.96

%

1/29/2027

 

6,774

6,526

6,713

 

0.7

%

Mirra-PrimeAccess Holdings, LLC

 

First Lien Term Loan

 

SOFR +

6.50

%,

1.00

% Floor 10

 

11.97

%

7/29/2026

 

24,438

24,151

24,229

 

2.4

%

Mirra-PrimeAccess Holdings, LLC

 

First Lien Revolving Loan

 

SOFR +

6.50

%,

1.00

% Floor 9 10

 

11.97

%

7/29/2026

 

685

625

662

 

0.1

%

NextGen Healthcare

 

First Lien Term Loan

 

SOFR +

6.00

%,

0.75

% Floor 10

 

11.37

%

11/11/2030

 

9,241

9,105

9,103

 

0.9

%

NextGen Healthcare

 

First Lien Delayed Draw Term Loan

 

SOFR +

6.00

%,

0.75

% Floor 9

 

11.37

%

11/10/2025

 

(17)

(36)

 

0.0

%

NextGen Healthcare

 

First Lien Revolving Loan

 

SOFR +

6.00

%,

0.75

% Floor 9

 

11.37

%

11/9/2029

 

(13)

(13)

 

0.0

%

SpecialtyCare, Inc.

First Lien Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

11.41

%

6/19/2028

13,451

13,166

12,336

1.2

%

SpecialtyCare, Inc.

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

11.41

%

6/19/2028

105

104

96

0.0

%

SpecialtyCare, Inc.

First Lien Revolving Loan

SOFR +

4.00

% 9 10

9.46

%

6/18/2026

149

133

61

0.0

%

Stepping Stones Healthcare Services, LLC

First Lien Term Loan

SOFR +

5.75

%,

0.75

% Floor 10

11.20

%

1/2/2029

24,071

23,792

23,558

2.4

%

Stepping Stones Healthcare Services, LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

0.75

% Floor 9 10

11.20

%

1/2/2029

5,402

5,330

5,254

0.5

%

Stepping Stones Healthcare Services, LLC

 

First Lien Revolving Loan

 

SOFR +

5.75

%,

0.75

% Floor 9

 

11.20

%

12/29/2026

 

(31)

(75)

 

0.0

%

Trinity Partners Holdings LLC

 

First Lien Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

11.03

%

12/21/2028

 

27,071

26,722

27,071

 

2.7

%

Trinity Partners Holdings LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 9

 

11.03

%

6/21/2025

 

(44)

 

0.0

%

TST Intermediate Holdings, LLC

 

First Lien Term Loan

SOFR +

5.75

%,

1.00

% Floor 10

 

11.03

%

11/27/2026

 

12,231

12,114

11,902

 

1.2

%

TST Intermediate Holdings, LLC

 

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

1.00

% Floor 9 10

 

11.20

%

11/27/2026

 

6,674

6,647

6,339

 

0.6

%

Total Health Care Providers & Services

 

 

 

262,119

259,700

 

 

 

 

 

 

Health Care Technology

 

 

 

 

 

Ellkay, LLC

First Lien Term Loan

SOFR +

6.25

%,

1.00

% Floor 10

11.78

%

9/14/2027

28,239

27,865

23,496

2.4

%

Ellkay, LLC

First Lien Revolving Loan

SOFR +

6.25

%,

1.00

% Floor 9

11.78

%

9/14/2027

(45)

(606)

(0.1)

%

96

Table of Contents

    

    

    

    

    

Par 

    

    

    

Percentage 

 

Type of 

Reference Rate 

Interest 

Amount / 

of Net 

 

Portfolio Company 1 2 3 4

Investment

and Spread

Rate

Maturity

Units

Cost 6

Fair Value

Assets 7

 

FINThrive Software Intermediate Holdings, Inc.

 

Second Lien Term Loan

 

SOFR +

6.75

%,

0.50

% Floor 10

 

12.22

%  

12/17/2029

 

21,519

 

21,118

 

17,011

 

1.7

%

GraphPAD Software, LLC

 

First Lien Term Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

11.22

%  

4/27/2027

 

4,090

 

4,063

 

4,031

 

0.4

%

GraphPAD Software, LLC

 

First Lien Term Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

11.22

%  

4/27/2027

 

19,600

 

19,468

 

19,318

 

1.9

%

GraphPAD Software, LLC

 

First Lien Term Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

11.19

%  

4/27/2027

 

17,063

 

16,964

 

16,817

 

1.7

%

GraphPAD Software, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

11.19

%  

4/27/2027

 

11,000

 

10,931

 

10,841

 

1.1

%

GraphPAD Software, LLC

 

First Lien Revolving Loan

 

ABR+

5.00

%,

1.00

% Floor 9 12

 

13.50

%  

4/27/2027

 

1,250

 

1,236

 

1,214

 

0.1

%

Imagine Acquisitionco, LLC

 

First Lien Term Loan

 

SOFR +

5.25

%,

1.00

% Floor 10

 

10.74

%  

11/16/2027

 

28,360

 

28,074

 

28,360

 

2.9

%

Imagine Acquisitionco, LLC

 

First Lien Revolving Loan

 

SOFR +

5.25

%,

1.00

% Floor 9

 

10.74

%  

11/16/2027

 

 

(45)

 

 

0.0

%

Total Health Care Technology

 

 

 

  

 

  

 

129,629

 

120,482

 

97

Table of Contents

    

    

    

    

    

Par 

    

    

    

Percentage of 

 

Type of 

Reference Rate 

Interest 

Amount /

Net 

 

Portfolio Company 1 2 3 4

Investment

and Spread

Rate

Maturity

 Units

Cost 6

Fair Value

Assets 7

 

Insurance

Accuserve

First Lien Term Loan

SOFR +

7.38

% 10

12.80

%

8/13/2029

27,310

26,708

27,006

2.7

%

Accuserve

First Lien Delayed Draw Term Loan

SOFR +

7.38

% 9

12.80

%

8/13/2024

(32)

(30)

0.0

%

AmeriLife Group LLC

 

First Lien Term Loan

SOFR +

5.75

%,

0.75

% Floor 10

11.14

%

8/31/2029

41,760

41,053

41,038

4.1

%

AmeriLife Group LLC

 

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

0.75

% Floor 9 10

11.14

%

8/31/2029

8,703

8,534

8,521

0.9

%

AmeriLife Group LLC

 

First Lien Revolving Loan

SOFR +

5.75

%,

0.75

% Floor 9

11.14

%

8/31/2028

(82)

(91)

0.0

%

ARMStrong Receivable Management

First Lien Term Loan

SOFR +

6.25

%,

1.00

% Floor 10

11.70

%

10/5/2029

14,746

14,530

14,525

1.5

%

ARMStrong Receivable Management

First Lien Delayed Draw Term Loan

SOFR +

6.25

%,

1.00

% Floor 9

11.70

%

10/6/2025

(36)

(74)

0.0

%

ARMStrong Receivable Management

First Lien Revolving Loan

SOFR +

6.25

%,

1.00

% Floor 9

11.70

%

10/5/2029

(4)

(4)

0.0

%

Captive Resources Midco, LLC

 

First Lien Term Loan

 

SOFR +

5.25

%,

0.75

% Floor 10

 

11.11

%

6/29/2029

 

31,030

 

30,539

 

30,720

 

3.1

%

Captive Resources Midco, LLC

 

First Lien Revolving Loan

 

SOFR +

5.25

%,

0.75

% Floor 9

 

11.11

%

7/1/2028

 

 

(33)

 

(22)

 

0.0

%

Euclid Transactional, LLC

 

First Lien Term Loan

 

SOFR +

6.80

% 10

 

12.27

%

10/2/2028

 

71,741

 

70,556

 

71,748

 

7.2

%

Foundation Risk Partners, Corp.

First Lien Term Loan

SOFR +

6.75

%,

0.75

% Floor 10

12.20

%

10/27/2028

38,669

37,342

39,029

3.9

%

Foundation Risk Partners, Corp.

First Lien Delayed Draw Term Loan

SOFR +

6.75

%,

0.75

% Floor 10

12.20

%

10/27/2028

18,072

17,937

18,240

1.8

%

Galway Borrower, LLC

 

First Lien Term Loan

 

SOFR +

5.75

%,

0.75

% Floor 10

 

11.10

%

9/29/2028

 

13,930

 

13,674

 

13,884

 

1.4

%

Galway Borrower, LLC

 

First Lien Term Loan

 

SOFR +

5.25

%,

0.75

% Floor 10

 

10.70

%

9/29/2028

 

64,368

 

63,851

 

62,939

 

6.3

%

Galway Borrower, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.75

%,

0.75

% Floor 9

 

11.10

%

10/28/2024

 

 

(186)

 

(69)

 

0.0

%

Galway Borrower, LLC

First Lien Revolving Loan

SOFR +

5.25

%,

0.75

% Floor 9

10.70

%

10/2/2028

(33)

(91)

0.0

%

Harrington Reinsurance Holdings Limited 11

 

Unsecured Note

 

N/A

 

7.25

%

6/29/2031

 

20,000

 

19,674

 

20,219

 

2.0

%

Neptune Flood Incorporated

First Lien Term Loan

SOFR +

6.25

%,

1.00

% Floor 10

11.72

%

5/8/2029

13,425

13,193

13,276

1.3

%

Neptune Flood Incorporated

 

First Lien Revolving Loan

 

SOFR +

6.25

%,

1.00

% Floor 9

 

11.72

%

5/8/2029

 

 

(12)

 

(8)

 

0.0

%

NFP Corp. 8 11

 

Unsecured Note

 

N/A

 

6.88

%

8/15/2028

 

5,639

 

4,766

 

5,743

 

0.6

%

OneDigital Borrower LLC

First Lien Term Loan

SOFR +

6.00

%,

0.50

% Floor 10

11.36

%

11/16/2027

18,599

18,432

18,404

1.9

%

OneDigital Borrower LLC

First Lien Delayed Draw Term Loan

SOFR +

6.00

%,

0.50

% Floor 9

11.36

%

9/16/2024

(144)

(103)

0.0

%

RSC Acquisition, Inc

First Lien Term Loan

SOFR +

5.50

%,

0.75

% Floor 10

11.03

%

11/1/2029

4,115

4,074

3,993

0.4

%

RSC Acquisition, Inc

First Lien Term Loan

SOFR +

5.50

%,

0.75

% Floor 10

11.03

%

11/1/2029

1,553

1,538

1,507

0.2

%

RSC Acquisition, Inc

First Lien Term Loan

SOFR +

5.50

%,

0.75

% Floor 10

11.00

%

11/1/2029

2,976

2,947

2,888

0.3

%

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

SOFR +

5.50

%,

0.75

% Floor 10

11.04

%

11/1/2029

32,705

32,705

31,740

3.2

%

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

SOFR +

5.50

%,

0.75

% Floor 10

11.04

%

11/1/2029

2,328

2,305

2,259

0.2

%

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

SOFR +

6.00

%,

0.75

% Floor 10

11.43

%

11/1/2029

3,000

2,993

2,956

0.3

%

RSC Acquisition, Inc

 

First Lien Delayed Draw Term Loan

 

SOFR +

6.00

%,

0.75

% Floor 9 10

 

11.43

%

11/1/2029

 

1,337

 

958

 

1,033

 

0.1

%

Total Insurance

 

 

 

  

 

  

 

427,747

 

431,176

 

IT Services

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Auctane Holdings, LLC

 

First Lien Term Loan

 

SOFR +

5.75

%,

0.75

% Floor 10

 

11.23

%

10/5/2028

 

39,300

 

38,698

 

38,702

 

3.9

%

Auctane Holdings, LLC

 

First Lien Term Loan

 

SOFR +

5.75

%,

0.75

% Floor 10

 

11.23

%

10/5/2028

 

12,895

 

12,697

 

12,699

 

1.3

%

Bottomline Technologies, Inc.

 

First Lien Term Loan

 

SOFR +

5.25

%,

0.75

% Floor 10

 

10.61

%

5/14/2029

 

87,280

 

85,823

 

84,216

 

8.5

%

Bottomline Technologies, Inc.

 

First Lien Revolving Loan

 

SOFR +

5.25

%,

0.75

% Floor 9

 

10.61

%

5/15/2028

 

 

(107)

 

(259)

 

0.0

%

Dcert Buyer, Inc. 8

Second Lien Term Loan

SOFR +

7.00

% 10

12.36

%

2/19/2029

10,203

10,077

9,335

0.9

%

Ensono, Inc.

 

Second Lien Term Loan

 

SOFR +

8.00

% 10

 

13.47

%  

5/28/2029

 

11,250

 

11,164

 

10,703

 

1.1

%

Helpsystems Holdings, Inc.

 

Second Lien Term Loan

 

SOFR +

6.75

%,

0.75

% Floor 10

 

12.35

%  

11/19/2027

 

10,000

 

10,000

 

9,191

 

0.9

%

Ministry Brands Purchaser, LLC

 

First Lien Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

10.96

%  

12/28/2028

 

17,346

 

17,212

 

16,722

 

1.7

%

Ministry Brands Purchaser, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

10.96

%  

12/28/2028

 

1,754

 

1,745

 

1,691

 

0.2

%

Ministry Brands Purchaser, LLC

 

First Lien Revolving Loan

 

SOFR +

5.50

%,

0.75

% Floor 9 10

 

10.96

%  

12/30/2027

 

904

 

893

 

843

 

0.1

%

Neptune BidCo US, Inc.

 

Second Lien Term Loan

 

SOFR +

9.75

%,

0.75

% Floor 10

 

15.26

%  

10/11/2029

 

12,500

 

12,164

 

12,165

 

1.2

%

Vision Solutions, Inc.

 

Second Lien Term Loan

 

SOFR +

7.25

%,

0.75

% Floor 10

 

12.89

%  

4/23/2029

 

30,000

 

29,776

 

27,405

 

2.8

%

98

Table of Contents

    

    

    

    

    

Par 

    

    

    

Percentage 

 

Type of 

Reference Rate 

Interest 

Amount /

of Net 

 

Portfolio Company 1 2 3 4

Investment

and Spread

Rate

Maturity

 Units

Cost 6

Fair Value

Assets 7

 

WWEX Uni Topco Holdings, LLC

Second Lien Term Loan

SOFR +

7.00

%,

0.75

% Floor 10

12.61

%

7/26/2029

20,000

19,489

18,272

1.8

%

Total IT Services

 

 

 

  

 

  

 

249,631

241,685

 

Professional Services

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Accordion Partners LLC

First Lien Term Loan

SOFR +

6.00

%,

0.75

% Floor 10

11.35

%

8/29/2029

23,057

22,606

22,455

2.3

%

Accordion Partners LLC

First Lien Term Loan

SOFR +

6.25

%,

0.75

% Floor 10

11.63

%

8/29/2029

2,024

1,967

2,015

0.2

%

Accordion Partners LLC

First Lien Delayed Draw Term Loan

SOFR +

6.00

%,

0.75

% Floor 10

11.38

%

8/31/2028

2,536

2,484

2,470

0.2

%

Accordion Partners LLC

First Lien Delayed Draw Term Loan

SOFR +

6.25

%,

0.75

% Floor 10

11.60

%

8/29/2029

2,024

1,970

2,015

0.2

%

Accordion Partners LLC

First Lien Delayed Draw Term Loan

SOFR +

6.25

%,

0.75

% Floor 9 10

11.63

%

8/31/2028

976

896

964

0.1

%

Accordion Partners LLC

First Lien Revolving Loan

SOFR +

6.00

%,

0.75

% Floor 9

11.38

%

8/31/2028

(36)

(8)

0.0

%

ALKU Intermediate Holdings, LLC

First Lien Term Loan

SOFR +

6.25

%,

0.75

% Floor 10

11.61

%

5/23/2029

3,686

3,600

3,601

0.4

%

Cherry Bekaert Advisory LLC

First Lien Term Loan

SOFR +

5.75

%,

0.75

% Floor 10

11.11

%

6/30/2028

4,364

4,279

4,277

0.4

%

Cherry Bekaert Advisory LLC

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

0.75

% Floor 9

11.11

%

6/30/2024

(54)

(113)

0.0

%

Explorer Investor, Inc.

 

First Lien Term Loan

 

SOFR +

6.00

%,

0.50

% 10

11.36

%

6/28/2029

28,626

27,259

27,212

2.7

%

Geosyntec Consultants, Inc.

 

First Lien Term Loan

 

SOFR +

5.25

%,

0.75

% 10

10.61

%

5/18/2029

10,337

10,185

9,983

1.0

%

Geosyntec Consultants, Inc.

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.25

%,

0.75

% 9 10

10.61

%

5/18/2029

2,192

2,145

2,042

0.2

%

Geosyntec Consultants, Inc.

 

First Lien Revolving Loan

 

SOFR +

5.25

%,

0.75

% 9

10.61

%

5/18/2027

(22)

(55)

0.0

%

IG Investments Holdings, LLC

First Lien Term Loan

SOFR +

6.00

%,

0.75

% Floor 10

11.48

%

9/22/2028

63,481

62,538

63,005

6.4

%

IG Investments Holdings, LLC

First Lien Term Loan

SOFR +

6.00

%,

0.75

% Floor 10

11.48

%

9/22/2028

4,900

4,864

4,863

0.5

%

IG Investments Holdings, LLC

First Lien Revolving Loan

SOFR +

6.00

%,

0.75

% Floor 9

11.48

%

9/22/2027

(63)

(38)

0.0

%

MBO Partners, Inc.

 

First Lien Term Loan

 

SOFR +

7.75

%,

1.00

% 10

13.25

%

5/23/2028

44,213

43,132

43,907

4.4

%

MBO Partners, Inc.

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.75

%,

0.75

% Floor 9

13.25

%

5/23/2028

12,425

12,181

12,340

1.2

%

PAS Parent, Inc.

First Lien Delayed Draw Term Loan

SOFR +

5.75

%,

0.75

% Floor 9

11.13

%

12/15/2025

(90)

(180)

0.0

%

PAS Parent, Inc.

First Lien Revolving Loan

SOFR +

5.75

%,

0.50

% 9

11.13

%

12/30/2027

(20)

(20)

0.0

%

People 2.0, Inc.

 

First Lien Term Loan

 

SOFR +

7.50

%,

1.00

% 10

12.85

%

7/12/2028

44,931

44,193

44,199

4.5

%

Williams Martson, LLC

 

First Lien Term Loan

 

SOFR +

5.75

%,

1.00

% 10

11.24

%

8/25/2028

15,762

15,289

15,373

1.6

%

Williams Martson, LLC

 

First Lien Delayed Draw Term Loan

 

SOFR +

5.75

%,

1.00

% 9

11.24

%

8/26/2024

(40)

(63)

0.0

%

Williams Martson, LLC

 

First Lien Revolving Loan

 

SOFR +

5.75

%,

1.00

% 9

11.24

%

8/25/2028

(52)

(55)

0.0

%

Total Professional Services

 

 

259,211

260,189

Real Estate Management & Development

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

2-10 Holdco, Inc.

 

First Lien Term Loan

 

SOFR +

6.00

%,

0.75

% Floor 10

 

11.46

%

3/26/2026

48,368

47,947

48,038

4.8

%

2-10 Holdco, Inc.

 

First Lien Revolving Loan

 

SOFR +

6.00

%,

0.75

% Floor 9

 

11.46

%

3/26/2026

(22)

(19)

0.0

%

Freedom Mortgage Corp 8 11

Unsecured Note

N/A

12.25

%

10/1/2030

2,333

2,288

2,551

0.3

%

Total Real Estate Management & Development

 

 

 

50,213

50,570

Software

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Anaplan, Inc.

 

First Lien Term Loan

 

SOFR +

6.50

%,

0.75

% Floor 10

 

11.85

%

6/21/2029

20,672

20,318

20,505

2.1

%

Anaplan, Inc.

 

First Lien Revolving Loan

 

SOFR +

6.50

%,

0.75

% Floor 9

 

11.85

%

6/21/2028

(23)

(13)

0.0

%

99

Table of Contents

    

    

    

    

    

Par 

    

    

    

Percentage 

 

Type of 

Reference Rate 

Interest

Amount /

of Net 

 

Portfolio Company 1 2 3 4

Investment

and Spread

 Rate

Maturity

 Units

Cost 6

Fair Value

Assets 7

 

Diligent Corporation

First Lien Term Loan

 

SOFR +

5.75

%,

1.00

% Floor 10

 

11.28

%

8/4/2025

29,175

29,048

28,527

2.9

%

Diligent Corporation

First Lien Term Loan

 

SOFR +

5.75

%,

1.00

% Floor 10

 

11.28

%

8/4/2025

9,725

9,683

9,509

1.0

%

Diligent Corporation

First Lien Revolving Loan

 

SOFR +

6.25

%,

1.00

% Floor 9 10

 

11.71

%

8/4/2025

2,700

2,682

2,625

0.3

%

GovDelivery Holdings, LLC

First Lien Term Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

10.98

%

1/29/2027

27,344

26,948

26,897

2.7

%

GovDelivery Holdings, LLC

First Lien Delayed Draw Term Loan

 

SOFR +

6.00

%,

1.00

% Floor 10

 

11.48

%

1/29/2027

33,573

33,141

33,024

3.3

%

GovDelivery Holdings, LLC

First Lien Revolving Loan

 

SOFR +

6.50

%,

1.00

% Floor 9 10

 

11.95

%

1/29/2027

504

485

473

0.0

%

GS Acquisitionco, Inc.

First Lien Term Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

11.00

%

5/22/2026

36,750

36,682

36,412

3.7

%

Hyland Software, Inc.

First Lien Term Loan

 

SOFR +

6.00

%,

0.75

% Floor 10

 

11.36

%

9/19/2030

25,301

24,932

24,924

2.5

%

Hyland Software, Inc.

First Lien Revolving Loan

 

SOFR +

6.00

%,

0.75

% Floor 9

 

11.36

%

9/19/2029

(17)

(18)

0.0

%

Mandolin Technology Intermediate Holdings, Inc.

Second Lien Term Loan

 

SOFR +

6.50

%,

1.00

% Floor 10

 

12.00

%

7/30/2029

17,500

17,359

15,762

1.6

%

Maverick 1 LLC

Second Lien Term Loan

 

SOFR +

6.75

%,

0.75

% Floor 10

 

12.28

%

5/18/2029

9,000

8,966

8,564

0.9

%

Orion Advisor Solutions, Inc.

Second Lien Term Loan

 

SOFR +

8.50

%,

1.00

% Floor 10

 

13.98

%

9/24/2028

16,500

16,393

15,995

1.6

%

Simplifi Holdings, Inc.

First Lien Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

10.96

%

10/1/2027

26,566

26,188

26,566

2.7

%

Simplifi Holdings, Inc.

First Lien Revolving Loan

 

SOFR +

5.50

%,

0.75

% Floor 9 10

 

10.96

%

10/1/2027

542

510

542

0.1

%

Syntax Systems Limited

First Lien Term Loan

 

SOFR +

5.50

%,

0.75

% Floor 10

 

10.96

%

10/29/2028

10,598

10,520

10,588

1.1

%

Syntax Systems Limited

 

First Lien Revolving Loan

 

SOFR +

5.50

%,

1.00

% Floor 10

 

10.96

%

10/29/2026

729

721

728

0.1

%

Tamarack Intermediate LLC

First Lien Term Loan

 

SOFR +

5.75

%,

0.75

% Floor 10

 

11.28

%

3/13/2028

21,162

20,844

20,802

2.1

%

Tamarack Intermediate LLC

First Lien Revolving Loan

 

SOFR +

5.75

%,

0.75

% Floor 9

 

11.28

%

3/13/2028

(49)

(60)

0.0

%

Total Software

 

 

285,331

282,352

Total Debt Investments

 

 

1,976,769

1,961,493

    

    

    

    

Par 

    

    

    

Percentage 

 

Type of 

Interest 

Acquisition

Amount /

of Net 

 

Portfolio Company 1 2 3

Investment

Rate

Date

 Units

Cost 4

Fair Value

Assets 5

 

Preferred Equity - 2.8%

Health Care Technology

Imagine Acquisitionco, LLC

Equity

N/A

N/A

11/16/2021

2,000

2,000

2,634

0.3

%

Total Health Care Technology

2,000

2,634

Insurance

Galway Borrower, LLC

Equity

N/A

14.00

%

4/28/2023

10,615

10,334

10,455

1.1

%

RSC Topco, Inc.

Equity

N/A

13.25

%

8/14/2023

5,259

5,112

5,110

0.5

%

Total Insurance

15,446

15,565

Software

GT Polaris Holdings, Inc

 

Equity

 

N/A

 

12.50

%  

6/6/2022

9,975

 

9,826

 

9,340

 

0.9

%

Total Software

 

 

9,826

9,340

Total Preferred Equity Investments

27,272

27,539

Common Equity and Warrants - 1.1%

Capital Markets

Resolute Investment Managers, Inc.

Equity

N/A

N/A

12/29/2023

48

1,217

1,217

0.1

%

Total Capital Markets

1,217

1,217

0.1

%

Financial Services

THL Fund IX Investors (Plymouth), L.P.

Equity

N/A

N/A

9/1/2023

3,732

3,732

3,732

0.4

%

Total Financial Services

3,732

3,732

Software

Spirit RR Holdings, Inc.

Equity

N/A

N/A

9/19/2022

3,586

3,635

4,574

0.5

%

Total Software

 

  

 

3,635

4,574

Warrants – 0.1%

Health Care Providers & Services

 

  

 

  

 

  

 

  

 

  

 

  

Giving Home Health Care

Warrants

 

N/A

 

N/A

 

8/19/2022

3

 

1,070

0.1

%

Total Health Care Providers & Services

 

 

  

 

1,070

Total Common Equity and Warrant Investments

8,584

10,593

1.1

%

Total Non-Controlled/Non-Affiliated Investments

 

  

 

$

2,012,625

$

1,999,625

(1)All of the Company’s investments are domiciled in the United States except for Harrington Reinsurance Holdings Limited and Syntax Systems Limited, which are domiciled in Bermuda and Canada, respectively.
(2)Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of ASC 820 fair value hierarchy.
(3)All investments are qualifying assets as defined under Section 55(a) of the Investment Company Act of 1940 except for Harrington Reinsurance Holdings Limited and Syntax Systems Limited.
(4)As of December 31, 2023, all investments are pledged as collateral unless otherwise stated.
(5)The date disclosed represents the expiration of the commitment period of the unfunded term loan. Upon expiration of the commitment period, the funded portion of the term loan may be subject to a longer maturity date.
(6)Cost represents the original cost adjusted for amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.
(7)Percentage is based on net assets of $991,422,092 as of December 31, 2023.
(8)Represents securities categorized as Level 2 assets under the definition of ASC 820 fair value hierarchy.
(9)This investment has an unfunded commitment as of December 31, 2023. For further details, see Note 5. Fair value includes an analysis of the unfunded commitment.
(10)The interest rate on this security is subject to the Secured Overnight Financing Rate, which at December 31, 2023 was 5.38%.
(11)Securities are exempt from registration under Rule 144A of the Securities Act of 1933. These securities represent a fair value of $39,898,460 or 2.0% of net assets as of December 31, 2023 and are considered restricted.
(12)The interest rate on this security is subject to the Alternate Base Rate, which at December 31, 2023 was 8.50%.

The accompanying notes are an integral part of these financial statements.

100

Table of Contents

Stone Point Credit Corporation

Notes to Financial Statements

December 31, 2024

(in thousands, except share/per share data, percentages and as otherwise noted)

Note 1. Organization

Organization

Stone Point Credit Corporation (the “Company”) was formed as a Delaware limited liability company on September 8, 2020 with the name Stone Point Capital Credit LLC. The Company has elected to be regulated as a business development company (a “BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In connection with its election to be regulated as a BDC, the Company converted to a Delaware corporation, changed its name to Stone Point Credit Corporation, and commenced operations on December 21, 2020. In addition, for tax purposes, Stone Point Credit Corporation has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Company is managed by Stone Point Credit Adviser LLC (the “Adviser”). The Adviser is a Delaware limited liability company that is registered with the Securities Exchange Commission (“SEC”) as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). Subject to the supervision of the Company’s board of directors (the “Board”), the Adviser manages the day-to-day operations of the Company and provides the Company with investment advisory and management services. The Adviser is an affiliate of Stone Point Capital LLC (“Stone Point Capital” or together with its credit-focused affiliates, as applicable, “Stone Point Credit”), which is an alternative investment management platform specializing in investments within the global financial services industry and related sectors.

On June 11, 2021, the Company formed SPCC Funding I LLC (the “SPV I”), a wholly-owned financing subsidiary, for the purpose of holding pledged investments as collateral under a financing facility.

On April 24, 2023, the Company formed SPCC Funding II LLC (the “SPV II,” and together with SPV I, the “SPVs”), a wholly-owned financing subsidiary, for the purpose of holding pledged investments as collateral under a financing facility. From time to time, the Company may form additional wholly - owned subsidiaries to facilitate its course of business.

The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns. The Company intends to invest primarily in senior secured or unsecured loans and, to a lesser extent, subordinated loans, mezzanine loans and equity-related securities including warrants, preferred stock and similar forms of senior equity, which may or may not be convertible into a portfolio company’s common equity.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the Company and the SPV. All intercompany balances and transactions have been eliminated in consolidation. All references made to the “Company, ” “we,” and “us” herein include Stone Point Credit Corporation and the consolidated SPV. The Company is an investment company and, therefore, applies the specialized accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services — Investment Companies. The Company’s fiscal year ends on December 31. The functional currency of the Company is U.S. dollars.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates and such differences could be material.

101

Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents consists of deposits in a money market account and demand deposits held at a custodian bank. Cash and cash equivalents are carried at cost, which approximates fair value. The Company’s deposits may, at times, exceed the insured limits under applicable law.

Investments at Fair Value

In accordance with Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company’s “Valuation Designee”. The Adviser, with the assistance of the Adviser’s Valuation Committee, subject to oversight by the Board, is responsible for determining the fair value of the Company’s investments in instances where there is no readily available market quotation. Investments for which market quotations are readily available may be priced by independent pricing services. From time to time, the Company retains an external, independent valuation firm to provide input, data, and valuation analyses on the Company’s portfolio companies.

The Company’s investment portfolio is recorded at fair value as determined in good faith in accordance with procedures established by the Board (“Valuation Policy”) and, as a result, there is and will be uncertainty as to the value of the Company’s portfolio investments. Under the 1940 Act, the Company is required to carry its portfolio investments at market value or, if there is no readily available market value, at fair value as determined in accordance with procedures established by the Board. There is not a public market or active secondary market for many of the types of investments in privately held companies that the Company intends to hold and make. The Company’s investments may not be publicly traded or actively traded on a secondary market but, instead, may be traded on a privately negotiated over-the-counter secondary market for institutional investors, if at all. As a result, these investments are valued quarterly at fair value as determined in good faith in accordance with the Valuation Policy approved by the Board.

The determination of fair value, and thus the amount of unrealized appreciation or depreciation the Company may recognize in any reporting period, is to a degree subjective, and the Adviser has a conflict of interest in making determinations of fair value. The types of factors that may be considered in determining the fair values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow, current market interest rates, precedent transactions and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, the valuations may fluctuate significantly over short periods of time due to changes in current market conditions. The determinations of fair value in accordance with the Valuation Policy may differ materially from the values that would have been used if an active market and market quotations existed for such investments. The Company’s net asset value could be adversely affected if the determinations regarding the fair value of the investments were materially higher than the values that the Company ultimately realizes upon the disposal of such investments.

Deferred Financing and Debt Issuance Costs

Financing costs incurred in connection with the Company’s borrowings (see Note 6) are deferred and amortized over the life of the corresponding facility. The Company records origination and other expenses related to its debt obligations as deferred financing and debt issuance costs. Deferred financing costs and debt issuance costs are presented on the Consolidated Statements of Assets and Liabilities as a direct deduction from the debt liability.

Net Asset Value per Common Share

In accordance with U.S. GAAP, the net asset value per share of the outstanding shares of common stock is determined at least quarterly by dividing the value of total assets minus liabilities by the total number of shares outstanding.

Revenue Recognition

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC Topic 606”), which requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company follows a five-step model to (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when

102

Table of Contents

(or as) the entity satisfies a performance obligation. In determining the transaction price, the Company includes variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized would not occur when the uncertainty associated with the variable consideration is resolved. Significant judgments are required in the application of the five-step model including; when determining whether performance obligations are satisfied at a point in time or over time; how to allocate transaction prices where multiple performance obligations are identified; when to recognize revenue based on the appropriate measure of the Company’s progress under the contract; and whether constraints on variable consideration should be applied due to uncertain future events.

Revenue from contracts with customers includes fee income (underwriting and arranger fees). The Company earns underwriting and arranger fees in securities offerings in which the Company acts as an underwriter or arranger, such as initial public offerings, follow-on equity offerings, debt offerings, and convertible securities offerings. Fee revenue relating to underwriting and arranger commitments is recorded at the point in time when all significant items relating to the underwriting or arranger process has been completed and the amount of the underwriting or arranger revenue has been determined. This generally is the point at which all of the following have occurred: (i) the issuer’s registration statement has become effective with the SEC or the other offering documents are finalized; (ii) the Company has made a firm commitment for the purchase of securities from the issuer; (iii) the Company has been informed of the number of securities that it has been allotted; and (iv) the issuer obtains control and benefits of the offering; which generally occurs on trade date. The Company, or its affiliates, may receive fees for capital structuring services. These fees are generally non-recurring and are recognized as fee income by the Company on the investment closing date. The following table presents revenues from contracts with customers disaggregated by fee type:

Year Ended

Year Ended

Year Ended

($ in thousands)

December 31, 2024

December 31, 2023

December 31, 2022

Fee Income

$

2,395

$

688

$

374

Total revenue from contracts with customers

$

2,395

$

688

$

374

ASC Topic 606 does not apply to revenue associated with financial instruments, and interest and dividend income.

Interest income is recorded on the accrual basis and includes amortization of premiums or accretion of discounts. Discounts to par value on securities purchased are accreted into interest income over the contractual life of the respective security using the effective interest method. Premiums to par value on securities purchased are amortized to the first call date into interest income using the effective interest method. The amortized cost of investments represents the original cost adjusted for the amortization of premiums or accretion of discounts, if any. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period. Discounts and premiums to par generally include loan origination fees, original issue discount and market discounts.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. Accrued interest is generally reversed when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may make exceptions to this treatment and determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection. As of each of December 31, 2024 and 2023, no investments were on non-accrual status.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. During the years ended December 31, 2024, 2023 and 2022 the Company earned $3,719, $1,422 and $600 of dividend income, respectively.

Organizational Expenses and Offering Costs

Organizational expenses are costs associated with the organization of the Company and are expensed as incurred. Offering costs are costs associated with the offering of common stock of the Company and are capitalized as deferred offering expenses in the Consolidated Statements of Assets and Liabilities. Deferred offering expenses are amortized over a twelve-month period from incurrence.

103

Table of Contents

Income Taxes

The Company has elected to be treated, and intends to qualify annually, as a RIC under the Code. So long as the Company maintains its tax treatment as a RIC, it generally will not be subject to corporate-level U.S. federal income taxes on any ordinary income or capital gains distributed to common stockholders of the Company (“Stockholders”) as dividends. To qualify as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements as well as distribute each taxable year dividends for U.S. federal income tax purposes of an amount generally at least equal to 90% of the Company’s “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses and is determined without regard to any deduction for dividends paid. In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.

The Company evaluates tax positions taken or expected to be taken while preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted later based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. There were no material uncertain income tax positions from inception through December 31, 2024. The Company’s federal and state tax returns for the prior three fiscal years remain open, subject to examination by the Internal Revenue Service and state tax authorities.

Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation

The Company measures realized gains or losses by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method, without regard to unrealized appreciation or depreciation previously recognized. Net change in unrealized appreciation or depreciation reflects the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation, when gains or losses are realized. During the year ended December 31, 2024, 2023, and 2022, the Company recorded $(5,762), $(133), and $1,072 of net realized gains (losses), respectively. During the years ended December 31, 2024, 2023 and 2022, the Company recorded $14,434, $16,375 and $(34,138) of unrealized appreciation (depreciation), respectively.

Distributions to Stockholders

Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board.

Dividend Reinvestment Plan

The Company has adopted an “opt out” dividend reinvestment plan (“DRIP”), under which a Stockholder’s distributions would automatically be reinvested under the DRIP in additional whole and fractional Shares, unless the Stockholder “opts out” of the DRIP, thereby electing to receive cash dividends.

The Company uses newly issued shares of Common Stock to implement the DRIP. Shares of Common Stock are issued at a price per share equal to the most recent net asset value per share determined by the Board.

Stockholders who receive distributions in the form of additional shares of Common Stock generally will be subject to the same U.S. federal, state and local tax consequences as Stockholders who elect not to reinvest distributions. Participation in the DRIP will not in any way reduce the amount of a Stockholder’s Capital Commitment.

104

Table of Contents

Consolidation

As provided under Regulation S-X and ASC Topic 946 - Financial Services - Investment Companies, the Company will generally not consolidate its investment in a company other than a wholly-owned investment company or controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidates the accounts of the Company’s SPVs in its consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation.

Segment Reporting

In accordance with Topic 280 – Segment Reporting (“ASC 280”), the Company has determined that it has a single operating and reporting segment. As a result, the Company’s segment accounting policies are the same as described herein and the Company does not have any intra-segment sales and transfers of assets.

The Company’s investment objective is to generate both current income and capital appreciation through its investments. The chief operating decision maker (“CODM”) is comprised of the Company’s chairman, president, chief financial officer and chief operating officer. The CODM assesses the performance and makes decisions of the Company on a consolidated basis primarily based on the Company’s net increase in stockholders’ equity resulting from operations (“net income”). In addition to numerous other factors and metrics, the CODM utilizes net income as a key metric in determining the amount of distributions to be distributed to the Company’s stockholders. As the Company’s operations comprise of a single reporting segment, the segment assets are reflected on the accompanying consolidated balance sheet as “total assets” and the significant segment expenses are listed on the accompanying consolidated statement of operations.

Recent Accounting Pronouncements

In June 2022, the FASB issued ASU No. 2022-03, “Fair Value Measurement (Topic 820),” which clarifies the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The amendments affect all entities that have investments in equity securities measured at fair value that are subject to a contractual sale restriction. ASU 2022-03 is effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. An entity that qualifies as an investment company under Topic 946 should apply the amendments in ASU No. 2022-03 to an investment in an equity security subject to a contractual sale restriction that is executed or modified on or after the date of adoption. The Company has adopted ASU 2022-03 and does not believe that it had a material effect on its consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). This change is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, allowing financial statement users to better understand the components of a segment’s profit or loss and assess potential future cash flows for each reportable segment and the entity as a whole. The amendments expand a public entity’s segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the CODM, clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures and providing new disclosure requirements for entities with a single reportable segment, among other new disclosure requirements. The amendments are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, and early adoption is permitted. The Company has adopted ASU 2023-07 for the fiscal year 2024 and concluded that the application of this guidance did not have any material impact on its consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023 - 09, “Income Taxes (Topic 740),” which updates income tax disclosure requirements related to rate reconciliation, income taxes paid and other disclosures. ASU 2023 - 09 is effective for public business entities for fiscal years beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of adopting ASU No. 2023 - 09 on the consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, “Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 2200-40),” which requires disaggregated disclosure of certain costs and expenses, including

105

Table of Contents

purchases of inventory, employee compensation, depreciation, amortization and depletion, in each relevant expense caption. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently assessing the impact of the guidance but does not expect it will have a material impact on its consolidated financial statements.

In November 2024, the FASB issued ASU 2024-04, “Debt – Debt with Conversion and Other Options (Subtopic 470-20), which clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04 is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently assessing the impact of the guidance but does not expect it will have a material impact on its consolidated financial statements. Other than the aforementioned guidance, the Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

Note 3. Agreements and Related Party Transactions

Investment Advisory Agreement

Subject to the supervision of the Board and pursuant to an investment advisory agreement between the Company and the Adviser (the “Investment Advisory Agreement”), the Adviser manages the day-to-day operations of the Company and provides the Company with investment advisory and management services. Among other things, the Adviser (i) determines the composition and allocation of the Company’s investment portfolio, the nature and timing of the changes therein and the manner of implementing such changes; (ii) identifies, evaluates and negotiates the structure of the investments made by the Company; (iii) performs due diligence on prospective portfolio companies; (iv) executes, closes, services and monitors the Company’s investments; (v) determines the securities and other assets that the Company will purchase, retain or sell; (vi) arranges financings and borrowing facilities for the Company and (vii) provides the Company with such other investment advisory, research and related services as the Company may, from time to time, reasonably require for the investment of its funds and (viii) to the extent permitted under the 1940 Act and the Advisers Act, on the Company’s behalf, and in coordination with any sub-adviser and any administrator, provides significant managerial assistance to those portfolio companies to which the Company is required to provide such assistance under the 1940 Act, including utilizing appropriate personnel of the Adviser to, among other things, monitor the operations of the Company’s portfolio companies, participate in board and management meetings, consult with and advise officers of portfolio companies and provide other organizational and financial consultation. The Adviser’s services under the Investment Advisory Agreement are not exclusive, and the Adviser is generally free to furnish similar services to other entities so long as its performance under the Investment Advisory Agreement is not adversely affected.

Under the Investment Advisory Agreement, the Company pays the Adviser (i) a base management fee and (ii) an incentive fee as compensation for the investment advisory and management services it provides the Company thereunder.

Base Management Fee

The Company pays to the Adviser an asset-based fee (the “Management Fee”) for management services in an amount equal to an annual rate of 1.30% of the average value of the Company’s gross assets (excluding cash and cash equivalents) as of the last day of the most recently completed calendar quarter and the last day of the immediately preceding calendar quarter payable quarterly in arrears. The Management Fee for any partial quarter is appropriately prorated based on the actual number of days elapsed during such partial quarter as a fraction of the number of days in the relevant calendar year. For the years ended December 31, 2024, 2023, and 2022, the Company incurred management fees of $30,071, $24,304 and $18,937 respectively. As of December 31, 2024 and 2023, the Company recorded base management fees payable of $8,013 and $6,532, respectively.

Incentive Fee

Beginning December 21, 2024, on the fourth anniversary of the date on which Stockholders are required to fund their initial drawdown (the “Incentive Commencement Date”), the Company will pay the Adviser an incentive fee (“Incentive Fee”) as set forth below. The Incentive Fee will consist of two parts. The first part (the “Investment Income Incentive Fee”) will be calculated and payable following the Incentive Commencement Date on a quarterly basis, in arrears, and will equal 15% of “pre-incentive fee net investment income” for the immediately preceding calendar quarter, subject to a quarterly preferred return of 1.75% (i.e., 7% annualized) measured on a quarterly basis. For purposes of computing the initial installment of the Investment Income Incentive Fee because the Incentive Commencement Date does not fall on the first day of a calendar quarter, then the initial payment of the

106

Table of Contents

Investment Income Incentive Fee shall be payable for the period that commences on the Incentive Commencement Date through the last day of the first complete calendar quarter immediately following the Incentive Commencement Date (March 31, 2025) and, thereafter, at the end of each subsequent calendar quarter as described above. The second part (the “Capital Gains Incentive Fee”) will be an annual fee that will also commence with the period beginning on the Incentive Commencement Date and will be determined and payable following the Incentive Commencement Date, in arrears, as of the end of each calendar year (or upon termination of the Investment Advisory Agreement) in an amount equal to 15% of realized capital gains, if any, determined on a cumulative basis from the Incentive Commencement Date (based on the fair market value of each investment as of such date, beginning December 31, 2024) through the end of such calendar year (or upon termination of the Investment Advisory Agreement), computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis from the Incentive Commencement Date (based on the fair market value of each investment as of such date) through the end of such calendar year (or upon termination of the Investment Advisory Agreement), less the aggregate amount of any previously paid Capital Gains Incentive Fees. Capital Gains Incentive Fee shall be payable for the period that commences on the Incentive Commencement Date through December 31, 2025. For the years ended December 31, 2024, 2023, and 2022, the Company did not incur any Incentive Fees.

Administration Agreement

The Adviser also serves as the administrator of the Company (in such capacity, the “Administrator”). Subject to the supervision of the Board, the Administrator provides the administrative services necessary for the Company to operate and the Company utilizes the Administrator’s office facilities, equipment and recordkeeping services. The Company reimburses the Administrator for all reasonable costs and expenses incurred by the Administrator in providing these services, facilities and personnel, as provided by the administration agreement by and between the Company and the Administrator (the “Administration Agreement”). In addition, the Administrator is permitted to delegate its duties under the Administration Agreement to affiliates or third parties, and the Company reimburses the expenses of these parties incurred directly and/or paid by the Administrator on the Company’s behalf.

The Company reimburses the Administrator for the allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including furnishing the Company with office facilities, equipment and clerical, bookkeeping and recordkeeping services at such facilities, as well as providing the Company with other administrative services. In addition, the Company reimburses the Administrator for the fees and expenses associated with performing compliance functions, and the Company’s allocable portion of the compensation of certain of the Company’s officers, including the Company’s Chief Financial Officer, Chief Compliance Officer and any support staff. The Adviser can waive any amounts owed to it under the Administration Agreement, at its discretion.

For the years ended December 31, 2024, 2023, and 2022, the Company incurred $976, $1,328 and $973 of administrative overhead expenses that were included in the Consolidated Statements of Operations as professional fees, respectively. As of December 31, 2024 and 2023, $213 and $312, respectively, of administrative overhead expenses remained payable on the Consolidated Statements of Assets and Liabilities as accounts payable and accrued expenses. For both the years ended December 31, 2024 and 2023, the Administrator has not elected to waive charges that would have been eligible for reimbursement under the terms of the Administration Agreement. For the year ended December 31, 2022, the Administrator has elected to waive additional charges that would have otherwise been eligible for reimbursement under the terms of the Administration Agreement which are not subject to recoupment.

Sub-Administration and Custodian Fees

On January 22, 2021, the Adviser entered into a sub-administration agreement with U.S. Bank Global Fund Services (the “Sub-Administrator”) under which the Sub-Administrator provides various accounting and other administrative services with respect to the Company. The Company pays the Sub-Administrator fees for services the Adviser determines are commercially reasonable in its sole discretion. The Company also reimburses the Sub-Administrator for all reasonable expenses. To the extent that the Sub-Administrator outsources any of its functions, the Sub-Administrator pays any compensation associated with such functions. The Sub-Administrator also serves as the Company’s custodian (the “Custodian”).

For the years ended December 31, 2024, 2023, and 2022, the Company incurred expenses for services provided by the Sub-Administrator and the Custodian of $1,864, $1,754 and $1,155 that were included on the Consolidated Statements of Operations as professional fees, respectively. As of December 31, 2024 and 2023, $470 and $313, respectively, remained payable on the Consolidated Statements of Assets and Liabilities as accounts payable and accrued expenses.

107

Table of Contents

Transfer Agent Fees

The Company has entered into a transfer agent servicing agreement with U.S. Bank Global Fund Services (the “Transfer Agent”). For the years ended December 31, 2024, 2023, and 2022, the Company incurred expenses for services provided by the Transfer Agent of $44, $69 and $51 that were included on the Consolidated Statements of Operations as professional fees, respectively. As of December 31, 2024 and 2023, $11 and $26, respectively, remained payable on the Consolidated Statements of Assets and Liabilities as accounts payable and accrued expenses.

Affiliated Capital Market Entities

The Adviser is an affiliate of SPC Capital Markets LLC, a Delaware limited liability company (the “Affiliated Broker-Dealer”), which is registered as a broker-dealer with the SEC and a member of FINRA and the Securities Investor Protection Corporation (together with the other Stone Point affiliated entities that conduct financial services, loan origination, structuring, placement or other similar business as a broker, dealer, distributor, syndicator, arranger or originator of securities or loans, collectively the “Affiliated Capital Market Entities”). During the year ended December 31, 2024, the Company paid the Affiliated Broker-Dealer a fee of $750 for services provided by the Affiliated Broker-Dealer in connection with the closing of the 2029 Notes (as defined herein). The Company did not pay the Affiliated Broker - Dealer any fees during the year ended December 31, 2023. During the year ended December 31, 2022, the Company paid the Affiliated Broker - Dealer a fee of $1,125 for services provided by the Affiliated Broker-Dealer in connection with the closing of the 2025 Notes (as defined herein). The Affiliated Broker Dealer may receive fees from other investors and portfolio companies in which the Company invests but will not collect fees from the Company for its portfolio investments.

To the extent permitted by the 1940 Act, the Affiliated Capital Market Entities may, among other assignments, arrange, structure, and/or place equity and debt securities to be issued by portfolio companies of the Company on a best efforts or firm commitment basis. These placements may from time to time include structuring of offerings, and placement of securities in public offerings of securities issued by portfolio companies of the Company. The Affiliated Capital Market Entities may act as a firm commitment underwriter (co-manager only) in public and private offerings of securities issued by portfolio companies of the Company. In certain limited circumstances, the Company may have a conflict resulting from the foregoing arrangements. When the Affiliated Capital Market Entities serve as underwriter with respect to the securities of a portfolio company of the Company, the Company may be subject to a “lock-up” period following the offering under applicable regulations or agreements during which time its ability to sell any securities that it continues to hold is restricted. This restriction may prevent the Company from disposing of such securities at an opportune time. To the extent permitted by the 1940 Act, the Company may make investments from time to time in transactions where Affiliated Capital Market Entities act as agent, broker, principal, arranger or syndicate manager or member on the other side of the transaction or for other parties in the transaction. The consent of the Board may be required to enter into certain of the Company’s potential investments and the failure of the Board to grant such consent would prevent the Company from consummating such investments, which could adversely affect the Company.

Co-Investment Exemptive Relief

The 1940 Act generally prohibits BDCs from entering into negotiated co-investments with affiliates absent an order from the SEC. On June 14, 2022, the SEC granted the Company exemptive relief (the “Order”) that permits the Company to co-invest alongside other funds managed by the Adviser or certain of its affiliates, if, among other things, a “required majority” (as defined in Section 57(o) of the 1940 Act) of the directors who are not “interested persons” of the Company, the Adviser of their respective affiliates as defined in Section 2(a)(19) of the 1940 Act (“Independent Directors”) make certain conclusions in connection with a co-investment transaction, including, but not limited to, that (1) the terms of the potential co-investment transaction, including the consideration to be paid, are reasonable and fair to the Company and Stockholders and do not involve overreaching in respect of the Company or Stockholders on the part of any person concerned, and (2) the potential co-investment transaction is consistent with the interests of Stockholders and is consistent with the Company’s then-current investment objective and strategies. The Order provides that, in connection with any co-investment transaction, the Company may participate in any such co-investment transaction on terms that are same to those applicable to the other funds managed by, or certain entities affiliated with, the Adviser or certain of its affiliates. To the extent an investment by such other fund or entity, as applicable, in an applicable co-investment opportunity is based on favorable terms, the Company will benefit from investing in such co-investment opportunity based on such favorable terms. In addition, the Order provides that, in connection with any such co-investment transaction, the Company will receive its pro rata share of any transaction fees (including break-up, structuring, monitoring or commitment fees but excluding brokerage or underwriting compensation permitted by section 17(e) or 57(k) of the 1940 Act), in respect of such co-investment transaction, based on the Company’s relative share of the amount invested or committed, as applicable, in such transaction.

108

Table of Contents

Note 4. Offering Costs

The Company has and may continue to bear expenses relating to its offering of its Common Stock, including the listing of its Common Stock on a national securities exchange. Offering expenses include, without limitation, legal, accounting, printing and other offering costs including those associated with the preparation of a registration statement in connection with any offering of Common Stock.

For the years ended December 31, 2024, 2023, and 2022, the Company incurred offering costs of $56, $97 and $116 that were included on the Consolidated Statements of Operations, respectively. As of both December 31, 2024 and 2023, $0 remained payable on the Consolidated Statements of Assets and Liabilities as offering costs payable.

Note 5. Commitments and Contingencies

Litigation and Regulatory Matters

From time to time, the Company may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Company’s rights under contracts with the Company’s portfolio companies. The Company and the Adviser are not currently a party to any material legal proceedings.

109

Table of Contents

Unfunded Portfolio Company Commitments

From time to time, the Company may enter into commitments to fund investments. As of December 31, 2024 and 2023, the Company had the following unfunded portfolio company commitments under loan and financing agreements:

110

Table of Contents

($ in thousands)

    

    

December 31, 2024

 

December 31, 2023

Portfolio Company

    

Type of Investment

    

 Par

    

Par

2-10 Holdco, Inc.

First Lien Revolving Loan

$

 

$

2,778

Accordion Partners LLC

 

First Lien Delayed Draw Term Loan

 

5,454

2,075

Accordion Partners LLC

 

First Lien Revolving Loan

 

3,636

2,034

Accuserve

First Lien Delayed Draw Term Loan

4,876

2,690

Accuserve

 

First Lien Revolving Loan

 

6,573

Acentra Holdings, LLC

 

First Lien Revolving Loan

 

1,287

Acentra Holdings, LLC

 

First Lien Delayed Draw Term Loan

 

8,715

Action Behavior Centers Therapy LLC

First Lien Revolving Loan

3,071

Action Behavior Centers Therapy LLC

First Lien Delayed Draw Term Loan

5,722

Alkeme Intermediary Holdings, LLC

 

First Lien Delayed Draw Term Loan

 

12,511

Amerilife Holdings LLC

 

First Lien Delayed Draw Term Loan

 

4,753

1,768

AmeriLife Group LLC

 

First Lien Revolving Loan

 

6,891

5,273

Anaplan, Inc.

 

First Lien Revolving Loan

 

1,546

1,546

Aprio Advisory Group, LLC

 

First Lien Delayed Draw Term Loan

 

4,741

Aprio Advisory Group, LLC

 

First Lien Revolving Loan

 

2,994

Arden Insurance Services LLC

First Lien Revolving Loan

1,463

ARMStrong Receivable Management

 

First Lien Delayed Draw Term Loan

 

1,020

4,955

ARMStrong Receivable Management

 

First Lien Revolving Loan

 

299

299

Baker Tilly Advisory Group, L.P.

First Lien Delayed Draw Term Loan

2,736

Baker Tilly Advisory Group, L.P.

First Lien Revolving Loan

3,835

Beacon Pointe Harmony, LLC

 

First Lien Delayed Draw Term Loan

 

9,390

9,874

Beacon Pointe Harmony, LLC

 

First Lien Revolving Loan

 

3,000

3,000

Belmont Buyer, Inc.

 

First Lien Revolving Loan

 

1,453

2,180

Belmont Buyer, Inc.

 

First Lien Delayed Draw Term Loan

 

4,235

2,616

Bottomline Technologies, Inc.

 

First Lien Revolving Loan

 

7,365

7,365

Captive Resources Midco, LLC

 

First Lien Revolving Loan

 

2,203

2,203

Chartis Group, LLC

 

First Lien Delayed Draw Term Loan

 

2,517

Chartis Group, LLC

 

First Lien Revolving Loan

 

1,259

Cherry Bekaert Advisory LLC

 

First Lien Delayed Draw Term Loan

 

638

5,625

Choreo Buyer, LLC

First Lien Delayed Draw Term Loan

15,560

Cliffwater, LLC

 

First Lien Revolving Loan

 

2,857

2,857

CNSI Holdings, LLC

 

First Lien Revolving Loan

 

912

Continental Buyer Inc.

 

First Lien Delayed Draw Term Loan

 

8,153

Continental Buyer Inc.

First Lien Revolving Loan

3,057

Diligent Corporation

 

First Lien Delayed Draw Term Loan

 

4,124

Diligent Corporation

 

First Lien Revolving Loan

 

5,997

2,300

Eclipse Buyer, Inc.

 

First Lien Revolving Loan

 

1,083

Eclipse Buyer, Inc.

First Lien Delayed Draw Term Loan

2,134

Ellkay, LLC

 

First Lien Revolving Loan

 

2,167

3,611

Exeter

First Lien Revolving Loan

8,797

Foundation Risk Partners, Corp.

 

First Lien Revolving Loan

 

4,407

Foundation Risk Partners, Corp.

 

First Lien Delayed Draw Term Loan

 

4,686

Galway Borrower LLC

 

First Lien Delayed Draw Term Loan

 

10,596

21,000

Galway Borrower, LLC

 

First Lien Revolving Loan

 

2,767

4,098

GaphPAD Software, LLC

First Lien Revolving Loan

1,250

Geosyntec Consultants, Inc.

First Lien Delayed Draw Term Loan

2,187

Geosyntec Consultants, Inc.

 

First Lien Revolving Loan

 

1,609

Giving Home Health Care

First Lien Revolving Loan

3,125

GovDelivery Holdings, LLC

First Lien Revolving Loan

2,193

1,910

GS Acquisitionco, Inc.

 

First Lien Revolving Loan

 

1,080

GS Acquisitionco, Inc.

First Lien Delayed Draw Term Loan

1,109

Guardian Restoration Partners Buyers, LLC

First Lien Revolving Loan

2,057

Guardian Restoration Partners Buyers, LLC

First Lien Delayed Draw Term Loan

9,082

HBWM Intermediate II, LLC

First Lien Revolving Loan

1,017

HBWM Intermediate II, LLC

First Lien Delayed Draw Term Loan

5,498

Hyland Software, Inc

First Lien Revolving Loan

1,199

1,199

IG Investments Holdings, LLC

First Lien Revolving Loan

3,509

5,058

Imagine Acquisitionco, LLC

First Lien Revolving Loan

4,399

4,630

KRIV Acquisition Inc.

 

First Lien Delayed Draw Term Loan

 

24,923

Kwol Acquisition Inc

 

First Lien Revolving Loan

 

329

230

LendingTree, Inc.

 

First Lien Delayed Draw Term Loan

 

3,000

MAI Capital Management Intermediate LLC

 

First Lien Revolving Loan

 

1,331

MAI Capital Management Intermediate LLC

 

First Lien Delayed Draw Term Loan

 

2,782

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

8,932

3,200

MB2 Dental Solutions, LLC

 

First Lien Delayed Draw Term Loan

 

111

Table of Contents

MB2 Dental Solutions, LLC

 

First Lien Revolving Loan

 

2,244

Ministry Brands Purchaser, LLC

First Lien Revolving Loan

1,695

791

Minotaur Acquisition, Inc.

First Lien Delayed Draw Term Loan

3,401

Minotaur Acquisition, Inc.

First Lien Revolving Loan

2,041

Mirra-Prime Access Holdings, LLC

First Lien Revolving Loan

685

2,055

More Cowbell II LLC

First Lien Delayed Draw Term Loan

5,444

5,444

More Cowbell II LLC

First Lien Revolving Loan

4,247

5,771

Neptune Flood Incorporated

 

First Lien Revolving Loan

 

750

New Mountain Capital LLC

Unsecured Notes

350

New Mountain Capital LLC

Unsecured Notes

557

New Mountain Capital LLC

Unsecured Notes

1,942

New Mountain Capital LLC

Unsecured Notes

2,657

OneDigital Borrower LLC

First Lien Delayed Draw Term Loan

9,771

Orion Advisor Solutions, LLC

Second Lien Delayed Draw Term Loan

6,524

NextGen Healthcare

First Lien Delayed Draw Term Loan

2,370

2,370

NextGen Healthcare

First Lien Revolving Loan

889

889

NXGen Buyer, Inc.

First Lien Revolving Loan

326

oneZero Financial Systems, LLC

First Lien Delayed Draw Term Loan

4,712

oneZero Financial Systems, LLC

First Lien Revolving Loan

3,365

PAS Parent Inc.

First Lien Delayed Draw Term Loan

1,476

9,000

PAS Parent Inc.

First Lien Revolving Loan

1,000

1,000

PAS Parent Inc.

First Lien Delayed Draw Term Loan

5,625

Petra Borrower, LLC

First Lien Delayed Draw Term Loan

3,193

6,875

Petra Borrower, LLC

First Lien Revolving Loan

2,456

2,750

Project K BuyerCo, Inc.

First Lien Revolving Loan

7,727

7,727

RSC Acquisition, Inc

First Lien Delayed Draw Term Loan

19,663

Simplifi Holdings, Inc.

First Lien Revolving Loan

2,892

2,349

Syntax Systems Limited

First Lien Revolving Loan

459

Southpaw AP Buyer, LLC

First Lien Delayed Draw Term Loan

260

Southpaw AP Buyer, LLC

First Lien Revolving Loan

868

SpecialtyCare, Inc.

First Lien Revolving Loan

446

914

Stepping Stones Healthcare Services, LLC

First Lien Revolving Loan

3,500

3,500

Stepping Stones Healthcare Services, LLC

First Lien Delayed Draw Term Loan

6,300

1,545

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

2,000

2,000

TA/WEG Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

5,602

3,941

TA/WEG Intermediate Holdings, LLC

First Lien Revolving Loan

1,135

Tamarack Intermediate, L.L.C.

First Lien Revolving Loan

3,516

3,516

THG Acquisition, LLC

First Lien Revolving Loan

2,706

THG Acquisition, LLC

First Lien Delayed Draw Term Loan

5,847

Titan Home Improvement, LLC

First Lien Delayed Draw Term Loan

4,605

Titan Home Improvement, LLC

First Lien Revolving Loan

3,837

Trinity Partners Holdings, LLC

First Lien Delayed Draw Term Loan

6,625

7,447

TST Intermediate Holdings, LLC

First Lien Delayed Draw Term Loan

5,817

5,769

TST Intermediate Holdings, LLC

First Lien Revolving Loan

890

Vital Care Buyer LLC

First Lien Revolving Loan

874

Williams Martson, LLC

First Lien Delayed Draw Term Loan

2,554

2,554

Williams Martson, LLC

First Lien Revolving Loan

2,235

2,235

Worldwide Insurance Network, LLC

First Lien Delayed Draw Term Loan

12,174

Total Par.

$

402,618

$

226,542

The unrealized appreciation or depreciation associated with unfunded portfolio company commitments is recorded in the financial statements and reflected as an adjustment to the valuation of the related security in the Consolidated Schedule of Investments as of each of December 31, 2024 and 2023. The par amount of the unfunded portfolio company commitments is not recognized by the Company until the commitment is funded.

The credit agreements of the unfunded portfolio company commitments contain customary lending provisions which are subject to the portfolio company’s achievement of certain milestones. In instances where the underlying company experiences material adverse effects that would impact the financial condition or business outlook of the company, there is relief to the Company from funding obligations for previously made commitments. Unfunded portfolio company commitments may expire without being drawn upon, and therefore, do not necessarily represent future cash requirements or future earning assets for the Company. The Company expects to maintain sufficient liquidity in the form of cash, financing capacity and undrawn capital commitments from our investors to cover any outstanding unfunded portfolio company commitments we may be required to fund.

112

Table of Contents

Note 6. Borrowings

In accordance with the 1940 Act, with certain limitations, BDCs are allowed to borrow amounts such that their asset coverage ratios, as defined in the 1940 Act, are at least 200% (or 150% if certain conditions are met) after such borrowing. As a result of complying with the requirements set forth in Section 61 of the 1940 Act, the Company is able to borrow amounts such that its asset coverage ratio is at least 150%, rather than 200%. As of December 31, 2024 and 2023, the Company’s asset coverage ratios were 194% and 193%, respectively.

The following table shows the Company’s outstanding debt as of December 31, 2024 and 2023:

    

December 31, 2024

Aggregate

Net

Principal 

Outstanding

Amount 

Carrying 

($ in thousands)

    

Committed

    

Principal

    

Available (1)

    

 Value (2)

Capital Call Facility

$

65,000

$

27,000

$

38,000

$

26,757

Revolving Credit Facility

850,000

680,000

170,000

671,821

Secured Credit Facility

300,000

200,000

100,000

197,076

2025 Notes

225,000

225,000

224,612

2029 Notes

200,000

200,000

197,660

Total

$

1,640,000

$

1,332,000

$

308,000

$

1,317,926

    

December 31, 2023

Aggregate

Net

Principal

Outstanding

Amount

Carrying

($ in thousands)

    

Committed

    

Principal

    

Available (1)

    

Value (2)

Capital Call Facility

$

85,000

$

52,000

$

33,000

$

51,663

Revolving Credit Facility

750,000

666,000

84,000

661,933

Secured Credit Facility

300,000

126,000

174,000

124,000

2025 Notes

225,000

225,000

223,657

Total

$

1,360,000

$

1,069,000

$

291,000

$

1,061,253

(1)The amount available may be subject to limitations related to the borrowing base under the Financing Facilities, outstanding letters of credit issued and asset coverage requirements.
(2)As of December 31, 2024 and 2023, all of the Company’s outstanding debt was categorized as Level 3 within the fair value hierarchy.

Capital Call Facility

Effective as of December 29, 2020 (the “Initial Closing Date”), the Company entered into a revolving credit facility (as amended, the “Capital Call Facility”) by and among, inter alios, the Company as the initial borrower, the lenders from time-to-time party thereto (collectively, the “Lenders”) and Capital One, National Association, as the administrative agent (the “Administrative Agent”), sole lead arranger and a Lender. On December 27, 2022, the Company executed a letter agreement (the “Second Amendment”) to amend its revolving credit agreement (as amended, the “Revolving Credit Agreement”), by and among, inter alios, the Company as the borrower, the Lenders and Capital One, National Association, as the administrative agent, sole lead arranger and a Lender.

113

Table of Contents

The Second Amendment, among other things, reduced the maximum borrowing capacity of the Company under the Capital Call Facility to $125 million from $200 million and changed the applicable margin for advances under the Capital Call Facility to SOFR plus 1.95% from SOFR plus 1.85%. The Second Amendment extended the scheduled maturity date of the loans under the Capital Call Facility from December 28, 2022 to December 27, 2023. The other material terms of the Capital Call Facility were unchanged.

On December 22, 2023, the Company amended the Capital Call Facility (the “Third Amendment”). The Third Amendment, among other things, extended the maturity date to December 27, 2024, reduced the maximum borrowing capacity of the Company under the Capital Call Facility to $85 million and increased the applicable margin for advances under the Capital Call Facility to SOFR plus 2.35% per annum from SOFR plus 1.95% per annum with respect to SOFR Loans (as defined in the Capital Call Facility) and to 1.35% per annum with respect to Reference Rate Loans (as defined in the Capital Call Facility). The other material terms of the Capital Call Facility were unchanged.

On December 27, 2024, the Company amended the Capital Call Facility (the “Fourth Amendment”). The Fourth Amendment, among other things, extended the maturity date to December 26, 2026, reduced the maximum borrowing capacity of the Company under the Capital Call Facility to $65 million, and bifurcated the unused fee such that if the average unused portion of the commitment of the Lenders during any calendar month is more than 50% of the amount of the commitment of the Lenders, the unused fee increased to .50% per annum multiplied by the daily unused portion of the commitment of the Lenders.

The proceeds of the loans under the Capital Call Facility may be used to acquire portfolio investments and such other uses as permitted under the Capital Call Facility. At the Company’s option, the Capital Call Facility will accrue interest at a rate per annum based on (i) a daily simple SOFR plus an applicable margin of 2.35% or (ii) the greatest of (1) the prime rate or (2) the federal funds effective rate plus 0.5% plus an applicable margin of 1.35%.

The maturity date is the earliest of: (a) December 26, 2025; (b) the date upon which the Administrative Agent declares the Company’s obligations under the Capital Call Facility (the “Obligations“) due and payable after the occurrence of an event of default under the Capital Call Facility; (c) 45 days prior to the termination of the Company’s Operative Documents (as defined in the Capital Call Facility); (d) 45 days prior to the date on which the Company’s ability to call capital commitments for the purpose of repaying the Obligations is terminated, and (e) the date upon which the Company terminates the commitments of the Lenders pursuant to Section 3.6 of the Capital Call Facility or otherwise.

The Capital Call Facility includes customary covenants as well as usual and customary events of default for revolving credit facilities of this nature.

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the Capital Call Facility approximated their fair value. As of December 31, 2024 and 2023, unamortized financing costs of $243 and $337, respectively, are being deferred and amortized over the remaining term of the Capital Call Facility. As of December 31, 2024 and 2023, the Company had an outstanding balance of $27,000 and $52,000, respectively. As of December 31, 2024 and 2023 the Capital Call Facility is presented on the Consolidated Statements of Assets and Liabilities net of unamortized financing costs, which result in outstanding balances totaling $26,757 and $51,663, respectively.

The following table shows additional information about the interest and financing costs related to the Capital Call Facility for the years ended December 31, 2024, 2023, and 2022:

Year Ended

Year Ended

Year Ended

($ in thousands)

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

Interest expenses related to the Capital Call Facility

$

2,666

$

2,994

$

2,927

Financing expenses related to the Capital Call Facility

354

454

556

Total interest and financing expenses related to the Capital Call Facility

$

3,020

$

3,448

$

3,493

Revolving Credit Facility

On June 28, 2021, SPV I entered into a senior secured revolving credit facility (as amended, the “Revolving Credit Facility”) with JPMorgan Chase Bank, National Association (“JPM”). JPM serves as administrative agent and lender, U.S. Bank, National

114

Table of Contents

Association, serves as collateral agent, securities intermediary and collateral administrator, and the Adviser serves as portfolio manager under the Revolving Credit Facility.

Advances under the Revolving Credit Facility bear interest at a per annum rate equal to: (a) for advances denominated in USD, Term SOFR (as defined in the Revolving Credit Facility), (b) for advances denominated in CAD, the average rate applicable to CAD bankers’ acceptances for a three-month period, (c) for advances denominated in GBP, the daily simple Sterling Overnight Index Average for each day, (d) for advances denominated in AUD, the three-month average bid reference rate administered by the Australian Financial Markets Association for Australian dollar bills, and (e) for advances denominated in Euros, the three-month Euro interbank offered rate, in each case, in effect, plus the applicable margin of 2.45% per annum (or, for advances denominated in GBP, 2.5693% per annum). SPV I paid and will pay, as applicable, a commitment fee of (x) initially, to but excluding September 28, 2021, 0.25% per annum, (y) from and including September 28, 2021 to but excluding the first anniversary of the Revolving Credit Facility, 0.50% per annum, and (z) from and including the first anniversary of the Revolving Credit Facility, 0.60% per annum, in each case, on the average daily unused amount of the financing commitments until the third anniversary of the Revolving Credit Facility.

On October 15, 2021, SPV I executed a letter agreement (the “Amendment”) to amend the Revolving Credit Facility. The Amendment increases the maximum borrowing capacity of SPV I under the Revolving Credit Facility between SPV I and JPM to $500 million from $250 million in accordance with the accordion feature in the Revolving Credit Facility that allows SPV I, under certain circumstances, to increase the size of the Revolving Credit Facility to an amount not to exceed $750 million in aggregate. The other material terms of the Revolving Credit Facility were unchanged. All amounts outstanding under the Revolving Credit Facility must be repaid by June 28, 2026.

On January 28, 2022, SPV I executed a letter agreement (the “Second Amendment”) to amend the Revolving Credit Facility. The Second Amendment increases the maximum borrowing capacity of SPV I under the Revolving Credit Facility by $250 million (the “Commitment Increase”) to an aggregate of $750 million from its previous $500 million borrowing capacity. The Second Amendment also (a) adds an accordion feature in the Revolving Credit Facility that allows SPV I, under certain circumstances, to increase the size of the Revolving Credit Facility by an additional $250 million (the “Accordion”) to an amount not to exceed $1 billion in the aggregate and (b) establishes a new tranche consisting of the Commitment Increase and the Accordion, whereby any new advances made under such tranche bear interest at a per annum rate equal to Term SOFR for a three-month tenor in effect, plus the applicable margin of 2.55% per annum.

On June 30, 2023, SPV I executed a letter agreement (the “Third Amendment”) to amend the Revolving Credit Facility. The Third Amendment revises the Revolving Credit Agreement to provide that all borrowings in U.S. dollars now bear interest at a rate based on Term SOFR. The Third Amendment also amends the accordion feature of the Revolving Credit Agreement to increase the maximum borrowing capacity of SPV I under the Revolving Credit Agreement to an aggregate of $1 billion. The other material terms of the Revolving Credit Facility were unchanged.

On June 27, 2024, SPV I executed a letter agreement (the “Fourth Amendment”) to amend the Revolving Credit Facility. The Fourth Amendment revises the Revolving Credit Agreement to effect an extension of the reinvestment period to June 27, 2027, and of the scheduled termination date to June 27, 2029. The amended Revolving Credit Agreement includes a non-call period from the effective date of the Fourth Amendment until June 27, 2026. The Fourth Amendment also increases the financing commitment from $750 million to $850 million and reduces the applicable margin from 2.55% per annum to 2.45% per annum with respect to SOFR loans, as well as changing the rate for Canadian Dollar advances from the Canadian Dollar Offered Rate (CDOR) to a three-month term rate based on the Canadian Overnight Repo Rate Average (CORRA). In connection with the Fourth Amendment, SPV I paid an upfront fee of $5,562,500. The other material terms of the Revolving Credit Facility were unchanged.

On September 12, 2024, SPV I executed a letter agreement (the “Fifth Amendment”) to amend the Revolving Credit Facility. Under the Fifth Amendment, JPM and each other lender party and each of their respective successors and permitted assigns have agreed to make Tranche A Advances and Tranche B Advances to the Company as specified according to a transaction schedule. The other material terms of the Revolving Credit Facility were unchanged. SPV I’s obligations to the lenders under the Revolving Credit Facility are secured by a first priority security interest in all of SPV I’s portfolio of investments and cash. The obligations of SPV I under the Revolving Credit Facility are non-recourse to the Company, and the Company’s exposure under the Revolving Credit Facility is limited to the value of the Company’s investment in SPV I.

The Revolving Credit Facility is secured by a security interest in the assets of SPV I and on any payments received by SPV I in respect of those assets. Assets pledged to the lenders under the Revolving Credit Facility will not be available to pay the debts of the Company if such assets have been used to repay or otherwise satisfy the obligations owed under the Revolving Credit Facility.

115

Table of Contents

In connection with the Revolving Credit Facility, SPV I made certain customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar facilities. The Revolving Credit Facility contains customary events of default for similar financing transactions, including if a change of control of SPV I occurs. Upon the occurrence and during the continuation of an event of default, the lenders may declare the outstanding advances and all other obligations under the Revolving Credit Facility immediately due and payable.

The occurrence of an event of default (as described above) or a Market Value Event (as defined in the Revolving Credit Facility) triggers a requirement that SPV I obtain the consent of JPM prior to entering into any sale or disposition with respect to portfolio assets, and the occurrence of a Market Value Event triggers the right of JPM to direct SPV I to enter into sales or dispositions with respect to any portfolio assets, in each case in JPM’s sole discretion.

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the Revolving Credit Facility approximated its fair value. As of December 31, 2024 and 2023, unamortized financing costs of $8,179 and $4,067, respectively, are being deferred and amortized over the remaining term of the Revolving Credit Facility. As of December 31, 2024 and 2023, the Revolving Credit Facility had an outstanding balance of $680,000 and $666,000, respectively. As of December 31, 2024 and 2023, the Revolving Credit Facility is presented in the Consolidated Statements of Assets and Liabilities net of unamortized financing costs, which results in an outstanding balance, totaling $671,821 and $661,933, respectively.

The following table shows additional information about the interest and financing costs related to the Revolving Credit Facility for the years ended December 31, 2024, 2023, and 2022:

Year Ended

Year Ended

Year Ended

($ in thousands)

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

Interest expenses related to the Revolving Credit Facility

$

54,436

$

54,030

$

27,106

Financing expenses related to the Revolving Credit Facility

1,507

1,782

1,627

Total interest and financing expenses related to the Revolving Credit Facility

$

55,943

$

55,812

$

28,733

Secured Credit Facility

On August 14, 2023, SPV II entered into a $300 million Credit Agreement (as amended, the “Secured Credit Facility”), with the lenders from time to time parties thereto, Goldman Sachs Bank USA, as syndication agent and administrative agent (the “Administrative Agent”), U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator, and U.S. Bank National Association, as collateral custodian.

The Secured Credit Facility is comprised of (i) a $250 million asset-based revolving loan facility (the “ABL Facility”) and (ii) a $50 million asset-based revolving loan facility (the “Revolver Facility”), each of which has its own borrowing base (comprised of its respective eligible assets, as approved by the Administrative Agent from time to time) but both of which are generally subject to the same terms under the Secured Credit Facility. No gain or loss is recognized on any purchases or sales to or from SPV II and the Company.

The Secured Credit Facility is secured by a security interest in the assets of SPV II and on any payments received by SPV II in respect of those assets. Assets pledged to the lenders under the Secured Credit Facility will not be available to pay the debts of the Company if such assets have been used to repay or otherwise satisfy the obligations owed under the Secured Credit Facility.

The Secured Credit Facility will mature on August 14, 2028, unless terminated earlier as provided in the Secured Credit Facility. For each of the ABL Facility and the Revolver Facility, SPV II may draw and redraw loans in U.S. dollars, euros or British pound sterling under the Secured Credit Facility during a commitment period ending on August 14, 2026, unless the commitments are terminated earlier as provided in the Secured Credit Facility. Loans drawn under the Secured Credit Facility will bear interest at Term SOFR plus 3.10% per annum and, in the case of loans drawn in euros or British pound sterling, an additional currency benchmark adjustment will apply. The Secured Credit Facility contains customary covenants, including certain limitations on the activities of SPV II, and customary events of default.

116

Table of Contents

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the Secured Credit Facility approximated its fair value. As of December 31, 2024 and 2023, unamortized financing costs of $2,924 and $2,000 are being deferred and amortized over the remaining term of the Secured Credit Facility. As of December 31, 2024 and 2023, the Secured Credit Facility had an outstanding balance of $200,000 and $126,000, respectively. As of December 31, 2024 and 2023 the Secured Credit Facility is presented in the Consolidated Statements of Assets and Liabilities net of unamortized financing costs, which results in an outstanding balance totaling $197,076 and $124,000, respectively.

The following table shows additional information about the interest and financing costs related to the Secured Credit Facility for the year ended December 31, 2024 and for the period ended from August 14, 2023 to December 31, 2023:

Year Ended

Period from August 14, 2023 to

($ in thousands)

    

December 31, 2024

    

December 31, 2023

Interest expenses related to the Secured Credit Facility

$

17,002

$

3,782

Financing expenses related to the Secured Credit Facility

576

165

Total interest and financing expenses related to the Secured Credit Facility

$

17,578

$

3,947

2025 Notes

On May 19, 2022, the Company entered into a Note Purchase Agreement (the “NPA”) governing the issuance of $225 million in aggregate principal amount of senior unsecured notes due May 19, 2025 (the “2025 Notes”) to qualified institutional investors in a private placement. $150 million of the 2025 Notes were delivered and paid for on May 19, 2022, and $75 million of the 2025 Notes were delivered and paid for on August 18, 2022.

The 2025 Notes have a fixed interest rate of 5.83% per year, subject to a step up of (1) 1.00% per year, to the extent and for so long as the 2025 Notes fail to satisfy certain investment grade rating conditions and/or (2) 1.50% per year, to the extent and for so long as either the ratio of the Company’s secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter-end, or the Company fails to deliver the required quarterly or annual financial statements and related certificates when due.

The 2025 Notes mature on May 19, 2025, unless redeemed, purchased or prepaid prior to such date by the Company in accordance with the terms of the NPA. Interest on the 2025 Notes is due semiannually in May and November of each year, beginning in November 2022. In addition, the Company is obligated to offer to repay the 2025 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the NPA, the Company may redeem the 2025 Notes in whole or in part at any time or from time to time at the Company’s option at par plus accrued interest to the prepayment date and, if redeemed on or before February 17, 2025, a make-whole premium.

As of each of December 31, 2024 and 2023, the carrying amount of the Company’s borrowings under the 2025 Notes approximated its fair value. For the years ended December 31, 2024 and 2023, unamortized debt issuance costs of $388 and $1,343, respectively, are being deferred and amortized over the remaining term of the 2025 Notes. For both the years ended December 31, 2024 and 2023, the 2025 Notes had an outstanding balance of $225,000. For the years ended December 31, 2024 and 2023, the 2025 Notes are presented in the Consolidated Statements of Assets and Liabilities net of unamortized debt issuance costs, which results in an outstanding balance, totaling $224,612 and $223,657, respectively.

The following table shows additional information about the interest and financing costs related to the 2025 Notes for the years ended December 31, 2024 and 2023:

Year Ended

Year Ended

($ in thousands)

    

December 31, 2024

    

December 31, 2023

Interest expenses related to the 2025 Notes

$

13,118

$

13,118

Financing expenses related to the 2025 Notes

1,055

1,037

Total interest and financing expenses related to the 2025 Notes

$

14,173

$

14,155

117

Table of Contents

2029 Notes

On September 17, 2024, the Company entered into a Note Purchase Agreement (the “September 2024 NPA”) governing the issuance of $200 million in aggregate principal amount of senior unsecured notes due September 15, 2029 (the “2029 Notes”) to qualified institutional investors in a private placement.

The 2029 Notes have a fixed interest rate of 6.70% per year, subject to a step up of (1) 1.00% per year, to the extent and for so long as the 2029 Notes fail to satisfy certain investment grade rating conditions and/or (2) 1.50% per year, to the extent and for so long as either the ratio of the Company’s secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter-end, or the Company fails to deliver the required quarterly or annual financial statements and related certificates when due. The Company intends to use the net proceeds from the offering of the 2029 Notes to repay existing Indebtedness and for general corporate purposes.

The 2029 Notes will mature on September 15, 2029 unless redeemed, purchased or prepaid prior to such date by the Company in accordance with the terms of the September 2024 NPA. Interest on the 2029 Notes will be due semiannually in April and October of each year, beginning in April 2025. In addition, the Company is obligated to offer to repay the 2029 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the September 2024 NPA, the Company may redeem the 2029 Notes in whole or in part at any time or from time to time at the Company’s option at par plus accrued interest to the prepayment date and, if redeemed on or before June 16, 2029, a make-whole premium.

As of December 31, 2024 the carrying amount of the Company’s borrowings under the 2029 Notes approximated its fair value. As of December 31, 2024 unamortized debt issuance costs of $2,340 are being deferred and amortized over the remaining term of the 2029 Notes. As of December 31, 2024 the 2029 Notes had an outstanding balance of $200,000. The 2029 Notes are presented on the Consolidated Statements of Assets and Liabilities net of unamortized debt issuance costs, which results in an outstanding balance, totaling $197,660 as of December 31, 2024.

The following table shows additional information about the interest and financing costs related to the 2029 Notes for the year ended December 31, 2024:

    

For the period from

September 17, 2024 to

($ in thousands)

December 31, 2024

Interest expense related to the 2029 Notes

$

3,611

Financing expenses related to the 2029 Notes

139

Total interest and financing expenses related to the 2029 Notes

$

3,750

118

Table of Contents

Note 7. Net Assets

Unregistered Sales of Equity Securities

For the years ended December 31, 2024, 2023, and 2022, the Company has completed the following share issuances:

(in thousands, except share information)

    

Number of Common

    

Aggregate

Common Stock Issuance Date

Stock Issued

 Offering Price

December 31, 2024

81,918

$

1,625

December 30, 2024(1)

565,762

11,223

September 27, 2024(1)

647,722

12,833

September 27, 2024

117,353

2,325

July 2, 2024

282,309

5,600

June 28, 2024

6,539,426

129,521

June 28, 2024(1)

 

634,347

12,564

April 2, 2024

 

126,843

250

March 28, 2024

 

3,402,804

66,893

March 26, 2024(1)

 

461,503

9,072

December 28, 2023

2,305,457

45,037

December 26, 2023(1)

 

264,628

5,169

September 29, 2023

 

2,578,558

49,900

September 27, 2023(1)

 

218,518

4,229

June 28, 2023

 

1,126,918

21,800

June 26, 2023(1)

 

2,522,293

4,881

April 3, 2023

 

56,599

1,094

March 29, 2023

 

980,749

18,906

March 27, 2023(1)

 

239,681

4,428

December 30, 2022

 

2,467,892

48,500

December 27, 2022(1)

 

186,283

3,666

September 28, 2022

 

5,000,901

99,900

September 26, 2022(1)

 

138,540

2,768

June 29, 2022

 

2,498,950

50,000

June 27, 2022(1)

 

100,633

2,013

March 29, 2022

 

1,986,561

40,000

March 25, 2022

 

2,734,196

55,000

March 24, 2022(1)

 

87,065

1,751

(1)Shares were issued to stockholders participating in the Company’s DRIP.

For information related to the Company’s share issuances from its date of inception through December 31, 2021, see “Subscriptions and Drawdowns” under “Financial Condition, Liquidity and Capital Resources” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

All issuances of common stock are to be made at a price at least equal to the current net asset value, with such calculation to be carried out consistent with the Company’s valuation policies and procedures. For the year ended December 31, 2024, the Company issued 12,745,829 shares of Common Stock at an average price of $19.78 through private placement offerings and stockholders participating in the Company’s DRIP resulting in gross proceeds to the Company of $251,906. For the year ended December 31, 2023, the Company issued 8,013,401 shares of Common Stock at an average price of $19.40 through private placement offerings and stockholders participating in the Company’s DRIP resulting in gross proceeds to the Company of $155.4 million. For the year ended December 31, 2022, the Company issued 15,201,021 shares of Common Stock at an average price of $19.97 through private placement offerings and stockholders participating in the Company’s DRIP resulting in gross proceeds to the Company of $303.6 million. As of December 31, 2024 and 2023, the Company had 63,054,004 and 50,308,175 shares outstanding, respectively. As of December 31, 2024 and 2023, the Company has received capital commitments totaling $1,512.9 million and $1,282.1 million, respectively. As of December 31, 2024 and 2023, the Company has unfunded capital commitments of $336.6 million and $311.9 million, respectively.

119

Table of Contents

The sales of Common Stock were made pursuant to subscription agreements entered into by the Company and its investors. Under the terms of the subscription agreements, investors are required to fund drawdowns to purchase shares of Common Stock up to the amount of their respective capital commitments on an as-needed basis with a minimum of ten business days’ prior notice to the funding date.

Each of the sales of Common Stock is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof and Regulation D thereunder. The Company is still accepting new commitments. The Company has not engaged in general solicitation or advertising with regard to the issuance and sale of the Common Stock and has not offered securities to the public in connection with such issuance and sale. The Company relied, in part, upon representations from the investors in the subscription agreements that each investor was an accredited investor as defined in Regulation D under the Securities Act.

Distributions

For the year ended December 31, 2024, the Company declared the following distributions.

($ in thousands, except per share information)

    

    

Distribution Rate per

    

Record Date

Payment Date

Share

Distribution Paid

December 27, 2024

December 31, 2024

$

0.600

$

37,444

September 26, 2024

September 27, 2024

$

0.650

$

40,067

June 26, 2024

June 28, 2024

$

0.650

$

35,220

March 25, 2024

March 26, 2024

$

0.650

$

32,700

For the year ended December 31, 2023, the Company declared the following distributions.

($ in thousands, except per share information)

    

    

Distribution Rate per

    

Record Date

Payment Date

Share

Distribution Paid

December 22, 2023

December 26, 2023

$

0.670

$

31,985

September 25, 2023

September 27, 2023

$

0.655

$

29,436

June 23, 2023

June 26, 2023

$

0.640

$

27,880

March 24, 2023

March 27, 2023

$

0.600

$

25,377

For the year ended December 31, 2022, the Company declared the following distributions.

($ in thousands, except per share information)

    

    

Distribution Rate per

    

Record Date

Payment Date

Share

Distribution Paid

December 23, 2022

December 27, 2022

$

0.550

$

21,802

September 23, 2022

September 26, 2022

$

0.510

$

17,596

June 24, 2022

June 27, 2022

$

0.405

$

12,970

March 23, 2022

March 24, 2022

$

0.425

$

11,515

Note 8. Investments

The following table presents the composition of the Company’s investment portfolio at cost and fair value as of December 31, 2024 and 2023.

    

December 31, 2024

    

December 31, 2023

 

Percent of

Percent of 

Amortized

Fair

Total Portfolio

Fair

Total Portfolio

Investments:

    

 Cost

    

Value

    

at Fair Value

    

Amortized Cost

    

Value

    

at Fair Value

 

First Lien Loans

$

2,207,578

$

2,209,392

88.2

%

$

1,732,531

$

1,727,610

86.3

%

Second Lien Loans

157,690

151,362

6.0

178,040

165,870

8.3

Unsecured Notes

 

90,353

91,375

3.7

66,198

68,012

3.4

Preferred Equity

34,833

36,226

1.5

27,272

27,540

1.4

Common Equity and Warrants

 

12,353

15,887

0.6

8,584

10,593

0.6

Total Investments

$

2,502,807

$

2,504,242

100.0

%

$

2,012,625

$

1,999,625

100.0

%

120

Table of Contents

The geographic composition of investments based on fair value as of December 31, 2024 and 2023 as follows:

    

December 31, 2024

    

December 31, 2023

 

U.S.

98.9

%

98.4

%

Non-U.S.

1.1

1.6

Total

100.0

%

100.0

%

The industry composition of investments based on fair value as of December 31, 2024 and 2023 was as follows:

    

December 31, 2024

    

December 31, 2023

 

Capital Markets

5.0

%

4.7

%

Diversified Consumer Services

0.7

0.6

Financial Services

9.5

10.8

Health Care Providers & Services

16.8

13.0

Health Care Technology

3.1

6.2

Insurance

21.9

22.3

IT Services

7.8

12.1

Professional Services

16.5

13.0

Real Estate Management & Development

4.6

2.5

Software

12.6

14.8

Consumer Finance

1.5

0.0

Total

100.0

%

100.0

%

Note 9. Fair Value of Investments

Under ASC Topic 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between a willing buyer and a willing seller at the measurement date. For the Company’s portfolio securities, fair value is generally the amount that the Company might reasonably expect to receive upon the current sale of the security. The fair value measurement assumes that the sale occurs in the principal market for the security, or in the absence of a principal market, in the most advantageous market for the security. If no market for the security exists or if the Company does not have access to the principal market, the security should be valued based on the sale occurring in a hypothetical market.

ASC 820 specifies a fair value hierarchy that prioritizes and ranks the level of observability of inputs used in determination of fair value. In accordance with ASC 820, these levels are summarized below:

Level 1 Valuations – include quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2 Valuations – include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 Valuations – include inputs that are unobservable and significant to the fair value measurement.

A financial instrument is categorized within the ASC Topic 820 valuation hierarchy based upon the lowest level of input to the valuation process that is significant to the fair value measurement. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized as Level 3 investments within the tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). Transfers between levels, if any, will be recognized at the beginning of the period in which the transfer occurred.

The Company’s investment portfolio includes certain debt and equity instruments of privately held companies for which quoted prices or other inputs falling within the categories of Level 1 and Level 2 are generally not available. In such cases, the Adviser determines the fair value of the Company’s investments in good faith primarily using Level 3 inputs. In certain cases, quoted prices or other observable inputs exist, and if so, the Adviser assesses the appropriateness of the use of these third-party quotes in determining fair value based on (i) the Adviser’s understanding of the level of actual transactions used by the broker to develop the quote and whether the quote was an indicative price or binding offer and (ii) the depth and consistency of broker quotes and the correlation of changes in broker quotes with underlying performance of the portfolio company.

121

Table of Contents

The Company applies the practical expedient provided by the ASC Topic 820 relating to investments in certain entities that calculate NAV per share (or its equivalent). ASC Topic 820 permits an entity holding investments in certain entities that either are investment companies, or have attributes similar to an investment company, and calculate NAV per share or its equivalent for which the fair value is not readily determinable, to measure the fair value of such investments on the basis of that NAV per share, or its equivalent, without adjustment. Investments which are valued using NAV per share as a practical expedient are not categorized within the fair value hierarchy as per ASC Topic 820.

There is no single standard for determining fair value in good faith, as fair value depends upon the specific circumstances of each individual investment. The recorded fair values of the Company’s Level 3 investments may differ significantly from fair values that would have been used had an active market for the securities existed. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the valuations currently assigned.

The following table presents the fair value hierarchy as of December 31, 2024.

($ in thousands)

    

Fair Value Hierarchy as of December 31, 2024

Description

    

Level 1

    

Level 2

    

Level 3

    

Total

First Lien Loans

$

$

33,634

$

2,175,758

2,209,392

Second Lien Loans

71,766

79,596

151,362

Unsecured Notes

3,435

87,940

91,375

Preferred Equity

36,226

36,226

Common Equity & Warrants

11,696

11,696

Subtotal

$

$

108,835

2,391,216

2,500,051

Investments measured at NAV

$

$

4,191

Total investments at fair value

$

$

108,835

2,391,216

2,504,242

The following table presents the fair value hierarchy as of December 31, 2023.

($ in thousands)

    

Fair Value Hierarchy as of December 31, 2023

Description

    

Level 1

    

Level 2

    

Level 3

    

Total

First Lien Loans

$

$

3,933

$

1,723,677

$

1,727,610

Second Lien Loans

14,466

151,404

165,870

Unsecured Notes

19,679

48,333

68,012

Preferred Equity

27,540

27,540

Common Equity & Warrants

10,593

10,593

Total investments at fair value

$

$

38,078

$

1,961,547

$

1,999,625

122

Table of Contents

The following tables present changes in the fair value of investments for which Level 3 inputs were used to determine the fair value as of and for the years ended December 31, 2024, 2023, and 2022:

($ in thousands)

First Lien

Second Lien

Unsecured

Preferred

Common Equity

 

Year Ended December 31, 2024

    

Loans

    

Loans

    

Notes

    

Equity

    

& Warrants

    

Total

Fair value, beginning of period

$

1,723,677

$

151,404

$

48,333

$

27,540

$

10,593

$

1,961,547

Purchases of investments

985,731

120,393

58,413

7,483

3,769

1,175,789

Proceeds from sales and principal payments

(552,507)

(158,593)

(19,641)

(730,741)

Realized gain (loss) on investments

6,348

(8,157)

(1,809)

Net change in unrealized appreciation/(depreciation)

5,627

6,061

656

1,125

1,066

14,535

Net accretion of discount and amortization of investments

6,880

251

180

79

7,390

Transfers into (out of) Level 3

(31,763)

(3,732)

(35,495)

Fair value, end of period

$

2,175,756

$

79,596

$

87,941

$

36,226

$

11,696

$

2,391,216

($ in thousands)

    

First Lien

    

Second Lien

    

Unsecured

    

Preferred

    

Common Equity

Year Ended December 31, 2023

    

Loans

    

Loans

    

Notes

    

Equity

    

& Warrants

Total

Fair value, beginning of period

$

1,391,696

$

149,314

$

31,325

$

9,925

$

3,635

$

1,585,895

Purchases of investments

452,849

16,558

16,594

5,217

491,218

Proceeds from sales and principal payments

(135,867)

(175)

(268)

(136,310)

Realized gain (loss) on investments

2,181

(670)

1,511

Net change in unrealized appreciation/(depreciation)

7,743

2,679

304

988

2,009

13,723

Net accretion of discount and amortization of investments

5,075

255

146

33

5,509

Transfers into (out of) Level 3

Fair value, end of period

$

1,723,677

$

151,404

$

48,333

$

27,540

$

10,593

$

1,961,547

($ in thousands)

    

First Lien

    

Second Lien

    

Unsecured

    

Preferred

    

Common Equity

    

Year Ended December 31, 2022

Loans

Loans

Notes

Equity

& Warrants

Total

Fair value, beginning of period

$

1,011,840

$

102,084

$

20,000

$

2,000

$

$

1,135,924

Purchases of investments

551,196

64,317

11,878

8,640

3,635

639,666

Proceeds from sales and principal payments

(161,001)

(15,043)

(176,044)

Realized gain (loss) on investments

63

154

217

Net change in unrealized appreciation/(depreciation)

(16,052)

(15,429)

(656)

(720)

(32,857)

Net accretion of discount and amortization of investments

5,650

211

103

5

5,969

Transfers into (out of) Level 3

13,020

13,020

Fair value, end of period

$

1,391,696

$

149,314

$

31,325

$

9,925

$

3,635

$

1,585,895

During the years ended December 31, 2024, there was one transfer out of Level 3 into Level 2 because of an increase in observable inputs and one transfer out of Level 3 as a result of utilizing NAV as a practical expedient. During the year ended December 31, 2023, there were no transfers into Level 3.During the year ended December 31, 2022, there was one transfer into Level 3 from Level 2 because of a decrease in unobservable inputs.

123

Table of Contents

The following table presents the net change in unrealized appreciation (depreciation) for Level 3 investments that were still held at December 31, 2024, 2023, and 2022:

($ in thousands)

Year Ended

Year Ended

Year Ended

Net Change in Unrealized Appreciation (Depreciation)

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

First Lien Loans

$

5,627

$

7,743

$

(16,052)

Second Lien Loans

6,061

2,679

(15,429)

Unsecured Notes

656

304

(656)

Preferred Equity

1,125

988

(720)

Common Equity & Warrants

1,066

2,009

Total

$

14,535

$

13,723

$

(32,857)

The following table presents quantitative information about the significant unobservable inputs of the Company’s Level 3 investments as of December 31, 2024. The weighted average range of unobservable inputs is based on the fair value of investments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Adviser’s determination of fair value.

($ in thousands)

    

December 31, 2024

Type of Investment

    

Fair Value

    

Valuation technique

    

Unobservable input

    

Range (weighted average)

First Lien Loans

$

1,973,337

Discounted Cash Flow

Discount Rate

8.4% - 17.5% (10.1%)

First Lien Loans

181,212

Market Transaction

Market Transaction

98.5% - 99.5% (99.0%)

First Lien Loans

21,207

Recovery Analysis

Recovery Rate

6.5x

Second Lien Loan

64,671

Discounted Cash Flow

Discount Rate

9.0% - 21.2% (14.1%)

Second Lien Loan

14,925

Market Transaction

Market Transaction

99.5%

Unsecured Notes

53,726

Discounted Cash Flow

Discount Rate

8.0% - 16.1% (12.7%)

Unsecured Notes

34,215

Market Transaction

Market Transaction

98.0% - 100.0% (98.9%)

Preferred Equity

33,086

Discounted Cash Flow

Discount Rate

13.2% - 15.0% (14.4%)

Preferred Equity

3,140

Enterprise Value Analysis

EBITDA Multiple

20.5x

Equity

11,696

Enterprise Value Analysis

EBITDA Multiple

6.5x – 25.0x (18.3x)

Total

$

2,391,216

The following table presents quantitative information about the significant unobservable inputs of the Company’s Level 3 investments as of December 31, 2023. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Adviser’s determination of fair value.

    

December 31, 2023

 

Type of Investment

    

Fair Value

    

Valuation technique

    

Unobservable input

    

Range (weighted average)

 

First Lien Loans

$

513,902

Discounted Cash Flow

Discount Rate

9.4% - 16.2% (11.0%)

First Lien Loans

1,209,775

Market Transaction

Market Transaction

95.1% - 101.0% (98.6%)

Second Lien Loan

151,404

Market Transaction

Market Transaction

79.1% - 100.0% (91.9%)

Unsecured Notes

20,219

Discounted Cash Flow

Discount Rate

10.6% - 10.6% (10.6%)

Unsecured Notes

28,114

Market Transaction

Market Transaction

90.7% - 100.0% (94.8%)

Preferred Equity

2,635

Discounted Cash Flow

Discount Rate

131.7%

Preferred Equity

24,905

Market Transaction

Market Transaction

93.6% - 98.5% (96.4%)

Common Equity

9,523

Market Transaction

Market Transaction

100.0% - 127.6% (113.2%)

Warrants

1,070

Market Transaction

Market Transaction

366.9%

Total

$

1,961,547

Increases or decreases in unobservable inputs in isolation would result in a higher or lower fair value measurement for such assets. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s investments.

124

Table of Contents

Note 10. Earnings Per Share

In accordance with the provisions of ASC Topic 260, Earnings per Share (“ASC 260”), basic and diluted net increase in net assets resulting from operations per common share is computed by dividing the net increase in net assets resulting from operations by the weighted average number of shares outstanding during the period. The methodology for the weighted average number of shares outstanding during the period utilizes the weighted average number of shares from December 31, 2022 through December 31, 2023, and December 31, 2023 through December 31, 2024. Other potentially dilutive common stock, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis. As of December 31, 2024 and 2023, there were no dilutive shares.

The following table sets forth the computation of basic and diluted earnings per common stock for the years ended December 31, 2024, 2023, and 2022:

Year Ended

Year Ended

Year Ended

($ in thousands, except share and per share information)

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

Net increase in net assets resulting from operations

$

153,600

$

133,472

$

31,850

Weighted average common shares of common stock outstanding—basic and diluted

57,255,840

44,712,958

33,466,524

Basic and diluted net increase in net assets resulting from operations per common share

$

2.68

$

2.99

$

0.95

Note 11. Taxes

The Company has elected to be treated and intends to qualify annually as a RIC, to distribute substantially all of its income and to comply with the other requirements of the Code applicable to RICs. Accordingly, no provision for federal taxes is required. In addition, by distributing during each calendar year substantially all of its net investment income, net realized capital gains and certain other amounts, if any, the Company intends not to be subject to a material federal excise tax. The Company did not have any liabilities for uncertain tax positions or unrecognized tax benefits as of December 31, 2024.

For the year ended December 31, 2024, the Company had $5,012 of undistributed ordinary income, $5,895 of capital losses, $1,448 of net unrealized appreciation on investments and $(172) of other temporary differences. For the year ended December 31, 2023, the Company had $5,338 of undistributed ordinary income, $133 of capital losses, $12,999 of net unrealized depreciation on investments and $(188) of other temporary differences. For the year ended December 31, 2022, the Company had $2,655 of undistributed ordinary income, $29,375 of net unrealized depreciation on investments and $(204) of other temporary differences. Total distributions declared during the years ended December 31, 2024, December 31, 2023, and 2022 were comprised entirely of ordinary income.

During the years ended December 31, 2024, 2023, and 2022, the Company recorded a Return of Capital Statement of Position (“ROCSOP”) adjustment for permanent book to tax differences of $206, $147 and $118, respectively, primarily due to the differing book and tax treatment of offering costs and excise taxes.

As of December 31, 2024 and 2023, the tax cost of the Company’s investments approximates its amortized cost.

125

Table of Contents

Note 12. Financial Highlights

The following per common stock data has been derived from information provided in the financial statements. The following is a schedule of financial highlights for the years ended December 31, 2024, 2023, 2022, 2021 and for the period from September 8, 2020 (inception) through December 31, 2020:

    

For the Period

 

September 8, 2020

 

Year Ended

Year Ended

Year Ended

Year Ended

(inception) through

 

($ in thousands, except share and per share information)

    

December 31, 2024

    

December 31, 2023

    

December 31, 2022

December 31, 2021

    

December 31, 2020

 

Per common stock operating performance:

Net asset value, beginning of year/period

$

19.71

$

19.32

$

20.14

$

19.39

$

20.00

Results of operations:

 

 

 

 

Net investment income (loss) 1

 

2.53

 

2.62

 

1.94

1.51

 

(0.61)

Net realized gains (losses) and unrealized appreciation (depreciation) 2

 

0.15

 

0.34

 

(0.87)

0.20

 

Net increase (decrease) in net assets resulting from operations

 

2.68

 

2.96

 

1.07

1.71

 

(0.61)

Distributions to Common Stockholders

 

 

 

 

Distributions from earnings

 

(2.55)

 

(2.57)

 

(1.89)

(0.96)

 

Net decrease in net assets resulting from distributions

 

(2.55)

 

(2.57)

 

(1.89)

(0.96)

 

Net asset value, end of year/period

$

19.85

$

19.71

$

19.32

$

20.14

$

19.39

Shares outstanding, end of year/period

 

63,054,004

 

50,308,175

 

42,294,773

27,093,753

 

1,250,050

Ratio/Supplemental data:

 

 

 

 

Net assets, end of year/period

$

1,251,497

$

991,422

$

817,186

$

545,569

$

24,233

Weighted average shares outstanding

 

57,255,840

 

44,712,958

 

33,466,524

11,072,368

 

233,393

3

Total return 4

 

14.34

%  

 

16.21

%  

 

5.35

%  

8.91

%  

 

(3.05)

%

Portfolio turnover

 

34.89

%  

 

11.09

%  

 

13.26

%  

9.90

%  

 

5

Ratio of operating expenses to average net assets 6

 

11.44

%  

 

12.20

%  

 

9.37

%  

5.81

%  

 

15.79

%

Ratio of net investment income (loss) to average net assets 6

 

12.51

%  

 

13.14

%  

 

9.36

%  

6.34

%  

 

(15.01)

%

1The per common stock data was derived by using weighted average shares outstanding.
2The amount shown at this caption is the balancing amount derived from the other figures in the schedule. The amount shown at this caption for a share outstanding throughout the year/period does not agree with the change in the aggregate appreciation and depreciation in portfolio securities for the period because of the timing of sales of the Company’s shares in relation to fluctuating market values for the portfolio.
3Calculated for the period November 17, 2020, the date of the first external issuance of shares, through December 31, 2020.
4Total return is based upon the change in net asset value per share between the opening and ending net asset values per share, assuming reinvestment of any distributions during the period. Total return is not annualized and does not include a sales load.
5Portfolio turnover is not applicable.
6The ratios reflect an annualized amount. Non-recurring expenses were not annualized. During the years ended December 31, 2024, 2023, 2022 and 2021 the Company incurred $56 , $97, $116 and $365 of Organizational and Offering Expenses, respectively. During the period from September 8, 2020 (inception) through December 31, 2020, the Company incurred $298 of Organizational and Offering expenses. Organizational and Offering Expenses were deemed to be non-recurring.

126

Table of Contents

Note 13. Subsequent Events

Management has evaluated subsequent events and transactions for potential recognition and/or disclosure through the date the financial statements were issued. Except as set forth below, there have been no subsequent events that occurred during such period that would require disclosure in this Form 10-K or would be required to be recognized in the consolidated financial statements as of and for the year ended December 31, 2024.

On March 3, 2025, (the “First Amendment Date”), SPV II entered into an amendment to its Secured Credit Facility which, among other things, reduces the spread to 2.00% per annum, extends the reinvestment period to three years after the First Amendment Date, and extends the maturity date to five years after the First Amendment Date.

127

Table of Contents

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

There are not and have not been any disagreements between the Company and its accountant on any matter of accounting principles, practices, or financial statement disclosure.

Item 9A. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As of December 31, 2024 (the end of the period covered by this report), our management, including our Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the 1934 Act). Based on that evaluation, our management, including the Principal Executive Officer and Principal Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

(b) Report of Management on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, and for performing an assessment of the effectiveness of internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management performed an assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2024 based upon the criteria in the 2013 Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on management’s assessment, management determined that the Company’s internal control over financial reporting was effective as of December 31, 2024.

Due to the Company’s status as an “emerging growth company” under the JOBS Act, the Company was not required to obtain an attestation report from the Company’s independent registered public accounting firm on the Company’s internal control over financial reporting as of December 31, 2024.

Item 9B. Other Information

Rule 10b5-1 Trading Plans

During the fiscal quarter ended December 31, 2024, none of our directors or executive officers adopted or terminated any contract, instruction, or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable

128

Table of Contents

PART III.

Item 10. Directors, Executive Officers and Corporate Governance

Holders of our common stock will vote for the election of directors. Each class of directors holds office for a three-year term. At each annual meeting of Stockholders, the successors to the class of directors whose terms expire at such meeting will be elected to hold office for a term expiring at the annual meeting of Stockholders held in the third year following the year of their election.

Each director holds office for the term to which he or she is elected or appointed and until his or her successor is duly elected and qualifies, or until his or her earlier death, resignation, retirement, disqualification or removal.

Directors

Information regarding the board of directors is as follows:

    

    

    

Expiration of

Name

Age

Position(s) Held

Term

Interested Directors

 

  

 

  

 

  

David J. Wermuth

 

56

 

Chairman

 

2026

Scott J. Bronner

 

41

 

President

 

2025

Independent Directors

 

  

 

  

 

  

Jennifer J. Burleigh

 

58

 

Director

 

2027

Scott E. Heberton

 

58

 

Director

 

2025

Peter E. Roth

 

66

 

Director

 

2026

The address for each director is c/o Stone Point Credit Corporation, 20 Horseneck Lane, Greenwich, Connecticut 06830.

Executive Officers Who Are Not Directors

Information regarding the Company’s current executive officers who are not directors is as follows:

Name

    

Age

    

Position(s) Held

Steven Henke

 

41

 

Chief Financial Officer and Treasurer

Brian J. Rooder

 

48

 

Chief Compliance Officer and Secretary

The address for each executive officer is c/o Stone Point Credit Corporation, 20 Horseneck Lane, Greenwich, Connecticut 06830.

Biographical Information

Interested Directors

David J. Wermuth Mr. Wermuth is the Chairman of the Board, Managing Director and General Counsel of the Adviser, Co-President, Chief Operating Officer and General Counsel Stone Point Capital, a member of the Investment Committees of the Adviser and the general partners of the Trident Funds, and a member of the Allocation Committee and Valuation Committee of the Adviser. Mr. Wermuth is also a member of Stone Point’s Risk and Compliance Committee and currently serves on the board of Stone Point Credit Income Fund. He joined the Stone Point platform in 1999 from Cleary, Gottlieb, Steen & Hamilton LLP, where from 1996 to 1999 he was a corporate attorney specializing in mergers and acquisitions. Prior to joining Cleary Gottlieb, Mr. Wermuth served as a law clerk to a federal judge of the U.S. Court of Appeals for the Ninth Circuit and as an auditor for KPMG Peat Marwick. Mr. Wermuth holds a B.A. from Yale University, an M.B.A. from the New York University Leonard N. Stern School of Business and a J.D. from Cornell Law School.

Scott J. Bronner is the President of the Company, Head of Stone Point Credit and Managing Director of Stone Point Capital, and a member of the Investment Committee, Allocation Committee and Valuation Committee of the Adviser. Mr. Bronner currently serves on the board of Stone Point Credit Income Fund. Prior to joining the Stone Point platform in 2009, Mr. Bronner was an Analyst in the Private Equity Division at Lehman Brothers Inc. Mr. Bronner holds a B.A. from Amherst College.

129

Table of Contents

Independent Directors

Jennifer J. Burleigh, a retired partner of Debevoise & Plimpton (“Debevoise”), focused her legal practice on advising sponsors of private investment funds covering a broad array of strategies, including leveraged buyout, energy/infrastructure, real estate, mezzanine and distressed debt and equity. Ms. Burleigh had significant experience in emerging markets fund formation, including assisting emerging market-based sponsors in accessing international markets. Ms. Burleigh also advised with respect to asset manager spin-outs, strategic investments in private investment firms and the establishment of new investment firms. Ms. Burleigh joined Debevoise in 1994, becoming a partner in 2002. She retired from practice in 2014 and has devoted her time to non-profit work and writing fiction. Ms. Burleigh currently serves on the board of Stone Point Credit Income Fund and Concord Academy in Concord, Massachusetts. Ms. Burleigh received her B.A. with honors from Stanford University in 1989, and her J.D. in 1994 from Columbia Law School, where she was a Harlan Fiske Stone Scholar and a managing editor of the Columbia Law Review.

Scott E. Heberton currently serves as an Advisor to Lovell Minnick Partners, an Independent Trustee of Stone Point Credit Income Fund and a Board Member and Executive Chairman of Omni Healthcare Financial, LLC following his retirement from Wells Fargo Securities in 2019. During his tenure at Wells Fargo Securities, Mr. Heberton served for over 10 years as Head of FIG Investment Banking and Capital Markets. He was a member of the Investment Bank’s Operating Committee as well as the Investment Banking Commitment Committee and Advisory Committee. Mr. Heberton’s extensive career in Financial Services has been primarily focused on advisory work and capital raising for the industry verticals of Specialty Finance, Residential and Commercial Real Estate and Alternative Asset Management. Mr. Heberton earned his M.B.A. from The Fuqua School of Business at Duke University and holds a Bachelor of Arts degree in Economics from the University of Virginia.

Peter E. Roth is the Managing Partner of the Rothpoint Group LLC, a consulting firm specializing in the financial services industry. Mr. Roth is a Non-Executive Director and Senior Independent Director of the City of London Investment Group plc, a publicly traded (London Stock Exchange) asset management firm. He is also Chairman of the Audit Committee and a member of the Nominations and Remuneration Committees. Mr. Roth serves as an Independent Trustee of the Guggenheim Credit Income Fund (and related entities) and is Chairman of the Audit Committee and a Member of the Nomination and Governance and Independent Trustee Committees. He also serves on the board of Stone Point Credit Income Fund. In the non-profit sector, he serves on the Board of St. Mary’s Healthcare System for Children and is Chairman of the Finance Committee and a member of the Executive Committee. Prior to establishing Rothpoint, Mr. Roth had a 35 year plus career in the financial services industry. He was the head of investment banking at Fox, Pitt, Kelton Inc. for thirteen years and a member of the firm’s Operating Committee. At Keefe, Bruyette & Woods, he joined as the Head of Insurance Investment Banking and later became the Chief Executive Officer of KBW Asset Management, an SEC registered investment firm specializing in the financial services industry. He served on the firm’s Operating Committee and was a member of the Board of Directors of KBW, Inc. at the time of its initial public offering. Mr. Roth received a Bachelor of Arts degree from the University of Pennsylvania and Master’s of Business Administration from The Wharton School at the University of Pennsylvania.

Executive Officers Who are Not Directors

Steven Henke is the Chief Financial Officer and Treasurer of the Company and a Vice President of Stone Point Credit. Mr. Henke has been with Stone Point since 2020 and is a member of the Valuation Committee, the Risk and Compliance Committee and the Disclosure Controls Committee. Previously, Mr. Henke was a Controller at TriplePoint Capital and Medley Capital and an Audit Manager at Ernst & Young. Mr. Henke holds a B.S. in Accounting from Fordham University and is a Certified Public Accountant in New York.

Brian J. Rooder is the Chief Compliance Officer and Secretary of the Company and Chief Compliance Officer and Counsel at Stone Point Credit. Mr. Rooder joined Stone Point Credit in June 2024 from TPG Angelo Gordon where from 2018 to 2024, he was a Managing Director and Senior Compliance Counsel. Prior to joining TPG Angelo Gordon, Mr. Rooder was the Chief Compliance Officer & Associate General Counsel of Pretium Partners from 2017 to 2018. In addition, Mr. Rooder was an Associate at Ropes & Gray and Davis Polk. Mr. Rooder holds a B.A. from the State University of New York at Albany, and a J.D. from Fordham University School of Law.

Other Officers

Sally DeVino is a Vice President of the Company and a Managing Director and the Chief Financial Officer of Stone Point Capital. She joined Stone Point in 1995. Previously, she was a Senior Manager with BDO Seidman, where for eight years she

130

Table of Contents

provided audit, tax and consulting services in the manufacturing, construction, banking and not-for-profit industries. Ms. DeVino holds a B.S. from Manhattan College and was a Certified Public Accountant.

Jacqueline M. Giammarco is the Chief Compliance Officer, Managing Director and Counsel of Stone Point Capital. She joined Stone Point in 2012 from MF Global where from 2007 to 2012, she was Senior Vice President and Assistant General Counsel. Prior to joining MF Global, Ms. Giammarco was a corporate partner at Katten Muchin Rosenman, joining the firm as an associate in the corporate department in 1997. Ms. Giammarco advised senior executives, boards of directors and in-house counsels on a variety of corporate legal matters. Ms. Giammarco holds a B.A. from Wilfrid Laurier University, an LL.B. from the University of Alberta Law School and an LL.M. in Corporate Law from the New York University School of Law.

Mike Hickey is a Managing Director and Tax Director at Stone Point. He joined Stone Point in 2019. Previously, he was a Principal in the Tax Finance Group at Apollo Global Management and an Executive Director in the Transaction Tax Group at Ernst & Young. Mr. Hickey holds an M.B.A. and LL.M. from New York University, a J.D. from Fordham University and a B.E. from Manhattan College.

Audit Committee

The Audit Committee is currently composed of all of the Independent Directors. Peter E. Roth serves as Chair of the Audit Committee. The Board has determined that Mr. Roth is an “audit committee financial expert” as that term is defined under Item 407 of Regulation S-K, as promulgated under the Exchange Act. Mr. Roth, Ms. Burleigh, and Mr. Heberton meet the current requirements of Rule 10A-3 under the Exchange Act. The Audit Committee operates pursuant to a charter approved by the Board, which sets forth the responsibilities of the Audit Committee. The Audit Committee’s responsibilities include establishing guidelines and making recommendations to the Board regarding the valuation of the Company’s investments; selecting the Company’s independent registered public accounting firm; reviewing with such independent registered public accounting firm the planning, scope and results of their audit of the Company’s financial statements; pre-approving the fees for services performed; reviewing with the independent registered public accounting firm the adequacy of internal control systems; reviewing the Company’s annual audited financial statements, and periodic filings; and receiving the Company’s audit reports and financial statements.

Nominating and Corporate Governance Committee

The members of the Nominating and Corporate governance committee are the Independent Directors. Jennifer J. Burleigh serves as Chair of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee is responsible for selecting, researching and nominating directors for election by the Stockholders, selecting nominees to fill vacancies on the Board or a committee of the Board, developing and recommending to the Board a set of corporate governance principles and overseeing the evaluation of the Board and management.

Code of Ethics

The Company and the Adviser have each adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain transactions by the Company’s personnel. These codes of ethics generally will not permit investments by the Company’s and the Adviser’s personnel in securities that may be purchased or sold by the Company.

Insider Trading Policy

The Company has adopted an Insider Trading Policy applicable to us, our officers and our directors that we believe is reasonably designed to promote compliance with insider trading laws, rules and regulations. A copy of the Insider Trading Policy has been filed as an exhibit to this Annual Report on Form 10-K.

131

Table of Contents

Item 11. Executive Compensation

Compensation of Executive Officers

The Company does not currently have any employees and does not expect to have any employees. Each of the Company’s executive officers is an employee of the Adviser and/or one of its affiliates. The Company’s day-to-day investment operations are managed by the Adviser. Most of the services necessary for the origination and management of the Company’s investment portfolio are provided by investment professionals employed by the Adviser and/or its affiliates.

None of the Company’s executive officers receive direct compensation from the Company. Certain of the Company’s executive officers and other members of the Investment Team, through their ownership interest in or management positions with the Adviser, may be entitled to a portion of any profits earned by the Adviser or its affiliates (including any fees payable to the Adviser under the terms of the Investment Advisory Agreement, less expenses incurred by the Adviser in performing its services under the Investment Advisory Agreement). The Adviser or its affiliates may pay additional salaries, bonuses, and individual performance awards and/or individual performance bonuses to the Company’s executive officers in addition to their ownership interest.

Compensation of Independent Directors

The Independent Directors’ annual fee is $100,000 plus $2,500 per each scheduled quarterly Board of Directors meeting attended, plus an additional $35,000 per year to be paid to the Chair of the Audit Committee and an additional $2,500 per year to be paid to the Chair of the Nominating & Corporate Governance Committee. The Independent Directors also receive reimbursement of reasonable out-of-pocket expenses incurred in connection with attending any meeting. No compensation is expected to be paid to the Interested Directors with respect to the Company.

The following table sets forth compensation of the Company’s Independent Directors for the fiscal year ended December 31, 2024.

    

Fees

    

    

All Other

    

Name

Earned (1)

Stock Awards (2)

Compensation

Total

Jennifer J. Burleigh

$

112,500

 

 

 

112,500

Scott Heberton

$

110,000

 

 

 

110,000

Peter E. Roth

$

145,000

 

 

 

145,000

(1)

No compensation is paid to our directors who are “interested persons,” as such term is defined in Section 2(a)(19) of the 1940 Act.

(2)

We do not maintain a stock or option plan, non-equity incentive plan or pension plan for our directors.

Timing of Grants of Options

The Company did not grant awards of stock options, stock appreciation rights or similar option-like instruments during fiscal year 2024. Accordingly, we have nothing to report under Item 402(x) of Regulation S-K.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth, as of March 24, 2025, the beneficial ownership of each director and executive officer of the Company, and the executive officers and directors as a group.

132

Table of Contents

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Unless otherwise indicated, the Company believes that each beneficial owner set forth in the table has sole voting and investment power and has the same address as the Company. Our address is 20 Horseneck Lane, Greenwich, Connecticut 06830.

    

Number of

    

 

Shares

 

Owned

Percentage

 

Name and Address of Beneficial Owner

Beneficially (1)

of Class (2)(3)

 

Interested Directors

David J. Wermuth

 

— 

 

%

Scott J. Bronner

 

37,948

 

*

%

Independent Directors

 

  

 

  

Jennifer J. Burleigh

 

 

%

Scott E. Heberton

 

 

%

Peter E. Roth

 

 

%

Executive Officers

 

  

 

  

Steven Henke

 

5,119

 

*

%

Brian J. Rooder

 

 

%

All executive officers and directors as a group (seven persons)

 

43,067

 

*

%

*

Represents less than 1%

(1)

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act.

(2)

Based on a total of 63,054,004 shares issued and outstanding on March 24, 2025.

(3)

As of March 24, 2025, the Company had 196 holders of its Common Stock.

Set forth below is the dollar range of equity securities beneficially owned by each of our directors as of March 24, 2025. We are not part of a “family of investment companies,” as that term is defined in the 1940 Act.

    

Dollar

Range of

Equity

Securities

Beneficially

Name of Director

Owned (1)(2)

Interested Directors

 

  

David J. Wermuth

 

None

Scott J. Bronner

 

Over $100,000

Independent Directors

 

  

Jennifer J. Burleigh

 

None

Scott E. Heberton

 

None

Peter E. Roth

 

None

(1)

The dollar ranges are: None, $1-$10,000, $10,001-$50,000, $50,001-$100,000, or Over $100,000.

(2)

Beneficial ownership has been determined in accordance with Rule 16a-1(a)(2) of the Exchange Act.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Various potential and actual conflicts of interest may arise from the overall investment activities of the Adviser for their own accounts and for the accounts of others. The following briefly summarizes some of these conflicts, but is not intended to be an exhaustive list of all such conflicts.

133

Table of Contents

Allocation of Time, Services or Functions

The Investment Team and other investment professionals and individuals providing services on behalf of the Adviser will continue to devote such time and attention to other present and future business activities and advisory relationships, including any other Stone Point Funds, as is required to discharge duties to them, and conflicts of interest may arise in allocating management time, services or functions among the Company, on the one hand, and any other present and future business activities and advisory relationships, on the other hand. Other conflicts of interest may arise for Stone Point and the Investment Team in connection with their management of the Company and other clients, including certain transactions involving investments by the Company and other clients in the same portfolio company (including in respect of timing, structuring, and terms of such investments and disposition thereof). As a result, certain members of the Investment Team and related business professionals may be unavailable to devote their time to the business activities of the Company. Also, in connection with prior investments by other Stone Point Funds, Stone Point and/or their portfolio companies may enter into confidentiality, exclusivity, non-competition or similar agreements that may limit the ability of the Company to pursue an investment in one or more companies. In addition, as a result of existing investments and activities, the Adviser and the Investment Team may from time to time acquire confidential information that they will not be able to use for the benefit of the Company.

Other Investment Activities

Among other personal investments (including real property and start-up venture opportunities), certain members of the Adviser hold certain passive investments, including investments in investment management firms (such investment management firms, referred to herein as the “Other Sponsors”). The Other Sponsors may target investment opportunities for their own behalf, or on behalf of investment funds and accounts for which they provide investment advisory services (collectively, “Other Sponsor Funds”), in various sectors and asset classes, including investment opportunities in the credit space. It is therefore possible that a particular investment opportunity could be identified by the Company and, separately, by one of the Other Sponsors for its own benefit or for the benefit of an Other Sponsor Fund that it advises. In addition, portfolio companies owned or managed by the Other Sponsors, Other Sponsor Funds or their respective affiliates may compete with, or hold conflicting interests in, potential or existing portfolio companies of the Company. In the event that any Other Sponsor is considered to be an “affiliate” of the Company under the 1940 Act, the Company’s participation in investment opportunities in which such Other Sponsors or Other Sponsor Funds also participate may be subject to restrictions similar to those discussed in “Co-investment with Third Parties” above, in which case any such transactions would need to be conducted pursuant to the terms of the Order. In situations when co-investment with Other Sponsor Funds is not permitted under the 1940 Act and related rules, existing or future staff guidance, or the terms and conditions of the Order, the Adviser, Other Sponsors and/or their respective affiliates will need to decide which client or clients will proceed with the investment.

Compensation Arrangements

The Adviser and its affiliates, including the Company’s officers and some of its directors, may face conflicts of interest caused by compensation arrangements with the Company and its affiliates, which could result in increased risk-taking by the Company. The Adviser and its affiliates will receive fees from the Company in return for their services, which may include certain management and incentive fees based on the amount of income or capital appreciation of the Company’s investments. These fees could influence the advice provided to the Company. Generally, the more equity the Company sells and the greater the risk assumed by the Company with respect to its investments, the greater the potential for growth in the Company’s assets and profits, and, correlatively, the fees payable by the Company to the Adviser or its affiliates. These compensation arrangements could affect the Adviser’s or its affiliates’ judgment with respect to recommending offerings of equity or the incurrence of debt and investments made by the Company, which allow the Adviser or the affiliate to earn increased management fees.

In particular, the fact that the base Management Fee is payable based upon the average value of the Company’s gross assets (which includes any borrowings used for investment purposes) may encourage the Adviser or its affiliates to use leverage to make additional investments. Such a practice could make such investments riskier than would otherwise be the case, which could result in higher investment losses, particularly during cyclical economic downturns. Under certain circumstances, the use of substantial leverage (up to the limits prescribed by the 1940 Act) may increase the likelihood of the Company defaulting on its borrowings, which would be detrimental to Stockholders.

As described in more detail below, the Incentive Fee payable by the Company to the Adviser or its affiliates may create an incentive for the Adviser or such affiliates to incur additional leverage and to make investments on the Company's behalf that are risky or more speculative than would be the case in the absence of such compensation arrangements. The way in which the Incentive Fee is

134

Table of Contents

determined may encourage the Adviser or the affiliates to use leverage to increase the leveraged return on the Company's investment portfolio.

Incentive Fees

Beginning December 21, 2024, a portion of the Incentive Fee is based on the Company’s pre-Incentive Fee net investment income regardless of any capital losses. In such case, the Company may be required to pay the Adviser an Incentive Fee for a fiscal quarter even if there is a decline in the value of the Company’s portfolio or if the Company incurs a net loss for that quarter.

Any Incentive Fee payable by the Company that relates to the pre-Incentive Fee net investment income may be computed and paid on income that may include interest that has been accrued but not yet received or interest in the form of securities received rather than cash (PIK income). PIK income will be included in the pre-Incentive Fee net investment income used to calculate the Incentive Fee to the Adviser even though the Company does not receive the income in the form of cash. If a portfolio company defaults on a loan that is structured to provide accrued interest income, it is possible that accrued interest income previously included in the calculation of the Incentive Fee will become uncollectible. The Adviser is not obligated to reimburse the Company for any part of the Incentive Fee it received that was based on accrued interest income that the Company never receives as a result of a subsequent default.

The quarterly Incentive Fee on income will be recognized and paid without regard to: (i) the trend of pre-Incentive Fee net investment income as a percent of adjusted capital over multiple quarters in arrears which may in fact be consistently less than the quarterly preferred return, or (ii) the net income or net loss in the current calendar quarter, the current year or any combination of prior periods.

For U.S. federal income tax purposes, the Company may be required to recognize taxable income in some circumstances in which the Company does not receive a corresponding payment in cash and to make distributions with respect to such income to maintain the Company’s tax treatment as a RIC and/or minimize corporate-level U.S. federal income or excise tax. Under such circumstances, the Company may have difficulty meeting the Annual Distribution Requirement (as described above) necessary to maintain RIC tax treatment under the Code. This difficulty in making the required distribution may be amplified to the extent that the Company is required to pay the Incentive Fee on income with respect to such accrued income. As a result, the Company may have to sell some of its investments at times and/or at prices the Company would not consider advantageous, raise additional debt or equity capital, or forgo new investment opportunities for this purpose. If the Company is not able to obtain cash from other sources, the Company may fail to qualify for RIC tax treatment and thus become subject to corporate-level U.S. federal income tax.

The Adviser

The Adviser will experience conflicts of interest in connection with the management of the Company’s business affairs relating to and arising from a number of matters, including: the allocation of investment opportunities by the Adviser and its affiliates; compensation to the Adviser; services that may be provided by the Adviser and its affiliates to issuers in which the Company invests; investments by the Company and other clients of the Adviser, subject to the limitations of the 1940 Act; the formation of additional investment funds managed by the Adviser; differing recommendations given by the Adviser to the Company versus other clients even though such other clients’ investment objectives may be similar to the Company’s; the Adviser’s use of information gained from issuers in the Company’s portfolio for investments by other clients, subject to applicable law; and restrictions on the Adviser’s use of “inside information” with respect to potential investments by the Company.

Specifically, the Company may compete for investments with affiliated BDCs or funds that are advised by the Adviser and its affiliates, subjecting the Adviser and its affiliates to certain conflicts of interest in evaluating the suitability of investment opportunities and making or recommending investments on the Company’s behalf. To mitigate these conflicts, the Adviser and its affiliates will seek to execute such transactions for all of the participating investment accounts, including the Company, on a fair and equitable basis and in accordance with the Adviser’s investment allocation policy, taking into account such factors as the relative amounts of capital available for new investments; cash on hand; existing commitments and reserves; the investment programs and portfolio positions of the participating investment accounts, including portfolio construction, diversification and concentration considerations; the investment objectives, guidelines and strategies of each client; the clients for which participation is appropriate; each client’s life cycle; targeted leverage level; targeted asset mix and any other factors deemed appropriate.

135

Table of Contents

Stone Point Funds

Actions taken by the Adviser and its affiliates on behalf of the Credit Funds or Stone Point Capital on behalf of the Trident Funds may be adverse to the Company and its investments, which could harm the Company’s performance. For example, the Company may invest in the same credit obligations as other Credit Funds, although, to the extent permitted under the 1940 Act, the Company’s investments may include different obligations or levels of the capital structure of the same issuer. The Trident Funds may be invested in portfolio companies that compete directly with the portfolio companies of the Company. Decisions made with respect to the securities held by one Stone Point Fund may cause (or have the potential to cause) harm to the securities of the issuer held by other Stone Point Funds (including the Company).

Minority Investor in Adviser

As of January 1, 2021, an affiliate of WAFRA (the “Wafra Investor”) holds an indirect, passive, minority stake in the Adviser, representing approximately 20% of the carry and net management company interest in the investment funds, accounts and investment vehicles managed by the Adviser, including the Company (the “Credit Vehicles”). Although the WAFRA Investor does not have the right to participate in the investment process or the day-to-day management of the Adviser or the Credit Vehicles, it may have financial or other interests that could conflict with the interests of the Credit Vehicles and its limited partners or shareholders. In addition, the Wafra Investor may invest in the same companies either at the same time, subject to regulatory requirements, or at different times, and may compete for investments directly and through other interests it holds.

Material Non-Public Information

Certain members of the Adviser may serve on investment or similar governing committees of portfolio companies of the Company, including those that engage in asset management. As a result, the Adviser and its affiliates may from time to time acquire confidential or material non-public information that they will not be able to use for the benefit of the Company, which may lead to the Company not being able to initiate a transaction that it otherwise might have initiated and not being able to sell an investment that it otherwise might have sold. Also, in connection with investments by other Stone Point Funds, the Adviser and its affiliates and/or portfolio companies of such other Stone Point Funds may enter into confidentiality, exclusivity, non-competition or similar agreements that may limit the ability of the Company to pursue an investment in one or more companies. In addition, as a result of existing investments and activities, the Adviser and the Investment Team may from time to time acquire confidential information that they will not be able to use for the benefit of the Company. Furthermore, by reason of their responsibilities in connection with their other activities in general, certain of the Adviser’s personnel may acquire confidential or material non-public information or be restricted from initiating transactions in certain securities. In those instances, the Company will not be free to act upon any such information. Due to these restrictions, the Company may not be able to initiate a transaction that it otherwise might have initiated and may not be able to sell a portfolio investment that it otherwise might have sold. Conversely, the Company may not have access to material non-public information in the possession of other Stone Point Funds which might be relevant to an investment decision to be made by the Company, and the Company may initiate a transaction or sell a portfolio investment which, if such information had been known to it, may not have been undertaken.

Conflicts of Interest Relating to Investments

The Company does not expect to invest in, or hold securities of, companies that are controlled by the Adviser or an affiliate’s other clients. However, the Adviser or an affiliate’s other clients may invest in, and gain control over, one of the Company’s portfolio companies. If the Adviser or an affiliate’s other client, or clients, gains control over one of the Company’s portfolio companies, it may create conflicts of interest and may subject the Company to certain restrictions under the 1940 Act. As a result of these conflicts and restrictions, the Adviser may be unable to implement the Company’s investment strategies as effectively as it could have in the absence of such conflicts or restrictions. For example, as a result of a conflict or restriction, the Adviser may be unable to engage in certain transactions that it would otherwise pursue. In order to avoid these conflicts and restrictions, the Adviser may choose to exit such investments prematurely and, as a result, the Company may forego any positive returns associated with such investments. In addition, to the extent that an affiliate’s other client holds a different class of securities than the Company as a result of such transactions, interests may not be aligned.

136

Table of Contents

Recommendations by the Adviser

The Adviser and its affiliates may give advice and recommend securities to other clients which may differ from advice given to, or securities recommended or bought for, the Company even though such other clients’ investment objectives may be similar to the Company’s, which could have an adverse effect on the Company’s business, financial condition and results of operations.

Potential Merger with or Purchase of Assets of Another Fund

The Adviser may in the future recommend to the Board that the Company merges with or acquires all or substantially all of the assets of one or more funds, including another Stone Point Fund. The Company does not expect that the Adviser would recommend any such merger or asset purchase unless it determines that it would be in the best interest of the Company and its Stockholders, with such determination dependent on factors it deems relevant, which may include the Company’s historical and projected financial performance and any proposed merger partner, portfolio composition, potential synergies from the merger or asset sale, available alternative options and market conditions. In addition, no such merger or asset purchase would be consummated absent the meeting of various conditions required by applicable law or contract, at such time, which may include approval of the Board and common equity holders of both funds. If the Adviser is the investment adviser of both funds, various conflicts of interest would exist with respect to any such transaction. Such conflicts of interest may potentially arise from, among other things, differences between the compensation payable to the Adviser by the Company and by the entity resulting from such a merger or asset purchase or efficiencies or other benefits to the Adviser as a result of managing a single, larger fund instead of two separate funds.

Affiliated Broker-Dealer

The Adviser is an affiliate of SPC Capital Markets LLC, a Delaware limited liability company (the “Affiliated Broker-Dealer”), which is registered as a broker-dealer with the SEC and a member of FINRA and the Securities Investor Protection Corporation. The Affiliated Broker-Dealer is authorized to engage in the following activities: (i) acting as broker or dealer selling corporate debt securities; (ii) acting as firm commitment underwriter; (iii) acting as real estate syndicator; (iv) investment advisory services (incidental to its role as broker-dealer), including acting as financial advisor to issuers of securities, and participants in mergers, acquisitions, sales, and dispositions of companies; and (v) private placements of securities. The Affiliated Broker Dealer, together with other Stone Point Credit-affiliated entities that conduct financial services, loan origination, structuring, placement or other similar business as a broker, dealer, distributor, syndicator, arranger or originator of securities or loans, may receive fees from other investors and portfolio companies in which the Company invests but will not collect fees from the Company.

To the extent permitted by the 1940 Act, the Affiliated Broker-Dealer may, among other assignments, arrange, structure, and/or place equity and debt securities to be issued by portfolio companies of the Company on a best efforts or firm commitment basis. These placements may from time to time include structuring of offerings, and placement of securities in public offerings of securities issued by portfolio companies of the Company. The Affiliated Broker-Dealer may act as a firm commitment underwriter (co-manager only) in public and private offerings of securities issued by portfolio companies of the Company. In certain limited circumstances, the Company may have a conflict resulting from the foregoing arrangements. When the Affiliated Broker-Dealer serves as underwriter with respect to the securities of a subsidiary of the Company, the Company may be subject to a “lock-up” period following the offering under applicable regulations or agreements during which time its ability to sell any securities that it continues to hold is restricted. This restriction may prevent the Company from disposing of such securities at an opportune time. To the extent permitted by the 1940 Act, the Company may make investments from time to time in transactions where the Affiliated Broker-Dealer is acting as agent, broker, principal, arranger or syndicate manager or member on the other side of the transaction or for other parties in the transaction. The consent of the Board may be required to enter into certain of the Company’s potential investments and the failure of the Board to grant such consent would prevent the Company from consummating such investments, which could adversely affect the Company.

Service Providers

Certain advisors and other service providers, or their affiliates (including accountants, administrators, lenders, bankers, brokers, investment advisers, attorneys, consultants, custodians, investment or commercial banking firms and certain other advisors and agents) to the Company or its portfolio companies may also provide goods or services to or have business, personal, political, financial or other relationships with Stone Point. Such advisors and service providers may be investors in the Company or Other Sponsored Funds, affiliates of Stone Point, current or former portfolio companies of Other Sponsored Funds, sources of investment opportunities or co-investors or counterparties therewith. These relationships may influence Stone Point Credit in deciding whether to select or recommend such a service provider to perform services for the Company or a portfolio company (the cost of which will generally be

137

Table of Contents

borne directly or indirectly by the Company or such portfolio company, as applicable). In certain circumstances, advisors and service providers, or their affiliates, may charge different rates or have different arrangements for services provided to Stone Point Credit or its respective affiliates as compared to services provided to the Company and its portfolio companies, which will result in more favorable rates or arrangements than those payable by the Company or such portfolio companies.

In addition, the portfolio companies of the funds managed by Stone Point may transact business with (or otherwise provide services and/or products to) one another. Those same portfolio companies may also transact business with Stone Point or Stone Point’s funds, employees or affiliates (including, without limitation, certain portfolio companies of Other Sponsored Funds becoming stockholders of the Company, or portfolio companies of the Company investing in Other Sponsored Funds). Such arrangements will generally be negotiated and executed at arm’s length, but certain factors may lead a portfolio company to pay higher fees in connection with the services and/or products provided as compared to other similar providers. Those factors include, without limitation, the complexity of the services and/or products being provided, the reputation of the portfolio company in providing such services and/or products, and the ability of the portfolio to meet specified time, budget or other constraints. Furthermore, Stone Point and/or the portfolio companies of the funds managed by it may enter into agreements collectively with vendors which provide products and services to Stone Point and/or the portfolio companies, generally in an effort to reduce costs and expenses. Stone Point may act as a host for the negotiation process associated with such agreements. Notwithstanding the foregoing, Stone Point acts solely as a liaison in connection with the evaluation of, and has no control over the entering into, definitive agreements by such portfolio companies. Any definitive agreements shall be executed solely by and between the applicable portfolio company and applicable counterparty, and such portfolio company (and not Stone Point, except where Stone Point is acting in its own capacity) shall be solely responsible for its obligations thereunder.

Advisors and Consultants

The Adviser may work with or alongside one or more consultants, advisors (including senior advisors and CEOs) and/or operating partners who are retained by the Adviser on a consultancy or retainer or other basis, to provide services to the Company. The functions undertaken by such persons with respect to the Company will not be exclusive and such persons may perform similar functions and duties for other organizations which may give rise to conflicts of interest. Such persons may also be appointed to the board of directors of companies and have other business interests which give rise to conflicts of interest with the interests of the Company or a portfolio company of the Company. Stockholders should note that such persons may retain compensation that will not offset the Management Fee payable to the Adviser, including that: (a) such persons are permitted to retain all directors’ fees, monitoring fees and other compensation received by them in respect of acting as a director or officer of, or providing other services to, a portfolio company and such amounts shall not be credited against the Management Fee; (b) certain of such persons may be paid a deal fee, a consultancy fee or other compensation where they are involved in a specific project relating to the Company, which fee will be paid either by the Company or, if applicable, the relevant portfolio company; and (c) such persons may be invited to invest in or alongside the Company in investments, as part of a participation scheme or otherwise, and will be entitled to retain all of the proceeds generated from such investments.

Valuation Matters

In accordance with Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company’s “Valuation Designee”. The Adviser, with the assistance of its Valuation Committee, subject to oversight by the Board, is responsible for determining the fair value of the Company’s investments in instances where there is no readily available market quotation. Investments for which market quotations are readily available may be priced by independent pricing services. From time to time, the Company retains an external, independent valuation firm to provide data and valuation analyses on the Company’s portfolio companies.

The Company’s investment portfolio is recorded at fair value as determined in good faith in accordance with procedures established by the Board (“Valuation Policy”) and, as a result, there is and will be uncertainty as to the value of the Company’s portfolio investments. Under the 1940 Act, the Company is required to carry its portfolio investments at market value or, if there is no readily available market quotation, at fair value as determined in accordance with the Valuation Policy. There is not a public market or active secondary market for many of the types of investments in privately held companies that the Company intends to hold and make. The Company’s investments may not be publicly traded or actively traded on a secondary market but, instead, may be traded on a privately negotiated over-the-counter secondary market for institutional investors, if at all. As a result, these investments are valued quarterly at fair value as determined in good faith in accordance with the Valuation Policy approved by the Board.

The determination of fair value, and thus the amount of unrealized appreciation or depreciation the Company may recognize in any reporting period, is to a degree subjective, and the Adviser has a conflict of interest in making fair value determinations. The types

138

Table of Contents

of factors that may be considered in determining the fair values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow, current market interest rates, precedent transactions and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, the valuations may fluctuate significantly over short periods of time due to changes in current market conditions. The determinations of fair value in accordance with the Valuation Policy approved by the Board may differ materially from the values that would have been used if an active market and market quotations existed for such investments. The Company’s net asset value could be adversely affected if the determinations regarding the fair value of the investments were materially higher than the values that the Company ultimately realizes upon the disposal of such investments.

Operating Policies

The Board will have the authority to modify or waive certain operating policies, investment criteria and strategies, in some cases without prior notice and without Stockholder approval. The Company cannot predict the effect any changes to current operating policies, investment criteria and strategies would have on its business, net asset value, operating results and the value of its securities. However, the effects might be adverse, which could negatively impact the Company’s ability to pay distributions and may cause Stockholders to lose all or part of their investment. Moreover, the Company will have significant flexibility in investing the net proceeds of its offering and may use the net proceeds from the offering in ways with which Stockholders may not agree.

Diverse Stockholders

The Stockholders include U.S. taxable and tax-exempt entities, and institutions from jurisdictions outside of the United States. Such Stockholders may have conflicting investment, tax and other interests with respect to their investments in the Company. The conflicting interests of individual Stockholders may relate to or arise from, among other things, the nature of investments made by the Company or the structuring of the acquisition of portfolio investments. As a consequence, conflicts of interest may arise in connection with decisions made by the Adviser, including in respect of the nature or structuring of investments, that may be more beneficial for one Stockholder than for another Stockholder, especially in respect of Stockholders’ individual tax situations. In selecting and structuring investments appropriate for the Company, the Adviser will consider the investment and tax objectives of the Company, rather than the investment, tax or other objectives of any Stockholder individually.

Other Transactions with Prospective and Actual Stockholders

Prospective investors should note that the Adviser and its affiliates from time to time engage in transactions with prospective and actual Stockholders or their affiliates that provide economic and business benefits to such Stockholders and the Adviser and its affiliates. Such transactions may be entered into prior to or coincident with a Stockholder’s admission to the Company or during the term of their investment. The nature of such transactions can be diverse and may include benefits relating to the Company and their portfolio companies. Examples include the ability to co-invest alongside the Company, recommendations to underwriters for allocations in initial public offerings, a broad range of commercial transactions in the ordinary course of business with such Stockholders, their affiliates and portfolio companies, and the purchase or disposition of interests to or from portfolio companies. In addition, the Adviser may acquire Common Stock from existing Stockholders without offering such secondary opportunities to the other Stockholders. In such event, the Adviser will have oral and written information concerning the portfolio companies that may be non-public and may be deemed material to a decision to sell shares of Common Stock, including any information regarding the business, operations, property, financial and other condition and creditworthiness of the portfolio companies, which may not be disclosed to the selling Stockholder prior to such acquisition.

Arrangements with Stone Point Capital

The Company has entered into a license agreement with Stone Point Capital, under which Stone Point Capital has granted the Company a non-exclusive, royalty-free, non-perpetual license to use the name and trademark “Stone Point.” Under this agreement, the Company has a right to use “Stone Point” for so long as the Company is a majority affiliate of Stone Point Capital and a private entity. Other than with respect to this limited license, the Company does not have a legal right to the “Stone Point” name. In the event the license agreement is terminated, the Company will be required to change its name and cease using “Stone Point” as part of the Company’s name.

139

Table of Contents

Item 14. Principal Accounting Fees and Services

The Audit Committee and the Independent Directors of the board of directors have selected KPMG LLP (“KPMG”) to serve as the independent registered public accounting firm for the Company for the years ended December 31, 2024 and 2023.

KPMG has advised us that neither the firm nor any present member or associate of it has any material financial interest, direct or indirect, in the Company or its affiliates.

    

Year Ended

Year Ended

Service:

    

December 31, 2024

    

December 31, 2023

Audit Fees

$

998,150

$

805,000

Audit-Related Fees

 

 

Tax Fees

 

44,000

 

45,000

All Other Fees

 

 

Total Fees:

$

1,042,150

$

850,000

Audit Fees: Audit fees consist of fees billed for professional services rendered for quarterly reviews and services that are normally provided by KPMG in connection with statutory and regulatory filings.

Audit-Related Fees: Audit-related services consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.

Tax Services Fees: Tax services fees consist of fees billed for professional tax services. These services also include assistance regarding federal, state, and local tax compliance.

All Other Fees: Other fees would include fees for products and services other than the services reported above.

Pre-Approval Policy: The Audit Committee has established a pre-approval policy that describes the permitted audit, audit-related, tax and other services to be provided by KPMG, the Company’s independent registered public accounting firm. The policy requires that the Audit Committee pre-approve the audit and non-audit services performed by the independent auditor in order to assure that the provision of such service does not impair the auditor’s independence.

Any requests for audit, audit-related, tax and other services that have not received general pre-approval must be submitted to the Audit Committee for specific pre-approval, irrespective of the amount, and cannot commence until such approval has been granted. Normally, pre-approval is provided at regularly scheduled meetings of the Audit Committee. The Audit Committee has delegated pre-approval authority to the Audit Committee Chair pursuant to Section 10A(i) of the Exchange Act. The member or members to whom such authority is delegated shall report any pre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committee does not delegate its responsibilities to pre-approve services performed by the independent registered public accounting firm to management.

140

Table of Contents

PART IV.

Item 15. Exhibits and Financial Statement Schedules

(a)

Financial Statements

(1)

The following financial statements are set forth in Item 8 of Part II:

 

Page

Report of Independent Registered Public Accounting Firm

84

Consolidated Statement of Assets and Liabilities as of December 31, 2024 and 2023

85

Consolidated Statement of Operations for the years ended December 31, 2024, 2023 and 2022

86

Consolidated Statement of Changes in Net Assets for the years ended December 31, 2024, 2023 and 2022

87

Consolidated Statement of Cash Flows for the years ended December 31, 2024, 2023 and 2022

88

Consolidated Schedule of Investments as of December 31, 2024 and 2023

89

Notes to Consolidated Financial Statements

101

(b)

Exhibits required to be filed by Item 601 of Regulation S-K

Please note that the agreements included as exhibits to this Form 10-K are included to provide information regarding their terms and are not intended to provide any other factual or disclosure information about us or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement that have been made solely for the benefit of the other parties to the applicable agreement and may not describe the actual state of affairs as of the date they were made or at any other time.

141

Table of Contents

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

3.1

Amended and Restated Certificate of Incorporation (1)

3.2

Amended and Restated Bylaws (17)

4.1

Form of Subscription Agreement *

4.2

Description of Securities *

10.1

Investment Advisory Agreement between Stone Point Capital Corporation and Stone Point Credit Adviser LLC, as the investment adviser (1)

10.2

Administration Agreement between the Company and Stone Point Credit Adviser LLC, as the Administrator (1)

10.3

Custody Agreement between Stone Point Capital Corporation and U.S. Bank National Association, as the custodian (1)

10.4

License Agreement between the Company and Stone Point Capital (1)

10.5

Form of Indemnification Agreement (1)

10.6

Form of Fund of Funds Investment Agreement (20)

10.7

Note Purchase Agreement by and between the Company and the purchasers party thereto, dated September 17, 2024 (19)

10.8

Note Purchase Agreement by and between the Company and the purchasers party thereto, dated May 19, 2022 (9)

10.9

Fourth Amendment to the Revolving Credit Agreement between Stone Point Credit Corporation, as the Initial Borrower, and Capital One, National Association, as the Administrative Agent, Sole Lead Arranger and a Lender, dated December 27, 2024 (21)

10.10

Third Amendment to the Revolving Credit Agreement between Stone Point Credit Corporation, as the Initial Borrower, and Capital One, National Association, as the Administrative Agent, Sole Lead Arranger and a Lender, dated December 22, 2023 (14)

10.11

Second Amendment to the Revolving Credit Agreement between Stone Point Credit Corporation, as the Initial Borrower, and Capital One, National Association, as the Administrative Agent, Sole Lead Arranger and a Lender, dated December 27, 2022 (8)

10.12

Amendment to Revolving Credit Agreement with Capital One, National Association (3)

10.13

First Amendment to the Revolving Credit Agreement between Stone Point Credit Corporation, as the Initial Borrower, and Capital One, National Association, as the Administrative Agent, Sole Lead Arranger and a Lender, dated as of December 28, 2021 (4)

10.14

Revolving Credit Agreement with Capital One, National Association (2)

10.15

Fifth Amendment to Loan and Security Agreement, dated as of September 12, 2024, among SPCC Funding I LLC, as borrower; Stone Point Credit Adviser LLC, as portfolio manager; U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator; U.S. Bank National Association, as securities intermediary; and JPMorgan Chase Bank, National Association, as administrative agent and lender. (18)

10.16

Fourth Amendment to Loan and Security Agreement, dated as of June 27, 2024, among SPCC Funding I LLC, as borrower; Stone Point Credit Adviser LLC, as portfolio manager; U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator; U.S. Bank National Association, as securities intermediary; and JPMorgan Chase Bank, National Association, as administrative agent and lender. (15)

10.17

Third Amendment to Loan and Security Agreement, dated as of June 30, 2023, among SPCC Funding I LLC, as borrower; Stone Point Credit Adviser LLC, as portfolio manager; U.S. Bank, National Association, as collateral agent, securities intermediary, and collateral administrator; and JPMorgan Chase Bank, National Association, as administrative agent and lender (10)

10.18

Amendment to Loan and Security Agreement between SPCC Funding I LLC and JPMorgan Chase Bank, National Association (7)

10.19

Amendment to Loan and Security Agreement between SPCC Funding I LLC and JPMorgan Chase Bank, National Association (6)

10.20

Loan and Security Agreement between SPCC Funding I LLC and JPMorgan Chase Bank, National Association (5)

10.21

Loan Sale and Contribution Agreement between the Company, as the seller, and SPCC Funding II, as the buyer, dated August 14, 2023 (12)

10.22

Non-Recourse Carveout Guaranty Agreement among the Company, U.S. Bank Trust Company, National Association, on behalf of certain secured parties, and Goldman Sachs Bank USA, dated August 14, 2023 (13)

14.1

Code of Ethics *

19.1

Insider Trading Policies and Procedures*

21.1

List of Subsidiaries*

31.1

Certification of Principal Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*

31.2

Certification of Principal Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*

32.1

Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

142

Table of Contents

32.2

Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Date File because XBRL tags are embedded within the Inline XBRL document*

101.SCH

Inline XBRL Taxonomy Extension Schema Document*

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document*

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document*

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)*

(1)

Previously filed as an exhibit to Amendment No. 1 to the Company’s registration statement on Form 10 (File No. 000-56209) filed with the SEC on November 25, 2020.

(2)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on January 4, 2021.

(3)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on April 7, 2021.

(4)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on December 30, 2021.

(5)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on June 30, 2021.

(6)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on October 20, 2021.

(7)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on February 1, 2022.

(8)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on January 3, 2023.

(9)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on May 25, 2022.

(10)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on July 7, 2023.

(11)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on August 17, 2023.

(12)

Previously filed as Exhibit 10.2 to the Company’s Form 8-K filed on August 17, 2023.

(13)

Previously filed as Exhibit 10.3 to the Company’s Form 8-K filed on August 17, 2023.

(14)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on December 22, 2023.

(15)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on July 1, 2024.

(16)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on September 19, 2024

(17)

Previously filed as Exhibit 3.1 to the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2022.

(18)

Previously filed as Exhibit 10.1 to the Company’s Form 10-Q filed on November 12, 2024

(19)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on September 19, 2024.

(20)

Previously filed as Exhibit 10.3 to the Company’s Form 10-Q for the quarter ended September 30, 2024.

(21)

Previously filed as Exhibit 10.1 to the Company’s Form 8-K filed on December 27, 2024.

*

Filed herewith.

**

Furnished herewith.

143

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Stone Point Credit Corporation

 

 

 

 

Date: March 24, 2025

 

By:

/s/ Scott J. Bronner

 

 

 

Name: Scott J. Bronner

 

 

 

Title: Principal Executive Officer

 

 

 

 

Date: March 24, 2025

 

By:

/s/ Steven Henke

 

 

 

Name: Steven Henke

 

 

 

Title: Principal Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10 - K has been signed below by the following person on behalf of the registrant and in the following capacities on March 24, 2025.

/s/ Scott J. Bronner

 

Scott J. Bronner

 

Director and Principal Executive Officer

 

 

 

/s/ David J. Wermuth

 

David J. Wermuth

 

Director and Chair of the Board of Directors

 

/s/ Peter E. Roth

 

Peter E. Roth

 

Director and Chair of the Audit Committee

 

 

 

/s/ Jennifer J. Burleigh

 

Jennifer J. Burleigh

 

Director and Chair of the Nominating and Corporate Governance Committee

 

 

 

/s/ Scott E. Heberton

 

Scott E. Heberton

 

Director

 

144